col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


2635 Results       Page 1

 [1]  [2] [ Next > ]
Oxford University Press: Open Forum Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―29 Impact of rituximab on COVID-19 in immunocompromised patients: a nationwide cohort study in Korea Chan Mi Lee, Suhyun Kim, Hyeon Jae Jo, Chang Kyung Kang, Wan Beom Park, Nam Joong Kim, et al. (+2)
2 [GO] 2025―Apr―24 Aerosolized dornase alfa (DNase I) for the treatment of severe respiratory failure in COVID-19: a randomized controlled trial Per Åkesson, Lisa Mellhammar, Magnus Rasmussen, Malin Inghammar, Sara Jesperson, Fredrik Månsson, et al. (+5)
3 [GO] 2025―Apr―11 Severe Parvovirus B19 associated myocarditis in children in the post COVID-19 era: a multicentre observational cohort study Neal Russell, James Hatcher, Tim Best, Judith Breuer, James Charlesworth, Peter Muir, et al. (+7)
4 [GO] 2025―Apr―09 Proportions of US Blood Donors with Serological Evidence of SARS-CoV-2 Infections Who Reported Survey-Based Diagnosed Infections During July 2020-December 2022 Akintunde Akinseye, David J Wright, Eduard Grebe, Mars Stone, Cassandra A Hathaway, Rebecca V Fink, et al. (+5)
5 [GO] 2025―Apr―01 Human source SARS-CoV-2 aerosol transmission to remote sentinel hamsters Chad J Roy, Michael R Barer, Veronica Ueckermann, Brandon Beddingfield, David Cordier, Bernard Fourie, et al. (+7)
6 [GO] 2025―Mar―31 SARS-CoV-2 Immune Complex Mediated Neutrophil Activation Kiana C Allen, Seth Warner, Heather L Teague, Marcos J Ramos-Benitez, Rui Miao, Xin Tian, et al. (+12)
7 [GO] 2025―Mar―29 COVID-19 Symptoms by Immunity Status and Predominant-Variant Period among US Blood Donors Matthew D McCullough, Bryan R Spencer, Jianrong Shi, Ian D Plumb, James M Haynes, Melisa Shah, et al. (+4)
8 [GO] 2025―Mar―14 Comparison of COVID-19 vs non-COVID-19 patients without hematological malignancies treated for invasive pulmonary aspergillosis: a 5-year retrospective cohort study with propensity-based adjustment Sara Volpi, Shaniko Kaleci, Erica Franceschini, Samuele Cantergiani, Gabriella Orlando, Adriana Cervo, et al. (+21)
9 [GO] 2025―Mar―10 Rates of Hospitalization and Death due to COVID-19 in U.S. Veterans with SARS-CoV-2 Infection in the XBB, JN.1, and KP Predominant Eras Taeyoung Choi, Yan Xie, Ziyad Al-Aly
10 [GO] 2025―Mar―07 Long-term sequelae following dengue infection versus SARS-CoV-2 infection in a paediatric population: a retrospective cohort study Liang En Wee, Jue Tao Lim, Janice Yu Jin Tan, Calvin Chiew, Chee-Fu Yung, Chia Yin Chong, et al. (+2)
11 [GO] 2025―Jan―29 P-1403. Measuring Impact of COVID-19 Pandemic using Novel EPII Survey on PLWH in New Orleans Angela McGaugh, Erik Meyers, Shruti Srinivasan, Mariza Francis, Crystal Zheng, Damion Grasso, et al. (+2)
12 [GO] 2025―Jan―29 P-1929. Impact of the COVID-19 Pandemic on the Risk Factors and Outcomes Associated with Candidemia Melat Endashaw, Austin Dykes, Rachael Clark, Laila Warrayat, Shiyuan Deng, Xianyan Chen, et al. (+2)
13 [GO] 2025―Jan―29 P-991. Repercussions of the COVID-19 Pandemic on Maternal and Congenital Syphilis in South Brazil: A Time Series Analysis 2010-2022 Fernando Echegaray, Christopher Hernandez, Kavya Sundar, Mary C Cambou, Eddy Segura, Marineide Melo, et al. (+3)
14 [GO] 2025―Jan―29 P-1205. The Impact of the COVID-19 Pandemic on Hospitalizations Associated with Respiratory Syncytial Virus (RSV) Illness Among Children and Adolescents in Ontario, Canada Sazini Nzula, Alexandra Goyette, Deshayne B Fell, Ceryl Tan, Natalie Nightingale, Maria Esther Perez Trejo, et al. (+2)
15 [GO] 2025―Jan―29 P-479. The Impact of the COVID-19 Pandemic on HIV Testing in Peru: An Interrupted Time Series Analysis from 2014 to 2022 Robinson A Yrene-Cubas, Jesus Perez-Castilla, Daniel E Reynaga-Cottle, Maria J Bringas-Queirolo, David Soriano-Moreno, Daniel Fernandez-Guzman, Jose A Gonzales-Zamora
16 [GO] 2025―Jan―29 P-1851. Influence of the COVID-19 Pandemic on Antimicrobial Resistance Patterns in Pediatric Group A Streptococcus Infections in Houston, TX Maria Gabriela Segura, Aya Aboulhosn, Misu A Sanson, Luis Vega, Sakina Chinwala, Lauren M Sommer, et al. (+2)
17 [GO] 2025―Jan―29 P-831. Six Years Retrospective Study on Staphylococcus aureus Bacteremia: Impact of Persistance and COVID-19 Pandemic on 30-Days Mortality Francesco Molà, Lidia Gazzola, Ottavia Viganò, Roberto Castoldi, Francesca Di Bartolomeo, Giorgio Giannetta, et al. (+2)
18 [GO] 2025―Jan―29 P-2366. Influenza-Specific Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic, New Vaccine Surveillance Network (2016-2023) Olla Hamdan, Justin Z Amarin, James W Antoon, Tess Stopczynski, Laura S Stewart, Eileen J Klein, et al. (+18)
19 [GO] 2025―Jan―29 P-2329. Diversity of Rhinovirus Types in Children During the COVID-19 Pandemic, New Vaccine Surveillance Network, 03/01/20-02/28/21 Dithi Banerjee, Anjana Sasidharan, Stephanie Gummersheimer, Minati Dhar, Janet A Englund, Eileen J Klein, et al. (+14)
20 [GO] 2025―Jan―29 215. Trends in Syphilis and the Impact of the COVID-19 Pandemic in Florida: A multiscale joinpoint regression analysis Evan Niu, Rachel Sareli, Paula A Eckardt, Candice Sareli, Jianli Niu
21 [GO] 2025―Jan―29 P-1919. Incidence of Invasive Group A Streptococcus Infection in relation to the COVID-19 Pandemic (GASCO) - a pilot study Hannah Bray, Jacob C Stremers, Adam Caulfield, Robert D Fulmer, Zachary Ciochetto, Gordana Simeunovic
22 [GO] 2025―Jan―29 P-1998. A new normal? Dynamic patterns of healthcare engagement during the COVID-19 pandemic among people with HIV Jasmine Manalel, Jennifer Kaufman, Yiyi Wu, Alvin Gao, Carey Brandenburg, Luis Scaccabarrozzi, et al. (+3)
23 [GO] 2025―Jan―29 P-1302. Alterations in the population structure and antimicrobial resistance of Salmonella enterica before and during the COVID-19 pandemic (2018 and 2020) in New York State Jose A Rodrigues, Odion O Ikhimiukor, Stephanie S R Souza, Matthew Marmion, Lisa Mingle, Danielle Wroblewski, et al. (+4)
24 [GO] 2025―Jan―29 P-695. Analysis of Seasonal Influenza Activity in Los Angeles County throughout the COVID-19 Pandemic Heidi Ransohoff, Elizabeth Traub, Annabelle de St Maurice
25 [GO] 2025―Jan―29 P-419. The Epidemiology of Healthcare-associated Infections in Jordanian Hospitals before and after the COVID-19 Pandemic Salwa A Nasrat, Mohammad Alhawarat, Mohammad Gharaibeh, Omar Sayyouh, Mohamed Ramadan, Mayar Said, Tamer Saied Osman
26 [GO] 2025―Jan―29 P-2296. Risk Factors for Invasive Aspergillus Infections among Lung Transplant Recipients in the Era of COVID-19 Pandemic Thomas Moffitt, Sravanthi Nandavaram, Jaime Soria, Thein Myint
27 [GO] 2025―Jan―29 P-1133. Preferred (Spoken) Language was a Major Correlate of Disparate Antibiotic Prescribing in the Pediatric Outpatient Setting Throughout the COVID-19 Pandemic Melissa E Day, Qing Duan, Justin Markham, Joshua D Courter, Kimberly Risma, Andrew F Beck, David Haslam
28 [GO] 2025―Jan―29 P-180. Enhancing Mortality Surveillance: Insights from Excess Deaths Analysis during the COVID-19 Pandemic Sinisa Skocibusic, Seila Cilovic Lagarija
29 [GO] 2025―Jan―29 P-457. Impact of Switching to Bictegravir- or Dolutegravir-based Antiretroviral Therapy on Weight in People Living with HIV during the COVID-19 Pandemic Nardine Karam, Monica Douglas, Stanley Moy
30 [GO] 2025―Jan―29 P-1950. An estimate of pediatric lives saved due to non-pharmacologic interventions during the early COVID-19 pandemic Jeremy Samuel Faust, Alexander Chen, Benjamin Renton, Chengan Du, Shu-Xia Li, Zhenqiu Lin, Harlan M Krumholz
31 [GO] 2025―Jan―29 P-1455. Socioeconomic and Regional Impact on Influenza Vaccination in Young Children During the COVID-19 Pandemic Tawny Saleh, Mary C Cambou, Karin Nielsen-Saines
32 [GO] 2025―Jan―29 P-1968. Mask fatigue, compliance, and illness among healthcare workers during the COVID-19 pandemic Ria Patel, Aparna Jayaram, Mirza Ali, Alfredo J Mena Lora
33 [GO] 2025―Jan―29 P-1436. Patient dissatisfaction increases the odds of inconsistent influenza vaccination completion following the onset of the COVID-19 pandemic Olivia Man, Jack W McHugh, Jeremy Young, Laurie Wilshusen, Lacey Hart, Tripp Welch, et al. (+2)
34 [GO] 2025―Jan―29 P-1153. Characteristics of Invasive Group A Streptococcal Infections (iGAS) in Children during the COVID-19 Pandemic Emma Granberry, Swetha Pinninti, Suresh Boppana
35 [GO] 2025―Jan―29 P-1808. Strategies for Antimicrobial Stewardship Program Resiliency During the COVID-19 Pandemic Rebecca Schwei, Meggie Griffin, Helena Ikenberry, Ashleen Kaur, Sarah Scalzo, Aurora E Pop-Vicas, et al. (+3)
36 [GO] 2025―Jan―29 P-1207. Resurgence of Respiratory Viral Infections Among Children Hospitalized in a Tertiary Care Hospital in Thailand After the COVID-19 Pandemic Tavitiya Sudjaritruk, Oramai Mueangmo, Jutamad Saheng, Tanachot Chaito, Suphara Manowong
37 [GO] 2025―Jan―29 P-2042. Development and Maintenance of a Pharmacist-Run COVID-19 Outpatient Treatment Clinic at a Veterans Affairs Hospital Sidorela Gllava, Tiffany Ward, Sung Soo Kim, Vivian Vega
38 [GO] 2025―Jan―29 P-343. The Feasibility of Safely and Efficiently Administering Antivirals to Nursing Home Residents During COVID-19 Outbreaks is Impaired by Polypharmacy and Comorbidities Amelia Milner, Brigid Wilson, Oteshia Hicks, Taissa A Bej, Corinne Kowal, Jennifer Pruskowski, et al. (+2)
39 [GO] 2025―Jan―29 P-2024. Multiple Cases of the Delta Substrain AY.29 with Casirivimab/Imdevimab Escape Mutation Identified in a Nosocomial COVID-19 Outbreak in a Hematology Ward Yuka Hamada, Hideki Kawamura, Naomi Shinkawa, Makoto Kuroda, Hajime Kamiya
40 [GO] 2025―Jan―29 P-1938. Impact of Race and Ethnicity on Patient-reported Health and Symptoms Following COVID-19 or Long COVID Diagnosis Thomas F Oppelt, Michael Caron, Jamie Zagorski, Rodney H Taylor, Chinonso Akano, Lisa McCorkell, et al. (+2)
41 [GO] 2025―Jan―29 644. Impact of COVID-19 on Tuberculosis Control and Surveillance: An 11-Year Retrospective Analysis in Belo Horizonte, Brazil Marco Aurélio Angelo, Débora De Vasconcelos, Giovana Ferreira, Meritxell Bassas, Laiz Almeida, Walisson Ferreira Carvalho, Bráulio R G M Couto
42 [GO] 2025―Jan―29 P-2039. Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan Yu-Chien Ho, Min-Chi Chang, Wen-Ying Lin, Chia-Ying Wu, Szu-Yu Liu, Chien Chuang, et al. (+3)
43 [GO] 2025―Jan―29 P-2271. Unraveling the Past: Analyzing the Effects of COVID-19 on Hematological Malignancy Patients - Observations from 2020 to 2022 Francesco Marchesi, Jon Salmanton-Garcia, Francesca Farina, Barbora Weinbergerová, Federico Itri, Julio Dávila-Valls, et al. (+13)
44 [GO] 2025―Jan―29 P-1958. Impact of COVID-19 on Acute Diverticulitis: Evidence of United States Hospitals in 2020 Thanathip Suenghataiphorn, Tuntanut Lohawatcharagul, Pojsakorn Danpanichkul, Jerapas Thongpiya, Natchaya Polpichai, Narathorn Kulthamrongsri, et al. (+3)
45 [GO] 2025―Jan―29 222. Effectiveness of the Original BNT162b2 Messenger RNA Vaccine Against COVID-19 Omicron Infection in Children Aged 6 Months to 4 Years in Japan Yuta Aizawa, Yugo Shobugawa, Jun Tachikawa, Tatsuki Ikuse, Chansu Shin, Takao Ikarashi, et al. (+9)
46 [GO] 2025―Jan―29 P-1961. Epidemiologic analysis of an alpha variant COVID-19 nosocomial cluster that occurred after completed vaccination of healthcare workers Hideki Kawamura, Koji Nakano, Norihisa Hanada, Koji Sameshima
47 [GO] 2025―Jan―29 P-2054. Effectiveness of a Single COVID-19 mRNA Vaccine Dose in Individuals Previously Infected with SARS-CoV-2: A Systematic Review Hannah R Volkman, Jennifer L Nguyen, Mustapha M Mustapha, Jingyan Yang, Luis Jodar, John M McLaughlin
48 [GO] 2025―Jan―29 P-1920. The influence of comorbidity, age, sex, and immunosuppression on COVID-19 mortality throughout the course of the SARS-CoV-2 pandemic in Europe: Data from the LEOSS study Julian Triebelhorn, Maria M Ruethrich, Susana M Nunes de Miranda, Jochen Schneider, Timm Westhoff, Margarete Scherer, et al. (+8)
49 [GO] 2025―Jan―29 P-143. Interpreting Prognostic Factors Associated with In-Hospital COVID-19 Mortality in a Peru Sample using Shapley Additive Explanations on Ensemble Learning Na Dai, Ruben K Briceno, Alex Castaneda, Miguel Tresierra, Maribel Esteban, Moises Rosas, Rene Hinojosa
50 [GO] 2025―Jan―29 P-1989. COVID-19 Mortality Among Immunocompromised Individuals is Consistently High Compared with Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England Lucy Carty, Sabada Dube, Carla Talarico, Richard McNulty, Nahila Justo, Renata Yokota, et al. (+7)
51 [GO] 2025―Jan―29 P-1456. Evaluating the Successes & Limitations of the University of Rochester Medical Center COVID-19 Monoclonal Antibody Program Troy J Anlage, Calvin Albrecht, Mike Sportiello, Christine Kim, Sage Hellerstedt, Zhongmou Sun, et al. (+3)
52 [GO] 2025―Jan―29 P-1194. Comparison of COVID-19 inpatient burden in hospitalized children age < 5 years, by SARS-CoV-2 variant Kathleen M Andersen, Thomas M Porter, Maya Reimbaeva, Maria McColgan, Santiago M C Lopez
53 [GO] 2025―Jan―29 P-2065. Profile and Risk Factors of Breakthrough COVID-19 Infections Among Healthcare Workers Post-Vaccination Mario M Panaligan
54 [GO] 2025―Jan―29 P-734. Clinical Characteristics and Outcomes of Respiratory Viral Infections in the Endemic Era: A Comparative Study of COVID-19, Influenza, and RSV Yu Jung Choi, Joon Young Song, Jang Wook Sohn, Won Suk Choi, Seong-Heon Wie, Jacob Lee, et al. (+9)
55 [GO] 2025―Jan―29 P-1931. Health-related quality of life one year after mild COVID-19 infection: a multicenter prospective cohort study Marciane Maria Rover, Fernando Scolari, Geraldine Trott, Mariana Dias Silva, Aline Paula Miozzo, Denise de Souza, et al. (+17)
56 [GO] 2025―Jan―29 P-2032. The Time to Return to Work in Healthcare Workers With COVID-19 Infection Treated With Ensitrelvir, a Novel Oral Inhibitor of 3C-Like Protease of SARS-COV-2 Makoto Katsuta, Masatoshi Kitazono, Naohito Nagai, Hiroto Karibe, Yusaku Takahashi, Yasuko Ariwa, et al. (+2)
57 [GO] 2025―Jan―29 P-1947. Risk of Severe COVID-19 Reinfection among Persons Hospitalized with a Primary COVID-19 Infection, Minneapolis-St. Paul, Minnesota Haley Wienkes, Paige D’Heilly, Erica Bye, Stephanie Meyer, Kathryn Como-Sabetti, Ruth Lynfield
58 [GO] 2025―Jan―29 P-2000. A Case-Control Study of the Risk of COVID-19 Infection in Underserved Persons with HIV (PWH) in Middle Tennessee Mallika Rao, Derek Wilus, Vladimir Berthaud
59 [GO] 2025―Jan―29 P-296. Risk Factors and Treatment Outcome of Multidrug-Resistant Acinetobacter baumanii Pneumonia with or without COVID-19 Infection in an Infectious Diseases Hospital from January 2020 to December 2022: A Retrospective Cohort Study Ryan R Yanes, Edna M Edrada, Rontgene Solante
60 [GO] 2025―Jan―29 P-1934. Differences between the Reporting of Post-COVID-19 Symptoms and the Associated Health-Related Quality of Life during and after COVID-19 Infection - results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network Sina M Hopff, Katharina Appel, Isabel Bröhl, Carolin Nürnberger, Patricia Wagner, Margarete Scherer, et al. (+27)
61 [GO] 2025―Jan―29 P-1942. Unexpected Cardiac Deaths in Patients with COVID-19 Infection Aimon Malik, Atika Jabeen, Hiam Chemaitelly, Anil G Thomas, Sherin Shams, Samah Saleem, et al. (+6)
62 [GO] 2025―Jan―29 P-678. Comparison between the Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Three Waves of the Pandemic Barbara Mares Porto, Daniella Nunes Pereira, Luciane Kopittke, Alisson Asevedo, Angélica Gomides dos Reis Gomes, Angelinda Behring, et al. (+14)
63 [GO] 2025―Jan―29 P-1973. Characteristics, Clinical Management, and Outcomes of Immunocompromised Patients Diagnosed with COVID-19 in the Outpatient Setting in France Essy Mozaffari, Aastha Chandak, Mark Berry, Gaelle Gusto, Giancarlo Pesce, Agnese Restuccia, et al. (+3)
64 [GO] 2025―Jan―29 P-1921. Risk Factors for Hospitalization due to COVID-19 in the Current Era of the Pandemic Bhavya Ancha, Keith W Hamilton, Lauren Dutcher, Kathleen Degnan, Kurt Palumbo, Amanda Binkley, Sahrish Ilyas
65 [GO] 2025―Jan―29 P-1956. COVID-19 in pediatric population in Peru, 2020-2023: national data analysis Brian Peña, Gabriel Carrasco, Theresa Ochoa, Rafaella Navarro
66 [GO] 2025―Jan―29 P-2026. Obeldesivir for the Treatment of COVID-19 in People with Risk Factors for Progression to Severe Disease: the BIRCH Study Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang, Yao-Shen Chen, Yiannis Koullias, Afsaneh Mozaffarian, et al. (+17)
67 [GO] 2025―Jan―29 P-2005. Long-term complications of COVID-19 in pediatric population in Lima, Peru Rafaella Navarro, Theresa Ochoa, Gabriel Carrasco, Brian Peña
68 [GO] 2025―Jan―29 P-1923. Outcomes of COVID-19 in Patients with Liver Cirrhosis Luanna Silva Monteiro Menezes, Pedro Ferrari Sales da Cunha, Magda Carvalho Pires, Lucas Rocha Valle, Rafael Lima Rodrigues Carvalho, Milena S Marcolino
69 [GO] 2025―Jan―29 P-2034. Inappropriate Outpatient Antibiotic Prescribing for COVID-19 in New York City, 2020-2022 Mary K Foote, Nisha Kochar, Nang Thu Thu Kyaw
70 [GO] 2025―Jan―29 90. Impact of anti-CD20 therapy on COVID-19 in immunocompromised patients: A nationwide cohort study in Korea Chan Mi Lee, Suhyun Kim, Seungyeon Kim, Jiyeon Bae, Hyeon Jae Jo, Chang Kyung Kang, et al. (+3)
71 [GO] 2025―Jan―29 P-2018. Nirmatrelvir versus Short-Course Remdesivir for Mild-to-Moderate COVID-19 in High Risk Hospitalized Patients: A Propensity Score-Matched Study Madeline Belk, Taylor Steuber, Jonathan Edwards
72 [GO] 2025―Jan―29 P-1930. Absence of Booster Vaccination and Low Cycle Threshold Values Predict Severe and Critical COVID-19 in Fully Vaccinated Individuals: A Multi-Center Retrospective Cohort Study Charles Kevin L Rivera, Ia Marie Donna Cruz, Mark Carascal, Ma Cristina Perez, Raul V Destura, Karl Evans R Henson
73 [GO] 2025―Jan―29 425. Revealing Seasonal Patterns in the Post-Pandemic Era: A Comparative Analysis of Burden and Seasonality of Influenza and COVID-19 in Europe and the US Nabila Shaikh, Robertus van Aalst, Rebecca C Harris, Clotilde El Guerche-Séblain
74 [GO] 2025―Jan―29 427. Underlying Medical Conditions and Vaccination Status among U.S. Children Aged ≤17 Years Hospitalized for COVID-19 in COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), January-December 2023 Rebecca J Free, Kadam Patel, Darpun Sachdev, Nisha B Alden, James Meek, Patricia A Ryan, et al. (+12)
75 [GO] 2025―Jan―29 P-1954. Wastewater-Based Surveillance More Accurately Describes Disease Burden Of COVID-19 In Communities with Less Than 60,000 Inhabitants - An Ontario-Wide Study Nada Hegazy, K Ken Peng, Joan Hu, Charmaine Dean, Elizabeth Renouf, Robert Delatolla
76 [GO] 2025―Jan―29 P-2009. COVID-19 in Children with Hematological/Oncological Diagnoses - Exploring Reasons for Better Clinical Outcomes Swetha Pinninti, Connie Trieu, Barbora Knoppova, Sunil Pati, Avangelos Barley, Misty Latting, et al. (+7)
77 [GO] 2025―Jan―29 P-2036. Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study Onyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, Upinder Singh, Masaharu Shinkai, Gerard Acloque, et al. (+19)
78 [GO] 2025―Jan―29 P-1912. Characteristics and Outcomes of Matched Vaccinated and Unvaccinated Patients Hospitalized for Covid-19 in 27 Hospitals During Brazil's Delta and Omicon Waves Eduardo V Moraes, Magda Carvalho Pires, Amanda A A Costa, Unaí Tupinambás, Milena S Marcolino
79 [GO] 2025―Jan―29 P-1941. COVID-19 Impact on Acute Pancreatitis Hospitalization and Mortality: A Retrospective United States Cohort Study Thanathip Suenghataiphorn, Tuntanut Lohawatcharagul, Phuuwadith Wattanachayakul, Narathorn Kulthamrongsri, Pojsakorn Danpanichkul, Natchaya Polpichai, Jerapas Thongpiya
80 [GO] 2025―Jan―29 P-1904. The Interaction of Serum Biomarkers and Lymphopenia on Pulmonary COVID-19 Illness Progression in Hospitalized Patients Gregorio Benitez, Matthew Kaczynski, Stephanos Vassilopoulos, Athanasios Vassilopoulos, Fadi Shehadeh, Karen T Tashima, Eleftherios Mylonakis
81 [GO] 2025―Jan―29 P-2002. Incidence and Risk of COVID-19 Hospitalization Among Unvaccinated Children Ousseny Zerbo, Julius Timbol, John R Hansen, Kristin Goddard, Evan Layefsky, Pat Ross, et al. (+4)
82 [GO] 2025―Jan―29 P-2006. Individuals on Immunosuppressive or Immunomodulatory Therapies Remain at Increased Risk of COVID-19 Hospitalization, Despite Vaccination: Findings from INFORM, a Retrospective Health Database Study in England Sabada Dube, Lucy Carty, Carla Talarico, Renata Yokota, Richard McNulty, Michelle Harley, et al. (+8)
83 [GO] 2025―Jan―29 P-1981. MMCD score for predicting kidney replacement therapy in hospitalized patients with COVID-19 from 2020 to 2022 Vanessa das Graças José Ventura, Polianna Delfino-Pereira, Magda Carvalho Pires, Alexandre Vargas Schwarzbold, Alzira de Oliveira Jorge, Angélica Gomides dos Reis Gomes, et al. (+22)
84 [GO] 2025―Jan―29 P-1977. Six-Month Trajectory of Symptoms of COVID-19 Fatigue by Age and BNT162b2 COVID-19 Vaccination Status: A Prospective Study among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy Manuela Di Fusco, Alexandra Berk, Kristen E Allen, Thomas M Porter, Mary B Alvarez, Joseph C Cappelleri, et al. (+2)
85 [GO] 2025―Jan―29 P-1909. Social Connectedness in the COVID-19 Pandemic’s Aftermath: The Influence of Disease Status Christopher Kricorian
86 [GO] 2025―Jan―29 P-2043. Outpatient Antiviral Treatment Among High-risk Patients with Mild to Moderate COVID-19 During the Omicron Surge Lingshan Syue, Nanyao Lee, Wen-Chien Ko
87 [GO] 2025―Jan―29 P-1940. Low Visceral Fat Volume and Hypoalbuminemia as Prognostic Markers in Hospitalized Patients with COVID-19 During the Omicron Variant Epidemic Shin Nakayama, Yoshitaka Wakabayashi, Kyotaro Kawase, Ai Yamamoto, Takatoshi Kitazawa
88 [GO] 2025―Jan―29 99. Impact of Covid-19, Divergent Genomic Modes of Transmission and Strain Replacement of Carbapenem-Resistant Organisms in a Single Hospital in Singapore over 12 years Ze Qin Lim, Dennis Loy, Sai Rama sridatta Prakki, Natascha May Thevasagayam, Vanessa Koh, Jie Yin Chua, et al. (+12)
89 [GO] 2025―Jan―29 P-2033. Patient Characteristics and Management of COVID-19 Diagnosed in the Outpatient Setting Mark Berry, Christian B Ramers, Manu Jain, Amos Lichtman, Ching-Yi Chuo, Anand Chokkalingam, Essy Mozaffari
90 [GO] 2025―Jan―29 P-2044. Analysis of Post COVID-19 Condition After Ensitrelvir Treatment in Asymptomatic or Mild-Symptoms Only Patients in the SCORPIO Phase2b/3 Study Takumi Imamura, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Yohei Doi, Masaya Yamato, et al. (+8)
91 [GO] 2025―Jan―29 P-1957. Spatiotemporal Association of COVID-19 Cases and Mortality with Exposure to Wildfire Particulate Matter in 2020 Thomas C McHale, David R Boulware, Kelly Searle, Leda Kobziar, Phineas Lampman, Julio C Zuniga-Moya, et al. (+4)
92 [GO] 2025―Jan―29 P-2057. Immunogenicity of COVID-19 Booster Vaccines in Mexico and Mongolia Justino Regalado-Pineda, Paola del Carmen Guerra-de-Blas, Megan C Grieco, Munguntsetseg Batkhuu, Eduardo Becerril-Vargas, Naranjargal Dashdorj, et al. (+15)
93 [GO] 2025―Jan―29 P-2038. A Pharmacist-Run Treatment Decision Program for High-Risk Outpatients with Mild-Moderate COVID-19 at an Urban Veteran's Affairs Medical Center Ryan Kuhn, Lauren Weslosky, Suganthini Krishnan Natesan, Sorabh Dhar
94 [GO] 2025―Jan―29 P-1032. Posaconazole for Prevention of COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: the POSACOVID Study Juergen Prattes, Daniele R Giacobbe, Cristina Marelli, Alessio Signori, Silvia Dettori, Greta Cattardico, et al. (+5)
95 [GO] 2025―Jan―29 P-1911. Covid-19 Associated Mucor-Aspergillosis Incidence, Management and Outcome analysis Venkat R Kola
96 [GO] 2025―Jan―29 P-1596. Procalcitonin: A Promising Tool in Post COVID-19 Antibiotic Prescribing at a Community Teaching Hospital Elizabeth Nothdurft, Nirmol Philip, Brenden Giblin
97 [GO] 2025―Jan―29 P-2014. Online Clinician Education Curriculum Results in Performance Changes in Clinical Practice Related to Incorporating COVID-19 Antiviral Therapies for Non-Hospitalized Patients Arun S Nair, Maria B Uravich, Catherine Capparelli
98 [GO] 2025―Jan―29 P-181. Limited oxygen therapy capacity against COVID-19 and the public health response in Zambia 2021 Suilanji Sivile, Takeaki Imamura, Tadatsugu Imamura, Paul Msanzya Zulu, Masuzyo Zyambo, Papytcho Ntambwe, et al. (+8)
99 [GO] 2025―Jan―29 P-1906. Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario, Canada Caroline Kassee, Moe H Kyaw, Zoe Zhong, Altynay Shigayeva, Catherine Martin, Lubna Farooqi, et al. (+8)
100 [GO] 2025―Jan―29 P-2072. COVID-19 and RSV Prevention Products in Pregnancy - Overcoming COVID-19 Network, United States, October 2023-March 2024 Regina Simeone, Margaret M Newhams, Laura D Zambrano, Amber Orzel, Megan Lindley, Amanda B Payne, et al. (+5)
101 [GO] 2025―Jan―29 P-1376. Impact of COVID-19 and Mpox on Inpatient Screening of STIs Samara Levine, Brian Carpenter, Amber C Streifel, Alexandria Shonk, Cara D Varley
102 [GO] 2025―Jan―29 P-583. Admission Diagnoses and Outcomes among Hospitalized People Living with HIV during Pre-COVID-19, COVID-19 and Post-COVID-19 Pandemic Periods Thana Khawcharoenporn, Pattarapoom Panutat
103 [GO] 2025―Jan―29 P-2367. Qualitative Analysis of Barriers to Outpatient Antiviral Treatment for COVID-19 and Influenza Patients Observed by Infectious Disease Specialists in North America, 2024 Souci Louis, Dennis Wang, Jordan Singleton, Dallas J Smith, Anastasia S Lambrou, Susan E Beekmann, et al. (+6)
104 [GO] 2025―Jan―29 P-2003. Clinical Outcomes of COVID-19 among Immunocompromised Patients at Siriraj Hospital Pakpoom Phoompoung, Jirapa Dilokruangchai
105 [GO] 2025―Jan―29 P-721. Risk Factors Associated with COVID-19 Among Fully Vaccinated Healthcare Workers in Lima, Peru Candice romero, Diana Ponce, Giselle Soto, Perrine Marcenac, Eva Leidman, Garrett W Mahon, et al. (+2)
106 [GO] 2025―Jan―29 P-1943. Risk Factors for Coronavirus disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients: The Predictive Value of KL-6 for CAPA and Mortality Seung Min Lee, Si-Ho Kim, Cheon-Hoo Jeon, Yu Mi Wi
107 [GO] 2025―Jan―29 P-1928. Virologic and Clinical Outcomes Among Participants Hospitalized in a Phase 3 Trial Comparing Molnupiravir with Placebo for Treating Mild-to-Moderate COVID-19 Matthew G Johnson, David W Hilbert, Erin Jensen, Dorothy McCoy, Brian Maas, Ying Zhang, et al. (+3)
108 [GO] 2025―Jan―29 P-1925. Incidence of long COVID symptoms during the year post admission among patients hospitalized for COVID-19 Mark Berry, Valentina Shvachko, Amanda Kong, Rohan Shah, Gina Brown, Anand Chokkalingam
109 [GO] 2025―Jan―29 P-1900. Temporal Course and Risk Factors of Coinfections in Patients Hospitalized for COVID-19 James L Vilkas, Ali Akmal, Akmal Sarwar, Yuxiu Lei, Timothy N Liesching
110 [GO] 2025―Jan―29 P-1901. Statin Use and Severe/Critical/Fatal Outcomes in Individuals with COVID-19 Adeel A Butt, Peng Yan, Obaid Shaikh
111 [GO] 2025―Jan―29 429. SARS-CoV-2 Fecal Shedding Dynamics Among People with Symptomatic COVID-19 Tiffany Hink, Katelyn L Parrish, Kimberly Reske, Olivia G Arter, Katheryn Ney, Victoria Joachimstaler, et al. (+9)
112 [GO] 2025―Jan―29 P-2020. Combination Therapy with Remdesivir and Corticosteroids is Associated with Lower Mortality Risk vs. Corticosteroids Monotherapy in Patients Hospitalised for COVID-19 Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Mark Berry, Thomas F Oppelt, et al. (+4)
113 [GO] 2025―Jan―29 P-2017. Patient Reported Outcomes of Nirmatrelvir/Ritonavir Treatment for High-risk, Nonhospitalized Adults with Symptomatic COVID-19 Ashley S Cha-Silva, Henriette Coetzer, Kelly Gebo, Jinma Ren, Amie Scott, Joseph C Cappelleri, et al. (+2)
114 [GO] 2025―Jan―29 P-2025. Resistance Analyses from the Remdesivir Phase 2/3 CARAVAN Study in Pediatric and Neonatal Participants Hospitalized with COVID-19 Jasmine Moshiri, Jiani Li, Lauren Rodriguez, Dong Han, Simin Xu, Pui Yan Ho, et al. (+7)
115 [GO] 2025―Jan―29 P-2041. In Vitro Resistance Profiling of S-892216, a Second Generation SARS-CoV-2 3CLpro Inhibitor for the Treatment of COVID-19 Sho Kawashima, Haruaki Nobori, Miyako Okane, Takashi Hashimoto, Kae Inoue, Yuko Yamano, et al. (+5)
116 [GO] 2025―Jan―29 P-1975. Detection of SARS-CoV-2 Specific Secretory IgA and Neutralizing Antibodies in Nasal Secretions of Seronegative Individuals Previously Exposed to COVID-19 Jason Shin Chwa, Minjun Kim, Yesun Lee, Wesley A Cheng, Yunho Shin, Jaycee Jumarang, et al. (+2)
117 [GO] 2025―Jan―29 P-2332. Pre to Post COVID-19 pandemic: Analyzing Recovery of Respiratory Viral Circulation Patterns Kim El Haddad, Wei Liu, Patrick Burke, Frank Esper
118 [GO] 2025―Jan―29 P-1209. Changes in Antiviral Prescription for Children with Influenza in U.S. Emergency Departments During the COVID-19 Pandemic: New Vaccine Surveillance Network (NVSN), 2016-2023 Tess Stopczynski, Olla Hamdan, Justin Z Amarin, James W Antoon, Laura S Stewart, James Chappell, et al. (+18)
119 [GO] 2025―Jan―29 P-358. Infection Prevention and Control Practice in Tertiary Care Military Hospitals in Bangladesh during COVID-19 Pandemic: Results from WHO IPCAF Assessment Tools Syed Abul Hassan Md Abdullah, Md Golam Dostogir Harun, Md Shariful Amin Sumon, Ishrat Jahan, Md Mahabub Ul Anwar, Taufiq H Siddiquee
120 [GO] 2025―Jan―29 P-325. Lingering Effect of the COVID-19 Pandemic: Unnecessary Glove Use by Medical Trainees at a Large Academic Medical Center Breanna Brown, Dawn Nolt, Judith A Guzman-Cottrill
121 [GO] 2025―Jan―29 P-1918. Incidence of viral rebound in hospitalized COVID-19 patients Tzu-Ping Weng, Lingshan Syue, Mingchi Li, Nan-Yao Lee
122 [GO] 2025―Jan―29 85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients Roy F Chemaly, Alexander Vlaar, Endry H T Lim, Bruce P Burnett, Camilla Chong, simon Rückinger, et al. (+5)
123 [GO] 2025―Jan―29 P-1984. AB2CO: a mortality risk score for COVID-19 patients admitted to intensive care units Virginia Mara Reis Gomes, Magda Carvalho Pires, Polianna Delfino-Pereira, Vandack Nobre, Milena S Marcolino
124 [GO] 2025―Jan―29 P-2053. Clinical Outcomes and Severity of Hospitalized COVID-19 Patients Among Partially and Fully Vaccinated Patients in Louisville, Kentucky Waqas Shahnawaz, T’shura Ali, Nouman Shafique, Jafir Wakeel, Daniya Sheikh, Vidyulata Salunkhe, et al. (+2)
125 [GO] 2025―Jan―29 P-2007. Prognosis of COVID-19 Patients with Preexisting Dementia: Findings from a Comprehensive Multicenter Propensity-Matched Cohort Study in Brazil Victor Schulthais Chagas, Lucas Emanuel F Ramos, Magda Carvalho Pires, Patryk Marques da Silva Rosa, Virginia Mara Reis Gomes, Joice Coutinho de Alvarenga, et al. (+4)
126 [GO] 2025―Jan―29 P-2040. Real-world safety and effectiveness of ensitrelvir in COVID-19 patients with risk factor : a post-marketing surveillance in Japan Satoru Takashima, Noriko Hayashi, Eri Tsukimura, Eriko Ogura
127 [GO] 2025―Jan―29 P-1967. Characteristics of the first immunocompromised patients to receive Sipavibart as an early access treatment for COVID-19 pre-exposure prophylaxis in France Paul Loubet, Benjamin Gaborit, Mathilde Salpin, Hélène Gardeney, Iliès Benotmane, Thomas Systchenko
128 [GO] 2025―Jan―29 P-1997. Real-world Effectiveness of Tixagevimab/cilgavimab for COVID-19 Pre-exposure Prophylaxis in Solid Organ Transplant Recipients during the BA.2.75 and BQ.1 Omicron Variant Period: A matched Case-control Dtudy Gun Rojanakit, Sasisopin Kiertiburanakul, Sarinya Boongird, Napan Sutharattanapong, Surasak Kantachuvesiri, Teerapat Yingchoncharoen, et al. (+2)
129 [GO] 2025―Jan―29 P-1706. Understanding Facility Bed Size Changes in NHSN over the COVID-19 Public Health Emergency Olivia Arar, Lisa Iguchi, Elizabeth Breitenstein, Alexia Y Zhang, Gregory B Tallman, Dat Tran, Jessina C McGregor
130 [GO] 2025―Jan―29 P-1926. Once Is Enough, Two Is Too Much: Unraveling Predictors of COVID-19 Readmission among Previously Hospitalized Patients Marta Colaneri, Marta Canuti, Ginevra Torrigiani, Lucia Dall’Olio, Chiara Bobbio, Sante Leandro Baldi, et al. (+13)
131 [GO] 2025―Jan―29 P-2282. Infectious Complications Following Lung Transplant for COVID-19 Related Respiratory Failure Nandita Kapur, Navina K Birk, Rachna Jayaprakash, Basmah Khalil, Rajan Singh, Zachary W Hanna, et al. (+2)
132 [GO] 2025―Jan―29 P-1963. Changes in COVID-19 Sentiment and Behavior among Healthcare Professionals Over Time in a Rural State Brianna S Wright, Daniel Kang, Aaron Scherer, Melissa Ward, Daniel Diekema, Loreen Herwaldt
133 [GO] 2025―Jan―29 P-1983. A Longitudinal Study of COVID-19 Sequelae and Immunity: Effects of SARS-CoV-2 Reinfection Paula M Bravver, Bryan Higgins, Michael Sneller
134 [GO] 2025―Jan―29 P-1971. Patterns of T cell receptor usage reveal associations with COVID-19 severity Zhongyan Lu, Emily Parsons, Stephanie A Richard, Camille Alba, Gauthaman Sukumar, John Rosenberger, et al. (+6)
135 [GO] 2025―Jan―29 P-1986. COVID-19 Surveillance in Infants, Minnesota, October 2023-January 2024 Abbey J Ruhland, Stephanie Meyer, Kathryn Como-Sabetti, Ashley Fell, Elle Talsma, Siobhan O’Toole, Ruth Lynfield
136 [GO] 2025―Jan―29 P-1825. Investigating the Impact of Immunomodulatory Drugs on Severe COVID-19 Through Transcriptomic Analysis Jeong Yeon Kim, Yoo Jin Sung, Eujin Hong, Hyun Uk Kim, Young Kyung Yoon
137 [GO] 2025―Jan―29 P-1994. Rapid COVID-19 Transmission and Multi-layered Interventions in a High-rise Detention Center from January to March 2022 in South Korea Jin Su Song, Pyoeng Gyun Choe, Wan Beom Park, Shin Young Lee, Seonju Yi
138 [GO] 2025―Jan―29 P-2013. Improving Access to COVID-19 Treatment for Longterm Care (LTC) Residents: An Integrated Operational Approach Ajit Johal, Mark Zhou
139 [GO] 2025―Jan―29 P-2021. How Have COVID-19 Treatment Guidelines and the Scientific Evidence Evolved throughout the Pandemic and Endemic Eras? Essy Mozaffari, Michele Bartoletti, Alpesh N Amin, Yohei Doi, Yohei Doi, Paul Loubet, et al. (+10)
140 [GO] 2025―Jan―29 P-2015. Evaluating the use of Monoclonal Antibodies - Sotrovimab, Casirivimab/Imedvimab (REGEN-COV) and Tixagevimab/Cilgavimab (EVUSHELD) for COVID-19 Treatment in Singapore Annabel Chua, Puay Hoon Eve Nah, Grace Hoo, Ying Hao, Jun Xin Tay, Barnaby Edward Young, et al. (+3)
141 [GO] 2025―Jan―29 P-1809. Strategies to Optimize Antibiotic Stewardship for Patients with COVID-19 Using a Systems Engineering Framework Michael Pulia, Meggie Griffin, Rebecca Schwei, Sarah Scalzo, Helena Ikenberry, Ashleen Kaur, et al. (+3)
142 [GO] 2025―Jan―29 P-1933. MASTARD-COVID-19: A MAtched-cohort Study of Specific-Treatment-requiring Autoimmune Rheumatic Diseases after COVID-19 Using Japanese Health Insurance Claims Data Ryuichi M Sada, Shungo Yamamoto, Saki Sada Minoda, Ryotaro Tajima, Shogo Miyazawa, Takuji Komeda, Satoshi Kutsuna
143 [GO] 2025―Jan―29 P-2060. Effectiveness of BNT162b2 COVID-19 Vaccination Against Long COVID Among Older Adults: A Nationwide Study Manuela Di Fusco, Abby Rudolph, Laura L Lupton, Joseph C Cappelleri, Alon Yehoshua, Laura A Puzniak, et al. (+2)
144 [GO] 2025―Jan―29 P-2046. Integrating Immunization Information System (IIS) and commercial health insurance claims data to improve COVID-19 vaccination capture among pregnant people Alexandra Stone, Wafa Tarazi, Nwanneamaka Ume, Andrea Steffens, Katherine Andrade, Garrett Gremel, et al. (+5)
145 [GO] 2025―Jan―29 P-2010. Association between Urbanicity and Up-to-date COVID-19 Vaccination Coverage among Healthcare Personnel and Residents of Nursing Homes - National Healthcare Safety Network, United States, March 3, 2024 Lori Haas, Darielle Oliver, Austin Woods, Hannah E Reses, Kira A Barbre, M I N N M SOE, et al. (+4)
146 [GO] 2025―Jan―29 P-2074. Evaluation of Adherence and Access to Booster COVID-19 Vaccination in Persons with HIV Tara Krishna, Shobha Swaminathan
147 [GO] 2025―Jan―29 P-57. Durability of SARS-CoV-2 specific Cellular Immune Response after COVID-19 Vaccination in PLWH Amit Sehgal, Neeraj Nischal, Sanjay Ranjan, Niranjan Mahishi, Pankaj Jorwal, Naveet Wig, et al. (+4)
148 [GO] 2025―Jan―29 P-2076. COVID-19 Vaccination Patterns and Timing among Privately Insured Pregnant Persons, 2020-2023 Lakshmi Panagiotakopoulos, Amadea Britton, Ruth Link-Gelles, Wafa Tarazi, Alexandra Stone, Nwanneamaka Ume, et al. (+5)
149 [GO] 2025―Jan―29 P-2064. COVID-19 Vaccination-infection Status and Immunological Profile: Identification of High-Risk Population for Targeted Booster Immunization In India Ankit Mittal, Deepika Gujjarlapudi, Vidyavathi devi Gajapathi Raju, Sadhana Yelamanchili Veturi, Rupjyoti Talukdar, Rupa Banerjee, et al. (+4)
150 [GO] 2025―Jan―29 P-98. The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in BNT162b2 primed individuals aged 18-< 50 and 50-< 70 years old Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen Marshall, Marie Estcourt, et al. (+12)
151 [GO] 2025―Jan―29 86. The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-< 70 years old Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen Marshall, Marie Estcourt, et al. (+12)
152 [GO] 2025―Jan―29 P-618. Investigating the Relationship Between COVID-19 Vaccine Accessibility and Coverage in Seattle and King County Amin Bemanian, Jonathan F Mosser
153 [GO] 2025―Jan―29 P-2059. Perceptions and Factors Associated with Uptake of Monovalent XBB.1.5 BNT162b2 COVID-19 Vaccine among Healthcare Workers in Peru Jose A Gonzales-Zamora, Julieta M Araoz-Salinas, Carlos Quispe-Vicuña, Martín Ernesto Reátegui García, Brando Ortiz-Saavedra, Anderson N Soriano-Moreno, et al. (+2)
154 [GO] 2025―Jan―29 571. Safety and Immunogenicity of Coadministered Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine With and Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age Joel Neutel, Rahsan Erdem, Qin Jiang, Kevin Cannon, Helen Stacey, Ryan Newton, et al. (+12)
155 [GO] 2025―Jan―29 P-2067. Antibody Response in People Living with HIV on Effective ART: A Comparison of CD4 T-cell counts >200 versus ≤200 cells/mm³ Following a Bivalent mRNA COVID-19 Vaccine Booster, with Evaluation of the Correlation Between Anti-RBD IgG (Anti-Receptor Binding Domain Immunoglobulin) and sVNT (SARS-CoV-2 Surrogate Virus Neutralization Test) Napon Hiranburana, Opass Putcharoen, Nattakarn Thippamom, Stephen J Kerr, Supaporn Wacharapluesadee, Anchalee Avihingsanon
156 [GO] 2025―Jan―29 P-733. Timing of Influenza and COVID-19 Vaccine Coadministration Among Adults During Two Influenza Seasons Yongming Zhao, Djeneba Djibo, K J Craig, Amanda Zaleski, Dorothea Verbrugge, Cheryl McMahill-Walraven
157 [GO] 2025―Jan―29 P-2069. Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Adults - IVY Network, 20 U.S. States Jennifer DeCuir, Yuwei Zhu, Cassandra Johnson, Adam S Lauring, Emily T Martin, Manjusha Gaglani, et al. (+24)
158 [GO] 2025―Jan―29 P-2050. Ad26.COV2.S (Janssen) COVID-19 Vaccine Effectiveness against Hospitalization in Europe: an id.DRIVE Study Chloé Wyndham-Thomas, E Claire Newbern, Ainara Mira-Iglesias, Akshat Dwivedi, Alejandro Orrico-Sánchez, Andrés Antón, et al. (+13)
159 [GO] 2025―Jan―29 P-2073. COVID-19 Vaccine Effectiveness in Patients with Lung Cancer and Mesothelioma in the Omicron Era Seyed M Hosseini-Moghaddam, Frances A Shepherd, Sarah Swayze, Jeffrey Kwong
160 [GO] 2025―Jan―29 P-2047. Public Health Impact and Economic Value of an Additional Dose of Pfizer-BioNTech XBB.1.5-adapted COVID-19 Vaccine for Older Adults in the United States Alon Yehoshua, Benjamin Yarnoff, Manuela Di Fusco, Santiago M C Lopez, Elizabeth A Thoburn, Abby Rudolph, Kinga Marczell
161 [GO] 2025―Jan―29 P-2075. Immunogenicity of co-administration of influenza vaccine and COVID-19 vaccine in healthy volunteers Nonthanat Tongsengkee, Nawamin Pinpathomrat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Sorawit Chittrakarn, Sarunyou Chusri
162 [GO] 2025―Jan―29 P-1988. COVID-19 vaccine induced antibodies in human milk: exploring form and function Amro Nasser, Dylan J Tuttle, Maris Wilkins, Priscilla Da Silva Castanha, Ernesto T A Marques, Anne-Marie Rick
163 [GO] 2025―Jan―29 P-2068. Assessing New York City’s COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution Nina Schwalbe, Marta C Nunes, Clare Cutland, Brian Wahl, Daniel Reidpath
164 [GO] 2025―Jan―29 P-2071. 2023-2024 COVID-19 Vaccine Uptake, Knowledge, and Attitudes among Individuals enrolled in a Household Transmission Study, Tennessee, New York, and Washington, January-April 2024 J Bradford Bertumen, Sara Benist, Erin South, E Ivy Oyegun, Sarah E Smith-Jeffcoat, Carlos G Grijalva, et al. (+13)
165 [GO] 2025―Jan―29 426. Effectiveness of Updated (2023-2024) Monovalent COVID-19 Vaccines - VISION Network, September 2023-March 2024 Ruth Link-Gelles, Elizabeth Rowley, Sarah E Reese, Omobosola Akinsete, Kristin K Dascomb, Stephanie Irving, et al. (+13)
166 [GO] 2025―Jan―29 P-2049. Interim Estimates of Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Outcomes Among Medicare Enrollees with End Stage Renal Disease - United States, September - December 2023 Amanda B Payne, Shannon Novosad, Ryan E Wiegand, Morgan Najdowski, Danica J Gomes, Megan Wallace, et al. (+6)
167 [GO] 2025―Jan―29 580. Pharmacokinetics (PK) and Safety of Nirmatrelvir/Ritonavir (NMV/r) in Non-Hospitalized Symptomatic Pediatric Patients Ages 6 Years and Older with COVID-19 who are at Increased Risk of Progression to Severe Disease (EPIC-Peds) Jacqueline Gerhart, Heidi Leister-Tebbe, Namita Singh, Phylinda L S Chan, Haihong Shi, William D H Carey, et al. (+6)
168 [GO] 2025―Jan―29 P-2063. Safety and Immunogenicity of Booster Vaccination Against COVID-19 with Whole-SARS-CoV-2-Virion Inactivated Vaccine KD-414: A Phase 1 Trial in Japan Michiko Koga, Masahiro Nojima, Kengo Sonoda, Ken Ishii, Yoshihiro Kawaoka, Fumitaka Nagamura, Hiroshi Yotsuyanagi
169 [GO] 2025―Jan―29 P-2048. COVID-19 XBB.1.5 Vaccine Uptake Based on State Vaccine Registries Compared to National Survey Data Angela Cook, Kathleen M Andersen, Matthew A Brouillette, Leah McGrath, John M McLaughlin
170 [GO] 2025―Jan―29 P-2062. COVID-19 XBB.1.5-adapted Vaccine Uptake in Immunocompromised Individuals Using Tokenized State Vaccine Registries Matthew A Brouillette, Farid L Khan, Santiago M C Lopez, Kathleen M Andersen, Tiange Yu, Benjamin T Carter, et al. (+2)
171 [GO] 2025―Jan―29 P-2008. Chronic Conditions as Risk Factors for COVID-19-Associated Hospitalization Among Adults, 2022-2023 Sarah Hamid, Gordana Derado, Huong Pham, Rebecca C Woodruff, Darpun Sachdev, Breanna Kawasaki, et al. (+14)
172 [GO] 2025―Jan―29 P-1999. Predictors of Mortality in Myelodysplastic Syndrome with COVID-19: A 2020-2021 National Study Madhumithaa Jagannathan, Barath Prashanth Sivasubramanian, Sonia Babu, Shanthi Reddy Sripathi, Avinash Javvaji, Priyanshu Jain, et al. (+5)
173 [GO] 2025―Jan―29 P-2027. Care at Home for Remdesivir Treatment of COVID-19: A Mixed Methods Study of Patient and Physician Experiences Julia K Nguyen, Rulin C Hechter, Deborah S Ling Grant, Janis F Yao, Cecilia Portugal, Jia-xiao M Shi, et al. (+2)
174 [GO] 2025―Jan―29 P-1917. Hospital-Acquired Infections and Their Impact on Length of Stay for Veterans with COVID-19: A Nationwide Cohort Study Haojia Li, Karim Khader, Barbara E Jones, Michael Rubin, Yue Zhang
175 [GO] 2025―Jan―29 P-2016. Nirmatrelvir-ritonavir and molnupiravir for the outpatient treatment of Covid-19: a population-based cohort study Anselm Jorda, Dominik Ensle, Hubert Eser, Florentin Glötzl, Benjamin Riedl, Ursula Karnthaler, Markus Zeitlinger
176 [GO] 2025―Jan―29 P-1922. Liver Function Test Abnormalities near Admission Predict Mortality for Patients with COVID-19: A Single-Center Study Lucia Cabrejos Hirashima, Nicole Naiman, Mamta K Jain
177 [GO] 2025―Jan―29 P-1966. Depression and Anxiety Symptoms During COVID-19: Age-Related Advantages in Well-Being Nicole S E Goh, Sharon Tan, Alex Yap, David Lye, Kelvin Bryan Tan
178 [GO] 2025―Jan―29 P-1978. Long-Term Mast Cell Activation Patterns in Systemic and Tissue-Resident Compartments Following COVID-19: Insights from a 2-Year Post-Infection Study Max Augustin, Lea Katharina Picard, Elisabeth Zenev, Melanie Ball, Isabella Rostocki, Elisabeth Pracht, et al. (+11)
179 [GO] 2025―Jan―29 P-1913. Characteristics, Clinical Management, and Outcomes of Leukemia, Lymphoma and Multiple Myeloma Patients Hospitalized with a Primary Diagnosis of COVID-19: Insights from Hospitals across the United States Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre Kalil, Mark Berry, Heng Jiang, et al. (+2)
180 [GO] 2025―Jan―29 428. Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology Jaspreet Banga, Taylor M Brock-Fisher, Brittany A Petros, Ariana T Leonelli, Katelyn S Messer, Audrey Nathanson, et al. (+9)
181 [GO] 2025―Jan―29 P-1799. Impact of coronavirus disease 2019 on infectious disease treatment and infection control: Multicenter study in Japan Hiroshi Kakeya, Shigeki Kakuno, Waki Imoto, Ayumi Shintani
182 [GO] 2025―Jan―29 P-1191. Maternal Antibodies Against Parechovirus-A3 Before and During the Coronavirus Disease 2019 Pandemic Jun Tachikawa, Yuta Aizawa, Kanako Watanabe, Kazufumi Haino, Koji Nishijima, Akihiko Saitoh
183 [GO] 2025―Jan―29 P-1210. Resurgence of Parechovirus-A3 Infection in Neonates and Young Infants after the Coronavirus Disease 2019 Pandemic in Japan Yuta Aizawa, Jun Tachikawa, Takayuki Yamanaka, Takayo Shoji, kenta Ito, Masashi Kasai, et al. (+10)
184 [GO] 2025―Jan―29 P-2052. Pre-existing Humoral Immunity to Seasonal Coronaviruses and Effect on SARS-CoV-2 Antibody Responses on SARS-CoV-2 Vaccination and Infection Etsuro Nanishi, Matthew K Hwang, Walter Byrne, Kimberly Thompson, Nicole Wisener, Julia Upton, et al. (+7)
185 [GO] 2025―Jan―29 P-714. Symptoms Associated with High Viral Loads of Common Cold Coronaviruses in Hematopoietic Cell Transplantation Recipients Chikara Ogimi, Faduma A Abukar, Alpana waghmare, Angela P Campbell, Keith R Jerome, Filippo Milano, et al. (+3)
186 [GO] 2025―Jan―29 P-2324. Detections of Endemic Coronaviruses in Medically Attended Respiratory Illness: Clinical Characteristics and Seasonal Trends from Two Public Health Surveillance Studies in Minnesota Kristen Bastug, Karen Martin, Kathryn Como-Sabetti, Hannah Friedlander, Jeffrey Sanders, Izzy Brandstetter-Figueroa, et al. (+5)
187 [GO] 2025―Jan―29 P-2028. Therapeutic Effect of Delayed Treatment with a Second-Generation 3CL Protease Inhibitor S-892216 in Hamsters Infected with SARS-CoV-2 Masaaki Nakashima, Haruaki Nobori, Alice Shimba, Satoshi Miyagawa, Akane Hayashi, Kazumi Matsumoto, et al. (+2)
188 [GO] 2025―Jan―29 P-1079. In Vitro and in Vivo Antiviral Activity of S-892216, a Second-Generation Oral 3CLpro Inhibitor against SARS-CoV-2 Haruaki Nobori, Sho Kawashima, Reiko Dodo, Yuki Maruyama, Takayo Haruna, Keiichiro Hirai, et al. (+21)
189 [GO] 2025―Jan―29 P-9. Standardized Model for SARS-CoV-2 and Influenza Vaccination of Hospitalized Patients: A Before-After Quality Improvement Study Amber L Linkenheld-Struk, Victoria R Williams, Karen Chan, Helene Carating, Romina Marchesano, Jennifer Do, et al. (+4)
190 [GO] 2025―Jan―29 371. Social Determinants of Vaccine Uptake: The Impact of Race and Vulnerability on Influenza, SARS-CoV-2, and RSV Vaccination Rates Zainab Albar, Christopher Ladikos, Daniel J Tisch, Robert Salata, Elie Saade
191 [GO] 2025―Jan―29 P-1960. Safety and Pharmacokinetics of Long-acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442) are Consistent after Repeat Dosing: Results from the PROVENT Substudy Andrew Ustianowski, Myron J Levin, Stéphane De Wit, Odile Launay, Hilde Bollen, Tommy Rampling, et al. (+15)
192 [GO] 2025―Jan―29 P-1979. Localized Nasal Mucosal SARS-CoV-2 Antibody Responses and Neutralization Potential based on Exposure History Minjun Kim, Jason S Chwa, Yunho Shin, Yesun Lee, Wesley A Cheng, Jaycee Jumarang, et al. (+2)
193 [GO] 2025―Jan―29 P-1935. Proteomic and transcriptomic signatures of SARS-CoV-2 associated myocarditis Simon Pollett, Josh Chenoweth, Clifton Dalgard, Nusrat J Epsi, Stephanie A Richard, Paul W Blair, et al. (+15)
194 [GO] 2025―Jan―29 P-1337. Analyzing SARS-CoV-2 Case Numbers and Clustering to Predict a Nursing Home Outbreak Yasin Abul, Kevin McConeghy, Frank Devone, Christopher Halladay, Stefan Gravenstein, James Rudolph
195 [GO] 2025―Jan―29 P-2051. Assessing SARS-CoV-2 Correlates Protection from Exposed Household Members: A Prospective Cohort Study (AB-PROTECT Study) Christopher Kandel, Maureen Taylor, Karen Colwill, Queenie Hu, Andrea Llanes, Gloria Crowl, et al. (+15)
196 [GO] 2025―Jan―29 P-418. A Need for Infection Prevention among Patients with ESKD on Maintenance Dialysis: a First Step in Understanding how SARS-CoV-2 Impacts this Population Shivani Aggarwal, Emily A Hu, Jennifer R Dusendang, Yuval Koren, Cátia Ferreira, Lisa Glasser, et al. (+3)
197 [GO] 2025―Jan―29 P-1840. Differential Memory CD4 T Cell Responses to SARS-CoV-2 in Children and Adults Pre- and Post-Pandemic Regina K Rowe, Nelson Huertas, Bailey Matthews, Jennifer L Nayak
198 [GO] 2025―Jan―29 P-2045. Humoral Response induced by Three-Dose Vaccination Schemes Against SARS-CoV-2 in Pediatric Hematopoietic Stem Cell Transplant Recipients: Experience from a Middle-Income Country Andrés Soffia, M Nicole Le Corre, Juan Pablo Torres, M Cecilia Vizcaya, Constanza Martinez-Valdebenito, Natalia González, et al. (+3)
199 [GO] 2025―Jan―29 P-1836. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice Haowen Qiao
200 [GO] 2025―Jan―29 P-164. Comparing long-term cardiovascular, neuropsychiatric, and autoimmune complications following dengue infection versus SARS-CoV-2 infection Jue Tao Lim
201 [GO] 2025―Jan―29 P-1951. Incidence of SARS-CoV-2 Infection among those 6 Months to 49 Years of Age in the Cascadia Prospective Cohort Study, Oregon and Washington, United States, July 1, 2022 - March 31, 2024 Mark A Schmidt, Neil D Yetz, Teresa Kimes, Cassandra Boisvert, Stephen P Fortmann, Holly C Groom, et al. (+30)
202 [GO] 2025―Jan―29 518. Newborn immune transcriptome changes rapidly and is shaped by maternal SARS-CoV-2 infection and/or vaccination Zhaohui Xu, Pablo J Sanchez, Shira H Cohen, Leire Pérez Latorre, Traci Pifer, Manish Rijal, et al. (+10)
203 [GO] 2025―Jan―29 P-1965. Non-Pharmaceutical Interventions and Protection Against SARS-CoV-2 Infection in a Changing Pandemic Landscape Meri Varkila, Catherine Ley, Maria de la Luz Sanchez, Julie Parsonnet
204 [GO] 2025―Jan―29 P-1905. Quality of Life 6 Months After SARS-CoV-2 Infection in Ambulatory and Hospitalized Patients from Lima, Peru: FUNCTION Cohort Study Carolina Coombes, Rodrigo Antonio A Cachay Figueroa, Takashi Watanabe, Isabel Ballena, Fernando Mejia, Felix Medina, et al. (+4)
205 [GO] 2025―Jan―29 P-727. Is there increased risk of RSV infection following SARS-CoV-2 infection in children? An EHR-based cohort study from the RECOVER Program Suchitra Rao, Andrea J Allen, Mitchell Maltenfort, Asuncion Mejias, Eneida Mendonca, Benjamin Horne, et al. (+4)
206 [GO] 2025―Jan―29 P-1964. Pre-exposure Prophylactic Treatment with Ensitrelvir Inhibited SARS-CoV-2 Infection in Hamster Aerosol Transmission Model Masaaki Nakashima, Haruaki Nobori, Takayuki Kuroda, Alice Shimba, Satoshi Miyagawa, Akane Hayashi, et al. (+3)
207 [GO] 2025―Jan―29 P-1944. The Natural History of SARS-CoV-2 Infection in Infants and the Role of Subsequent Infections on Protection: A Prospective Cohort in Mexico City Alejandra Molina-Sanchez, Laura Angelica Rodriguez-Dorantes, Sandra Rajme-López, Pilar Ramos-Cervantes, Allison R Cline, Mary A Staat, Guillermo Miguel Ruiz-Palacios
208 [GO] 2025―Jan―29 P-1992. Significant Positive Correlation of PD-1 and PD-L1 Levels in Children with Post-acute Sequelae of SARS-CoV-2 Infection in Taiwan Yu-Lung Hsu, Pei-Chi Chen, Lawrence Shih-Hsin Wu, Kai-Sheng Hsieh, Huan-Cheng Lai, Hsiao-Chuan Lin, et al. (+2)
209 [GO] 2025―Jan―29 P-1936. Does SARS-CoV-2 Infection or Vaccination Impact Menstrual Health? Results From a Longitudinal Cohort Study Among Military Health System Beneficiaries Caleb Mayes, Catherine Berjohn, Celia Byrne, Rhonda E Colombo, Evan Ewers, Ryan Flanagan, et al. (+20)
210 [GO] 2025―Jan―29 88. Efficacy of nirmatrelvir-ritonavir in high-risk trial participants with prior SARS-CoV-2 infection or vaccination: a pooled analysis John M McLaughlin, Heidi Leister-Tebbe, Weihang Bao, Romina Quercia, Jennifer Hammond
211 [GO] 2025―Jan―29 P-2342. Dynamics of indirect protection against SARS-CoV-2 infection through vaccine- and infection-acquired immunity Sophia T Tan, Isabel Rodríguez-Barraquer, Ada T Kwan, Seth Blumberg, Justine Hutchinson, David Leidner, et al. (+3)
212 [GO] 2025―Jan―29 92. Obeldesivir Reduced SARS-CoV-2 Infectious Titers in the BIRCH Phase 3 Clinical Trial Lauren Rodriguez, Anca Streinu-Cercel, Juan M Gonzalez Del Castillo, Yiannis Koullias, Afsaneh Mozaffarian, Kim Etchevers, et al. (+8)
213 [GO] 2025―Jan―29 P-2061. Long-term Follow Up of Pfizer-BioNTech BNT162b2 mRNA Vaccinations Reveals Persistent Disparities between SARS-CoV-2 Naive and Infected Individuals in the Context of Breakthrough Infections Emelie Marklund, Anna Lundgren, Mats Bemark, Kristina Nyström, Ying Li, Aylin Yilmaz, et al. (+2)
214 [GO] 2025―Jan―29 P-2030. Remdesivir and Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants Lauren Rodriguez, J Lizbeth Reyes Zamora, Dong Han, Nadine Peinovich, Clarissa Martinez, Pui Yan Ho, et al. (+6)
215 [GO] 2025―Jan―29 P-1849. Investigating the Impact of SARS-CoV-2 on the Immune Response to Other Pathogens Using VirScan Epitope Profiling Linda M Sircy, Elizabeth M Krantz, Ryan S Basom, Louise E Kimball, Rachel Blazevic, Khaleel Yahya, et al. (+8)
216 [GO] 2025―Jan―29 P-1995. A Nationwide Cohort Study of Delta and Omicron SARS-CoV-2 Outcomes and Vaccine Effectiveness amongst Individuals with Chronic Heart Failure or Ischemic Heart Disease Liang En Wee, Enoch Xueheng Loy, Jue Tao Lim, Sharon Tan, David Lye, Kelvin Bryan Tan
217 [GO] 2025―Jan―29 P-1924. Impact of the SARS-CoV-2 Pandemic on Medically Attended Acute Gastroenteritis Incidence and Health Care Utilization in the U.S Mark A Schmidt, Matthew T Slaughter, John F Dickerson, Holly C Groom, Judy L Donald, Maureen O’Keeffe-Rosetti, et al. (+3)
218 [GO] 2025―Jan―29 424. SARS-CoV-2 Positivity and Genetic Relationships among Cases within Households in the Cascadia Prospective Cohort Study, July 2022 to May 2023 Amanda M Casto, Tara M Babu, Sarah N Cox, Collrane J Frivold, Julia C Bennett, Allison L Naleway, et al. (+31)
219 [GO] 2025―Jan―29 P-1982. SARS-CoV-2 Rebound during Acute Infection is Associated with Long COVID Nisha Ramdeep, Carly Herbert, Annukka A R Antar, Apurv Soni, Yukari C Manabe
220 [GO] 2025―Jan―29 P-1948. Differential Patterns of Protection from Natural Infection against SARS-CoV-2 Reinfection in the Pre-Omicron and Omicron Eras Hiam Chemaitelly, Houssein H Ayoub, Laith J Abu-Raddad
221 [GO] 2025―Jan―29 641. Real-Time Whole Genome Sequencing Surveillance of Healthcare Associated SARS-CoV-2, Respiratory Syncytial Virus (RSV) and Influenza Vatsala Rangachar Srinivasa, Marrisa P Griffifth, Rose Patrick, Kady D Waggle, Dumebi Okonkwo, Daria Van Tyne, et al. (+4)
222 [GO] 2025―Jan―29 P-1907. Comparing Multisystem Inflammatory Syndrome in Children (MIS-C) Case Characteristics Across Periods of SARS-CoV-2 (SC2) Variant Predominance in Los Angeles County (LAC): 2020-2023 Christina Collins, Annabelle de St Maurice, Elizabeth Traub, Israa Khanqadri, Lauren E Finn
223 [GO] 2025―Jan―29 P-1952. SARS-CoV-2 Self-Testing Modalities Demonstrate Concerning Inaccuracies Among Rural, Minority Populations: The ALL-IN SC Study Madeleine M Meyer, Stella C W Self, Virginie Daguise, Melissa Nolan
224 [GO] 2025―Jan―29 P-2012. Predicting Persistent SARS-CoV-2 Shedding in Immunocompromised Patients: A Probability-Based Approach Eui Jin Chang, Jun-Won Kim, Choi-Young Jang, Sung Woon Kang, Ji Yeon Kim, Seongman Bae, et al. (+11)
225 [GO] 2025―Jan―29 P-2363. Efficacy Of SARS-CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome John K Chia, David Wang
226 [GO] 2025―Jan―29 P-2001. Limited Yield of Weekly SARS-CoV-2 Surveillance Testing Among Asymptomatic Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients Marie H Wilson, Elizabeth M Krantz, Steven A Pergam, Marco Mielcarek, Suni Elgar, Emily A Rosen, et al. (+5)
227 [GO] 2025―Jan―29 P-1946. Epidemiology and Factors Associated with SARS-CoV-2 Transmission Among Students Following Resumption of Face-to-Face Classes in a Private University in Metro Manila, Philippines Dianne Hazel P Do, Jay Ron O Padua
228 [GO] 2025―Jan―29 P-100. Durable immune response induced by self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidates against variants of concern (VOC) in HIV-negative and people living with HIV (PLWH) populations in South Africa, irrespective of prior SARS-CoV-2 vaccination Atul Nagare, Elizabeth Martin, A Koen, E Mitha, Khatija Ahmed, M Dhar, et al. (+11)
229 [GO] 2025―Jan―29 P-2352. Post-pandemic SARS-CoV-2 vaccination and infection status and risk of influenza-like illnesses and work absenteeism in healthcare workers - a prospective cohort study Tamara K Dörr, Joanne Lacy, Tala Ballouz, Alexia Cusini, Fabian Grässli, Sarah Haile, et al. (+11)
230 [GO] 2025―Jan―29 P-2070. SARS-CoV-2 Vaccination Rates Among a Cohort of Pediatric Solid Organ Transplant Recipients Christopher Reis, Elizabeth H Ristagno, Theresa Madigan
231 [GO] 2025―Jan―29 P-1972. SARS-CoV-2 Vaccine-Induced IgG4 Response Negatively Correlates with Neutralizing Antibodies and Fc Effector Functions Raj Kalkeri, Mingzhu Zhu, Shane Cloney-Clark, Anand Parekh, Drew Gorinson, Rongman Cai, et al. (+9)
232 [GO] 2025―Jan―29 P-1955. Trends in Skilled Nursing Facility Outbreak Characteristics by Prevalent SARS-CoV-2 Variant - Los Angeles County, July 2020 - January 2024 Brendan O’Shea, Amanda Neikirk, Israa Khanqadri, Camellia Babaie, Zachary A Rubin, Prabhu Gounder
233 [GO] 2025―Jan―29 P-1945. Genomic Surveillance of SARS-CoV-2 Variants among Children Enrolled in the New Vaccine Surveillance Network (NVSN) - Kansas City Dithi Banerjee, Stephanie Gummersheimer, Anjana Sasidharan, Benjamin R Clopper, Heidi L Moline, Rangaraj Selvarangan
234 [GO] 2025―Jan―29 P-1953. Youden’s Index Ensures the Accuracy of Wastewater-based Surveillance of SARS-CoV-2 Variants by Allele-Specific RT-qPCR or Genomic Sequencing Md Pervez Kabir, Elisabeth Mercier, Nada Hegazy, Tram B Nguyen, Chandler H Wong, Lakshmi Pisharody, et al. (+4)
235 [GO] 2025―Jan―29 P-1916. The impact of SARS-CoV-2 VOCs on clinical outcomes: an Umbrella Review Federico Fama, Rebecca Fattore, Paolo Raimondo, Fabio Brivio, Darcy Holmes, Toussaint Muheberimana, et al. (+4)
236 [GO] 2025―Jan―29 P-2023. A ‘Variant-Proof’ Cocktail Of Two Heavy Chain-Only Antibodies Targets 3 Epitopes In The Spike Protein S1 And S2 Subunits And Broadly Neutralizes SARS-Cov-2 With Exceptional Potency Toon Venneman, Florence M Herschke, Rinaldi Manuela, Van Royen Tessa, Christophe Blanchetot, Bert Schepens, et al. (+9)
237 [GO] 2025―Jan―29 P-102. Six-Month Safety, Durability, and Cross-Neutralization of the SARS-CoV-2 XBB.1.5-Containing Vaccine Frances Priddy, Nichole McGhee, Spyros Chalkias, Jordan L Whatley, Brandon Essink, Adam Brosz, et al. (+9)
238 [GO] 2025―Jan―29 P-1915. Factors Associated with Post-discharge Mortality among SARS-CoV-2-infected Adult Patients with Severe Acute Respiratory Infection in Bangladesh during 2020-2023 Saju Bhuiya, Md Ariful Islam, Tanzir Ahmed Shuvo, Md Abdul Aleem, Md Zakiul Hassan, Fahmida Chowdhury
239 [GO] 2025―Jan―29 P-1033. Post-transplant Outcomes in Kidney Transplant Recipients with Invasive Fungal Infections Prior vs. After the Emergence of SARS-CoV2 Jiashu Xue, Mary Grace Bowring, Darin B Ostrander, Nitipong Permpalung, Lucy X Li
240 [GO] 2025―Jan―29 89. First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses Dinesh De Alwis, Francesco Borriello, Eric Carlin, Rounak Nassirpour, Stephanie Straley, Anna Allen, et al. (+8)
241 [GO] 2025―Jan―29 P-1976. Incidence and Outcomes of Community-Onset Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections in the Pre- and Post-COVID-19 Pandemic Jessica Chung, May Thet Hmu Tun, Khin Htet Htet Soe, Tin Mee Mee Aung, May Thu Zin, Franklin Liu, et al. (+3)
242 [GO] 2025―Jan―29 P-33. Vaccine Hesitancy in HIV Patients Following the COVID19 Pandemic Kory Kropman, Amit T Vahia, Susan M Szpunar, Leonard B Johnson
243 [GO] 2025―Jan―29 P-355. Skin Lesions and the Use of Personal Protective Equipment in Healthcare Workers from Lima, Peru during the COVID 19 Pandemic Carolina Coombes, Paula Arribas-Garcia, Amira Llerena-Delgado, Rodrigo M Carrillo-Larco, Manuel Armando del Solar-Chacaltana
244 [GO] 2025―Jan―29 P-1316. Influenza Antiviral Prescribing Practices for Outpatients with an Acute Respiratory Illness and at Increased Risk for Influenza-Associated Complications pre- and post-COVID-19 pandemic - United States, 2016-2022 Jessie R Chung, Sascha Ellington, Ashley Price
245 [GO] 2025―Jan―29 P-202. 7- Year experience with Clostridioides difficile Infection (CDI): pre- and post-COVID-19 pandemic, effect of diagnostic stewardship and the gender difference Mariam Younas, Ann Newell, Anthony Armor, Carlos Rios-Bedoya
246 [GO] 2025―Jan―29 P-1104. Single-Dose and Repeat Single-Dose Ascending Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza Shawn Flanagan, Ozlem Equils, Roxana E Rojas, Tristan Baguet, Sy-Shi Wang, Voon Ong, Taylor Sandison
247 [GO] 2025―Jan―29 P-1991. Unique Demographic Characteristics of Patients Experiencing Long COVID Christopher Kricorian
248 [GO] 2025―Jan―29 P-1908. The Relationship Between Long COVID and PHQ-4 Measures of Emotional Health Christopher Kricorian
249 [GO] 2025―Jan―29 P-1927. Utilization of Patient Characteristics and the Area Deprivation Index (ADI) To Evaluate Referral Patterns for Long COVID at a Tertiary-Care Veterans Affairs (VA) Medical Center Martha Brennan, Brigid Wilson, Usha Stiefel
250 [GO] 2025―Jan―29 P-1974. Surface Protein Profiling of Extracellular Vesicles: A Novel Biomarker Approach for Long COVID Diagnosis? Gentaro Ikeda, Prasanna Jagannathan, Mario Leki, Hiroyuki Inoue, Vanessa El Kamari, Arya V Dadhania, et al. (+5)
251 [GO] 2025―Jan―29 P-1939. Health status and symptom perception among patients recently diagnosed with Long COVID in the United States Thomas F Oppelt, Michael Caron, Jamie Zagorski, Rodney H Taylor, Chinonso Akano, Lisa McCorkell, et al. (+2)
252 [GO] 2025―Jan―29 578. Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH Carolyn Bramante, Til Sturmer, Jared Huling, John Buse, Steve Johnson, Christopher Lindsell, et al. (+4)
253 [GO] 2025―Jan―29 P-1910. Long COVID Resolution Status and Health Impacts Christopher Kricorian
254 [GO] 2025―Jan―29 P-1985. Effect of vaccination on long COVID risk: An analysis of 3.6 million older US adults Yasin Abul, Daniel Harris, Preeti Chachlani, Kaley Hayes, Vincent Mor, Stefan Gravenstein
255 [GO] 2025―Jan―29 P-1902. Routine Anti-Nuclear Antibody (ANA) Testing in Patients Experiencing Long COVID: Worth it? Abigail Ghorbani, Nora Strong, MaryJane Keller, Luis Ostrosky-Zeichner
256 [GO] 2025―Jan―28 Viral burden and illness severity during acute SARS-CoV-2 infection predict persistent long COVID symptoms Elisabeth Brandstetter Figueroa, Anne E P Frosch, Kristina S Burrack, Gayathri Dileepan, Rachael Goldsmith, Morgan Harris, et al. (+7)
257 [GO] 2025―Jan―16 Ratio of Infections to COVID-19 Cases and Hospitalizations in the United States based on SARS-CoV-2 Seroprevalence Data, September 2021-February 2022 Yangyang Deng, Yun Kim, Anna Bratcher, Jefferson M Jones, Muloongo Simuzingili, Adi V Gundlapalli, et al. (+3)
258 [GO] 2025―Jan―08 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of US Children Bozena J Katic, Aspasia Katragkou, Jessica L Alvitres, Manisha Gurumurthy, Charles Li, Joseph V Schwab, et al. (+12)
259 [GO] 2024―Dec―31 The effect of nirmatrelvir-ritonavir on short- and long-term adverse outcomes from COVID-19 among patients with kidney disease: A propensity-score matched study Ian A Strohbehn, Tianqi Ouyang, Meghan D Lee, Sophia Zhao, Destiny Harden, Sherley M Mejia, et al. (+3)
260 [GO] 2024―Nov―26 Baseline Statin Use Appears to Protect Against Severe COVID-19 Eric A Meyerowitz, Arthur Y Kim
261 [GO] 2024―Oct―10 Impact of COVID-19 Pandemic on Group A Streptococcal Necrotizing Soft-Tissue Infections: A Retrospective Cohort Study Gioia Epprecht, David Weller, Daniel A Hofmaenner, Angeliki M Andrianaki, Pascal M Frey, Silvio D Brugger, Annelies S Zinkernagel
262 [GO] 2024―Oct―01 Diagnostic utility of SARS-CoV-2 nucleocapsid antigenemia: a meta-analysis Gregory L Damhorst, Sydney E Martin, Eli Wilber, Hans Verkerke, Michael Goodman, Wilbur A Lam
263 [GO] 2024―Sep―25 Symptoms 6 Weeks After COVID-19 are Reduced Among US Healthcare Personnel Receiving Additional Vaccine Doses during the Omicron Period, December 2021-April 2022 Nicholas M Mohr, Ian D Plumb, Eliezer Santos León, Malea Pinckney, Karisa K Harland, Anusha Krishnadasan, et al. (+39)
264 [GO] 2024―Sep―25 Impact of COVID-19 Nonpharmaceutical Interventions on Bordetella pertussis, Human Respiratory Syncytial Virus, Influenza Virus, and Seasonal Coronavirus Antibody Levels: A Systematic Review Channah M Gaasbeek, Maxime Visser, Rory D de Vries, Marion Koopmans, Rob van Binnendijk, Gerco den Hartog
265 [GO] 2024―Sep―19 Estimating the effect of COVID-19 vaccination and infection variant on post-COVID-19 venous thrombosis or embolism risk Andrew O’Carroll, Stephanie A Richard, Celia Byrne, Jennifer Rusiecki, Ben Wier, Catherine M Berjohn, et al. (+24)
266 [GO] 2024―Sep―18 The Value of Medical Chart Reviews: A Methodological Approach to Supplement Mortality Data During Pandemic Outbreaks Elizabeth M Boos, Maxwell Holtmann, Jack DeHovitz, James M Tesoriero, Redd Driver, Charles Gonzalez
267 [GO] 2024―Sep―17 Effectiveness of the first and second SARS-CoV-2 vaccine dose: a nationwide cohort study from Austria on hybrid versus natural immunity Alena Chalupka, Uwe Riedmann, Lukas Richter, Ali Chakeri, Ziad El-Khatib, Martin Sprenger, et al. (+9)
268 [GO] 2024―Sep―10 Estimated deaths averted in adults by COVID-19 vaccination in select Latin American and Caribbean Countries Alexandra Savinkina, Daniel M Weinberger, Cristiana M Toscano, Lucia H De Oliveira
269 [GO] 2024―Sep―09 Benefits of repeated SARS-CoV-2 vaccination and virus-induced cross-neutralization potential in immunocompromised transplant patients and healthy individuals David Hauser, Lorena Urda, Christopher Lang, Christian Mittelholzer, Fabian Otte, Enja Kipfer, et al. (+6)
270 [GO] 2024―Sep―07 A systematic review of nirmatrelvir/ritonavir and molnupiravir for the treatment of COVID-19 Alyson Haslam, Vinay Prasad
271 [GO] 2024―Sep―05 Correction to: Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach
272 [GO] 2024―Aug―28 Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras Melanie D Swift, Laura E Breeher, Ross Dierkhising, Joel Hickman, Matthew G Johnson, Daniel L Roellinger, Abinash Virk
273 [GO] 2024―Aug―28 Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-associated Emergency Department and Urgent Care Encounters in Immunocompetent Pregnant Persons, VISION Network, June 2022-August 2023 Allison Avrich Ciesla, Victoria Lazariu, Kristin Dascomb, Stephanie A Irving, Brian E Dixon, Manjusha Gaglani, et al. (+12)
274 [GO] 2024―Aug―26 The Impact of the COVID-19 Pandemic on Substance Use Disorders Risk among People Living with HIV Enrolled in HIV Care in the United States: an Interrupted Time Series Analysis Jennifer P Jain, Megan J Heise, Nadra E Lisha, Carlos H Moreira, David V Glidden, Greer A Burkholder, et al. (+11)
275 [GO] 2024―Aug―10 Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Covid-19: A Comparison across Age Strata Grace X Li, Komal Gopchandani, Noah Brazer, Ashley Tippett, Chris Choi, Hui-Mien Hsiao, et al. (+21)
276 [GO] 2024―Aug―10 Opportunities for enhanced public health surveillance via molecular detection and sequencing of diverse respiratory viruses from self-collected SARS-CoV-2 antigen test swabs Kat Schmidt, Simon D Pollett, Stephanie A Richard, Vivian Hogan, Emily Hone, Jennifer Rothenberg, et al. (+13)
277 [GO] 2024―Jul―24 Dry swabs and dried saliva as alternative samples for SARS-CoV-2 detection in remote areas in Lao PDR Bountoy Sibounheuang, Latsaniphone Boutthasavong, Danoy Chommanam, Koukeo Phommasone, Siribun Panapruksachat, Viladeth Praphasiri, et al. (+8)
278 [GO] 2024―Jul―23 Predicting COVID-19-Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study Merlin Moni, Dipu T Sathyapalan, Fabia Edathadathil, M Abdul Razak, Sivapriya G Nair, Chithira V Nair, et al. (+7)
279 [GO] 2024―Jul―19 Global Epidemiology and Seasonality of Human Seasonal Coronaviruses: A Systematic Review Rory Wilson, Dory Kovacs, Mairi Crosby, Antonia Ho
280 [GO] 2024―Jul―18 Higher Prevalence of Immunosuppression Among US Adults: Implications for COVID-19 and Respiratory Pathogen Vaccinations Yijia Li, Camille N Kotton
281 [GO] 2024―Jul―10 Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Pre-Exposure Prophylaxis: Experience from a Single Medical Center Keith W Hamilton, Elvis Hua, Lauren Dutcher, Holly Fernandez Lynch, Paul Junker, Abigail G Doucette, et al. (+18)
282 [GO] 2024―Jul―10 Effects of recent prior dengue infection on risk and severity of subsequent SARS-CoV-2 infection: a retrospective cohort study Nicole Tang, Jue Tao Lim, Borame Dickens, Calvin Chiew, Lee Ching Ng, Po Ying Chia, et al. (+4)
283 [GO] 2024―Jul―08 Similar limited protection against SARS-CoV-2 Omicron infection in vaccinated individuals with HIV and comparable controls Myrthe L Verburgh, Anders Boyd, Maarten F Schim van der Loeff, Margreet Bakker, Ferdinand W N M Wit, Marc van der Valk, et al. (+77)
284 [GO] 2024―Jul―08 Eighteen-Month Outcomes Among Pregnant and Nonpregnant Reproductive-Aged People Hospitalized for Coronavirus Disease 2019 Lisa M Bebell, Ann E Woolley, Kaitlyn E James, Andy Kim, Mary-Ruth Joyc, Kathryn J Gray, et al. (+8)
285 [GO] 2024―Jul―02 Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana Wonderful T Choga, Ontlametse T Bareng, Natasha O Moraka, Dorcas Maruapula, Irene Gobe, Nokuthula S Ndlovu, et al. (+15)
286 [GO] 2024―Jun―29 SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions Courtney E Harris, Vineeta Vaidya, Zhou Lan, Michael Klompas, Chanu Rhee, Lindsey Baden, Meghan A Baker
287 [GO] 2024―Jun―26 Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus-2 and other Coronaviruses, December 2019-July 2020 Kacie Grimm, Paula Saá, Narayanaiah Cheedarla, Michael S Gerty, Jamel A Groves, Roger Y Dodd, et al. (+2)
288 [GO] 2024―May―31 Performance of SARS-CoV-2 Diagnostics Based on Symptom Onset and Close Contact Exposure: An analysis from the Test Us At Home prospective cohort study Carly Herbert, Biqi Wang, Honghuang Lin, Yi Yan, Nathaniel Hafer, Caitlin Pretz, et al. (+28)
289 [GO] 2024―May―31 In Utero Exposure to Maternal SARS-CoV-2 Infection is Associated with Higher Left Ventricular Mass in Toddlers Mollie W Ockene, Duraisamy Balaguru, Ingrid L Ma, Samuel C Russo, Allison K Arpante, Alexandra Clifford, et al. (+7)
290 [GO] 2024―May―24 Varicella zoster virus-induced neurological disease after COVID-19 Vaccination: A Multicenter Observational Cohort Study Meital Elbaz, Tomer Hoffman, Dafna Yahav, Sarah Dovrat, Nesrin Ghanem-Zoubi, Alaa Atamna, et al. (+13)
291 [GO] 2024―May―03 The DARPin antiviral ensovibep for non-hospitalized patients with COVID-19: Results from EMPATHY, a randomized, placebo-controlled Phase 2 study Jeff Kingsley, Nagalingeswaran Kumarasamy, Luis Abrishamian, Marc Bonten, Awawu Igbinadolor, Martha Mekebeb-Reuter, et al. (+17)
292 [GO] 2024―Apr―29 Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based testing and healthcare claims Scott P Kelly, Lisa M McEwen, Magnus Isaksson, Sarah Murphy, Simon White, Matthew E Levy, et al. (+10)
293 [GO] 2024―Apr―29 A Comparison of Recruitment Methods for a Remote, Nationwide Clinical Trial for COVID-19 Treatment Katrina M Hartman, Barkha Patel, Via Rao, Aubrey A Hagen, Hanna G Saveraid, Regina Fricton, et al. (+12)
294 [GO] 2024―Apr―25 Global seasonal activities of respiratory syncytial virus before the COVID-19 pandemic: a systematic review Songwei Shan, Weixin Zhang, Huizhi Gao, Pei-Yu Huang, Zhanwei Du, Yuan Bai, et al. (+5)
295 [GO] 2024―Apr―24 Machine Learning-based Analysis of Publications Funded by the National Institutes of Health's Initial COVID-19 Pandemic Response Anirudha S Chandrabhatla, Adishesh K Narahari, Taylor M Horgan, Paranjay D Patel, Jeffrey M Sturek, Claire L Davis, et al. (+2)
296 [GO] 2024―Apr―16 Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen Essy Mozaffari, Aastha Chandak, Chidinma Chima-Melton, Andre C Kalil, Heng Jiang, EunYoung Lee, et al. (+5)
297 [GO] 2024―Apr―03 Rural-urban differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization, 2020 to 2023 Mohammed Yousufuddin, Maryam Mahmood, Ebrahim Barkoudah, Fatimazahra Badr, Kanika Khandelwal, Warren Manyara, et al. (+5)
298 [GO] 2024―Apr―02 Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis Julio C Zuniga-Moya, Benjamin Papadopoulos, Armaghan-E-Rehman Mansoor, Patrick B Mazi, Adriana M Rauseo, Andrej Spec
299 [GO] 2024―Apr―01 Immune Responses in Discharged COVID-19 Patients with and without Long COVID Symptoms Yeming Wang, Li Guo, Dan Cui, Hui Zhang, Qiao Zhang, Lili Ren, et al. (+11)
300 [GO] 2024―Mar―26 Analysis of National Institutes of Health Funding for the COVID-19 Pandemic Adishesh K Narahari, Taylor M Horgan, Anirudha S Chandrabhatla, D Chris Gist, Paranjay D Patel, Mark A Lantieri, et al. (+4)
301 [GO] 2024―Mar―19 An upsurge of measles cases in Mali - a consequence of pandemic-associated disruption in routine immunization Nginache Nampota-Nkomba, Adama Mamby Keita, Jane Juma, Diakaridia Sidibe, Nana Kourouma, Seydou Sissoko, et al. (+8)
302 [GO] 2024―Mar―19 An intense out-of-season rebound of the influenza activity after the relaxation of COVID-19 restrictions in Beijing, China Li Zhang, Wei Duan, Chunna Ma, Jiaojiao Zhang, Ying Sun, Jiaxin Ma, et al. (+5)
303 [GO] 2024―Mar―18 Impact of the COVID-19 Pandemic on Candida auris Infections: A Retrospective Analysis in an Academic Medical Center in New York City Sarah Schaefer, Gopi Patel, Emily Walits, Kalani Thaler
304 [GO] 2024―Mar―13 Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses Susanna E Barouch, Taras M Chicz, Ross Blanc, Domenic R Barbati, Lily J Parker, Xin Tong, et al. (+2)
305 [GO] 2024―Mar―06 Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6-12 Months Postinfection Zoe O Demko, Tong Yu, Sarika K Mullapudi, M Gabriela Varela Heslin, Chamia A Dorsey, Christine B Payton, et al. (+6)
306 [GO] 2024―Feb―28 Which Topics Drive Dissemination? Alternative Bibliometrics Analysis of the Highest-Ranking Articles in Three Infectious Diseases Journals Before COVID-19 Jasmine R Marcelin, Shipra Goel, William N Niehaus, Robert C Messersmith, Kelly A Cawcutt
307 [GO] 2024―Feb―23 COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO) - A Randomized-Controlled Clinical Trial Michelle Le, Lauren Khoury, Yang Lu, Connor Prosty, Maxime Cormier, Mathew P Cheng, et al. (+9)
308 [GO] 2024―Feb―20 Correction to: 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022
309 [GO] 2024―Feb―13 Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort Slade Decker, Shaoming Xiao, Carly Dillen, Christina M Schumacher, Aaron M Milstone, Matthew Frieman, Amanda K Debes
310 [GO] 2024―Feb―06 Burnout, Compassion Fatigue and the Long Haul of Caring for Long COVID Christian B Ramers, John D Scott, Bruce B Struminger
311 [GO] 2024―Feb―05 Overestimation of Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission in Settings of High Community Transmission: Insights From an Informal Settlement Community in Salvador, Brazil Juan P Aguilar Ticona, Nivison Nery, Matt Hitchings, Emilia M M Andrade Belitardo, Mariam O Fofana, Murilo Dorión, et al. (+11)
312 [GO] 2024―Feb―02 Healthcare Provider N95 Respirator Contamination Worn Behind Face Shields with SARS-CoV-2 during Routine Clinical Care of Patients with COVID-19 Amanda M Graves, Bobby G Warren, Aaron Barrett, Sarah S Lewis, Becky Smith, David J Weber, et al. (+2)
313 [GO] 2024―Feb―01 Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic Jennifer Milucky, Kadam Patel, Monica E Patton, Pam Daily Kirley, Elizabeth Austin, James Meek, et al. (+23)
314 [GO] 2024―Jan―29 Real-world Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged ≥65 Years in the Pre-Delta and High Delta Periods Yun Lu, Arnstein Lindaas, Kathryn Matuska, Hector S Izurieta, Rowan McEvoy, Mikhail Menis, et al. (+7)
315 [GO] 2024―Jan―24 Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study Panpan Zhu, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Jimin Shi, Yanmin Zhao, et al. (+6)
316 [GO] 2024―Jan―20 Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel Emily J Ciccone, Deanna R Zhu, Annika K Gunderson, Sam Hawke, Rawan Ajeen, Evans K Lodge, et al. (+16)
317 [GO] 2024―Jan―16 Viewpoint on HIV medical care retention guidelines in the COVID-19 pandemic era and beyond: lessons learned from Electronic Health Record screening and outreach Ethan Moitra, Paola C Jiménez Muñoz, Martha C Sanchez, Megan M Pinkston
318 [GO] 2024―Jan―10 Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study Cléa Melenotte, Nathalie Chavarot, Anne-Sophie L’Honneur, Sylvain Bodard, Morgane Cheminant, Adrien Flahault, et al. (+18)
319 [GO] 2024―Jan―09 Effectiveness of mRNA booster vaccine against COVID-19 infection and severe outcomes among persons with and without immune dysfunction: a retrospective cohort study of national electronic medical record data in the United States Jing Sun, Qulu Zheng, Alfred J Anzalone, Alison G Abraham, Amy L Olex, Yifan Zhang, et al. (+10)
320 [GO] 2024―Jan―05 Disparities in COVID-19 Clinical Outcomes and Vaccination Coverage Among Migrants with HIV in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis Daniel K Nomah, Yesika Díaz, Andreu Bruguera, Sergio Moreno-Fornés, Jordi Aceiton, Juliana Reyes-Urueña, et al. (+10)
321 [GO] 2024―Jan―03 Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine Tara M Babu, Xiaoying Shen, R Scott McClelland, Zijun Wang, Stacy Selke, Chloe Wilkens, et al. (+10)
322 [GO] 2024―Jan―02 Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial Jennifer Hendrick, Jennie Z Ma, Heather M Haughey, Rachael Coleman, Uma Nayak, Alexandra Kadl, et al. (+5)
323 [GO] 2023―Dec―30 Clinical outcomes of U.S. adults hospitalized for COVID-19 and influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021-September 2022 Noah Kojima, Christopher A Taylor, Mark W Tenforde, Dawud Ujamaa, Alissa O’Halloran, Kadam Patel, et al. (+29)
324 [GO] 2023―Dec―29 COVID-19 Convalescent Plasma Therapy: Long Term Implications Hyunah Yoon, Yi Li, Keith S Goldfeld, Gia F Cobb, Caroline L Sturm-Reganato, Luis Ostrosky-Zeichner, et al. (+84)
325 [GO] 2023―Dec―23 Genomic Epidemiology of SARS-CoV-2 in a County Jail Timileyin Adediran, Chad Zawitz, Ali Piriani, Emily Bendict, Stephanie Thiede, Hannah Barbian, et al. (+6)
326 [GO] 2023―Dec―22 Oral COVID-19 antiviral uptake among a highly vaccinated U.S. cohort of adults with SARS-CoV-2 infection between December 2021 and October 2022 Yanhan Shen, McKaylee M Robertson, Sarah G Kulkarni, Laura Puzniak, Joann M Zamparo, Kristen E Allen, et al. (+7)
327 [GO] 2023―Dec―22 Clinical setting comparative analysis of uropathogens and antibiotic resistance: a retrospective study spanning the COVID-19 pandemic Alexandra M Young, Mark M Tanaka, Christopher Yuwono, Michael C Wehrhahn, Li Zhang
328 [GO] 2023―Dec―22 Breaking Barriers: A Single-Center Real-World Experience With Recruitment and Administration of COVID-19 Monoclonal Antibodies and Opportunities for Improvement Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez
329 [GO] 2023―Dec―21 Prevalence of endemic respiratory viruses during the COVID-19 pandemic in urban and rural Malawi Elen Vink, Louis Banda, Abena S Amoah, Stephen Kasenda, Jonathan M Read, Chris Jewell, et al. (+6)
330 [GO] 2023―Dec―18 Three Years of the Coronavirus Disease 2019 Pandemic in a European Region: A Population-Based Longitudinal Assessment in Madrid Between 2020 and 2022 Juan Berenguer, María J Calvo-Alcántara, Alejandro Alvaro-Meca, José C Estévez, Miguel Basanta, Sergio Ruiz, et al. (+10)
331 [GO] 2023―Dec―12 Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic Samantha Fry, Kulkanya Chokephaibulkit, Sridevi Pallem, Ouzama Henry, Yongjia Pu, Agnes Akawung, et al. (+44)
332 [GO] 2023―Dec―07 A multinational case series describing successful treatment of persistent SARS-CoV-2 infection caused by Omicron sublineages with prolonged courses of nirmatrelvir/ritonavir. Luke B Snell, Aimee McGreal-Bellone, Clemency Nye, Sarah Gage, Prijay Bakrania, Tom G S Williams, et al. (+10)
333 [GO] 2023―Dec―07 Use of rapid antigen triple test nasal swabs (COVID-VIRO ALL-IN TRIPLEX: SARS-CoV-2, respiratory syncytial virus, and influenza) in children with respiratory symptoms: a real-life prospective study Robert Cohen, Hervé Haas, Olivier Romain, Stéphane Béchet, Catherine Romain, Camille de Truchis de Lays, et al. (+4)
334 [GO] 2023―Dec―07 Risk of Severe Maternal Morbidity Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection During Pregnancy Annette K Regan, Onyebuchi A Arah, Deshayne B Fell, Sheena G Sullivan
335 [GO] 2023―Nov―30 Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children Adriana Weinberg, Michael J Johnson, Krystle Garth, Elena W Y Hsieh, Ross Kedl, Daniela Weiskopf, et al. (+5)
336 [GO] 2023―Nov―29 Incidence of SARS-CoV-2 breakthrough infections after vaccination in adults: A population-based survey through March 1, 2023 Stacia M DeSantis, Ashraf Yaseen, Tianyao Hao, Luis León-Novelo, Yashar Talebi, Melissa A Valerio-Shewmaker, et al. (+13)
337 [GO] 2023―Nov―29 Using a Health Information Exchange to Characterize Changes in HIV Viral Load Suppression and Disparities During the COVID-19 Pandemic in NYC Emma Tucker, Harry Reyes Nieva, Kayla Schiffer, Michael T Yin, Delivette Castor, Peter Gordon, et al. (+2)
338 [GO] 2023―Nov―29 Effectiveness of Sotrovimab in Preventing COVID-19-related Hospitalizations or Deaths Among U.S. Veterans during Omicron BA.1 Yinong Young-Xu, Caroline Korves, Gabrielle Zwain, Sacha Satram, Myriam Drysdale, Carolina Reyes, et al. (+5)
339 [GO] 2023―Nov―29 Nasopharyngeal Viral Load is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection Meng Xu, Meagan P O’Brien, Andrea T Hooper, Eduardo Forleo-Neto, Flonza Isa, Peijie Hou, et al. (+7)
340 [GO] 2023―Nov―27 279. Inhaled Sargramostim (rhu GM-CSF) Leads to Enhanced SARS-CoV-2 Virus-Specific Immune Response and Viral Clearance: Results of the Biomarker Cohort of a Randomized, Double-Blind, Placebo-Controlled Phase 2b Trial in Non-Hospitalized Patients with COVID-19 Ila Joshi, Fiona Garner, Debasish F Roychowdhury, Lorinda Simms, Sanjeev Ahuja, John L McManus, et al. (+4)
341 [GO] 2023―Nov―27 2700. Reducing the Dose of Mycophenolate in Solid Organ Transplant Recipients Diagnosed with SARS-CoV-2 Infection Increases the Risk of Severe COVID-19 Marion Gillcrist, Stephen Waller, Ryan M Taylor, Nathan C Bahr, Diane M Cibrik, Zubair Shah, Albert Eid
342 [GO] 2023―Nov―27 2316. SARS-CoV-2 N-antibody Seropositivity in Healthcare Personnel without a Known History of COVID-19 Sajal K Tiwary, Carrie O’Neal, Kate Peacock, Rachel Bosserman, Candice Cass, Mostafa Amor, et al. (+12)
343 [GO] 2023―Nov―27 448. Real World Evaluation of Clinical Outcomes for Short-Duration Remdesivir Therapy in Hospitalized Patients with Mild-Moderate COVID-19 Kelsey N Williams, Timothy P Gauthier, Stacey W Baker, Jefferson Cua
344 [GO] 2023―Nov―27 2502. Best Practice Alert for Hepatitis C Virus Screening Demonstrates Importance of Reminders during Disruptive Times (COVID-19) Alec R Mason, A L exander P Radunsky, Stephanie M Reyes, Jennifer McBryde, Mamta K Jain
345 [GO] 2023―Nov―27 2338. Robust and Persistent B Cell Responses Following Third Dose SARS-CoV-2 Vaccine Determine Protection from COVID-19 Joanne Byrne, Lili Gu, Alejandro García-León, Colette Marie Gaillard, Julen Tomás-Cortázar, Riya Negi, et al. (+22)
346 [GO] 2023―Nov―27 2290. Neurological Symptoms of Long - COVID in Mexican Ambulatory Adults with Mild COVID-19 Jorge-Baruch Díaz-Ramírez, Jorge Bryan Ortega Marquez, Yazmín González-Valadez, Luis-Alberto Cortazar-Maldonado, José-Antonio Morales-Fernández, Miguel A Pérez-Sastré, et al. (+12)
347 [GO] 2023―Nov―27 249. SARS-CoV-2 Spike Immune Complexes Induce NETosis in COVID-19 Kiana C Allen, Marcos J Ramos-Benitez, Heather Teague, Daniel S Chertow, Jeffrey R Strich, Seth Warner
348 [GO] 2023―Nov―27 509. A Comparison of Tocilizumab and Baricitinib for Hospitalized Patients with Severe COVID-19 Priyanka Aytoda, Benjamin Albrecht, Sarah B Green, Gavin Harris, Lindsay M Busch, Mary Elizabeth Sexton, et al. (+2)
349 [GO] 2023―Nov―27 472. The impact of sarcopenia on unfavorable outcomes in lung transplant patients with COVID-19 Min Han, Jung Ah Lee, Su Jin Jeong, Jung Ho Kim, Jin Young Ahn, Jun Yong Choi, et al. (+2)
350 [GO] 2023―Nov―27 422. Impact of Respiratory Virus Co-Infection in Pediatric COVID-19 Manvita Mareboina, Katrina Bakhl, James Fisher, Simrat Jassal, Jessica E Ericson, Patrick Gavigan
351 [GO] 2023―Nov―27 511. Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment For COVID-19 Ashish Bhargava, Susan M Szpunar, Mamta Sharma, Louis Saravolatz
352 [GO] 2023―Nov―27 535. Risk Factors for Seeking Medical Care Following Monoclonal Antibody Treatment For COVID-19 I S M A I L O MALIK, Susan M Szpunar, Natali Salaytah, Ashish Bhargava, Mamta Sharma
353 [GO] 2023―Nov―27 502. Telemedicine Service for Evaluation of Pediatric Outpatients at High Risk for Severe COVID-19 Kathryn E Weakley, Kristina Bryant
354 [GO] 2023―Nov―27 513. Evaluating the safety of baricitinib versus tocilizumab in hospitalized patients with COVID-19 Kendall Brickel, Lyndsi Meyenburg, Dusten T T Rose, Neil Pan
355 [GO] 2023―Nov―27 2374. Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir against COVID-19 Hailey J Park, Sophia T Tan, Tomás M León, Seema Jain, Robert Schechter, Nathan C Lo
356 [GO] 2023―Nov―27 439. Impact of viral load in HIV adult patients hospitalized with COVID-19 Alberto Romero Garcia, Chee Yao Lim, Jorge Gutierrez, Afsheen Afzal, Dwayvania Miller, Alexander La Fortune, et al. (+2)
357 [GO] 2023―Nov―27 505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19 Elham Amini, Mark Shelton, Anuja Raut, Anna Kwan, Deqing Xiao, Shuguang Chen, et al. (+4)
358 [GO] 2023―Nov―27 506. Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19 Kristen Andreatta, Jiani Li, Lauren Rodriguez, Dong Han, Simin Xu, Jason K Perry, et al. (+3)
359 [GO] 2023―Nov―27 2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19 Holly Biggs, Kelly A Jackson, Joelle Nadle, Susan Petit, Susan M Ray, Ghinwa Dumyati, et al. (+5)
360 [GO] 2023―Nov―27 2486. Winners and Losers: MDROs In The Time of COVID-19 Hwang Ching Chan, Geraldine Tingting Foo, Ka Lip Chew, Paul Ananth Tambyah, Jyoti Somani
361 [GO] 2023―Nov―27 1794. Analysis of Antimicrobial Resistance Patterns in a Large Sample of US Hospitals Before and After COVID-19 Tarjani M Ranade, Meggie Griffin, Rebecca Schwei, Michael Pulia
362 [GO] 2023―Nov―27 1346. Genetic Variation at the Interferon λ Locus and Association with Clinical Outcome and Severity of COVID-19 Dana Alalwan, Riya Negi, Alejandro García-León, Gurvin Saini, Colette Marie Gaillard, Grace Kenny, et al. (+10)
363 [GO] 2023―Nov―27 1357. Initial and Peak Serum Levels of Krebs von den Lungen-6 for Prediction of Prognosis in Patients with COVID-19 Geonui Kim, Hyeonwoo Kwon, Sang Hyun Ra, Eui Jin Chang, Seongman Bae, Jiwon Jung, et al. (+6)
364 [GO] 2023―Nov―27 2310. Shifting COVID-19 admission screening practices- An Interrupted Time Series Analysis Rossana M Rosa, Mayan Gilboa, Adriana Jimenez, David Andrews, Huy Dinh, Katiuska Parra, et al. (+2)
365 [GO] 2023―Nov―27 1823. Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from the First Year of the Pandemic Upton D Allen, Michelle Barton, Julia Upton, Annette Bailey, Aaron Campigotto, Mariana Abdulnoor, et al. (+16)
366 [GO] 2023―Nov―27 2283. COVID-19 among Febrile Patients Presenting without Respiratory Symptoms in Six Hospitals along the Thai-Lao and Thai-Myanmar Borders, 2021-2011 Saithip Bhengsri, Emily Bloss, Beth Skaggs, Pongpun Sawatwong, Nuttagarn Chuenchom, Tanaphat Lertwitayakumjorn, et al. (+7)
367 [GO] 2023―Nov―27 471. In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab-Cilgavimab (T/C) Pre-Exposure Prophylaxis (PrEP) Ghady Haidar, Jana L Jacobs, Erin Salese, Justin Ludwig, Amy Heaps, Urvi Parikh, et al. (+18)
368 [GO] 2023―Nov―27 469. Outcomes of COVID-19 among hospitalized patients under Rituximab: the experience of a Portuguese hospital Maria João M S Gonçalves, Eduarda Pena, Frederico Duarte, Susana Oliveira, Clara Batista, Mário Guimarães, et al. (+3)
369 [GO] 2023―Nov―27 2333. Knowledge, attitudes, and practices regarding vaccination against COVID-19 among medical students at a private university in Lima - Peru Benjamin Ramos-Rojas, Sebastian Lopez-Rivera, Karla Tafur-Bances, Jose A Gonzales-Zamora, Jorge Alave
370 [GO] 2023―Nov―27 470. Clinical Effectiveness of The Monoclonal Antibody Combination Tixagevimab-Cilgavimab (T/C) as Pre-Exposure Prophylaxis (PReP) of COVID-19 among Patients (pts) with Moderate to Severe Immunocompromised (IC) Conditions across a Large U.S. Healthcare System: A Propensity Score-Matched Retrospective Cohort Study Ghady Haidar, Justin Ludwig, Donald M Yealy, Haley Camacho, Tina Chinakarn, Kevin Kip, et al. (+14)
371 [GO] 2023―Nov―27 501. Risk Factors for Persistent Active COVID-19 Among Patients Receiving B-Cell Depleting Therapy versus Non-B-Cell Immunosuppression Kevin Voll, Jacob Kartes, Emily S Spivak, Hannah Imlay
372 [GO] 2023―Nov―27 504. Individual and Neighborhood Factors Associated with Failure to Vaccinate Against COVID-19 Among Pregnant Persons Ousseny Zerbo, Thomas Ray, Bruce Fireman, Evan Layefsky, Kristin Goddard, Pat Ross, et al. (+2)
373 [GO] 2023―Nov―27 476. Increased Depression and Anxiety Associated with COVID-19 among Recipients of HIV Healthcare Services at Sexual Health Clinic in NYC Simian Huang, Jason Zucker, Delivette Castor, Caroline Carnevale, Elijah LaSota, Joshua Klein, et al. (+7)
374 [GO] 2023―Nov―27 2705. Predictors of Severe COVID-19 among Solid Organ Transplant Recipients Marion Gillcrist, Stephen Waller, Ryan M Taylor, Nathan C Bahr, Diane M Cibrik, Zubair Shah, et al. (+2)
375 [GO] 2023―Nov―27 409. Unvaccinated Adolescents Bear the Majority of Disease Burden of Severe COVID-19 Among Those Admitted to the Intensive Care Unit (ICU) Ashlesha Kaushik, Corey Thieman, Sandeep Gupta
376 [GO] 2023―Nov―27 2623. Persistence of SARS-CoV-2 S IgG Antibodies in Children that suffered from COVID-19 and Association of Antibody Levels with Vaccination Status Federico Di Gregorio, María S Tineo, Florencia A Bonnin, Lidia Torrado, María F Pavan, Lorena I Ibañez, et al. (+6)
377 [GO] 2023―Nov―27 433. Thromboinflammation in COVID-19 and association with death in patients on ECMO Andrew Platt, Viviane Callier, Zonghui Hu, Seth Warner, Syndey R Stein, Megan Anders, et al. (+21)
378 [GO] 2023―Nov―27 2328. COVID-19 and CLABSI: Riding the Pandemic Waves with an Active Infection Prevention Intervention Rama Thyagarajan, Kristin E Mondy, Lisa K Sturm, Coutney Watson, Karl Saake, Collin Miller, et al. (+2)
379 [GO] 2023―Nov―27 1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza - IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 - April 11, 2023 Katharine Yuengling, Diya Surie, Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A Ginde, et al. (+19)
380 [GO] 2023―Nov―27 412. Comparison of Outcomes in Pneumonia Patients Hospitalized with COVID-19 and Influenza in Connecticut, 2015-2020 Daewi Kim, Kimberly Yousey-Hindes
381 [GO] 2023―Nov―27 2347. Factors Associated with COVID-19 and Influenza Vaccine Coadministration in Rhode Island Lisa M Gargano, Dora M Dumont
382 [GO] 2023―Nov―27 1937. Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 - December 31, 2022 Alexandra F Dalton, Sarah Baca, Julia Raykin, Cria Perrine, Tegan Boehmer, Emilia Koumans, et al. (+2)
383 [GO] 2023―Nov―27 1834. Impact of COVID-19 and Socioeconomic Status on Food Insecurity in the US Adult Population: Analysis of the 2021 National Health Interview Survey Jincong Q Freeman, Xinyi Li, Yong Gun Lee, Adam W Scott, Yijin Xiang
384 [GO] 2023―Nov―27 1349. Unveiling the Link between COVID-19 and the Gut Microbiome in an Outpatient Cohort with Mild to Moderate Illness Isin Y Comba, Ruben A Mars, Mitchell Dumais, Trena Van Gorp, Jonathan Harrington, John C O’Horo, Purna C Kashyap
385 [GO] 2023―Nov―27 1847. A mixed methods approach to understanding the perceived risk of COVID-19 and vaccination perceptions among people living with HIV in Nebraska Titilola Labisi, Nada Fadul, Moses New-Aaron, Jason Coleman, Anthony Podany, Keyonna King
386 [GO] 2023―Nov―27 458. Risk of COVID-19 and vaccine immunogenicity in pediatric solid organ transplant recipients - a single center study in South Korea Jee Yeon Baek, Kyoung Ihn, Hong Koh, Keum Hwa Lee, Min Young Kim, Sinyoung Kim, et al. (+4)
387 [GO] 2023―Nov―27 527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies G O R D A N A SIMEUNOVIC, Liam R Sullivan, Heather Brooks, Sonia K Gentile
388 [GO] 2023―Nov―27 2317. The Impact of Universal versus Targeted Symptomatic COVID-19 Arrival Testing in Basic Military Trainees Marquise Westbrook, James Aden, John Kieffer, Erin Winkler, Theresa Casey, Dianne Frankel, et al. (+4)
389 [GO] 2023―Nov―27 393. Comparison of COVID-19 Associated Complications in Children during the First and Second Omicron Waves in Taiwan Jiun-An Chen, Huan-Cheng Lai, Yu-Lung Hsu, Hsiao-Chuan Lin, Chien-Heng Lin, Hsiu-Mei Wei, et al. (+3)
390 [GO] 2023―Nov―27 1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020-April 2021. Kadam Patel, Pam Daily Kirley, Breanna Kawasaki, James Meek, Kyle P Openo, Maya Monroe, et al. (+12)
391 [GO] 2023―Nov―27 405. Incidence and Potential Risk Factors of COVID-19 Associated Pulmonary Aspergillosis (CAPA) Waki Imoto, Koichi Yamada, Yukihiro Kaneko, Hiroshi Kakeya
392 [GO] 2023―Nov―27 514. Nirmatrelvir/ritonavir or Molnupiravir for Treatment of Non-hospitalized Patients with COVID-19 at Risk of Disease Progression Adeel A Butt, Peng Yan, Obaid Shaikh
393 [GO] 2023―Nov―27 2353. SARS-CoV-2 Variants among US Veterans after COVID-19 Bivalent Vaccine Administration Mark Holodniy, Ying Pei, Gary Stack, Christopher L Wade, Yashpal Agrawal, Nicholas Barasch, et al. (+4)
394 [GO] 2023―Nov―27 1034. COVID-19 Bloodstream Infection Outcomes Stratified by Social Determination Index (SDI) in NYC Public Hospital System Chee Yao Lim, Kenneth Johan, Jorge Gutierrez, Alberto Romero Garcia, Afsheen Afzal, Mohannad Al-Khateeb Al-Khateeb, et al. (+8)
395 [GO] 2023―Nov―27 2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies Muneerah M Aleissa, Sonya Davey, Rebecca Rooks, Natalie E Izaguirre, Bridget Yates, Urwah Kanwal, et al. (+3)
396 [GO] 2023―Nov―27 2379. An Urban Detroit Clinic’s Experience in Bivalent COVID-19 Booster Uptake in People Living with HIV Jahanavi M Ramakrishna, Abdullah Yesilyaprak, Lea M Monday, Gretchen Snoeyenbos Newman
397 [GO] 2023―Nov―27 2354. Factors associated with COVID-19 booster vaccine hesitancy: a nation-wide, cross-sectional survey in Japan Hitoshi Honda, Akane Takamatsu, Toshiki Miwa, Yasuharu Tokuda
398 [GO] 2023―Nov―27 2366. Profile and Outcomes of Vaccinated Adult Individuals with COVID-19 Breakthrough Infections Hospitalized in a Tertiary Hospital in the Philippines Mark Ramon Victor B Llanes, Regina Berba
399 [GO] 2023―Nov―27 303. Tissue-compartment specific differences in T-cell response found in 44 fatal COVID-19 cases Trevor M Stantliff, Andrew Platt, Syndey R Stein, Cihan Oguz, Kevin M Vannella, Sabrina Ramelli, et al. (+2)
400 [GO] 2023―Nov―27 2320. Impact of Lifting School Mask Mandates on Community COVID-19 Cases and Hospitalizations: A Nationwide, Retrospective Cohort Study with an Event Study Design Zeynep Ertem, Anesh Danesharasteh, Elissa Schechter-Perkins, Richard Nelson, Lloyd Fisher, Shira Doron, Westyn Branch-Elliman
401 [GO] 2023―Nov―27 1380. Machine Learning-based Estimation of Unconfirmed COVID-19 Cases from a 10,000-Household Survey in Gilgit-Baltistan, Pakistan Daniel S Farrar, Lisa G Pell, Yasin Muhammad, Sher Hafiz, Lauren Erdman, Diego G Bassani, et al. (+12)
402 [GO] 2023―Nov―27 2329. What Causes a Cluster to Grow? Factors Associated with a Nosocomial COVID-19 Cluster at a University Hospital in Central Tokyo Hilary Osaka, Yasuaki Tagashira, Yoshiaki Gu, Kunihiko Takahashi
403 [GO] 2023―Nov―27 1369. Effect of COVID-19 on Antibiotic Consumption: An Analysis of the COVID-19 Community Research Partnership Olivia Randazza, Michael E DeWitt, John C Williamson
404 [GO] 2023―Nov―27 420. Prevalence of comorbidities and COVID-19 vaccination among COVID-19 deaths Zin Lyons, Lauren DiBiase, Emily Sickbert-Bennett, David J Weber
405 [GO] 2023―Nov―27 2485. Candida auris Hospital Cluster: Were Our Unwelcome Guests Driven Away by the COVID-19 Delta Surge? Jyoti Somani, Nazira Muhammad Fauzi, Revathi Sridhar, Hwang Ching Chan, Isaac Taoyang Low, Ka Lip Chew, Dale Fisher
406 [GO] 2023―Nov―27 2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods James Baggs, Natalie McCarthy, Sujan Reddy, Hannah Wolford
407 [GO] 2023―Nov―27 521. A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease Geoffrey Dow
408 [GO] 2023―Nov―27 541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression Moritz Platzer, David Totschnig, Christoph Wenisch, Alexander Zoufaly
409 [GO] 2023―Nov―27 547. Molnupiravir and Nirmatrelvir/Ritonavir Effectiveness in Reducing the Risk for COVID-19 Disease Progression and Death Dimitrios Paraskevis, Mary Gkova, Kassiani Mellou, Kassiani Mellou, Kassiani Gkolfinopoulou, Evangelia Georgia Kostaki, et al. (+11)
410 [GO] 2023―Nov―27 2364. Predictive Ability of mRNA COVID-19 Vaccines Against COVID-19 Disease Severity Ashley Lew, Ashley Tippett, Luis W Salazar, Laila Hussaini, Chris Choi, Khalel De Castro, et al. (+15)
411 [GO] 2023―Nov―27 2213. History of Infection and Worry about COVID-19 Drive Antibiotic Use for “Flu- or COVID-like” Symptoms in the United States and Mexico during the Pandemic Jose Luis Camarena, Brooke Hawkes, Edward Bedrick, Katherine Ellingson
412 [GO] 2023―Nov―27 2524. Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects Haruaki Kurasaki, Masaki Ohuchi, Katsuma Matsui, Masatoshi Matsumoto, Kazutaka Nagatomo, Naoki Kawamura, et al. (+8)
413 [GO] 2023―Nov―27 526. Treatment Inconsistencies of Patients Hospitalized with COVID-19 during Four Waves in Almaty, Kazakhstan, 2020-2021 Saya Gazezova, Roberta Horth, Manar Smagul, Lena Kasabekova, Shokhruh Usmanov, S A N A M ZIKRIYAROVA, Dilyara Nabirova
414 [GO] 2023―Nov―27 533. Use of Different Communication Types for Telehealth for COVID-19 During Implementation of a State Telehealth Test to Treat Program in Minnesota Sarah Lim, Paige Dubelko, Walter James, Erin McLachlan, David Tsay, Ruth Lynfield
415 [GO] 2023―Nov―27 518. Comparable Outcomes of Remdesivir and Sotrovimab among High-risk Patients with Mild to Moderate COVID-19 During the Omicron BA.1 Surge Supavit Chesdachai, Christina G Rivera (O'Connor), Kristin Mara, Hiliary R Teaford, Maria Gonzalez Suarez, Jennifer J Larsen, et al. (+3)
416 [GO] 2023―Nov―27 522. Real-World, Retrospective Descriptive Study of COVID-19 Outpatient Therapeutic Uptake in High-Risk Patients Subsequently Hospitalized for COVID-19 During the Omicron Period in the US Amie Scott, Laura A Puzniak, Michael V Murphy, Darrin W Benjumea, Andrew Rava, Michael Benigno, et al. (+7)
417 [GO] 2023―Nov―27 432. Predictors for oxygen requirements in patients hospitalized with COVID-19 during the Omicron surge, January 2022 Jonathan K Pinsky, Mary Anderson, Ines M Casey, Jason M Pinsky
418 [GO] 2023―Nov―27 361. Evaluation of Resistance to Nirmatrelvir/ritonavir in Evaluation of Protease Inhibition for COVID-19 (EPIC) High-Risk and Standard-Risk Clinical Trials Mary Lynn Baniecki, Shunjie Guan, Zhenyu Wang, Yan Chen, Weihang Bao, Wen He, et al. (+8)
419 [GO] 2023―Nov―27 2633. Nasal Colonization Status of Respiratory Viruses in Patients During the COVID-19 Epidemic Period at a Tertiary Hospital in Japan Tomohiro Katsuta, Ryo Niiya, Yukitsugu Nakamura, Naoki Shimizu
420 [GO] 2023―Nov―27 2626. Natural History of RSV Infection in Outpatient Episodes Among Adults in the United States using an EHR Data Source by COVID-19 Era Diana Garofalo, Joshua T Swan, Emily Webber, Sally R Omidvar, Margaret Tawadrous, Glenn Pixton, et al. (+6)
421 [GO] 2023―Nov―27 2627. Natural History of RSV Infection in Outpatient Episodes Among Children in the United States using Two EHR Data Sources by COVID-19 Era Diana Garofalo, Sima Toussi, Joshua T Swan, Maria Kudela, Padmalatha Reddy, Emily Webber, et al. (+7)
422 [GO] 2023―Nov―27 2292. Measuring Effectiveness against a Shifting Variant Landscape: COVID-19 Example in the Department of Veterans Affairs Scott L DuVall, Julie A Lynch, Patrick R Alba, Michael E Matheny, Marc A Suchard, Amanda R Shields, et al. (+6)
423 [GO] 2023―Nov―27 1767. Ventilation in Non-Healthcare Congregate Settings: Capacity-Building Assessments to Reduce COVID-19 Exposure Risks, California 2022 - 2023 Jared G Wiegand, Kyle T Peerless, Robert Stepp, Elon Ullman, Taria Greenberg, Cameron R Stainken, et al. (+3)
424 [GO] 2023―Nov―27 1176. Assessing the Impact of Collaborative Antimicrobial Stewardship Guidelines on the Use of Antibiotics in Hospitalized Veterans with COVID-19 from Five Veterans Health Administration (VHA) Hospitals Neena Thomas-Gosain, Kelly W Davis, Sage Hendrickson, Todd Hulgan, Parmida Parvaz, Caroline Powers, et al. (+3)
425 [GO] 2023―Nov―27 391. Patients Hospitalized for Acute Coronary Syndrome with Concomitant COVID-19 have Worse Clinical Outcomes Deepali Boothankad Sharath, Leonid Khokhlov, Usha Thapa, Amr Aboelnasr, Leanne Pereira, Jose Improvola, Anar Patel
426 [GO] 2023―Nov―27 1444. Candida auris Outbreak in a COVID-19 Hospital: Detection and Containment Victor Baylon-Valdez, Gloria Mayela Aguirre-García, Claudia E Guajardo-Lara, Mary C Aleman-Bocanegra, Michel F Martínez-Reséndez
427 [GO] 2023―Nov―27 1095. Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England Sabada Dube, Yi Lu, Richard McNulty, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
428 [GO] 2023―Nov―27 498. Covid-19 Hospitalization Rates in Kidney Transplant Patients Treated with Tixagevimab/Cilgavimab Katherine Dugan, Jillian Casale, Heather DeSanto, Colleen Dowling, Steven Smoke
429 [GO] 2023―Nov―27 461. COVID-19 Hospitalizations among Vaccinated and Unvaccinated Immunocompromised Children, 23 States, December 2022 - April 2023 Angela P Campbell, Laura D Zambrano, Margaret M Newhams, Michael J Wu, Regina Simeone, Amber Orzel, et al. (+3)
430 [GO] 2023―Nov―27 430. Clinical Features and Outcomes of COVID-19 Hospitalized Adults by Variant Maria A Perez, Ashley Tippett, Ludy R Carmola, Laila Hussaini, Luis W Salazar, Olivia Reese, et al. (+17)
431 [GO] 2023―Nov―27 2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation Skyler Radziszewski, Siddharth Swamy, Ruchi Jain, Keri Bicking, Themba Nyirenda
432 [GO] 2023―Nov―27 2314. Association Between Behavior and Risk of COVID-19 in a Cohort of Healthcare Personnel Holly Shoemaker, Haojia Li, Yue Zhang, Jeanmarie Mayer, Michael Rubin, Morgan M Millar, et al. (+6)
433 [GO] 2023―Nov―27 2341. Response to Vaccination Against COVID-19 in a Community Oncology Practice: a Rational for Antibody Testing Goar Egoryan, Guillermo Rodriguez-Nava
434 [GO] 2023―Nov―27 2392. Impact of Vaccination Against SARS-CoV-2 on Severity and Mortality in Hospitalized Patients with COVID-19 in a Referral Hospital in Nicaragua N O R V I N G VEGA-JARQUIN, Guillermo D Porras-Cortés
435 [GO] 2023―Nov―27 446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort Maria Sundaram, Oluwakemi Alonge, Joshua Petrie, Leora R Feldstein, Melissa A Rolfes, Yoshihiro Kawaoka, et al. (+3)
436 [GO] 2023―Nov―27 523. Efficacy and Safety of Nirmatrelvir/Ritonavir for COVID-19 in Adolescents Kiriam Escobar Lee, Philip J Lee, Brenda I Anosike
437 [GO] 2023―Nov―27 903. Prevalence of Underlying Conditions Associated With Higher Risk for Severe RSV, Influenza, or COVID-19 in Adults in the United States, 2017-2018 Parinaz Ghaswalla, Abby Hitchens, Sean D Candrilli, Justin Carrico, Katherine A Hicks, Eleanor Wilson, et al. (+2)
438 [GO] 2023―Nov―27 1859. Median Income by Location of Residence and Clinical Outcomes of Hospitalized Persons with COVID-19 in an Urban Veterans Affairs Medical Center Matthew Tuck, Heather Rivasplata, Steven Towers, Angelike P Liappis, Cherinne Arundel, Anca Dinescu, et al. (+7)
439 [GO] 2023―Nov―27 485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Per Ljungman, Anne M Spanjaart, Gloria Tridello, Nina Knelange, Rafael de la Camara, Marie Jose Kersten, Stephan Mielke
440 [GO] 2023―Nov―27 438. Predicting Severe and Critical COVID-19 in Fully Vaccinated Individuals: a Single Center Retrospective Cohort Study Charles Kevin L Rivera, Mark B Carascal, Ma Cristina Perez, Raul V Destura, Karl Evans R Henson
441 [GO] 2023―Nov―27 1355. The SARS-CoV-2 Monoclonal Antibody AZD3152 Potently Neutralizes Historical and Emerging Variants and is Being Developed for the Prevention and Treatment of COVID-19 in High-risk Individuals Joseph R Francica, Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores, et al. (+17)
442 [GO] 2023―Nov―27 447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection Elizabeth G Taylor, Ashley Tippett, Luis W Salazar, Laila Hussaini, Chris Choi, Khalel De Castro, et al. (+15)
443 [GO] 2023―Nov―27 528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients Andrea Haddad, Mohammad Moussa, Ray Y Hachem, Ying Jiang, Hiba Dagher, Patrick Chaftari, et al. (+2)
444 [GO] 2023―Nov―27 2300. Incidence of COVID-19 in Irish Healthcare Workers: Preliminary Results from PRECISE-5 Claire Kenny, Jonathan McGrath, Gavin Kelly, Shane Walsh, Conor Moran, Lee Flynn, et al. (+8)
445 [GO] 2023―Nov―27 537. Safety and Effectiveness of Ensitrelvir for the Treatment of COVID-19 in Japanese Clinical Practice: A Post-marketing Surveillance (Interim Analysis) Eriko Ogura, Noriko Nakagawa, Noriko Hayashi, Eri Tsukimura, Satoru Takashima
446 [GO] 2023―Nov―27 520. Polymerized type I collagen as a treatment for COVID-19 in Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Manuel Martínez-Rojas, Oscar Rodrigo Jiménez-Flores, et al. (+14)
447 [GO] 2023―Nov―27 1503. Impact of Sars-Cov-2 (Covid-19) in Patients Living with HIV from United States National Inpatient Sample Database Premalkumar M Patel, Daniel Acosta, Esha Vallabhaneni, Fernando Poli De Frias, Yavani Singh, Christopher Lopez, Claudio Tuda
448 [GO] 2023―Nov―27 2625. Characteristics and Outcomes of COVID-19 in Patients with a Left Ventricular Assist Device Jorge Fleites, Yoichiro Natori, Jacques Simkins, Hoda Butrous, Jospeh Bauerlein, Anita Phancao, et al. (+3)
449 [GO] 2023―Nov―27 1509. Clinical Features and Outcomes of COVID-19 in People Living with HIV in South Korea: a Nationwide Population-based Cohort Study Young Kyung Yoon, Jeong Yeon Kim, Yujin Jeong, Hyong Gin Ahn, Jin Woong Suh, Sun Bean Kim, Jang Wook Sohn
450 [GO] 2023―Nov―27 2365. Effectiveness of COVID-19 Vaccines Against Medically Attended COVID-19 in Pregnant Persons Within the VISION Network, December 2021 - April 2023 Allison Avrich Ciesla, Ruth Link-Gelles, Katherine E Fleming-Dutra, Victoria Lazariu, Kristin K Dascomb, Shaun J Grannis, et al. (+9)
451 [GO] 2023―Nov―27 414. Sex differences in clinical presentation and outcomes amongst hospitalized patients with COVID-19 in Singapore Matthew C Y Koh, Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Nicholas W S Chew, et al. (+3)
452 [GO] 2023―Nov―27 465. Use of Monoclonal Antibodies for COVID-19 in Solid Organ Transplant Recipients: A Single-Center Experience Keven Gomez, Jonathan T Arcobello, Sandy Chang
453 [GO] 2023―Nov―27 404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients Jonathan Herman, Caroline Atyeo, Yonatan Zur, Claire Cook, Naomi Patel, Kathleen Vanni, et al. (+11)
454 [GO] 2023―Nov―27 403. Demographics, Characteristics and Health Outcomes of US Individuals Diagnosed With COVID-19 in the Outpatient Setting Rikisha Gupta, Valentina Shvachko, Amos Lichtman, Mark Berry, Florentin Scarlat, Anand Chokkalingam
455 [GO] 2023―Nov―27 550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting Vinny P Vo, Shu Lu, Madiha Shah, Hien Nguyen
456 [GO] 2023―Nov―27 534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States Gui Liu, Nicolae Done, Yan Song, Hardik Goswami, Travis Wang, Hesen Li, et al. (+3)
457 [GO] 2023―Nov―27 406. Incidence and Risk Factors for Hospital-Acquired Blood Stream Infections in Patients Hospitalized with COVID-19 in the University Medical Centre, Lithuania Ieva Kubiliute, Jurgita Urboniene, Fausta Majauskaite, Birute Zablockiene, Ligita Jancoriene
458 [GO] 2023―Nov―27 1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021 Hannah Wolford, Natalie McCarthy, James Baggs, Sujan Reddy
459 [GO] 2023―Nov―27 548. Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection Yuko Tsuge, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, Takumi Imamura, et al. (+3)
460 [GO] 2023―Nov―27 413. Living with Long COVID: A Study on Persistent Symptoms and Vaccination Outcomes Two Years After COVID-19 Infection Yoonjung Kim, Shin-Woo Kim, Sohyun Bae, Hyun-Ha Chang
461 [GO] 2023―Nov―27 2620. Normalization of eosinophil count is predictive of reduced oxygen requirement during Covid-19 infection Benjamin Davido, Karim Jaffal, Isabelle Vaugier, Stephane Bourlet, Pierre De Truchis, Djillali Annane
462 [GO] 2023―Nov―27 542. Evaluation of Remdesivir to the Outcomes of Hospitalized Patients with COVID-19 Infection in a Tertiary Care Hospital in Southern India Jomel Raju, Maria Tom
463 [GO] 2023―Nov―27 181. COVID-19 Infection is a Key Factor in Mortality for Staphylococcus aureus and Candida sp. Bloodstream Infections: an Evaluation of Outcomes before and during the COVID-19 Pandemic Reese Cosimi, Florian Daragjati, Subhangi Ghosh, Ana Cristina Perez Moreno, Collin Miller, Karl Saake, Mohamad G Fakih
464 [GO] 2023―Nov―27 399. Recent COVID-19 infection is associated with high risk of mortality among patients with Staphylococcus aureus bacteremia Emily Eichenberger, Allison Pall, Stepy Thomas, Susan M Ray
465 [GO] 2023―Nov―27 549. Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial Yuko Tsuge, Takuhiro Sonoyama, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Masaya Yamato, et al. (+2)
466 [GO] 2023―Nov―27 2331. Characteristics Associated with Hospital-Acquired COVID-19 Infections in Los Angeles County Heidi D Sato, Kelsey OYong, Zachary Rubin
467 [GO] 2023―Nov―27 388. Evaluating Rates of Co- and Secondary Infections in Pediatric Patients with COVID-19 Infections in Relation to Antibiotic Prescribing: An Observational Study Brian S Allen, Sarah E Firmani, Bonnie C Prokesch
468 [GO] 2023―Nov―27 2377. The Influence of the COVID-19 Infodemic on Vaccine Hesitancy: A Prospective Survey-Based Study Cameron Quon, Macey Walker, Lisa Graves
469 [GO] 2023―Nov―27 508. Nirmatrelvir/ritonavir use among patients with cancer and COVID-19 is associated with improved clinical outcomes: Single-institution case-control study Panos Arvanitis, Kendra Vieira, Jeremy L Warner, Dimitrios Farmakiotis
470 [GO] 2023―Nov―27 2324. COVID-19 Knowledge, Attitudes, and Practices Among People Living with HIV in Sub-Saharan Africa Brennan R Cebula, Allahna Esber, Nicole Dear, Valentine Sing’oei, Jonah Maswai, Michael Iroezindu, et al. (+5)
471 [GO] 2023―Nov―27 478. COVID-19 maternal antibody concentrations in twin infants: impact of multiple pregnancy on transplacental antibody transfer during pregnancy Alisa B Kachikis, Mindy Pike, Linda Eckert, Alexis L Baranoff, Hye Cho, Jennifer E Stolarczuk, et al. (+3)
472 [GO] 2023―Nov―27 546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital Grant T Stimes, Brittany Rodriguez, Amanda Gillispie, Tanya J Hilliard, Flor M Munoz, Lisa Forbes Satter
473 [GO] 2023―Nov―27 492. Risk Factors for COVID-19 Mortality in ≥90 year old Inpatients: Retrospective Case Series Raphaela Martina C Pineda, Monica Castro, Gerald Kristoffer E Boy, Sushil Pant
474 [GO] 2023―Nov―27 1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022 Anna R Yousaf, Josephine Mak, Lisa Gwynn, Robin Bloodworth, Ramona Rai, Zuha Jeddy, et al. (+13)
475 [GO] 2023―Nov―27 2081. COVID-19 mRNA Vaccine Effectiveness against Hospitalizations among U.S. Children and Adolescents During Omicron Variant Predominance Laura D Zambrano, Margaret M Newhams, Michael J Wu, Regina Simeone, Amber Orzel, Natasha B Halasa, et al. (+3)
476 [GO] 2023―Nov―27 1888. The Impact of COVID-19 on Adherence to Directly Observed Therapy Among a Tuberculosis Treatment Cohort Victoria Overbeck, Samantha Malatesta, Tara Carney, Bronwyn Myers, Charles Parry, C Robert Horsburgh, et al. (+5)
477 [GO] 2023―Nov―27 387. Understanding the Impact of COVID-19 on Cognitive Function Using a Scalable, App-based, Self-administered Tool in the Military Liana Andronescu, Stephanie A Richard, Emily Hone, Ann Scher, David Lindholm, Katrin Mende, et al. (+23)
478 [GO] 2023―Nov―27 1436. Effect of Personal Protective Equipment Conservation Due to COVID-19 on Multidrug Resistant Organisms in a Hospital Group Josephine Fox, Carole Leone, Heather Gasama, Lydia J Grimes- Jenkins, Munigala Satish, Helen Wood, et al. (+3)
479 [GO] 2023―Nov―27 444. The disruptive effects of COVID-19 on the incidence of hospital acquired staphylococcus aureus bacteremia (HA-SAB) and its associated factors with mortality in a tertiary teaching hospital in an upper-middle income country Sasheela Sri La Sri Ponnampalavanar, Sheron Sir Loon Goh, Arulvani Rajandra, Nur Alwani Suhaimi, Siti Norintan Zainon, Sazali Basri, et al. (+3)
480 [GO] 2023―Nov―27 1771. A Novel Approach to Distributing COVID-19 Oral Antivirals During a Public Health Emergency Using a Pharmacy Home Delivery Model in New York City, 2022 Mary M K Foote, Elizabeth Diago Navarro, Matthew Silverstein, Niroshan Shanmugarajah, Meredith Eddy, Ramona Lall, et al. (+4)
481 [GO] 2023―Nov―27 580. Changes in Serotype Distribution of Invasive Pneumococcal Infections in South Korea Before and After the COVID-19 Outbreak Da Yun Kang, Ye Eun Kim, Ki Wook Yun, Eun Hwa Choi
482 [GO] 2023―Nov―27 654. Changing trends of molecular characteristics and antimicrobial susceptibility of hypervirulent Klebsiella pneumoniae in community-acquired liver abscess before and after COVID-19 outbreak in South Korea Miri Hyun, Ji Yeon Lee, Hyun ah Kim
483 [GO] 2023―Nov―27 2303. Detection of COVID-19 Outbreaks in Hospitals Using Built Environment Testing for SARS-CoV-2 Lucas Castellani, Derek MacFadden, Jason Moggridge, Bryan Feenstra, Makenna Wiebe, Sawith Abey, et al. (+8)
484 [GO] 2023―Nov―27 2359. Relative effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines in adults at higher risk for severe COVID-19 outcomes Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Ni Zeng, Mac Bonafede, Thierry Ducruet, et al. (+6)
485 [GO] 2023―Nov―27 398. Increased Risk of Severe COVID-19 Outcomes Across all Groups of Individuals with Hematological Malignancies, Solid Tumors, and Solid Organ Transplants Compared with the General Population: Initial Results from INFORM, a Retrospective Health Database Observational Study in England Richard McNulty, Sabada Dube, Yi Lu, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
486 [GO] 2023―Nov―27 2654. International Multi-Center Study Comparing the Effect of Obinutuzumab or Rituximab Treatment in Hematological Patients on COVID-19 Outcomes During the Omicron Surge Tal Shafat, Daniel Grupel, Tzvika Porges, Ana Belkin, Ofir Deri, Yonatan Oster, et al. (+20)
487 [GO] 2023―Nov―27 1096. Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England Sabada Dube, Yi Lu, Richard McNulty, Sophie Graham, Sofie Arnetorp, Nahila Justo, et al. (+7)
488 [GO] 2023―Nov―27 1347. Do Class 3 Semaphorins Play a Role in COVID-19 Outcomes in Patients with Non-alcoholic Fatty Liver Disease? Martina Vargovic, Branimir Gjurasin, Lara Samadan, Adriana Vince, Neven Papic
489 [GO] 2023―Nov―27 2733. Evusheld (AZD7442) Uptake and COVID-19 Outcomes in Solid Organ Transplant Recipients: A Secondary Analysis Haya Hayek, Tess Stopczynski, Asim Khanfar, Yasmeen Z Qwaider, Justin Z Amarin, Madge I Stuhlreyer, et al. (+11)
490 [GO] 2023―Nov―27 1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves Dean Follmann, Xiaowei Wang, Peter Gilbert, Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al. (+9)
491 [GO] 2023―Nov―27 660. Pediatric Rotavirus Hospitalization Rates in the Military Health System Before and During the COVID-19 Pandemic Matthew Penfold, Sarah Prabhakar, Apryl Susi, Michael Rajnik, Cade M Nylund, Matthew Eberly
492 [GO] 2023―Nov―27 980. Risk Factors for Central Line Associated Bloodstream Infection Prior to and During the COVID-19 Pandemic Jennifer Priem, Mindy Sampson, Shelley Kester, Werner Bischoff, Catherine Passaretti, Casey Stephens
493 [GO] 2023―Nov―27 1622. Increase in Congenital Toxoplasmosis and Acute Toxoplasmosis Among Pregnant Women in the US during the COVID-19 pandemic Despina Contopoulos-Ioannidis, Valerie Bonetti, Jose G Montoya
494 [GO] 2023―Nov―27 2175. Emergence of Dual-Carbapenemase Producing Enterobacterales in Chile After the COVID-19 Pandemic Aura Villamil, Paula I Rodas, Ana M Quesille-Villalobos, Jose R W Martinez, Manuel Alcalde-Rico, Valeria E Quiroz, et al. (+7)
495 [GO] 2023―Nov―27 1556. Increase in New HIV Diagnoses Following Decrease in Use of Pre-Exposure Prophylaxis (PrEP) During the COVID-19 Pandemic Li Tao, J Carlo Hojilla, Valentina Shvachko, Juan Yang, Christoph C Carter, Moupali Das, Melanie de Boer
496 [GO] 2023―Nov―27 2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic Ryuji Koizumi, Shinya Tsuzuki, Yusuke Asai, Norio Ohmagari
497 [GO] 2023―Nov―27 1649. Tracking and reporting antibiotic use: Rising antibiotic prescriptions for URI illness in children during the COVID-19 pandemic. Emily Clemons, Matthew Whiteman, Lisa Garavaglia, Shipra Gupta
498 [GO] 2023―Nov―27 2194. Implementation of the CDC’s Core Elements of Antibiotic Stewardship: A Survey of Long-Term Care Facilities During the COVID-19 Pandemic Catherine (Cathy) Cichon, Jenna Preusker, Mounica Soma, Danny Schroeder, Trevor C Van Schooneveld, Scott J Bergman, Muhammad Salman Ashraf
499 [GO] 2023―Nov―27 394. Consistency of AZD7442 (Cilgavimab/Tixagevimab) Pharmacokinetics Across Prophylaxis and Treatment and Adult and Pediatric Participants: Application of Population Pharmacokinetics to Enable Rapid Decision-Making During the COVID-19 Pandemic Lindsay E Clegg, Oleg Stepanov, Henning Schmidt, Ventakesh Pilla Reddy, Weifeng Tang, Michael Gibbs, et al. (+8)
500 [GO] 2023―Nov―27 2415. Health Outcome Disparities in Device-Associated Healthcare Infections Before and During the COVID-19 Pandemic Werner Bischoff, Joni Evans, Catherine Passaretti, Andrea Fernandez
501 [GO] 2023―Nov―27 2319. Trends in Health Services Utilization among Veterans with HIV Before and During the COVID-19 Pandemic Ruth O Adekunle, Ahmed Mohamed, Charlene Pope, Mulugeta Gebregziabher, Robert Axon
502 [GO] 2023―Nov―27 2274. Trends in Empiric Antibiotic Utilization for Patients Hospitalized with Community-Onset SARS-CoV-2 Infections and Viral Sepsis During the COVID-19 Pandemic Claire N Shappell, Michael Klompas, Sanjat Kanjilal, Christina Chan, Caroline S McKenna, Chanu Rhee
503 [GO] 2023―Nov―27 2483. Rise in inpatient Candida auris cases at a tertiary hospital in Washington, DC during the COVID-19 pandemic Daniel Seeger, Matthew Spence, Marc O Siegel, Tara Palmore, Gizachew Demessie, Irvin Ibarra Flores, et al. (+5)
504 [GO] 2023―Nov―27 2375. Contemporary Patterns and Predictors of Influenza and COVID-19 Vaccination Among US Adults During the COVID-19 Pandemic Christopher Bush, Katherine E Mues, Shaina Desai, Brent Arakaki, Priyadarshani Dharia, Parinaz Ghaswalla, Yoonyoung Park
505 [GO] 2023―Nov―27 1256. Changes in Antimicrobial Stewardship (AS) Core Element Implementation among Oregon Hospitals following the COVID-19 Pandemic Jessina C McGregor, Lisa Iguchi, Elizabeth Breitenstein
506 [GO] 2023―Nov―27 230. Risk factors for bacteremia in patients receiving extracorporeal membrane oxygenation (ECMO) during the COVID-19 pandemic Curtis Hendrix, Christopher Radcliffe, Hossam Tantawy, Scott C Roberts
507 [GO] 2023―Nov―27 1734. Influenza, SARS-CoV-2, and routine childhood vaccines - trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic Marisa Orbea, Anurag Panjabi, Michelle Lopez, Rachel Cunningham, Julie A Boom, C Mary Healy, Claire Bocchini
508 [GO] 2023―Nov―27 1683. Severe Group A Streptococcus Infections Amongst Pediatric Patients in the Lehigh Valley, Pennsylvania Following the COVID-19 Pandemic Stormie Gough, Jonathan Berback, Tibisay Villalobos
509 [GO] 2023―Nov―27 2244. What Happened? Antibiotic Resistance During the First Two Years of the SARS-CoV-2 (COVID-19) Pandemic Matthew P Crotty, Joel Henderson, Jacqueline Hohulin, Jennifer Wright, Mingyang Cui, Julie Alexander, et al. (+3)
510 [GO] 2023―Nov―27 2322. Challenges Faced by Perinatally-Infected Young People Living with HIV in Kenya During the COVID-19 Pandemic Manjot Singh, Winstone Nyandiko, Allison DeLong, Celestine Ashimosi, Dennis Munyoro, Janet Lidweye, et al. (+10)
511 [GO] 2023―Nov―27 1235. A Retrospective Review of Antimicrobial Stewardship Audit and Feedback: Assessing Acceptance of Stewardship Recommendations During the COVID-19 Pandemic Melissa A Colaluca, Michelle Korson, Dora E Wiskirchen, Jessica Abrantes-Figueiredo
512 [GO] 2023―Nov―27 1748. Viral and Bacterial Etiology of Acute Gastroenteritis in Children < 5 Years Old at a Major Pediatric Referral Center Before and During the COVID-19 Pandemic Olla Hamdan, Tess Stopczynski, Justin Z Amarin, Yasmeen Z Qwaider, Haya Hayek, Laura S Stewart, et al. (+6)
513 [GO] 2023―Nov―27 2495. Inpatient Hepatitis C Virus Testing Increased During the COVID-19 Pandemic Brendan J Fitzgerald, Mamta K Jain, A L exander P Radunsky, Lauren N Cooper, Laura Hansen
514 [GO] 2023―Nov―27 1036. Reporting of SARS-CoV-2 testing results among PEPFAR and non-PEPFAR countries in Sub-Saharan Africa during the first year of the COVID-19 pandemic Benjamin C Johnson, Charles B Holmes
515 [GO] 2023―Nov―27 185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic Renuga Vivekanandan, Kelsey Witherspoon, Christopher J Destache
516 [GO] 2023―Nov―27 333. How the COVID-19 Pandemic Accelerated Development of our Complex Outpatient Oral Antimicrobial Therapy (COpAT) Program Joy J Juskowich, Jesse M Thompson, Arif R Sarwari
517 [GO] 2023―Nov―27 883. The Current State of Access: Inequitable Access to Infectious Disease Physicians in the Time of the COVID-19 Pandemic and Declining Fellowship Match Rates Benjamin P Fuller, Andrew Strumpf, Kathleen A McManus
518 [GO] 2023―Nov―27 1832. Rise in Deaths from Firearm Injury and Drug Overdose During COVID-19 Pandemic and its Impact on Organ Donation in the United States Roshan Dhand, Abhay Dhand, Seigo Nishida, Kenji Okumura
519 [GO] 2023―Nov―27 1817. Skin and Soft Tissue Infection Incidence Before and During the COVID-19 Pandemic at A Large Safety Net Healthcare System Prudencio Merino, Deborah Kupferwasser, Evelyn A Flores, Donna Phan Tran, Abisay Ortega, Loren G Miller
520 [GO] 2023―Nov―27 2242. Leveraging the McGeer criteria to Determine the Frequency of Potentially Inappropriate Antibiotic Prescribing for Urinary and Respiratory Tract Infections Prior to and During the COVID-19 pandemic at a Skilled Nursing Facility Paulina M Colombo, Ferris A Ramadan, Dilsharan Kaur, Katherine Ellingson
521 [GO] 2023―Nov―27 157. Implementation of multidisciplinary diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital Yasuhiro Sasaki, Masataka Yano, Ayumi Umehara, Yasuaki Tagashira
522 [GO] 2023―Nov―27 1343. Drug Education Needs of HCPs and Patients During the COVID-19 Pandemic Based on Over 60,000 Unsolicited Medical Information Requests Globally Over 3 Years (2020-2022) Sonia K Sandhu, Linda Chen
523 [GO] 2023―Nov―27 2258. "Identification of Respiratory Viral Pathogens Using Real-Time PCR Was Not Associated with Reduced Antibiotic Use During the COVID-19 Pandemic, but Displayed Viral-Viral Interactions" Asif Khan, Daynha P Marti Ojeda, Richard A Murphy, Joel Elzweig, Victoria W Lacasse, Suzette Rovelsky
524 [GO] 2023―Nov―27 1894. Delay in TB care before and during the COVID-19 pandemic, Dushanbe, Tajikistan, 2022 Rajabali Sharifov, Dilyara Nabirova, Zulfiya Haybullo Tilloeva, Sanam Zikriyarova, Salomudin Yusufi, Navruz Jafarov, Roberta Horth
525 [GO] 2023―Nov―27 805. Did Mask Mandates have an Affect on Pulmonary Mycoses? Trends of Coccidioidomycosis Incidence during COVID-19 Pandemic Era in California and Texas Nirusha Abeydeera, Linda Pham, Andrew Hwang, Napatkamon Ayutyanont
526 [GO] 2023―Nov―27 2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut Johanna Gleason-Vergados, Maria Correa, James Meek, David Banach
527 [GO] 2023―Nov―27 442. Unveiling Factors Associated with Mortality in Mucormycosis Patients: Insights from Second and Third Waves of COVID-19 Pandemic in India Vagisha Sharma, Kushal Kriplani, Isha Preet Tuli
528 [GO] 2023―Nov―27 2658. Mortality among children hospitalized with suspected pneumonia during the COVID-19 pandemic in India (PREVAIL study) Yangyupei Yang, Maria D Knoll, Anurag Agarwal, Vikas Manchanda, Melissa Higdon, Rajeshwar Dayal, et al. (+11)
529 [GO] 2023―Nov―27 2321. Prevalence and determinants of depression among healthcare workers during the COVID-19 pandemic in Khujand, Tajikistan, 2022 Jamila Silemonshoeva, Roberta Horth, Zulfiya Haybullo Tilloeva, Navruz Jafarov, S A N A M ZIKRIYAROVA, Dilyara Nabirova
530 [GO] 2023―Nov―27 1338. Changes in Volume and Diagnoses in a Pediatric Emergency Department during the COVID-19 Pandemic in Northeast Mexico Paulina Blanco Murillo, Oscar Tamez-Rivera, Rommy E Pineda-Magaña, Lucia Escobedo-Berumen, Ricardo J Estrada-Mendizabal, Katheryne P Madrazo-Aguirre, et al. (+2)
531 [GO] 2023―Nov―27 2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada Pranav Tandon, Kevin Brown, Nick Daneman, Bradley J Langford, Valerie Leung, Lindsay Friedman, Kevin Schwartz
532 [GO] 2023―Nov―27 832. Epidemiology, Clinical Characteristics, Treatment and Outcome of Mucormycosis during COVID-19 Pandemic in the VA Health System Nirmal Muthukumarasamy, Hiroyuki Suzuki
533 [GO] 2023―Nov―27 694. Impact of COVID-19 Pandemic on Clostridioides difficile Infection Rates and Risk Factors in Maryland Kaytlynn Marceaux-Galli, Rebecca Perlmutter, David Blythe, Lucy Wilson
534 [GO] 2023―Nov―27 1508. The effects of the COVID-19 pandemic on depression severity and viral load non-suppression among people with HIV accessing care in an urban infectious disease clinic in Baltimore, MD Tarfa Verinumbe, Catherine Lesko, Richard Moore, Anthony Fojo, Jeanne Keruly, LaQuita N Snow, et al. (+2)
535 [GO] 2023―Nov―27 2462. The impact of the COVID-19 pandemic on hospital-acquired infections and multidrug-resistant organisms, and comparison with seasonal influenza Halima Dabaja-Younis, Zmira Silman, Jalal Tarabeia, Khetam Hussein
536 [GO] 2023―Nov―27 1365. Self-Reported Impacts of COVID-19 Pandemic on Patients with Bronchiectasis and Nontuberculous Mycobacterium Pulmonary Infections: Healthcare Avoidance and Other Impacts Across Delta and Omicron Waves Haley Miller, Jeremy Hawkins, Sarah A R Siegel, Arielle G Hernandez, Emily Henkle, Kevin L Winthrop
537 [GO] 2023―Nov―27 1671. Impact of COVID-19 Pandemic on Rates of Positive Blood Cultures and Contaminations in Children Hiroyuki Aiba, Masaki Yamada, Toshihiro Matsui, chikara Ogimi
538 [GO] 2023―Nov―27 2631. The impact of the COVID-19 pandemic on seasonal respiratory virus circulation in Korean children Kyo Jin Jo, Yoon Ha Hwang, Yechan Kyung, Ju-Suk Lee, Su Eun Park
539 [GO] 2023―Nov―27 2479. Impact of the COVID-19 pandemic on the hospital acquisition of multidrug-resistant organism in two Greek hospitals Polyxeni Karakosta, Elisavet Kousouli, Sophia Vourli, Panagiota Christina Georgiou, Vasiliki Mamali, Olympia Zarkotou, Spyros Pournaras
540 [GO] 2023―Nov―27 1440. Hand Hygiene in Nursing Homes During And After The Covid-19 Pandemic Outbreak Ida H Sandbekken, Borghild Løyland, Åsmund Hermansen, Inger Utne, Ellen Karine Grov
541 [GO] 2023―Nov―27 2297. Trends in Respiratory Pathogens Detected by Using a Multiplex PCR Panel during the Different COVID-19 Pandemic Phases in Taiwan Yu-Lung Hsu, Yan-Yi Low, Chiung-Tzu Hsiao, Yu-Chang Chang, Hong-Mo Shih, Hsiao-Chuan Lin, et al. (+2)
542 [GO] 2023―Nov―27 1094. Comparison of Demographic and Clinical Characteristics in Survivors Vs. Decedents with Multisystem Inflammatory Syndrome in Children (MIS-C) During the COVID-19 Pandemic-CDC National Surveillance, February 2020-December 2022 Anna R Yousaf, Katherine N Lindsey, Ami B Shah, Allison D Miller, Michael J Wu, Michael Melgar, et al. (+2)
543 [GO] 2023―Nov―27 2228. Knowledge, Attitudes, and Practices Regarding Antibiotic Use during the COVID-19 Pandemic: A Comparison of United States (US) Survey Respondents Living in the US-Mexico Border Region with those Living in Non-border Regions Maja Subelj, Jose Luis Camarena, Brooke A Hawkes, Katherine Ellingson
544 [GO] 2023―Nov―27 1870. Changes of Tuberculosis Incidence and Mortality after COVID-19 Pandemic: A Interrupted Time-series Analysis Jungju Lee, Byung Chul Chun
545 [GO] 2023―Nov―27 2257. Cost-Benefit Analysis of Fidaxomicin (FDX) as First Line Treatment for Initial Episode of Clostridioides difficile Infection (CDI) during the COVID-19 Pandemic: A Quality Control/Improvement (QC/QI) Project at a Tertiary Care Veterans Affairs Medical Center (VAMC) over a 4-year period Sumaiya F Khaja, Ryan Kuhn, Sajjad Ali, Suganthini Krishnan Natesan
546 [GO] 2023―Nov―27 426. The diagnosis and treatment of COVID Associated Pulmonary Aspergillosis in patients requiring Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) in the Republic of Ireland during the COVID-19 pandemic: A Retrospective Review Rhea O’Regan, Gillian Crowe, Maureen Lynch, Eavan Muldoon, Jennifer Hastings
547 [GO] 2023―Nov―27 2434. Healthcare-associated Infections in the Era of COVID-19 Pandemic: An Experience from a Tertiary Care Hospital in Long Island, New York Monirul I Sajib, Tamasin Adams, Susan V Donelan, Roderick Go, Miguel A Saldivar
548 [GO] 2023―Nov―27 1709. Shifting Infection Spectrum in Febrile Neutropenic Pediatric Cancer Patients During the COVID-19 Pandemic: An Impact Assessment Aditya Dabas, Vagisha Sharma, Amitabh Singh, Kushal Kriplani, Rajni Gaind, Rani Gera
549 [GO] 2023―Nov―27 1457. Carbapenem-resistant Acinetobacter baumannii in an Intensive Care Unit during the COVID-19 pandemic: An Outbreak Investigation Utilizing Whole Genome Sequencing Samantha Williams, Rochelle T Thompson Kolawole, Bhagyashri Navalkele, Melinda Grubb, Sheila Fletcher, Daphne Ware, Ashley Robinson
550 [GO] 2023―Nov―27 149. Stewardship Efforts during the COVID-19 Pandemic: Impact on Antibiotic Prescribing Practices of Ambulatory Care Providers for Common (non-COVID-19) Viral Respiratory Syndromes Melinda Mackey, Reese Cosimi, Florian Daragjati, Erin Rice, Collin Miller, Aaron Shoemaker, Mohamad G Fakih
551 [GO] 2023―Nov―27 2471. Comparison of Dialysis Infection Events in Outpatient End Stage Renal Facilities Pre- and During the COVID-19 Pandemic: Louisiana, 2018-2021 Grace Lee, Erica Washington, Ashlyn Pinkins
552 [GO] 2023―Nov―27 2323. Pediatric Infectious Diseases Outpatient Telehealth Services During the COVID-19 Pandemic: Single Center Experience Celisse Zabalo, Athanasios Tsalatsanis, Ambuj Kumar, Claudia M Espinosa, Amol Purandare, Carina A Rodriguez, Claudia Gaviria-Agudelo
553 [GO] 2023―Nov―27 1763. Attendance and Learning Outcomes of Statewide Infection Prevention and Control Education and Support Webinars Initiative During the COVID-19 Pandemic: The Nebraska Experience Rebecca Martinez, Mounica Soma, Josette McConville, Laura "Kate" Tyner, Matthew Donahue, Muhammad Salman Ashraf, Daniel M Brailita
554 [GO] 2023―Nov―27 417. Impact of Post-acute Sequelae of COVID-19 (PASC) on Healthcare Workers (HCW) in NYC Public Hospital in the South Bronx Chee Yao Lim, Jorge Gutierrez, Alberto Romero Garcia, Pinal Patel, Kenneth Johan, Israel Duran, et al. (+9)
555 [GO] 2023―Nov―27 695. Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients Therese Mathew, Rhema Maria Punnoose
556 [GO] 2023―Nov―27 1212. Impact of Infectious Diseases Fellow Collaboration in the Medical Intensive Care Unit and Medical Intermediate Unit on Antimicrobial Utilization in COVID-19 Patients Smit Rajput, Franklin Mikell, Aaron Kipp, Jennifer Emberger
557 [GO] 2023―Nov―27 428. Risk Stratification and Clinical Outcomes in a Mixed Vaccination Cohort of COVID-19 Patients Admitted in a Tertiary Hospital Using ISARIC 4C Scores May Anne S Pascual, John Robinson L Reyes
558 [GO] 2023―Nov―27 525. Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years Kohei Fujita, Osamu Kanai, Hiroaki Hata, Takao Odagaki, Tadashi Mio
559 [GO] 2023―Nov―27 2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era Osamu Kanai, Kohei Fujita, Hiroaki Hata, Takao Odagaki, Tadashi Mio
560 [GO] 2023―Nov―27 1367. COVID-19 Patients Expressed Distinct Clinical Trait Signatures at Index Hospitalizations Across the Four SARS-CoV-2 Pandemic Waves in Florida Ian Motie, John Sia, Joseph Seaman, Karen Hamad, Wilhelmine Wiese-Rometsch, Robert A Smith, Manuel E Gordillo
561 [GO] 2023―Nov―27 2269. Inpatient Antibiotic Prescribing for Symptomatic COVID-19 Patients in a Large US Sample, 2020-2022 Michael Pulia, Meggie Griffin, Daniel J Hekman, Rebecca Schwei, Aurora E Pop-Vicas, Lucas Schulz, et al. (+3)
562 [GO] 2023―Nov―27 427. Bloodstream infections among adult COVID-19 patients in Colombian hospitals between 2020-2021 Christian Pallares, María Virginia Villegas, Jessica Porras, Karen Melissa Ordoñez, Elsa Yasmín Vente, Erika Vanessa Patiño, Sandra Milena Gómez
563 [GO] 2023―Nov―27 1341. Clinico-demographic Features and Mortality of COVID-19 Patients in Southwest Michigan Alana Pinheiro Alves, Alec Johnson, Benjamin I Bizer, Matthew Belardo, Kathryn Garber, Mujahed Abbas
564 [GO] 2023―Nov―27 2289. Accuracy of the National Early Warning Score 2 (NEWS2) in predicting Mortality and ICU Admission among COVID-19 patients in the Emergency Department of a Tertiary Private Hospital in the Philippines Bernice Ong-dela Cruz, Darlene Mae E Cledera
565 [GO] 2023―Nov―27 416. Poor clinical outcomes of COVID-19 patients receiving rituximab during the Omicron era Chan Mi Lee, Chang Kyung Kang, Hyeon Jae Jo, Pyoeng Gyun Choe, Nam Joong Kim, Wan Beom Park, Myoung-don Oh
566 [GO] 2023―Nov―27 449. Elevated Lactate Dehydrogenase in Convalescent Severe COVID-19 Patients Reflects Delayed Clinical Recovery and Activated Th1 and Th17 Responses Jinyoung Yang, Ho Cheol Jang, Min Seo Kang, Keon Young Lee, Young Ho Lee, Kyungmin Huh, et al. (+6)
567 [GO] 2023―Nov―27 540. A Dose-Comparison Study of Methylprednisolone on Mortality in COVID-19 Patients Require Oxygen in A Tertiary Hospital in Thailand Pattraporn Piyapan, Viranpat Masamhisak
568 [GO] 2023―Nov―27 1345. Clinical Characteristics and Outcomes of Mild to Moderate COVID-19 Patients with Abnormal Chest Radiologic Findings Treated in the Hospitels in Thailand Naruemit Sayabovorn, Pochamana Phisalprapa, Weerachai Srivanichakorn, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Tullaya Sitasuwan, et al. (+10)
569 [GO] 2023―Nov―27 483. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with Hemodialysis Xin Li, Huajian Ying, Feng Sun, Yaxin Fan, Yi Li, Xiaofen Liu, et al. (+5)
570 [GO] 2023―Nov―27 423. Development and Validation of a Predictive Model of New-Onset Deep Vein Thrombosis/Pulmonary Embolism Among Hospitalized COVID-19 Patients: A Retrospective Cohort Study Qingqing Meng, Guillermo Rodriguez-Nava, Goar Egoryan, Armen Kishmiryan
571 [GO] 2023―Nov―27 515. The Impact of Prolonged Steroid Use on Critically Ill COVID-19 Patients: A Retrospective Cohort Study Jaijun Han, Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Ho Choi, et al. (+4)
572 [GO] 2023―Nov―27 87. The safety and efficacy advantage of blocking C5a vs C5 in critically ill, COVID-19 patients: Results from PANAMO, a Phase 3 randomized controlled trial Bruce P Burnett, Endry H T Lim, Alexander Vlaar, Sanne De Bruin, Matthijs Brouwer, Maria Habel, et al. (+8)
573 [GO] 2023―Nov―27 2389. Surveillance evaluation of COVID-19 pharmacovigilance-Karakalpakstan, Uzbekistan, 2022 Yunis Tursinov, Botirjon Kurbanov, Alfiya Denebayeva, Roberta Horth, Dilyara Nabirova
574 [GO] 2023―Nov―27 543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol Adriana Rauseo, Tatyana Der, Radica Alicic, Bindu Balani, Caryn Morse, Pearl Zakroysky, et al. (+3)
575 [GO] 2023―Nov―27 551. Efficacy of adjusting steroids dose in non-ICU COVID-19 pneumonia patients with chest radiology deterioration Qingqing Wang, Bijie Hu
576 [GO] 2023―Nov―27 451. Pre- and Post-implementation Comparison of the Impact of Emergency Department (ED)-Based COVID-19 Point-of-Care Testing on ED Patient Metrics Katherine Z J Fenstermacher, Eili Klein, Jeanne Mumford, Barbara Maliszewski, Gai Cole, Mustapha O Saheed, Richard E Rothman
577 [GO] 2023―Nov―27 1886. Prevalence Of Latent TB Infection Among Critically Ill COVID-19 Population In a Tertiary Teaching Hospital In Mexico Santiago Montiel, Benjamin Valente-Acosta
578 [GO] 2023―Nov―27 493. ENDURANCE - EffectiveNess of Evusheld for COVID-19 Pre-exposUre PRophylAxis iN ImmunoCompromised PatiEnts - A Pilot Study James Polega, Heather Brooks, Rebecca Emery, Joshua D Donkin, Kevin Fitzgerald, G O R D A N A SIMEUNOVIC
579 [GO] 2023―Nov―27 494. Real-world effectiveness of tixagevimab/cilgavimab for COVID-19 pre-exposure prophylaxis in solid organ transplant recipients during the Omicron variant period Gun Rojanakit, Sasisopin Kiertiburanakul, Sarinya Boongird, Napan Sutharattanapong, Teerapat Yingchoncharoen, Abhasnee Sobhonslidsuk, Jackrapong Bruminhent
580 [GO] 2023―Nov―27 2230. Consumption of Quinolones, Macrolides, and Beta-Lactam Antibiotics at a Tertiary Care Veterans Affairs Medical Center (VAMC) during COVID-19 Pre-pandemic and Pandemic periods: A 4-year Analysis and Implications for Antimicrobial Stewardship Sajjad Ali, Ryan Kuhn, Sumaiya F Khaja, Suganthini Krishnan Natesan
581 [GO] 2023―Nov―27 1363. Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mAb) in Development for COVID-19 Prevention Kathryn Mahoney, Deepali Gupta, Yong Li, Natalia Betancourt, Aanika Das, Ed Campanaro, Pete Schmidt
582 [GO] 2023―Nov―27 2332. COVID-19 Primary Series and Booster Vaccination and Potential for Immune Imprinting Hiam Chemaitelly, Houssein H Ayoub, Laith J Abu-Raddad
583 [GO] 2023―Nov―27 2387. Assessment of COVID-19 primary series vaccination and factors associated with early and late uptake among Servicemembers in the Military Health System Laveta Stewart, Megan Clare Craig-Kuhn, Erica Sercy, Caryn Stern, Brock Graham, Amber Michel, et al. (+6)
584 [GO] 2023―Nov―27 397. The Three COVID-19 Prognostic Tools (CALL, 4Cs, NLR): Head-to-Head Comparison George Doumat, Hady Yazbeck, Hassan Itani, Rayyan Wazzi-Mkahal, Mario Badr, Elie Moussa, et al. (+3)
585 [GO] 2023―Nov―27 1098. COVID-19 Reinfections in Older Adults: Risk Factors for Poor Outcomes Elizabeth Lando-King, Keeley Morris, Scott Seys, Zachary Zirnhelt, Elle Talsma, Haley Wienkes, et al. (+2)
586 [GO] 2023―Nov―27 429. Risk of COVID-19 Related Deaths for SARS-CoV-2 Omicron (B.1.1.529) Compared With Delta (B.1.617.2): A Retrospective Cohort Study Shon Paulson, Jomel Raju
587 [GO] 2023―Nov―27 552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study) Kazuko Yamamoto, Tsuyoshi Inoue, Kenta Jounai, Ryohei Tsuji, Daisuke Fujiwara, Naoki Iwanaga, et al. (+10)
588 [GO] 2023―Nov―27 2312. COVID-19 risk factors before and after the vaccines among hospital workers: Have they changed? Fernando Rosso, David E Rebellon-Sanchez, Julio Llanos-Torres, Eric Tafurt
589 [GO] 2023―Nov―27 2311. Predictive cut-off values for anti-N and anti-S antibodies for COVID-19 risk identification David E Rebellón Sánchez, Julio Llanos-Torres, Eric Tafurt, Fernando Rosso
590 [GO] 2023―Nov―27 524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies Lindsey Force, Chris Blair, Joshua Duckworth, Mazin Abdelghany, Ngoc-Quyen Nguyen, Robert H Hyland, et al. (+4)
591 [GO] 2023―Nov―27 392. The Impact of Therapeutic Interventions on Post-Acute Sequelae of SARS-CoV-2 (PASC) in COVID-19 Survivors: A Retrospective Analysis Andrea S Calderon, Kristin Englund
592 [GO] 2023―Nov―27 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment Sarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, Vanessa Olivo, Ellen Sano, Sara H Goodman, et al. (+31)
593 [GO] 2023―Nov―27 2315. Hidden in Plain Sight: Latent Class Analysis of Respiratory Infection Symptoms based on COVID-19 Testing and Vaccination History Xiaowu Sun, Laura L Lupton, Coetzer Henriette, Jonathan DeShazo, Alexandra Berk, Laura Anatale-Tardiff
594 [GO] 2023―Nov―27 468. Associations of Socioeconomic Status and Care Access Measures with COVID-19 Testing in Patients with Breast Cancer Jincong Q Freeman, Xinyi Li, Yong Gun Lee, Ted O Akhiwu
595 [GO] 2023―Nov―27 475. "The Outcomes and Adverse Effects of COVID-19 Therapies in High-Risk Children" Johanna Holschier, Alison Boast, Christine Plover, Suzanne Boyce, Sarah McNab, Nigel Curtis, Amanda Gwee
596 [GO] 2023―Nov―27 2294. Severity and characteristics of patients hospitalized during Delta and Omicron-predominant COVID-19 time periods in Los Angeles County Carmon Greene, Heidi D Sato, Kelsey OYong, Elizabeth Traub, Zachary Rubin
597 [GO] 2023―Nov―27 2293. Examining social vulnerability and its effect on COVID-19 transmission in households Sara H Goodman, Alexandra Mellis, Carlos G Grijalva, H Keipp Talbot, Melissa Stockwell, Son H McLaren, et al. (+15)
598 [GO] 2023―Nov―27 1366. Temporal changes in Demographics, Characteristics and Treatments for Patients enrolled in the Canadian Treatments for COVID-19 Trial Samiha Mohsen, Srinivas Murthy, Ruxandra Pinto, Robert Fowler
599 [GO] 2023―Nov―27 856. CT-proET-1 and sFlt-1 as Predictors of Clinical Outcomes in a COVID-19 US Cohort Johnny Atallah, Natalie Atallah, Vahe Panossian, Hailey Warren, Damian Inlall, Andrej Schwabe, et al. (+3)
600 [GO] 2023―Nov―27 2393. Factors Associated with Time to COVID-19 Vaccination among People with HIV Aasith Villavicencio Paz, Alex P Sanchez-Covarrubias, Fatemeh Ghadimi, Hervette Nkwihoreze, Raymond Zelada, Helen Koenig, Florence Momplaisir
601 [GO] 2023―Nov―27 2388. Factors Associated with COVID-19 Vaccination Among Racial/Ethnic Minority Populations with HIV, Miami-Dade County, Florida, 2022 Mary Jo Trepka, Daisy Ramirez-Ortiz, Michele Jean-Gilles, Robert Ladner, Tan Li, Diana Sheehan
602 [GO] 2023―Nov―27 2376. Trends in COVID-19 vaccination among reproductive-aged in Jamaica: a comparison of two time periods Jodian Pinkney, Laura Bogart, Kamali Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, et al. (+5)
603 [GO] 2023―Nov―27 462. Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life Cristina Cardemil, Flor M Munoz, Yi Cao, Fei Gao, Christine M Posavad, Martina L Badell, et al. (+16)
604 [GO] 2023―Nov―27 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection Melissa A Rolfes, H Keipp Talbot, Kerry Grace Morrissey, Melissa Stockwell, Yvonne A Maldonado, Huong McLean, et al. (+31)
605 [GO] 2023―Nov―27 2361. Prevalence of Zoster Infection Post mRNA COVID-19 Vaccination Compared to Influenza Vaccination Mark S Lazbin, David C Kaelber
606 [GO] 2023―Nov―27 1836. Disparities in COVID-19 Vaccination Coverage Among a Large Patient Population in a Network of Community-Based Healthcare Organizations Holly C Groom, Frances Biel, Bradley Crane, Evelyn Sun, Joanna Georgescu, Eric Weintraub, et al. (+5)
607 [GO] 2023―Nov―27 2335. Up-to-date COVID-19 vaccination coverage among healthcare personnel in nursing homes -National Healthcare Safety Network Sushmitha Ananth, Hannah E Reses, Heather Dubendris, Kira A Barbre, Emily Wong, Meng Lu, Jeneita Bell
608 [GO] 2023―Nov―27 499. Level of Cord Blood Anti-SARs-CoV-2 Antibodies in Infants Born During 2021-2023 to The Mothers Who Had Received COVID-19 Vaccination During Pregnancy Nophathai Sojisirikul, Keswadee Lapphra, Kulkanya Chokephaibulkit
609 [GO] 2023―Nov―27 1144. Dissociative Neurological Symptom Reactions Following COVID-19 Vaccination in Adolescents in Japan Yuho Horikoshi, Takayuki Yamanaka, Yuta Aizawa, Yukitsugu Nakamura, Takayo Shoji, Toshihiko Okumura, Yoshiaki Cho
610 [GO] 2023―Nov―27 2339. COVID-19 Vaccination in Adults and Children. Cross-Sectional Study of Adults', Pediatricians' and Parents' perceptions and Acceptance of COVID-19 Vaccine in Colombia Margarita Cortés, Andrea Puentes, Mónica Arenas, Carlos Arango, José Brea, Claudia Beltran, Roberto Debbag
611 [GO] 2023―Nov―27 1726. Characterization of humoral immune responses to COVID-19 vaccination in children in Canada: interim analysis from the Severe acute respiratory syndrome-related coronavirus 2 PRevalence In children and youNG adults in British Columbia (SPRING) Study Gabrielle N Gaultier, Mandy Lo, Brynn McMillan, Amy Lee, Bing Cai, Tony Harn, et al. (+9)
612 [GO] 2023―Nov―27 2351. Concordance Between Sources of COVID-19 Vaccination Information Among Children Aged 5-18 years, May 2021-March 2023 Sarah Hamid, Laura D Zambrano, Regina Simeone, Margaret M Newhams, Natasha B Halasa, Katherine E Fleming-Dutra, et al. (+4)
613 [GO] 2023―Nov―27 2345. Factors associated with COVID-19 vaccination refusal among U.S. Immigration and Customs Enforcement detainees Carlo Foppiano Palacios, Mark Travassos
614 [GO] 2023―Nov―27 747. Employer requirements of COVID-19 vaccination reported by healthcare personnel, April 2022 Marie de Perio, Anup Srivastav, Anthony Laney, Carla Black, Hilda Razzaghi
615 [GO] 2023―Nov―27 2348. Identifying Barriers Against COVID-19 Vaccination: A Prospective Study Gabriela S Generette, William Graft, Kayeromi Gomez, Basil Muhan, Jeana Kim, Kovas Polikaitis, et al. (+3)
616 [GO] 2023―Nov―27 1727. Household Vaccination Status and Attitudes towards Pediatric COVID-19 Vaccination: A survey at four New Jersey clinic-based pediatric practices Bozena J Katic, Jessica L Alvitres, Uzma Hasan, Aspasia Katragkou, Stephen M Friedman, Joseph V Schwab, et al. (+14)
617 [GO] 2023―Nov―27 1780. COVID-19 Vaccine Accessibility and Uptake among U.S. Children Aged 6 Months-4 Years and 5 Years-11 Years by Domains of Social Vulnerability Rohan Khazanchi, Benjamin Rader, Jonathan Cantor, Dena M Bravata, Kathleen A McManus, Christopher Whaley, et al. (+2)
618 [GO] 2023―Nov―27 2344. Clinical Profile and Immunologic Response from COVID-19 Vaccine Among People Living with HIV Enrolled in a Treatment Hub in the Philippines Mark John Festin, Regina Berba, Christine P Ramos, Jodor Lim
619 [GO] 2023―Nov―27 2358. Safety Profiles of Three Major Types of COVID-19 Vaccine among Two Cohorts of People Living with HIV Thana Khawcharoenporn, Sirashat Hanvivattanakul
620 [GO] 2023―Nov―27 2369. kinetics of total and neutralizing SARS-CoV-2 spike antibodies after the 2nd and 3rd dose of the BNT162b2 covid-19 vaccine and association with epidemiological characteristics and breakthrough infection Athanasios Michos, Elizabeth-Barbara Tatsi, Filippos Filippatos, Charilaos Dellis, Vasiliki Syriopoulou
621 [GO] 2023―Nov―27 479. Optimizing maternal COVID-19 vaccine antibodies in low birthweight infants: is timing everything? Alisa B Kachikis, Mindy Pike, Linda Eckert, Alexis L Baranoff, Hye Cho, Amber L Young, et al. (+3)
622 [GO] 2023―Nov―27 1938. CoviLiv™, a Novel Intranasal Live-Attenuated COVID-19 Vaccine Candidate, Induces Robust Humoral and Cellular Immunity in First-In-Human Clinical Trial CDX-CoV-001 Johanna K Kaufmann, Keri Wyllie, Yiwen Zhao, Lasmy Tea, Sybil Tasker, Leena R Yeolekar, et al. (+2)
623 [GO] 2023―Nov―27 496. Maternal Participation in Enrollment Interview and Risk of Bias in a Multicenter Pediatric Network Evaluating COVID-19 Vaccine Effectiveness in Infants Regina Simeone, Laura D Zambrano, Margaret M Newhams, Natasha B Halasa, Katherine E Fleming-Dutra, Amber Orzel, et al. (+3)
624 [GO] 2023―Nov―27 1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study Gabrielle N Gaultier, Brynn McMillan, Mandy Lo, Bing Cai, Jean Zheng, Hennady Shulha, et al. (+9)
625 [GO] 2023―Nov―27 385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2 Grant C Paulsen, Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Sungeen Hill, Emily Wasserman, et al. (+18)
626 [GO] 2023―Nov―27 362. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to Toddlers and Children 6 Months to < 5 Years of Age Who Previously Received Original BNT162b2 as a 3-Dose Primary Series Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Justice Kofi Boakya-Appiah, Xia Xu, Emmanuel Walter, et al. (+17)
627 [GO] 2023―Nov―27 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults Jennifer Whitaker, Paulina Rebolledo, Nadine Rouphael, Getahun Abate, Tara M Babu, Anna Wald, et al. (+16)
628 [GO] 2023―Nov―27 2340. COVID-19 Vaccine Hesitancy among Faculty Members, College Students and Health Care Workers in Lebanon George Doumat, Mohamad Ali Tfaily, Rayyan Wazzi-Mkahal, Zeina Kanafani
629 [GO] 2023―Nov―27 490. Identifying and Evaluating the Drivers of COVID-19 Vaccine Hesitancy Among Individuals with HIV in New Jersey Jessica Occhiogrosso, Leena Rijhwani, Divya Rijhwani, Aravind Rajagopalan, Theresa C Fox, Roseann Marone, et al. (+3)
630 [GO] 2023―Nov―27 2390. Factors Affecting Parental COVID-19 Vaccine Hesitancy in Cancer Parents with Minor Children Kazue Umetsu, Kazuhiro Kosugi, Tomoko Takahashi, Daisuke Fujisawa, Takashi Kawaguchi, Emi Kubo, et al. (+11)
631 [GO] 2023―Nov―27 2384. Exploring COVID-19 Vaccine Hesitancy in Unvaccinated Adults within a Semi-Urban Population of South India: A Qualitative Investigation Dipu T Sathyapalan, Sivapriya Nair, Vrinda Nampoothiri, Merlin Moni
632 [GO] 2023―Nov―27 2336. General Safety Profile of mRNA-1273 (Moderna COVID-19 Vaccine) in the Elderly Population Kate Anteyi, Veronica Urdaneta, Priyadarshani Dharia, Magalie Emile-Backer, Vaishali Khamamkar, Daina Esposito, Walter Straus
633 [GO] 2023―Nov―27 2385. Factors associated with delay of completion of a two-dose COVID-19 vaccine primary series among servicemembers in the Military Health System Erica Sercy, Laveta Stewart, Megan Clare Craig-Kuhn, Caryn Stern, Brock Graham, Amber Michel, et al. (+6)
634 [GO] 2023―Nov―27 2370. Characterizing Predictors of COVID-19 Vaccine Refusal in an Urban Southern California Jail Nazia Qureshi, Loren G Miller, Stephen Judge, Ngoc Dung Tran, Sean O Henderson
635 [GO] 2023―Nov―27 2357. Descriptive Analyses of mRNA-1273 (Moderna COVID-19 vaccine) Spontaneous Reports by Geographic Regions Magalie Emile-Backer, Vaishali Khamamkar, Priyadarshani Dharia, Samantha St Laurent, Cindy Ke Zhou, Daina Esposito, et al. (+2)
636 [GO] 2023―Nov―27 2382. Sociodemographic and Occupational Characteristics Associated with Delayed and Low COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY Savanah Russ, Christopher J Myers, Erin Licherdell, Acacia Bowden, Ellen Chinchili, Runda Dahhan, et al. (+3)
637 [GO] 2023―Nov―27 2360. Factors Affecting COVID-19 Vaccine Uptake in People Living with HIV Victoria N Kunkel, Nathan A Summers, Nupur Singh
638 [GO] 2023―Nov―27 2386. Examining Ways to Increase COVID-19 Vaccine Uptake through Motivational Interviewing Summer M Reyes, Sydney A Reyes, Tyler Walsh, Jamee T SHELLEY, Humza Agha, Ana V Torres, et al. (+6)
639 [GO] 2023―Nov―27 2367. Six-month Humoral Response Following Two Or Three Doses Of Covid-19 Vaccines As Primary Vaccination Followed Or Not By a Booster Dose In Specific Populations - ANRS0001S COV-POPART Cohort Study Paul LOUBET, Camille Gilbert, David Laplaud, Martine Laville, Bruno Laviolle, Jean-Daniel Lelièvre, et al. (+10)
640 [GO] 2023―Nov―27 2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin ) Debdeep Mitra, Neerja Saraswat
641 [GO] 2023―Nov―27 1371. Results From the COVID-19 Vaccines Discrete Choice Experiment Pre-Test Qualitative Interviews in Canada, Germany, the UK, and US General Population Sumitra Sri Bhashyam, L G Shane, Hannah B Lewis, Marie de la Cruz, Jayne Galinsky, Keeva Demchuk, et al. (+3)
642 [GO] 2023―Nov―27 1720. Immunogenicity of COVID-19 Vaccines in Youth with Inflammatory Bowel Disease Blake T Cirks, Emily Parsons, Emily Samuels, Eric D Laing, Michael Rajnik, Allison M Malloy
643 [GO] 2023―Nov―27 408. Clinical Spectrum of Pediatric Long COVID and Impact of COVID-19 Vaccines on the Clinical Course Dina Kamel, Jeffrey Bender, David Warburton, John C Wood, Sindhu Mohandas
644 [GO] 2023―Nov―27 507. Impact of COVID-19 variant prevalence on hospitalization rate among individuals receiving monoclonal antibodies within a community health-system Gretchen S Arnoczy, Andrew Kessell, Felicia M Vielbaum, Brenda Brock, Rebecca Carter, Jan M Scholl
645 [GO] 2023―Nov―27 459. Characteristics and Presentations of Hospitalized Children due to three predominate COVID-19 variants within a healthcare network Sejal M Bhavsar, Katharine N Clouser, Hailey Connolly, Jasmine Gadhavi, Ranbir Kaur, Tara Lozy, et al. (+7)
646 [GO] 2023―Nov―27 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein Tatsuro Kawamura, Masaki Ohuchi, Takayuki Nagasawa, Hirofumi Ohashi, Naoko Iwata-Yoshikawa, Nozomi Shiwa-Sudo, et al. (+13)
647 [GO] 2023―Nov―27 88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial Deepa B Gotur, Anuj Malik, Vadim Markovtsov, Lucy Yan, Wolfgang Dummer, Ziad Mallat
648 [GO] 2023―Nov―27 512. Interim Results of a Prospective Cohort Study to Monitor the Emergence of Resistance in Immunocompromised Non-Hospitalized Patients With COVID-19 Who Were Treated with Sotrovimab in Great Britain: LUNAR Study  Judith Breuer, Myriam Drysdale, Jill Walker, Jennifer Han, Magdalena Gorczycka, Alicia Aylott, et al. (+4)
649 [GO] 2023―Nov―27 2308. Exploring the Seasonality of COVID-19 with Machine Learning: A Distinct Bimodal Pattern? Guillermo Rodriguez-Nava, Lucy S Tompkins, Karen McIntyre, Bryan Bohman, Jorge Salinas
650 [GO] 2023―Nov―27 1861. Prevalence of COVID-19 within Predominantly Black Church Congregations in Ontario, Canada Nicole Wisener, Alice Litosh, Walter Byrne, Matthew Hwang, Kimberly Thompson, Upton D Allen
651 [GO] 2023―Nov―27 740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020 Kelly A Jackson, Sydney Resler, Joelle Nadle, Susan Petit, Kimberly Yousey-Hindes, Susan M Ray, et al. (+11)
652 [GO] 2023―Nov―27 2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023 Jennifer DeCuir, Yuwei Zhu, Manjusha Gaglani, Adit A Ginde, Nicholas Mohr, Kevin Gibbs, et al. (+24)
653 [GO] 2023―Nov―27 516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death Ashley S Cha-Silva, Meghan B Gavaghan, Jennifer L Nguyen, Ronika Alexander-Parrish, Jingyan Yang, Jaymin Patel, et al. (+3)
654 [GO] 2023―Nov―27 1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of COVID-19: 15-Month Final Analysis of the PROVENT Phase 3 Study Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Rohini Beavon, Jesse Thissen, Seth Seegobin, et al. (+3)
655 [GO] 2023―Nov―27 529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Phase 3 Study F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Jesus Abraham Simón Campos, Douglas Arbetter, Seth Seegobin, et al. (+5)
656 [GO] 2023―Nov―27 2234. Ambulatory Prescribing Trends of Azithromycin and Systemic Glucocorticoids in Patients Diagnosed with COVID-19: A Large Healthcare Network Analysis in Massachusetts Shamsuddin Anwar, Maureen Campion, Kap Sum Foong, Shira Doron, Gabriela Andujar Vazquez
657 [GO] 2023―Nov―27 474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting Jun Hirai, Nobuaki Mori, Daisuke Sakanashi, Nobuhiro Asai, Mao Hagihara, Hiroshige Mikamo
658 [GO] 2023―Nov―27 491. Risk Factors for Severe Pediatric COVID-19: A Systematic Review Carlos R Oliveira, Zachary I Willis, Gabriela Maron, Paul K Sue, Brenda I Anosike, Laura Bio, et al. (+5)
659 [GO] 2023―Nov―27 510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data Christopher F Bell, Tasneem Lokhandwala, Daniel C Gibbons, Myriam Drysdale, Jane Wang, Emily Lloyd
660 [GO] 2023―Nov―27 1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study Myron J Levin, Andrew Ustianowski, Jesse Thissen, Seth Seegobin, Rohini Beavon, Kanika Dey, et al. (+5)
661 [GO] 2023―Nov―27 2643. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-2023 Adam Blatt, Mina Suh, Zachary Wolf, Emory Waddell, Christopher B Nelson
662 [GO] 2023―Nov―27 530. Population Pharmacokinetic Analysis of Ensitrelvir, an Inhibitor of 3C-like (3CL) Protease of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for patients with SARS-Cov-2 Infection Toru Ishibashi, Luna Nomura, Ryosuke Shimizu, Ryuji Kubota
663 [GO] 2023―Nov―27 482. Long-Term Outcomes of Coronavirus disease 2019 and Risk Factors for Prolonged SARS-CoV-2 Infection in Lymphoma Patients: Multicenter, Retrospective Cohort Study Jung Ah Lee, Min Han, Sangmin Ahn, Yongseop Lee, Joon-sup Yeom, Jun Yong Choi, et al. (+8)
664 [GO] 2023―Nov―27 1479. Analysis of Depression in People Living with Human Immunodeficiency Virus (HIV) During the Coronavirus Disease 2019 Pandemic in 4 African Countries Paul Adjei, Nicole Dear, Allahna Esber, Hannah Kibuuka, Jonah Maswai, John Owuoth, et al. (+4)
665 [GO] 2023―Nov―27 2355. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children Tatsuki Ikuse, Yuta Aizawa, Satoshi Hasegawa, Masashi Takahashi, Takanori Hayashi, Miyako Kon, et al. (+3)
666 [GO] 2023―Nov―27 1337. Detection of SARS-CoV-2 using an electrostatic precipitator air sampler in hospital patient rooms of coronavirus disease-2019 and public areas Hiroaki Baba, Kyohei Fukuda, Mie Yoshida, Kouichi Kitabayashi, Shinjirou Katsushima, Hiroki Sonehara, et al. (+5)
667 [GO] 2023―Nov―27 531. Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease-2019: an updated systematic review and meta-analysis Su Jin Jeong
668 [GO] 2023―Nov―27 1752. Seasonal Human Coronavirus in Pediatric Patients enrolled by the New Vaccine Surveillance Network, 2016-2020 Samar Musa, Xueyan Zhang, G K Balasubramani, Natasha B Halasa, Laura S Stewart, Jennifer E Schuster, et al. (+13)
669 [GO] 2023―Nov―27 1103. Endemic Coronavirus Infections in a US Cohort of Children from Birth to 4 Years Daniel C Payne, Ardythe L Morrow, Shannon C Conrey, Meredith L McMorrow, Monica McNeal, Liang Niu, et al. (+10)
670 [GO] 2023―Nov―27 304. Immunoproteasome Inhibition Augments Endoplasmic Reticulum Stress and Enhances Disease During Coronavirus Respiratory Infection Jacob C Steigmann, Lauren Suttenberg, Xiaofeng Zhou, Jason Weinberg
671 [GO] 2023―Nov―27 918. Identification of novel druggable host targets for Middle East respiratory syndrome coronavirus using a quantitative phosphoproteomics approach Jasper F W Chan, Bingjie Hu, Kenn K H Chik, Shuofeng Yuan, Hin Chu
672 [GO] 2023―Nov―27 367. Safety and Immunogenicity of a 50-μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in Adolescents Amparo Figueroa, Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Monali Patel, et al. (+6)
673 [GO] 2023―Nov―27 880. Diagnostic Testing Sample-Type Preferences: Results From An International Survey On SARS-CoV-2 Sumaira Akbarzada, Nithya Narayanan, Leah Salzano, Emily R Tobik, Sarah Megiel, Craig Duni, et al. (+3)
674 [GO] 2023―Nov―27 450. Performance Evaluation of PMMV as an internal control for the wastewater surveillance of SARS-CoV-2 Hosoon Choi, John David Coppin, Piyali Chatterjee, Emma Brackens, Lynn Mayo, Munok Hwang, et al. (+3)
675 [GO] 2023―Nov―27 634. Head-to Head Comparison of the Performance of BIOFIRE® SPOTFIRE® Respiratory/Sore throat Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV and Cobas® SARS-CoV-2 & Influenza A/B Assay for Detection of Respiratory Viruses Dithi Banerjee, Anjana Sasidharan, Stephanie Gummersheimer, Sydnie Petty, Amanda M Hayes, Minati Dhar, Rangaraj Selvarangan
676 [GO] 2023―Nov―27 473. Trends among hospitalized pregnant patients with laboratory-confirmed SARS-CoV-2 - COVID-NET, 14 U.S. States, January 2021-January 2023 Fiona P Havers, Michael Whitaker, Jennifer Milucky, Monica E Patton, Bhoomija Chatwani, Shua Chai, et al. (+15)
677 [GO] 2023―Nov―27 2298. Penetration of SARS-CoV-2 Alpha, Delta, and Omicron Variants in the USA Hosoon Choi, Munok Hwang, John David Coppin, Piyali Chatterjee, Chetan Jinadatha
678 [GO] 2023―Nov―27 390. Corticosteroid Treatment in Severe Patients with SARS-CoV-2 and Chronic HBV Co-infection: A Retrospective Multicenter Study Sanju Biju, Shon Paulson, Jomel Raju
679 [GO] 2023―Nov―27 2651. Successful Sequencing and Genotyping of SARS-CoV-2 and Influenza Viruses from Self-Collected Nasal Swabs for SARS-CoV-2 Rapid Antigen Testing Kat Schmidt, Stephanie A Richard, Emily Hone, Simon Pollett, Rezalina Tant, Michele Wayman, et al. (+8)
680 [GO] 2023―Nov―27 539. Efficacy in Multiple SARS-CoV-2 Animal Models Supports Phase 3 Dose Selection for Obeldesivir Jared Pitts, Darius Babusis, Rita Humeniuk, David Martinez, Robert M Cox, Alexandra Schäfer, et al. (+18)
681 [GO] 2023―Nov―27 1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study Brynn McMillan, Gabrielle N Gaultier, Ana Citlali Marquez, Tahereh Valadbeigy, Bonny So, Sydney Schwartz, et al. (+13)
682 [GO] 2023―Nov―27 2305. The effect of SARS-CoV-2 antibody testing on the results of admission screening Kenji Ota, Tomohiro Yamakawa, Daisuke Sasaki, Fujiko Mitsumoto-Kaseida, Norihito Kaku, Kosuke Kosai, et al. (+5)
683 [GO] 2023―Nov―27 1796. Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Qualitative Results of an Emerging Infections Network Survey, March 2022 Scott S Santibanez, Adi Gundlapalli, Susan E Beekmann, Timothy M Uyeki, Panayampalli Satheshkumar, Ian D Plumb, et al. (+4)
684 [GO] 2023―Nov―27 454. How Useful is SARS-CoV-2 Antigen Detection in Individuals Admitted to the Hospital With no Respiratory Symptoms? Monique A Prince, Wajeeha Aiman, Modupeoluwa Owolabi, Alaa Muhanna, Evans Martin, Joe Hessell, Jihad Slim
685 [GO] 2023―Nov―27 639. Are SARS-CoV-2 antigenemia measurements still relevant? Comparison of Omicron era to early pandemic plasma nucleocapsid levels Gregory L Damhorst, Hans Verkerke, Sydney E Martin, Eli Wilber, Wilbur A Lam
686 [GO] 2023―Nov―27 452. Ongoing Surveillance of SARS-CoV-2 for In Silico Analysis to Monitor the Performance of SARS-CoV-2 Assays in BIOFIRE® Panels Eleanor K Horrocks, Toma Todorov, Alexandra Debernardi, Usha Spaulding, Tanner Robinson, Jeremiah Antosch, et al. (+3)
687 [GO] 2023―Nov―27 434. Characteristics and long-term outcomes of SARS-CoV-2 associated myocarditis cases in the Military Health System Simon Pollett, Stephanie A Richard, Catherine Berjohn, Josh Chenoweth, Paul Blair, Clifton Dalgard, et al. (+18)
688 [GO] 2023―Nov―27 377. Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4th dose boosters Terry Nolan, Georgia Deliyannis, Sabine Braat, Lilith Allen, Jennifer Audsley, Marcin Ciula, et al. (+32)
689 [GO] 2023―Nov―27 2396. In Nursing Home Residents, SARS-CoV-2 Boosters Reduced Sex Disparity in Vaccine Response Observed in Primary Series Brigid Wilson, Stefan Gravenstein, Sabra L Klein, Carson Smith, Anna Yin, Patrick Shea, et al. (+3)
690 [GO] 2023―Nov―27 467. Maternal Antibody and Placental Transfer Increases with Hybrid Immunity Against SARS-CoV-2 but Transferred Antibody is Qualitatively Different Ketrah Dekanich, Kristen Smith, Eric D Laing, Wei Wang, Carol D Weiss, Emily C Samuels, et al. (+23)
691 [GO] 2023―Nov―27 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study Alexandra Mellis, Sarah E Smith-Jeffcoat, Joshua Petrie, H Keipp Talbot, Kerry Grace Morrissey, Melissa Stockwell, et al. (+30)
692 [GO] 2023―Nov―27 441. Prior SARS-CoV-2 Diagnosis is a Risk Factor for Herpes Zoster in Younger Adults: A Nested Case-control Study in the EPICC Cohort Kat Schmidt, Stephanie A Richard, Catherine Berjohn, Tahaniyat Lalani, Alfred Smith, Rupal Mody, et al. (+24)
693 [GO] 2023―Nov―27 2079. Maternal hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone Sylvia M LaCourse, Erica A Wetzler, Morgan C Aurelio, Jaclyn N Escudero, Stacy Selke, Alex L Greninger, et al. (+7)
694 [GO] 2023―Nov―27 1336. Presence of Antibodies to non-SARS-CoV-2 Associates With Generation of Neutralizing Antibodies to SARS-CoV-2 Following mRNA Vaccination Roukaya Al Hammoud, Gabriela P Del Bianco, Anoma Somasunderam, Stacy Gomez Hernandez, Kaleigh Riggs, Syed Hashmi, et al. (+2)
695 [GO] 2023―Nov―27 1792. SARS-CoV-2 Genomic Surveillance System Development as a Model for Other Emerging Pathogens in Texas Saroj Rai, Rania Milleron, Rachel Lee, Blake M Hanson, Marlisa Hardy, Eric Boerwinkle, et al. (+3)
696 [GO] 2023―Nov―27 500. Durability of antibody response after booster vaccination against SARS-CoV-2 in kidney transplant recipients with or without prior infection Thornthun Ueaphongsukkit, Athiphat Banjongjit, Yingyos Avihingsanon, Suwasin Udomkarnjananun, Natavudh Townamchai, Kamonwan Jutivorakool, Jakapat Vanichanan
697 [GO] 2023―Nov―27 2299. Genomic Epidemiology of SARS-CoV-2 in Metropolitan Detroit Jagjeet Kaur, Katherine Gurdziel, Benjamin Wasinski, Nivisa Vakeesan, Sayed Hassan Raza, Wanqing Liu, et al. (+2)
698 [GO] 2023―Nov―27 464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding Eui Jin Chang, Jungmin Lee, Sung-Woon Kang, So Yun Lim, Ji Yeun Kim, Choi-Young Jang, et al. (+2)
699 [GO] 2023―Nov―27 497. Safety and tolerability of 2000mg intravenous sotrovimab dose in immunocompromised participants uninfected with SARS-CoV-2 in the PROTECT-V trial Davinder Dosanjh, Wendi Qian, Francis Dowling, Louise Crowley, Michael Chen-Xu, Rona M Smith
700 [GO] 2023―Nov―27 2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population A Koen, E Mitha, J Allagappen, A Nagare, M Dhar, M Marrali, et al. (+13)
701 [GO] 2023―Nov―27 477. Characteristics and Long-Term Outcomes of Cardiac Complications of SARS-CoV-2 in Youth: Results from the EPICC YES C3 Prospective Longitudinal Cohort Module Milissa U Jones, Stephanie A Richard, Allison M Malloy, Kirk N Liesemer, Rebecca Sainato, Joseph May, et al. (+20)
702 [GO] 2023―Nov―27 411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection A Reum Kim, Eui Jin Chang, SeongMan Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, et al. (+4)
703 [GO] 2023―Nov―27 2082. Effectiveness of Bivalent mRNA Vaccines in Preventing SARS-CoV-2 Infection Among Children Aged 5-17 years: an Evaluation of Multicenter Prospective Cohorts, United States, September 2022 - January 2023 Leora R Feldstein, Amadea Britton, Lauren Beacham, Ryan E Wiegand, Jasmine Ruffin, Melissa Briggs-Hagen, et al. (+22)
704 [GO] 2023―Nov―27 288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination So Yun Lim, Jineui Kim, Ji-Soo Kwon, Sung-Woon Kang, Eui Jin Chang, Seongman Bae, et al. (+6)
705 [GO] 2023―Nov―27 2656. Longitudinal Trends in Attributable Causes of Death Among US Veteran Patients with Documented SARS-CoV-2 Infection between January 2021 and March 2023 Caitlin A Trottier, Jennifer La, Lucy Li, Nathanael Fillmore, Paul Monach, Westyn Branch-Elliman, Shira Doron
706 [GO] 2023―Nov―27 2306. A serosurvey of healthcare workers caring for, or handling specimens from, individuals exposed to, or diagnosed with, SARS-CoV-2 infection (COVID-HEROES) Alyssa Pradhan, Dominic E Dwyer, Linda Hueston, Will Asquith, Ravindra Dotel, Ralph Nanan, et al. (+13)
707 [GO] 2023―Nov―27 1624. SARS-CoV-2 Maternal Vaccination Induces More Efficient Placental Antibody Transfer to Newborns than SARS-CoV-2 Infection During Pregnancy Leire Pérez Latorre, Shira H Cohen, Paula Rodriguez-Molino, Hannah Kim, Mariah Eisner, Traci Pifer, et al. (+16)
708 [GO] 2023―Nov―27 1364. Association Between Tixagevimab/Cilgavimab Administration and Self-Reported SARS-CoV-2 Infection During the Omicron Surge Daniya S Mathew, Patricia Saunders-Hao, Sumeet Jain, Trever Ball, Amparo Abel-Bey, Keisha Bowman, et al. (+3)
709 [GO] 2023―Nov―27 400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study Michelle Floris-Moore, Melissa Stockwell, Carlos G Grijalva, H Keipp Talbot, Alexandra Mellis, Sarah E Smith-Jeffcoat, et al. (+20)
710 [GO] 2023―Nov―27 484. Clinical Description of SARS-CoV-2 Infection in Patients with Primary Antibody Deficiency Who Received Tixagevimab/Cilgavimab Prophylaxis Sung Min Lim, Je Hee Shin, Jee Yeon Baek, Ji Young Lee, Ji-Man Kang, Jong Gyun Ahn
711 [GO] 2023―Nov―27 536. Development of post acute sequelae of SARS-Cov-2 infection (long Covid) in outpatient receiving monoclonal antibodies Amelia Neto, Vivek Kak
712 [GO] 2023―Nov―27 421. Impact of SARS-CoV-2 Infection on Physical Fitness in Air Force Basic Trainees Elena M Crouch, Joseph Marcus, Heather Yun, Theresa Casey, John Kieffer, Erin Winkler, et al. (+2)
713 [GO] 2023―Nov―27 456. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment Sangmin Ahn, Yongseop Lee, Min Han, Jung Ah Lee, Jung Ho Kim, Su Jin Jeong, et al. (+4)
714 [GO] 2023―Nov―27 489. Spatial transcriptomic analysis of placental tissue demonstrates differential gene expression in pregnancies with SARS-CoV-2 infection, SARS-CoV-2 placentitis, and controls Leena B Mithal, Ramon Lorenzo-Redondo, Ashwin Sunderraj, Elisheva D Shanes, Jeffrey A Goldstein
715 [GO] 2023―Nov―27 2296. Trends in reasons for hospital admission among adults ≥18 years hospitalized with laboratory-confirmed SARS-CoV-2 infection-COVID-19-Associated Hospitalization Surveillance Network (COVID-NET), 14 U.S. States, June 2020 - January 2023 Fiona P Havers, Michael Whitaker, Monica E Patton, Michael Melgar, Art Reingold, Nisha B Alden, et al. (+14)
716 [GO] 2023―Nov―27 460. SARS-CoV-2 Infection-Induced Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions - United States, 2020-2022 Anna Bratcher, Jefferson M Jones, Aaron Harris, Kristie E N Clarke
717 [GO] 2023―Nov―27 1351. Predictors of Loss of Infectivity Among Healthcare Workers with Primary and Recurrent SARS-CoV-2 infection: An Observational Cohort Study Stefka Dzieciolowska, Yves Longtin, Hugues Charest, Tonya Roy, Judith Fafard, Ines Levade, et al. (+6)
718 [GO] 2023―Nov―27 2301. Viral Kinetics of Sequential SARS-CoV-2 Infections Stephen Kissler, James Hay, Joseph Fauver, Christina Mack, Caroline Tai, Deverick Anderson, et al. (+3)
719 [GO] 2023―Nov―27 503. Post-vaccination SARS-CoV-2 Infections and Immune Response in People with Immune Disorders Mackenzie Zendt, Fausto Bustos Carrillo, Rahul Subramanian, Viviane Callier, Ana Ortega-Villa, Emily Ricotta
720 [GO] 2023―Nov―27 2307. Respiratory Virus Testing Strategy on Admission to Hospital in a Season where SARS-CoV-2 is Co-circulating with Seasonal Respiratory Viruses Paige Reason, Victoria R Williams, Lorraine Maze Dit Mieusement, Heather Candon, Xena Li, Robert Kozak, Jerome A Leis
721 [GO] 2023―Nov―27 1344. Stakeholders’ Perspectives of the Establishment of SARS-CoV-2 Monoclonal Antibody Infusion Centers in Rural Southwestern Virginia: A Qualitative Analysis with Realist Interview Approach Hyun Sue Kim, Anthony Baffoe-Bonnie
722 [GO] 2023―Nov―27 2368. SARS-CoV-2 mRNA vaccination induces B cell immunity in the tonsils and adenoids of children Qin Xu, Pamela Mudd, Hengameh Behzadpour, Lorenza Bellusci, Gabrielle Grubbs, Sara Pourhashemi, et al. (+11)
723 [GO] 2023―Nov―27 2352. The Dynamic Change in Humeral Immunity Against SARS-CoV-2 Omicron Subvariants in Patients with Breakthrough Infection: The Prospective Cohort Study Monprach Harnphadungkit, Opass Putcharoen, Supaporn Wacharapluesadee
724 [GO] 2023―Nov―27 480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients K O H E I KAMEGAI, Noriko Iwamoto, Naoya Itoh, Masahiro Ishikane, Yusuke Asai, Nana Akazawa, et al. (+14)
725 [GO] 2023―Nov―27 453. Distribution of cycle threshold values and the associated factors of SARS-CoV-2 omicron variant in a community setting in Japan Yoshikazu Mutoh, Takumi Umemura, Toshihiko Ichihara
726 [GO] 2023―Nov―27 545. Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants Lauren Rodriguez, Jiani Li, Dong Han, Ross Martin, Jasmine Moshiri, Nadine Peinovich, et al. (+3)
727 [GO] 2023―Nov―27 2362. SARS-CoV-2 Omicron Variants Associated with Less Severe Disease in Hospitalized Patients Irrespective of Baseline Risk Factors and Immunity Austin Lee, Eric Kawaguchi, Christina Vu, Brianna Ray, Joy Suh, Vanya Vojvodic, et al. (+7)
728 [GO] 2023―Nov―27 2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized, Observer-Blind, Active-Controlled Trial Ivan T Lee, Catherine A Cosgrove, Patrick Moore, Marcin Bula, Philip Kalra, Paul Dargan, et al. (+22)
729 [GO] 2023―Nov―27 2330. Ventilation Strategies Based on an Aerodynamic Analysis During a Large-Scale SARS-CoV-2 Outbreak in an Acute-Care Hospital Se Yoon Park, Jungyeon Yu, Jin Su Song, Shin Young Lee, Jin Hwa Kim, Yeon Su Jeong, et al. (+4)
730 [GO] 2023―Nov―27 1340. Towards better understanding of the epidemiology of SARS-CoV-2 PCR conversion in hospitalized patients: a case-control study Farrin A Manian, Chaitanya A Karlapalem
731 [GO] 2023―Nov―27 2326. SARS-CoV-2 PCR Cycle Threshold Trends in Immunocompromised Patients and Implications for Isolation Precautions Courtney E Harris, Vineeta Vaidya, Michael Klompas, Chanu Rhee, Lindsey R Baden, Meghan Baker
732 [GO] 2023―Nov―27 2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022 Sandra N Bulens, Amanda Hall, Jesse T Jacob, Gillian Smith, Lucy E Wilson, Elisabeth Vaeth, et al. (+16)
733 [GO] 2023―Nov―27 1356. "Correlates of protection against SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study" Emilie Goguet, Cara Olsen, William A Meyer, Sara Ansari, Tonia Conner, John H Powers, et al. (+42)
734 [GO] 2023―Nov―27 1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis Francesco Borriello, Grace Marden, Hongru Li, Eric Carlin, Geetika Sharma, Monica Menzenski, et al. (+13)
735 [GO] 2023―Nov―27 419. Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims Shishi Luo, Lisa M McEwen, Scott P Kelly, Magnus Isaksson, Sarah Murphy, Simon White, et al. (+9)
736 [GO] 2023―Nov―27 2337. Immunogenicity and Safety of a Heterologous Booster Dose of Omicron Subvariant (BA.1 and BA.5) and Bivalent SARS-CoV-2 Recombinant Spike Protein Vaccines: A Phase 3, Randomized, Clinical Trial Chijioke Bennett, Wayne Woo, Alex Marcheschi, Raburn M Mallory
737 [GO] 2023―Nov―27 2318. Utility of Routine Asymptomatic Post-Admission SARS-CoV-2 Screening in a Rehabilitation Facility Victoria R Williams, Larry Robinson, Morty Eisenberg, Robert Kozak, Kuldeep Virdi, Heather Candon, Jerome A Leis
738 [GO] 2023―Nov―27 436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults Megha Priyadarshi, Manish Soneja, Saurav Sekhar Paul, Ayush Agarwal, Praveen Kumar Tirlangi, Shilpa Sachan, et al. (+2)
739 [GO] 2023―Nov―27 1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period - IVY Network, 5 U.S. States, April 11, 2022 - February 1, 2023 Zoe M Raglow, Diya Surie, James Chappell, Yuwei Zhu, Emily T Martin, Jennie H Kwon, et al. (+20)
740 [GO] 2023―Nov―27 1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study So Yun Lim, Jun-Won Kim, Ji Yeun Kim, Sung-Woon Kang, Choi-Young Jang, Eui Jin Chang, et al. (+8)
741 [GO] 2023―Nov―27 2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity - Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST Anahita Fathi, Christine Dahlke, Svenja Hardtke, Sibylle C Mellinghoff, Leonie Mayer, Leonie M Weskamm, et al. (+9)
742 [GO] 2023―Nov―27 455. Changing epidemiology of SARS-CoV-2 testing, positivity rates, and variant distribution in children and adults over multiple pandemic waves in New York City Priya Velu, Charlene Thomas, Sophie Rand, Melissa Cushing, Zachary Grinspan, Erika Abramson, et al. (+5)
743 [GO] 2023―Nov―27 2285. Using Genomic Sequencing to Describe SARS-CoV-2 Transmission Dynamics in U.S. Major League Soccer Clubs Joseline Velasquez-Reyes, Ludy R Carmola, Jacquelyn Turcinovic, Isaac Schneider, Margot Putukian, Kyle Sherry, et al. (+13)
744 [GO] 2023―Nov―27 2295. Documented SARS-CoV-2 Transmission Events Between Patients and Hospital Staff Alison Han, Heike Bailin, Jennifer Kwan, Michael Bell, Brooke K Decker, Tara Palmore
745 [GO] 2023―Nov―27 2284. SARS-CoV-2 Transmission in Utah Nursing Homes Julia Bohman, Karim Khader, Alun Thomas, Jeffrey Ferraro, Matthew H Samore
746 [GO] 2023―Nov―27 463. Immunogenicity and Safety of mRNA-based SARS-CoV-2 vaccination in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review Jorge Luis Cardenas-Alvarez, Abel Triana, Juan Uribe, Dan Morgenstern-Kaplan, John M Reynolds, Mohammed Raja, Yoichiro Natori
747 [GO] 2023―Nov―27 2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series Alison Uriel, Pedro Garbes, A Nagare, J C Kuan, Christine Palmer, K Bae, et al. (+16)
748 [GO] 2023―Nov―27 2636. Discovery of Spike Identification (SpiID) Nanobody Panel for SARS-CoV-2 Vaccine Development Qi Li, Jennifer Doering, Zepei Ma, Nicholas Mantis, Lisa Cavacini, Yang Wang
749 [GO] 2023―Nov―27 2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model Ross N England, Elizabeth Drapeau, Reihaneh Hosseinzadeh, Drew Weissman, Scott Hensley
750 [GO] 2023―Nov―27 466. Immunogenicity of 2nd, 3rd, 4th SARS-CoV-2 Vaccines in Renal Patient Populations Michael Chen-Xu, Daniel Cooper, Rainer Döffinger, Rachel Jones, Rona M Smith
751 [GO] 2023―Nov―27 2304. Surveillance strategies for the detection of new SARS-CoV-2 variants across epidemiological contexts Kirstin Oliveira Roster, Stephen M Kissler, Enoma Omoregie, Jade Wang, Helly Amin, Steve Di Lonardo, et al. (+2)
752 [GO] 2023―Nov―27 2287. Goal! Goal! Goal! Detection of SARS-CoV-2 Variants in Travelers During the FIFA World Cup, Qatar 2022 - CDC Traveler-Based Genomic Surveillance Program, November 2022-January 2023 Katrina M Byrd, Stephen Bart, Teresa C Smith, Samantha M Loh, Sarah Anne J Guagliardo, Benjamin Rome, et al. (+6)
753 [GO] 2023―Nov―27 2291. SARS-CoV-2 Viral Kinetics Among Immunologically Naïve Adults: Comparison by Variant and Reinfection Status Margaret K Doll, Brianna Levenson Shakoor, Louise E Kimball, Jeffery Crukley, Nina Ozbek, Rachel L Blazevic, et al. (+14)
754 [GO] 2023―Nov―27 2286. A comparison of SARS-CoV-2 wastewater-based surveillance in a sentinel community versus a large metropolitan sewershed in Massachusetts, 2020-2023 Tyler Brown, Sowmya R Rao, Daniel Begemann, Flor Amaya, Barry Keppard, Amir Mohareb, et al. (+6)
755 [GO] 2023―Nov―27 2325. Five-day quarantine of patients exposed to SARS-CoV-2 within hospitals in the Omicron variant era Eun Ju Choo
756 [GO] 2023―Nov―27 2313. Population-based Incidence of SARS-CoV-2-associated Hospitalizations across the Age Spectrum in New York City, 2020-2021 Lisa Saiman, Edward E Walsh, Angela R Branche, Angela Barrett, Luis R Alba, Sonia Gollerkeri, et al. (+3)
757 [GO] 2023―Nov―27 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 Diane Lee, Robyn Mitchell, Linda Pelude, Charles Frenette, Bonita Lee, Marie-Astrid Lefebvre, et al. (+3)
758 [GO] 2023―Nov―27 2646. Characterization of Respiratory Infections Before and After the Emergence of SARS-CoV-2: Beyond the “Tripledemic” Michaela Powell, Jay Jones
759 [GO] 2023―Nov―27 2624. The Usual Suspects: A Retrospective Analysis of Pediatric Respiratory Viral Testing During the Pandemic Iris Cazali, Diego Erdmenger, Karin roldan
760 [GO] 2023―Nov―27 1755. Hospitalizations for Respiratory Viruses among Children 5-17 Years of Age in the Pre-COVID-19 Pandemic Era, the New Vaccine Surveillance Network, 2016-2020 Leila C Sahni, Justin Z Amarin, Tess Stopczynski, Andrew J Spieker, Laura S Stewart, Mary A Staat, et al. (+16)
761 [GO] 2023―Nov―27 1320. Pneumococcal Meningitis Before and During Covid - 19 Pandemic in Uruguay, South America (2017 - 2022). Marcos Delfino, Ana P Méndez, Monica Pujadas Ferrer, María Catalina Pírez
762 [GO] 2023―Nov―27 2514. Single Ascending Dose Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza Shawn Flanagan, Voon Ong, Tristan Baguet, Roxana E Rojas, Sy-Shi Wang, Ozlem Equils
763 [GO] 2023―Nov―27 912. Influence of a Global Pandemic on Bronchiolitis at a Bronx Hospital Michael Rosenberg, Karen Schaeffer, Alexandra J Boni, Christiaan Strydom
764 [GO] 2023―Nov―27 896. Epidemiology and effect of pandemic on regional coxsackie viral testing Ramesh Kordi, Arthur Chang, Mark D Hicar
765 [GO] 2023―Nov―27 1372. Impact of Age, Gender, Ethnicity, Comorbidities, and Vaccination Status on Long COVID in a Brooklyn Community Calvin Ta
766 [GO] 2023―Nov―27 425. Characterization and predictive risk scoring of long COVID in a South Indian cohort after breakthrough COVID infection; a prospective single centre study Merlin Moni, Pranav Nair, Chithira Nair, Kiran Kulirankal, Elizabeth Corley, Fabia Edathadathil, et al. (+2)
767 [GO] 2023―Nov―27 1370. Prevalence and predictors of post-covid-19 (long covid) in India Vignesh Kumar, Jency Maria Koshy, S Divyashree, Suneetha Narreddy, Priscilla Rupali, Sowmya Sathyendra
768 [GO] 2023―Nov―27 396. Clinical Characterization of Long COVID in Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Manuel Martínez-Rojas, Oscar Rodrigo Jiménez-Flores, et al. (+14)
769 [GO] 2023―Nov―27 445. An Ongoing Battle from a Forgotten War: Long COVID in Mississippi, October 2021 - September 2022 Manuela Staneva, Thomas Dobbs
770 [GO] 2023―Nov―27 1860. Long COVID Incidence by Sociodemographic Factors in a Large National Payor Database K J Craig, Amanda Zaleski, Michael Wiggins, Leah Altieri-Alger, Dorothea Verbrugge, Richard R Watkins
771 [GO] 2023―Nov―27 1362. Pediatric long COVID subphenotypes: an EHR-based study from the RECOVER program Vitaly Lorman, Xing Song, Suchitra Rao, Andrea J Allen, Levon Utidjian, L Charles Bailey
772 [GO] 2023―Nov―27 431. Title Implementing a Comprehensive Care Model as a Proposal for Long Covid Syndrome Care in a Latin American Country Jaime Andres Pineda Capera, Carlos Alvarez, Nathali Carolina Gonzalez Alvarado, Juan Manuel Correa Hernandez, Paola Andrea Rengifo Bobadilla, Patrick Francois Tarquino Aparicio
773 [GO] 2023―Nov―27 1358. Persistence of Omicron-Related Long COVID: Examining Prevalence and Impact at 12 Months Post-Acute Infection Yoonjung Kim, Shin-Woo Kim, Hyun-Ha Chang, Sohyun Bae
774 [GO] 2023―Nov―15 Decreased self-reported physical fitness following SARS-CoV-2 infection and the impact of vaccine boosters in a cohort study Stephanie A Richard, Ann I Scher, Jennifer Rusiecki, Celia Byrne, Catherine M Berjohn, Anthony C Fries, et al. (+198)
775 [GO] 2023―Nov―14 Effect of inhaled ciclesonide in non-critically ill hospitalized patients with COVID-19: a multicenter observational study in Japan Jun Suzuki, Shiro Endo, Takayuki Suzuki, Teppei Sasahara, Shuji Hatakeyama, Yuji Morisawa, et al. (+7)
776 [GO] 2023―Nov―07 Efficacy of mRNA-1273 against SARS-CoV-2 acquisition in young adults from March-December 2021 Kathryn E Stephenson, Jasmine R Marcelin, Audrey E Pettifor, Holly Janes, Elizabeth Brown, Moni Neradilek, et al. (+23)
777 [GO] 2023―Nov―07 Antibody response after the third SARS-CoV-2 vaccine in solid organ transplant recipients and people living with HIV (COVERALL-2) Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+159)
778 [GO] 2023―Nov―07 Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab Victoria G Hall, Thi H O Nguyen, Lilith F Allen, Louise C Rowntree, Lukasz Kedzierski, Brendon Y Chua, et al. (+17)
779 [GO] 2023―Nov―06 Hepatic steatosis and weight gain during COVID-19 pandemic among people living with HIV: impact of therapy with tenofovir alafenamide M Santos, A Corma-Gómez, J Martín Carmona, M Pérez-García, C Martín-Sierra, P Rincón-Mayo, et al. (+4)
780 [GO] 2023―Oct―25 Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial Scott R Goldsmith, Fahrettin Covut, Mark Fiala, Zhifu Xiang, Zahid Iqbal, Nathan Moore, et al. (+13)
781 [GO] 2023―Oct―18 Effect of swine glyco-humanized polyclonal neutralizing antibody on survival and respiratory failure in patients hospitalized with severe COVID-19: A Randomized, placebo-controlled Trial Benjamin Gaborit, Bernard Vanhove, Karine Lacombe, Thomas Guimard, Laurent Hocqueloux, Ludivine Perrier, et al. (+313)
782 [GO] 2023―Oct―10 Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis Thomas C Scheier, Stephanie Carlin, Nicola K Wills, Sean Wasserman, Dominik Mertz, John W Eikelboom
783 [GO] 2023―Oct―07 Antibiotic use among hospitalized patients with COVID-19 in the United States, March 2020-June 2022 Christine Kim, Hannah Wolford, James Baggs, Sujan Reddy, Lauri A Hicks, Melinda Neuhauser, Sarah Kabbani
784 [GO] 2023―Oct―06 Fever and Leukocytosis are Poor Predictors of Bacterial Coinfection in Patients with COVID-19 and Influenza Receiving Extracorporeal Membrane Oxygenation Luke B Jackson, Michal J Sobieszczyk, James K Aden, Joseph E Marcus
785 [GO] 2023―Oct―02 Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study Matthew L Bosworth, Boran Shenhuy, A Sarah Walker, Vahé Nafilyan, Nisreen A Alwan, Margaret E O’Hara, Daniel Ayoubkhani
786 [GO] 2023―Oct―01 Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England Shannah Gates, Samreen Ijaz, Hatice Baklan, Charlotte Washington, Su Brailsford, Maria Zambon, Heli Harvala
787 [GO] 2023―Sep―29 Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022 Palak Patel, Kristin E Schrader, Catherine E Rice, Elizabeth Rowley, Robyn A Cree, Malini B DeSilva, et al. (+14)
788 [GO] 2023―Sep―28 Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children Jianling Xie, Nathan Kuppermann, Todd A Florin, Daniel J Tancredi, Anna L Funk, Kelly Kim, et al. (+47)
789 [GO] 2023―Sep―20 Remdesivir is associated with reduced mortality in COVID-19 patients requiring supplemental oxygen including invasive mechanical ventilation across SARS-CoV-2 variants Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, EunYoung Lee, et al. (+5)
790 [GO] 2023―Sep―20 Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022 Iris Finci, Madelyn Yiseth Rojas Castro, Iris Hasibra, Jonilda Sulo, Albana Fico, Rovena Daja, et al. (+10)
791 [GO] 2023―Sep―08 Effectiveness of an mRNA vaccine booster dose against COVID-19 among U.S. healthcare personnel, October 2021-July 2022 Ian D Plumb, Nicholas M Mohr, Melissa Hagen, Ryan Wiegand, Ghinwa Dumyati, Karisa K Harland, et al. (+31)
792 [GO] 2023―Sep―08 What Long COVID Prevention Strategies Suggest About Its Pathophysiology Lao-Tzu Allan-Blitz, Howard Hu, Jeffrey D Klausner
793 [GO] 2023―Sep―06 Protection of Covid-19 vaccination against hospitalisation during the era of Omicron BA.4 and BA.5 predominance: a nationwide case-control study based on the French National Health Data System Laura Semenzato, Jérémie Botton, Stéphane Le Vu, Marie-Joëlle Jabagi, François Cuenot, Jérôme Drouin, et al. (+3)
794 [GO] 2023―Aug―31 Proteomic profiling of urine from hospitalised patients with severe pneumonia due to SARS-CoV-2 versus other causes: a preliminary report Lindsay Wilson, Ju-Wei Chang, Stuart Meier, Tariq Ganief, Naadir Ganief, Suzette Oelofse, et al. (+5)
795 [GO] 2023―Aug―22 Correction to: Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic Review
796 [GO] 2023―Aug―10 Humoral Immune Response to mRNA COVID-19 Vaccination Among Children 5-11 in a Multisite Prospective Cohort study, September 2021-September 2022 Zoe L Lyski, Cynthia Porter, Jennifer L Uhrlaub, Katherine D Ellingson, Zuha Jeddy, Lisa Gwynn, et al. (+20)
797 [GO] 2023―Aug―10 Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study May Y Liew, Josh I Mathews, Amy Li, Rohan Singh, Salvador A Jaramillo, Zoe F Weiss, et al. (+12)
798 [GO] 2023―Aug―09 Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19 Hailey J Park, Sophia T Tan, Tomás M León, Seema Jain, Robert Schechter, Nathan C Lo
799 [GO] 2023―Aug―09 Comparison of Tocilizumab versus Baricitinib in Clinical Outcomes Among Hospitalized Patients with COVID-19: Experience from a Public Hospital System in New York City Subin Sunny, Ami Tran, Jennifer Lee, Marie Abdallah, Nimra Chaudhry, John Quale
800 [GO] 2023―Aug―08 The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a model for rapid evidence review and dynamic practice recommendations during a public health emergency George L Anesi, Kathleen Degnan, Lauren Dutcher, Stephen Saw, Christina Maguire, Amanda Binkley, et al. (+20)
801 [GO] 2023―Aug―07 The STOP COVID 2 study: Fluvoxamine vs placebo for outpatients with symptomatic COVID-19, a fully-remote randomized controlled trial Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, et al. (+18)
802 [GO] 2023―Jul―26 Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis Marta Colaneri, Emanuele Maria Giusti, Camilla Genovese, Lucia Galli, Andrea Lombardi, Andrea Gori
803 [GO] 2023―Jul―26 Sexual behaviour and STI incidence in sexually active MSM living with HIV in times of COVID-19 Catrina Mugglin, Kalongo Hamusonde, Luisa Salazar-Vizcaya, Katharina Kuseijko, Dunja Nicca, David Haerry, et al. (+64)
804 [GO] 2023―Jul―24 Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People with Human Immunodeficiency Virus: Cohort Study John J Hanna, Liyu B Geresu, Marlon I Diaz, Milan Ho, Julia A Casazza, Madison A Pickering, et al. (+11)
805 [GO] 2023―Jul―21 A brief peer-led intervention to increase COVID-19 vaccine uptake among people who inject drugs in San Diego County: Results from a pilot randomized controlled trial Steffanie A Strathdee, Daniela Abramovitz, Alicia Harvey-Vera, Tara Stamos-Buesig, Carlos F Vera, Irina Artamonova, et al. (+4)
806 [GO] 2023―Jul―21 Viral determinants of acute COVID-19 symptoms in a non-hospitalized adult population in the pre-Omicron era Sarah A Goldberg, Scott Lu, Miguel Garcia-Knight, Michelle C Davidson, Michel Tassetto, Khamal Anglin, et al. (+15)
807 [GO] 2023―Jul―20 Cross-Sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals Marilyn Whelan, Yannick Galipeau, Nicole White-Al Habeeb, Danijela Konforte, Mohamed Abou El Hassan, Ronald A Booth, et al. (+3)
808 [GO] 2023―Jul―20 Decreased Pneumococcal Carriage Among Older Adults in Denmark During the COVID-19 Lockdown Michaela Tinggaard, Hans-Christian Slotved, Randi Føns Petersen, Nichlas Hovmand, Thomas Benfield
809 [GO] 2023―Jul―13 Post COVID-19 syndrome 2 years following the first wave: the role of humoral response, vaccination and reinfection Maddalena Peghin, Maria De Martino, Alvisa Palese, Stefania Chiappinotto, Federico Fonda, Valentina Gerussi, et al. (+5)
810 [GO] 2023―Jul―12 Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial Adrienne E Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas, R몺 Hussain, et al. (+22)
811 [GO] 2023―Jul―11 Humoral and cellular immune responses of patients living with HIV (PLWH) after 3 doses of m-RNA BNT162b2 SARS-CoV-2 vaccine: a prospective cohort study Luba Tau, David Hagin, Tal Freund, Tamar Halperin, Amos Adler, Rotem Marom, et al. (+7)
812 [GO] 2023―Jul―10 A Descriptive Cohort Study of Drug Utilization Patterns among Patients Hospitalized with COVID-19 in the United States, January 2021- February 2022 Sarah E Vititoe, Priya Govil, Aidan Baglivo, Elisha Beebe, Elizabeth M Garry, Nicolle M Gatto, et al. (+9)
813 [GO] 2023―Jul―10 SARS-CoV-2 Vaccine-Induced Immune Responses among Hematopoietic Stem Cell Transplant Recipients Afoke Kokogho, Trevor A Crowell, Muneerah Aleissa, Ana-Mihaela Lupan, Sonya Davey, Jun Bai Park Chang, et al. (+3)
814 [GO] 2023―Jul―07 Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Hospitalized Participants With COVID-19 Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, Arthur Bergman, Tong Zhu, Frances Hackman, et al. (+17)
815 [GO] 2023―Jul―07 Safety, Virology, Pharmacokinetics, and Clinical Experience of High-dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-label Clinical Trial Jaynier Moya, Marisol Temech, Sergio Parra, Erick Juarez, Reinaldo Hernandez-Loy, Juan C Moises Gutierrez, et al. (+11)
816 [GO] 2023―Jul―03 Carbapenem-Resistant Acinetobacter spp. Infection in Critically Ill Patients with Limited Treatment Options: a Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic Maddalena Giannella, Stefano Verardi, Andreas Karas, Hasania Abdel Hadi, Hervé Dupont, Alex Soriano, et al. (+3)
817 [GO] 2023―Jun―30 Sero-Epidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France Alix de Thoisy, Tom Woudenberg, Stéphane Pelleau, Françoise Donnadieu, Laura Garcia, Laurie Pinaud, et al. (+8)
818 [GO] 2023―Jun―27 Geographic targeting of COVID-19 testing to maximize detection in Los Angeles County Katherine M Jia, Rebecca Kahn, Rebecca Fisher, Sharon Balter, Marc Lipsitch
819 [GO] 2023―Jun―24 Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans Jennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, Jonathan Adams, Katrina Deardoff, Anna Korpak, et al. (+43)
820 [GO] 2023―Jun―17 Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru Rifat S Rahman, Marco A Tovar, Jesús Peinado, J Santiago Palomino, Claudio Ramirez, Fernando Llanos-Zavalaga, et al. (+10)
821 [GO] 2023―Jun―10 Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE) Michael G Ison, Debra F Weinstein, Marta Dobryanska, Anna Holmes, Anne-Marie Phelan, Yong Li, et al. (+9)
822 [GO] 2023―Jun―09 Successful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, Ryan D Cassaday, Guang-Shing Cheng, Zahra Kassamali Escobar, et al. (+7)
823 [GO] 2023―Jun―08 Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients with COVID-19 Using Nationwide Real-World Data: An Observational Matched Cohort Study from The Japan COVID-19 Task Force Hiromu Tanaka, Shotaro Chubachi, Ho Namkoong, Yasunori Sato, Takanori Asakura, Ho Lee, et al. (+54)
824 [GO] 2023―Jun―02 Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward Allyson L Russell, Lee M Hampton, Antara Sinha, Francisco J Luquero, Jalaa’ Abdelwahab
825 [GO] 2023―May―31 Long COVID Clinical Phenotypes Up to Six Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms Michael Gottlieb, Erica S Spatz, Huihui Yu, Lauren E Wisk, Joann G Elmore, Nicole L Gentile, et al. (+98)
826 [GO] 2023―May―27 Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive COVID-19 Treatment Trial (ACTT) as a Test Case Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine, Katherine Yang, Zanthia Wiley, Nikolaus Jilg, et al. (+36)
827 [GO] 2023―May―25 Correction to: Effectiveness of COVID-19 mRNA Vaccines in Preventing COVID-19-Associated Outpatient Visits and Hospitalizations Among American Indian and Alaska Native Persons, January-November 2021: A Test-Negative Case-Control Analysis Using Surveillance Data
828 [GO] 2023―May―25 Relative effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines and homologous boosting in preventing COVID-19 in adults in the US Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Meg Sredl, Mac Bonafede, Thierry Ducruet, et al. (+7)
829 [GO] 2023―May―24 A Prospective Study of Key Correlates for Household Transmission of SARS-CoV-2 Elizabeth R Brown, Meagan P O’Brien, Brian Snow, Flonza Isa, Eduardo Forleo-Neto, Kuo-Chen Chan, et al. (+4)
830 [GO] 2023―May―24 Association between SARS-CoV-2 variants and frequency of acute symptoms: Analysis of a multi-institutional prospective cohort study - December 20, 2020 - June 20, 2022 Ralph C Wang, Michael Gottlieb, Juan Carlos Montoy, Robert Rodriguez, Huihui Yu, Erica S Spatz, et al. (+103)
831 [GO] 2023―May―24 Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron Michael G Ison, Myra Popejoy, Nikolay Evgeniev, Maria Tzekova, Kathryn Mahoney, Natalia Betancourt, et al. (+54)
832 [GO] 2023―May―22 Association between Cycle Threshold value and Vaccination Status among SARS-CoV-2 Omicron variant cases in Ontario in December, 2021 Saranyah Ravindran, Jonathan B Gubbay, Kirby Cronin, Ashleigh Sullivan, Austin Zygmunt, Karen Johnson, et al. (+2)
833 [GO] 2023―May―21 Understanding the Relationship Between Antiviral Prescription Data and COVID-19 Incidence in New York City: A Retrospective Cohort Study Christina M Kaul, Gabriel M Cohen, Matthew Silverstein, Andrew B Wallach, Elizabeth Diago-Navarro, Robert S Holzman, Mary K Foote
834 [GO] 2023―May―19 Multiregional population-based cohort study for evaluation of the association between herpes zoster and mRNA vaccinations for SARS-CoV-2: the VENUS Study Chieko Ishiguro, Wataru Mimura, Yukari Uemura, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
835 [GO] 2023―May―17 Incidence rates and clinical characteristics of patients with confirmed myocarditis or pericarditis following COVID-19 mRNA vaccination: experience of the Veterans Health Administration through October 9, 2022. Jing Luo, Kwan Hur, Cedric Salone, Nina Huang, Muriel Burk, Lucy Pandey, et al. (+3)
836 [GO] 2023―May―17 Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges among Vaccinated Healthcare Workers at a Boston Hospital Maura C Dodge, Lei Ye, Elizabeth R Duffy, Manisha Cole, Susan H Gawel, Martha M Werler, et al. (+3)
837 [GO] 2023―May―17 Rapid emergence of potentially transmissible SARS-CoV-2 with resistance to combination monoclonal antibody therapy Jana L Jacobs, Ghady Haidar, Asma Naqvi, Kevin D McCormick, Michele Sobolewski, Benjamin R Treat, et al. (+16)
838 [GO] 2023―May―11 Prevalence of SARS-CoV-2 viremia in pre-symptomatic blood donors in the delta and omicron variant eras Paula Saá, Rebecca V Fink, Hina Dawar, Clara Di Germanio, Leilani Montalvo, David J Wright, et al. (+12)
839 [GO] 2023―May―11 Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
840 [GO] 2023―May―08 Association of Self-Reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE) Wendy P Bannister, Dorthe Raben, Palle Valentiner-Branth, Martin Tolstrup, Lykke Larsen, Britta Tarp, et al. (+20)
841 [GO] 2023―May―05 Genomic Epidemiology of a SARS-CoV-2 Outbreak in a U.S. Major League Soccer Club: Was it travel related? Ludy R Carmola, Jacquelyn Turcinovic, Garrison Draper, David Webner, Margot Putukian, Holly Silvers-Granelli, et al. (+11)
842 [GO] 2023―May―03 Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, et al. (+26)
843 [GO] 2023―May―03 Systematic review of the prevalence of Long Covid Mirembe Woodrow, Charles Carey, Nida Zia�n, Rebecca Thomas, Athena Akrami, Vittoria Lutje, et al. (+2)
844 [GO] 2023―May―02 Investigation of blood plasma viral nucleocapsid antigen as a marker of active SARS-CoV-2 Omicron variant infection Gregory L Damhorst, Nils Schoof, Phuong-Vi Nguyen, Hans Verkerke, Eli Wilber, Kaleb McLendon, et al. (+13)
845 [GO] 2023―Apr―20 Large diffusion of SARS-CoV-2 after the successive epidemiological waves, including Omicron, in Guinea and Cameroon: implications for vaccine strategies Mamadou Saliou Kalifa Diallo, Marie Amougou-Atsama, Ahidjo Ayouba, Cece Kpamou, Eric Donald Mimbe Taze, Guillaume Thaurignac, et al. (+13)
846 [GO] 2023―Apr―19 Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients with COVID-19: A Post-Hoc Analysis in a Phase 1/2/3 Double-Blind Trial Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, Ernesto Oviedo-Orta, Meagan P O’Brien, Veronica Mas Casullo, et al. (+11)
847 [GO] 2023―Apr―19 Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine Nabin K Shrestha, Patrick C Burke, Amy S Nowacki, James F Simon, Amanda Hagen, Steven M Gordon
848 [GO] 2023―Apr―19 Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections Daniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, John H Beigel, Tatiana Beresnev, Valeria D Cantos, et al. (+24)
849 [GO] 2023―Apr―19 Neutralizing Antibody Responses to mRNA COVID-19 Vaccines versus SARS-CoV-2 Infection Among Pregnant Women and Vaccine Induced Antibody Transfer to Infants Fatimah S Dawood, Alan Tita, Melissa S Stockwell, Gabriella Newes-Adeyi, Kristina Wielgosz, Cynthia Gyamfi-Bannerman, et al. (+12)
850 [GO] 2023―Apr―19 Correction to: A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
851 [GO] 2023―Apr―18 Correction to: Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study
852 [GO] 2023―Apr―13 Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, Amadea Britton, Katherine E Fleming-Dutra, Joseph Miller, et al. (+6)
853 [GO] 2023―Apr―13 Immunogenicity, Safety, and Breakthrough SARS-CoV-2 infections after COVID-19 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study Dima Kabbani, Demitra M Yotis, Victor H Ferreira, Sarah Shalhoub, Sara Belga, Varalika Tyagi, et al. (+11)
854 [GO] 2023―Apr―13 Factors associated with COVID-19 vaccine uptake among pregnant women and nonpregnant women of reproductive-age in Jamaica Jodian A Pinkney, Laura M Bogart, Kamali N Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, et al. (+6)
855 [GO] 2023―Apr―13 Host Expression Profiling from Diagnostic COVID-19 Swabs Associate Upper Respiratory Tract Immune Responses with Radiologic Lung Pathology and Clinical Severity Robert A Kozak, Elsa Salvant, Veronica Chang, Anastasia Oikonomou, Mia J Biondi, Jordan J Feld, et al. (+8)
856 [GO] 2023―Apr―12 Factors Associated with Enrollment into Inpatient COVID-19 Randomized Controlled Trials - A Cross-Sectional Analysis Matthew Kaczynski, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Eleftheria Atalla, Maria Tsikala-Vafea, et al. (+3)
857 [GO] 2023―Apr―12 Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Response to Comment Nathaniel M Lewis, Jillian Rhoads, Wesley H Self, Diya Surie
858 [GO] 2023―Apr―12 Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment Amnuay Kleebayoon, Viroj Wiwanitkit
859 [GO] 2023―Apr―06 Successful Treatment of Prolonged SARS-CoV-2 Infection in Patients with Immunodeficiency with Extended Nirmatrelvir/Ritonavir: Case Series Madison Breeden, Samuel L Aitken, Ji Hoon Baang, Misty Gravelin, Daniel R Kaul, Adam S Lauring, et al. (+2)
860 [GO] 2023―Mar―31 Antibody response after third vaccination with mRNA-1273 or BNT162b2: Extension of a randomised controlled SARS-CoV-2 non-inferiority vaccine trial in patients with different levels of immunosuppression (COVERALL-2) Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+19)
861 [GO] 2023―Mar―28 Longitudinal Neutralizing and Functional Antibody Responses to SARS-CoV-2 Variants following mRNA COVID-19 Vaccination Xuemin Chen, Caroline Ciric, Theda Gibson, Larry J Anderson, Evan J Anderson, Christina A Rostad
862 [GO] 2023―Mar―28 SARS-CoV-2 Neutralizing Antibody Responses after Community Infections in Children and Adults Fatimah S Dawood, Alexia Couture, Xueyan Zhang, Melissa S Stockwell, Christina A Porucznik, Joseph B Stanford, et al. (+9)
863 [GO] 2023―Mar―27 Effectiveness of COVID-19 mRNA vaccines in preventing COVID-19-associated outpatient visits and hospitalizations among American Indian and Alaska Native persons, January-November 2021: a test-negative case-control analysis using surveillance data Chelsea S Lutz, Rachel M Hartman, Deionna E Vigil, Amadea Britton, Amanda B Burrage, Angela P Campbell, et al. (+21)
864 [GO] 2023―Mar―27 Hybrid immunity provides protective advantage over vaccination or prior remote COVID-19 alone Abinash Virk, Matthew G Johnson, Daniel L Roellinger, Christopher G Scott, Priya Sampathkumar, Laura E Breeher, Melanie Swift
865 [GO] 2023―Mar―21 COVID-19 Associated Pulmonary Aspergillosis: A Non-Invasive Screening Model for Additional Diagnostics Nitipong Permpalung, Teresa Po-Yu Chiang, Robin K Avery, Darin Ostrander, Kausik Datta, Dorry L Segev, et al. (+4)
866 [GO] 2023―Mar―21 Neutralizing Antibody Responses After SARS-CoV-2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted By Nirmatrelvir/Ritonavir (NM/r) Treatment Aaron F Carlin, Alex E Clark, Aaron F Garretson, William Bray, Magali Porrachia, AsherLev T Santos, et al. (+3)
867 [GO] 2023―Mar―18 Surveillance of SARS-CoV-2 and variants using digital droplet polymerase chain reaction at a large university and healthcare system in California Chrysovalantis Stafylis, Olivier Pernet, Cassidy Hernandez-Tamayo, Andrea Kovacs, Jane Emerson, Pamela M Ward, et al. (+25)
868 [GO] 2023―Mar―18 Analyzing An Emerging Pandemic on Twitter: Monkeypox Lauren N Cooper, Alexander P Radunsky, John J Hanna, Zachary M Most, Trish M Perl, Christoph U Lehmann, Richard J Medford
869 [GO] 2023―Mar―11 Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial Marta Trigo-Rodríguez, Sheila Cárcel, Ana Navas, Reinaldo Espíndola-Gómez, José Carlos Garrido-Gracia, María Ángeles Esteban Moreno, et al. (+18)
870 [GO] 2023―Mar―07 Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection Kristin L Moffitt, Mari M Nakamura, Cameron C Young, Margaret M Newhams, Natasha B Halasa, J Nelson Reed, et al. (+31)
871 [GO] 2023―Mar―04 When should healthcare workers with COVID-19 return to work? An analysis of follow-up antigen test results after a positive COVID test Anthony Baffoe-Bonnie, Mandy C Swann, Hyun Sue Kim
872 [GO] 2023―Mar―04 Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients Meera Shah, Kelly Reveles, Rebecca Moote, Elizabeth Hand, Dean Kellogg III, Rebecca L Attridge, et al. (+2)
873 [GO] 2023―Mar―02 Effectiveness of fourth dose of COVID-19 mRNA vaccine in elderly population during Omicron BA.2 and BA.5 circulation: nationwide cohort study in Korea (K-COVE) Seon Kyeong Park, Young June Choe, Eun Jung Jang, Ryu Kyung Kim, Do-Sang Lim, Seonju Yi, et al. (+6)
874 [GO] 2023―Feb―24 Optimal Duration of Systemic Corticosteroids in COVID-19 Treatment: A Systematic Review and Meta-analysis Paddy Ssentongo, Nyein Yu, Navya Voleti, Surya Reddy, David Ingram, Vernon M Chinchilli, Catharine I Paules
875 [GO] 2023―Feb―22 COVID-19 and Outpatient Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara Cosgrove, Ramanan Laxminarayan, Eili Klein
876 [GO] 2023―Feb―21 Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient COVID-19 from Influenza Lauren L Luciani, Leigh M Miller, Bo Zhai, Karen Clarke, Kailey Hughes Kramer, Lucas J Schratz, et al. (+6)
877 [GO] 2023―Feb―21 Lessons From the Field: Rapid Antigen Testing Is Efficient and Practical for Mitigation of Coronavirus Disease 2019 Outbreaks in Long-Term Care Facilities David A Miller, Lael Duncan, Lindsey Termini, Lee Ann Prebil, David Witt, Stephen A McCurdy
878 [GO] 2023―Feb―18 Use of SARS-CoV-2 Antibody Tests by U.S. Infectious Disease Physicians: Results of an Emerging Infections Network Survey, March 2022 Adi V Gundlapalli, Susan Beekmann, Jefferson M Jones, Natalie Thornburg, Kristie E N Clarke, Timothy M Uyeki, et al. (+8)
879 [GO] 2023―Feb―14 Population-level effectiveness of an inactivated whole-virion COVID-19 vaccine: A test negative case-control study in the Dominican Republic Eddy Pérez-Then, Marija Miric, Han-Zhu Qian, Ying Qing Chen, Yixin Wang, Virginia Vallejo, et al. (+109)
880 [GO] 2023―Feb―13 Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial Dean Follmann, Holly E Janes, Eric Chu, Lakshmi Jayashankar, Christos J Petropoulos, Leonid Serebryannyy, et al. (+18)
881 [GO] 2023―Feb―09 Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine Francis Mwimanzi, Hope R Lapointe, Peter K Cheung, Yurou Sang, Fatima Yaseen, Rebecca Kalikawe, et al. (+17)
882 [GO] 2023―Feb―04 Association of cytomegalovirus serostatus with SARS-CoV-2 vaccine responsiveness in nursing home residents and healthcare workers Michael L Freeman, Oladayo A Oyebanji, Daniela Moisi, Michael Payne, Maegan L Sheehan, Alejandro B Balazs, et al. (+5)
883 [GO] 2023―Feb―03 SARS-CoV-2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person Living With HIV Dara Khosravi, Hannah Soloff, Rose M Langsjoen, Andrei Bombin, Colleen F Kelley, Susan M Ray, et al. (+7)
884 [GO] 2023―Feb―02 Factors Associated with Long Covid Symptoms in an Online Cohort Study Matthew S Durstenfeld, Michael J Peluso, Noah D Peyser, Feng Lin, Sara J Knight, Audrey Djibo, et al. (+11)
885 [GO] 2023―Jan―28 Pneumocystis jirovecii infections among COVID-19 Patients: A Case Series and Literature Review Paul Amstutz, Nathan C Bahr, Karen Snyder, D Matthew Shoemaker
886 [GO] 2023―Jan―19 Correction to: 494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis
887 [GO] 2023―Jan―18 High SARS-CoV-2 antibody prevalence after the third epidemic wave (May - October 2021) in Matadi, Democratic Republic of the Congo Yannick Munyeku-Bazitama, Patient Okitale-Talunda, Patrick Mpingabo-Ilunga, Marc K Yambayamba, Paul M Tshiminyi, Aime Umba-Phuati, et al. (+12)
888 [GO] 2023―Jan―18 Correction to: Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality
889 [GO] 2023―Jan―09 Validity of COVID-19 ICD10s in the Urgent Care Setting and Impact on Antibiotic Prescribing Rates Natalia Medvedeva, Sharon Ong’uti, Adam L Hersh, Amy Chang, Emily Mui, Edward Stenehjem, et al. (+2)
890 [GO] 2023―Jan―09 Correlates of COVID-19 Inpatient Mortality at a Southern California Community Hospital with a Predominantly Hispanic/Latino Adult Population Nicole M Gatto, Debbie Freund, Pamela Ogata, Lisa Diaz, Ace Ibarrola, Mamta Desai, et al. (+2)
891 [GO] 2023―Jan―08 Laboratory Evaluation Links Some False-Positive COVID-19 Antigen Test Results Observed in a Field Study to a Specific Lot of Test Strips Alyssa M Carter, Alexander Viloria Winnett, Anna E Romano, Reid Akana, Natasha Shelby, Rustem F Ismagilov
892 [GO] 2023―Jan―08 Challenges in harnessing shared within-host SARS-CoV-2 variation for transmission inference Katharine S Walter, Eugene Kim, Renu Verma, Jonathan Altamirano, Sean Leary, Yuan J Carrington, et al. (+7)
893 [GO] 2022―Dec―31 Absolute and Relative Vaccine Effectiveness (VE) of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022 Nathaniel M Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A Ginde, et al. (+51)
894 [GO] 2022―Dec―29 Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI) Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, Maria Krutikov, Hadjer Nacer-Laidi, Borscha Azmi, et al. (+9)
895 [GO] 2022―Dec―28 A longitudinal study of SARS-CoV-2 antibody response in a subset of United States blood donors Laura Tonnetti, Roger Y Dodd, Donna D Burke, Paula Saá, Bryan R Spencer, Meng Xu, et al. (+2)
896 [GO] 2022―Dec―23 Which curve are we flattening? The disproportionate impact of COVID-19 among economically marginalized communities in Ontario, Canada, was unchanged from wild-type to omicron Huiting Ma, Adrienne K Chan, Stefan D Baral, Christine Fahim, Sharon Straus, Beate Sander, Sharmistha Mishra
897 [GO] 2022―Dec―22 Persistent symptoms and sequelae after SARS-CoV-2 infection not requiring hospitalization: Results from Testing Denmark, a Danish cross-sectional survey Maarten van Wijhe, Kamille Fogh, Steen Ethelberg, Kasper Karmark Iversen, Henrik Nielsen, Lars Østergaard, et al. (+23)
898 [GO] 2022―Dec―20 Pre-Existing Population Immunity and severe acute respiratory syndrome coronavirus 2 Variant Establishment and Dominance Dynamics in the United States: An Ecological Study Pierre O Ankomah, Mark J Siedner, Roby P Bhattacharyya
899 [GO] 2022―Dec―16 Antibiotic consumptions and bacterial resistance rates in hospitalized COVID-19 patients: a retrospective study during the three first surges Karim Jaffal, Frédérique Bouchand, Christine Lawrence, Hélène Mascitti, Clara Duran, Djillali Annane, Aurélien Dinh
900 [GO] 2022―Dec―16 Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa Simiso Sokhela, Bronwyn Bosch, Andrew Hill, Bryony Simmons, Joana Woods, Hilary Johnstone, et al. (+13)
901 [GO] 2022―Dec―16 Association between population-level factors and household secondary attack rate of SARS-CoV-2: A systematic review and meta-analysis Can Wang, Xiaotong Huang, Eric H Y Lau, Benjamin J Cowling, Tim K Tsang
902 [GO] 2022―Dec―15 1911. A Pilot Study to Evaluate the Effectiveness of Nasal and Oral Povidone Iodine in Reducing the Burden of Severe Acute Respiratory Syndrome 2 RNA in Patients with COVID-19 Sarah Redmond, Lucas D Jones, Alexandria Nguyen, Hussein Ghaddara, Jennifer Cadnum, Curtis Donskey
903 [GO] 2022―Dec―15 1928. A Population-Based Propensity Score-Matched Study of COVID-19 Vaccination on Clinical Outcomes in Hospitalized Adult Patients with COVID-19 Jianli Niu, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E Sareli
904 [GO] 2022―Dec―15 2160. Mucosal Antiviral Cytokine Responses Are Impaired in Children and Adolescents with Severe COVID-19 Ana M Quintero, Shira H Cohen, Zhaohui Xu, Fang Ye, Sara Mertz, Kaitlyn N Massey, et al. (+6)
905 [GO] 2022―Dec―15 LB1528. Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19 Matthew W McCarthy
906 [GO] 2022―Dec―15 LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R Walsh, Brandon Essink, Adam Brosz, et al. (+13)
907 [GO] 2022―Dec―15 1083. Clinical Features and Long-Term Follow-up of Children Evaluated for Persistent Unwellness Following Acute COVID-19 Kathryn E Weakley, Allegra Schikler, Julianne V Green, Daniel B Blatt, Shanna M Barton, Victoria A Statler, Gary S Marshall
908 [GO] 2022―Dec―15 1079. Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19 Selin Somersan-Karakaya, Eleftherios Mylonakis, Ernesto Oviedo-Orta, Meagan P O’Brien, Veronica Mas Casullo, Jenni Mou, et al. (+10)
909 [GO] 2022―Dec―15 1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19 Christina Maguire, Adrienne Terico, Hinal Patel, George L Anesi, Kathleen Degnan, Lauren Dutcher, et al. (+4)
910 [GO] 2022―Dec―15 1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19 Anil K Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, et al. (+16)
911 [GO] 2022―Dec―15 1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19 Ramy H Elshaboury, Meagan L Adamsick, Joanne Huang, Marisa Winkler, Musie Ghebremichael, Fiona Cheung, et al. (+5)
912 [GO] 2022―Dec―15 1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19 Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari
913 [GO] 2022―Dec―15 930. Weakening the waves: Impact of a syndrome-based antimicrobial stewardship intervention during COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Mirza Ali, Rodrigo M Burgos
914 [GO] 2022―Dec―15 1114. Comparative analysis between Polymerized Type I Collagen and Baricitinib as potential treatment for COVID-19 Luis Del Carpio-Orantes, Sergio García-Mendez, Jesús Salvador Sánchez-Díaz, Andrés Aguilar-Silva, Omar García-Hernández, Raúl Enrique Salazar-Lizárraga, et al. (+6)
915 [GO] 2022―Dec―15 1113. Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19 Kathryn Mahoney, Kristin Narayan, Natalia Betancourt, Yong Li, Deepali Gupta, Pamela Hawn, et al. (+2)
916 [GO] 2022―Dec―15 1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19 Neva Braccialarghe, Rosario Alessandro Cavasio, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Iannetta Marco, et al. (+2)
917 [GO] 2022―Dec―15 1140. Outcomes and Complications of Tocilizumab and Baricitinib use in Transplant Patients with COVID-19 Maria A Mendoza, Raymund R Razonable, Omar M Abu Saleh
918 [GO] 2022―Dec―15 1132. Integrated Quantitative Systems Pharmacology (QSP) Characterizing Viral Dynamics After Intramuscular (IM) Adintrevimab (ADI) Administration in Participants with Mild to Moderate Coronavirus Disease (COVID-19) Evan Tarbell, Scott A Van Wart, Myra Popejoy, Kristin Narayan, Ellie Hershberger, Xia Pu, et al. (+4)
919 [GO] 2022―Dec―15 1044. Identification and Characterization of an Unconventional NK Subset in COVID-19 Andrew Platt, Izabella Lach, Jeffrey R Strich, Gustaf Wigerblad, Ryan Curto, Shreya Singireddy, et al. (+6)
920 [GO] 2022―Dec―15 1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-19 Joel A Kammeyer, Meghan M Deutsch, Victoria R Starnes, Makoto Ibaraki, Victoria Soewarna, Basmah Khalil, et al. (+10)
921 [GO] 2022―Dec―15 1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
922 [GO] 2022―Dec―15 481. Risk Factors and Clinical Outcomes of Candidemia Associated with Severe Coronavirus Disease 2019 (COVID-19) Tanaya Bhowmick, Sugeet Jagpal, Tilly Varughese, Purvi Patel, Polly Jen, Tyler Maxwell, et al. (+10)
923 [GO] 2022―Dec―15 939. Barriers and facilitators in the implementation of ASP in Mexico and the impact of COVID-19 María Alejandra Cortés-Ortíz, Anahí Dreser, Jennifer Hegewisch-Taylor, Julián Romero-Mónico, Jorge Quiroz
924 [GO] 2022―Dec―15 304. Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19 Phillip J Yates, Jennifer Moore, Jennifer Han, Andrew Skingsley, Gretja Schnell, Andrea L Cathcart, et al. (+3)
925 [GO] 2022―Dec―15 305. Clinical scoring system to predict viable viral shedding in patients with COVID-19 Sung Woon Kang, Ji Yeon Kim, Heedo Park, Sunghee Park, So Yun Lim, SeongMan Bae, et al. (+9)
926 [GO] 2022―Dec―15 274. Epidemiology and Antimicrobial Treatment Impact of Procalcitonin in Patients with COVID-19 Anna Conlon, Krishna Rao, Sandro Cinti, Zoey Chopra, Shannon E Cahalan
927 [GO] 2022―Dec―15 281. Not the sharpest of tools: Procalcitonin and bacterial co-infections in patients admitted with COVID-19 Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Stephanie Echeverria, Sorel Lira, Rodrigo M Burgos
928 [GO] 2022―Dec―15 283. Post COVID-19 syndrome and quality of life impairment in a cohort of severe COVID-19 Carla M Roman-Montes, Guillermo A Guaracha-Basañez, Yesenia C Flores-Soto, Maria Fernanda Gonzalez, Luis Alfredo Ponce-de-leon, Karla M Tamez-Torres, José Sifuentes-Osornio
929 [GO] 2022―Dec―15 881. Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19 Yijia Li, Linda J Harrison, Kara W Chew, Joseph J Eron, Eric S Daar, David A Wohl, et al. (+10)
930 [GO] 2022―Dec―15 242. Association Between Procalcitonin and Antimicrobial Usage in Patients with COVID-19 Mahmoud H Aly, Eris Cani, Lendelle Raymond, Cosmina Zeana
931 [GO] 2022―Dec―15 2358. Dementia and Cognitive Concerns are Risk Factors for Mortality in People with Human Immunodeficiency Virus and COVID-19 Shibani S Mukerji, Douglas R Wilcox, Emily A Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, et al. (+5)
932 [GO] 2022―Dec―15 251. Clinical Features and Outcomes of Pneumothorax and Pneumomediastinum in COVID-19 Sangeeta Adusumilli, Ashish Bhargava, Rene Franco
933 [GO] 2022―Dec―15 300. Trends in electrocardiographic and cardiovascular manifestations of patients hospitalized with COVID-19 Jinghao Nicholas Ngiam, Wilson Goh, Meng Ying Sim, Srishti Chhabra, Tze Sian Liong, Nicholas W S Chew, et al. (+5)
934 [GO] 2022―Dec―15 319. Clinical accuracy and utility of plasma microbial cell free DNA NGS for the diagnosis of invasive aspergillosis in patients with hematologic malignancy and COVID-19 Ki Hyun Lee, Joon-sup Yeom, Jun Yong Choi, Nam Su Ku, Su Jin Jeong, Jung Ho Kim, et al. (+9)
935 [GO] 2022―Dec―15 289. Prolonged Corticosteroid Usage, Associated Infectious Complications, and High Mortality in Adult Patients with COVID-19 Rebecca Chu, Veronica B Zafonte, Kelly L Cervellione, Andrew S Miele, Farshad Bagheri, Javeria Shakil
936 [GO] 2022―Dec―15 878. Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19 Mark Giganti, Kara W Chew, Joseph J Eron, Jonathan Z Li, Mauricio Pinilla, Carlee Moser, et al. (+10)
937 [GO] 2022―Dec―15 79. Long-term Health Outcomes of Individuals who are Infected with SARS-CoV-2 and Develop COVID-19 Lilac Tene, Tobias Bergroth, Anna Eisenberg, Gabriel Chodick
938 [GO] 2022―Dec―15 785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19 Jiyoung Lee, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Sang-Oh Lee, et al. (+3)
939 [GO] 2022―Dec―15 257. Coinfection Characteristics among Children with COVID-19 Itzel Villanueva García, Nancy Evelyn Aguilar Gómez, Aarón Espinosa Atri, Angela Patricia Vedia Márquez, Juan Antonio Gallegos Marin, Ana Ruth Hernández Tepach
940 [GO] 2022―Dec―15 297. Secondary Bacterial Blood Stream Infections in Patients Hospitalized with COVID-19 Fareeha Adnan, Mariam A Khan, Amna Umer, Nazia Khursheed
941 [GO] 2022―Dec―15 925. Remdesperate for Stewardship: Impact of a Remdesivir Stewardship Strategy on the Care of Patients with COVID-19 Admitted to a Community Teaching Hospital Jillian Hayes, Ahmed Ghonim, Leslie Wooten, Jenny Sippel-Tompkins, Victor Herrera, Amy L Carr
942 [GO] 2022―Dec―15 1867. Characteristics and Outcomes of Patients with SARS-CoV-2 Reinfections Requiring Treatment in a COVID-19 Ambulatory Treatment Program Kelsie Cowman, Austin Golia, Yi Guo, Terrence D McSweeney, Mei H Chang, Hongkai Bao, Priya Nori
943 [GO] 2022―Dec―15 1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races. Hina Farooq, Shivanjali Shankaran
944 [GO] 2022―Dec―15 1788. COVID-19 and Antibiotic Prescriptions in the United States: A County-level Analysis Alisa Hamilton, Suprena Poleon, Jerald Cherian, Sara E Cosgrove, Ramanan Laxminarayan, Eili Y Klein
945 [GO] 2022―Dec―15 261. COVID-19 and Diabetes Mellitus: Glycemic Control and Risk Factors for Mortality, experience from Pakistan. Asma Nasim, Sunil Kumar
946 [GO] 2022―Dec―15 293. Risk factors for COVID-19 associated pulmonary aspergillosis (CAPA) in severe COVID-19 and impact of airborne fungal contamination within negative pressure isolation room Jung Ah Lee, Sanggwon Ahn, Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Chang Hyup Kim, et al. (+8)
947 [GO] 2022―Dec―15 1922. Outbreak and Management of COVID-19 and Infection Prevention Control Practices at a Community Living Center in Veterans Administration Hospital, North Texas John J Hanna, Denisse Silva-Rodriguez, Angela Christie-Smith, Andrew O Psenicka, Sherry R Reid, Ikwo K Oboho
948 [GO] 2022―Dec―15 290. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in Children with COVID-19 and MIS-C Gulhadiye Avcu, Sema Yıldırım Arslan, Mehmet Soylu, Melis Bilen, Candan Çiçek, Zümrüt Şahbudak Bal, et al. (+2)
949 [GO] 2022―Dec―15 1039. Clinical and Economic Impact of COVID-19 and Serologic Protection among Farm Workers: Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study Daniel Olson, Diva M Calvimontes, Molly Lamb, Kelsey Lesteberg, Edgar Barrios, Neudy Rojop, et al. (+15)
950 [GO] 2022―Dec―15 1217. An outbreak of carbapenem-resistant Acinetobacter baumannii in an isolation ward for COVID-19 and successful outbreak control with infection control measures Ki Hyun Lee, Joon-sup Yeom, Nam Su Ku, Su Jin Jeong, Jin Young Ahn, Jung Ho Kim, et al. (+6)
951 [GO] 2022―Dec―15 1074. Surveillance of SARS-CoV-2 variants of concern (VOC) in hospital wastewater (WW) and its correlation with hospitalized cases of COVID-19 and the occurrence of outbreaks Nicole Acosta, Maria Bautista Chavarriaga, Barbara Jean M Waddell, Janine McCalder, Kristine Du, Puja Pradhan, et al. (+33)
952 [GO] 2022―Dec―15 1043. Gastrointestinal manifestations of COVID-19 and their association with disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Ysalda E Santana, Alicia Rodriguez, Johan Ramos, Mariel Suarez
953 [GO] 2022―Dec―15 262. COVID-19 associated fungal co-infections in Solid Organ Transplant Recipients: A single center case series Akshay M Khatri, Jacques Simkins, Neeraj Sinha, Anita Phancao, Gaetano Ciancio, Lilian M Abbo, et al. (+3)
954 [GO] 2022―Dec―15 266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis Diego Ramonfaur, Jack Salto-Quintana, Nadia Hernández-Mata, Gloria Mayela Aguirre-García, Hiram Villanueva-Lozano, Michel Martínez-Reséndez
955 [GO] 2022―Dec―15 263. COVID-19 Associated Pulmonary Aspergillosis (CAPA) at a Hospital in Nicaragua: Prevalence and Risk Factors for Mortality. Armando J López-Gaitán, Sunaya V Marenco-Avilés, Maikelyn A Castillo-Cano, Guillermo D Porras-Cortés
956 [GO] 2022―Dec―15 294. Risk factors of COVID-19 associated pulmonary aspergillosis in a high endemic setting and development of a bedside clinical risk prediction score. Merlin Moni, Teny M M John, Abdul Razak Moosa, Kiran G Kulirankal, Fabia Edathadathil, T S Dipu
957 [GO] 2022―Dec―15 264. COVID-19 Associated Pulmonary Aspergillosis in Intensive Care Patients Based on Duration of Corticosteroid Administration Meera D Shah, G Christina Gutierrez, Rebecca Moote, Kelly R Reveles, Elizabeth O Hand
958 [GO] 2022―Dec―15 1041. Association of SARS-CoV-2 Viral load in COVID-19 at the hospital representation Ashish Bhargava, Hemang Patel, Natali Salaytah, Elisa Akagi, Louis Saravolatz, Mamta Sharma
959 [GO] 2022―Dec―15 1042. Inflammatory Representation of COVID-19 at the Time of Hospitalization: An Insight into the Mild, Moderate, Severe and Critical COVID-19 Disease Ashish Bhargava, Hemang Patel, Elisa Akagi, Mamta Sharma, Claudia V Santos, Wei Zhao, et al. (+7)
960 [GO] 2022―Dec―15 282. Occurrence of adverse events and factors related to prognosis in a cohort of patients hospitalized with COVID-19 at University hospital - UNICAMP, Brazil. Maitê V Luz, Julian F Silva, Hugo D Ceccato, Paulo J Souza, Pedro M E Villar, Paulo R A Mendes, et al. (+3)
961 [GO] 2022―Dec―15 1951. Guiding COVID-19 Booster Vaccinations by COVID-19 Quantitative Spike Ig Antibody Titers Regardless of HIV Status, Immunosuppression, and Age Ricky K Hsu, Laurence Brunet, Jennifer S Fusco
962 [GO] 2022―Dec―15 788. Risk Factors for Severe COVID-19 Breakthrough Infections: A Retrospective, Nationwide Cohort Study Austin D Vo, Westyn Branch-Elliman, Jennifer La, Matthew Ronan, Mary Brophy, Julie Wu, et al. (+4)
963 [GO] 2022―Dec―15 1571. Hospital COVID-19 Burden Impact on Inpatient Antibiotic Use Rates Elizabeth Dodds Ashley, Yuliya Lokhnygina, Danielle Doughman, Katherine R Foy, Alicia D Nelson, April Dyer, et al. (+13)
964 [GO] 2022―Dec―15 1121. Does Anti-Vaccine Equal Anti-Antibody? Differing Rates of Veteran Acceptance of Monoclonal Antibody Therapies for COVID-19 By Prior Vaccination Status Martha Brennan, Amy Hirsch Shumaker, Usha Stiefel
965 [GO] 2022―Dec―15 1078. Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
966 [GO] 2022―Dec―15 1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Michael Mansour
967 [GO] 2022―Dec―15 1065. Patient-Reported Reasons for Non-Participation in Inpatient COVID-19 Clinical Research: Results from a Multi-Center VA Embedded Randomized Trial Samira Reyes Dassum, Ryan Ferguson, Patricia Woods, Maura Flynn, Karen Visnaw, Sara J Schiller, et al. (+3)
968 [GO] 2022―Dec―15 1942. Effect of SARS-CoV-2 Vaccination in a Frailty COVID-19 Cohort: a Real Life Experience in a Northern Italy Hospital Chiara Russo, Luca Tagliafico, Laura Labate, Marta Ponzano, Michele Mirabella, Federica Portunato, et al. (+7)
969 [GO] 2022―Dec―15 781. COVID-19 Outcomes in the Immunocompromised Population of the COVID-19 Community Research Partnership John C Williamson, Gregory B Strylewicz, Michael E DeWitt, Diane Uschner, Ashvi Soni, Morgana Mongraw-Chaffin, et al. (+11)
970 [GO] 2022―Dec―15 530. Characterization of the Proteomic Changes via SARS-CoV-2 Infection or Vaccination in the COVID-19 Community Research Partnership (CCRP) Michael E DeWitt, David M Herrington, John C Williamson, Austin L Seals, Thomas F Wierzba, Aleksandra Binek, et al. (+2)
971 [GO] 2022―Dec―15 1868. Characterization of COVID-19 Symptoms and Outcomes by Variant Period in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Michael E DeWitt, Sharon Edelstein, Ashley H Tjaden, David M Herrington, John Schieffelin, Michael A Gibbs, et al. (+2)
972 [GO] 2022―Dec―15 1049. Breakthrough SARS-CoV-2 Infections after Vaccination in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Diane Uschner, Matthew Bott, Gregory B Strylewicz, Sharon Edelstein, Kristen Miller, William H Lagarde, et al. (+13)
973 [GO] 2022―Dec―15 1523. Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods - North Carolina COVID-19 Community Research Partnership (NC-CCRP) Ashley H Tjaden, Michael A Gibbs, Michael S Runyon, William Weintraub, Yhenneko Taylor, Sharon Edelstein
974 [GO] 2022―Dec―15 1913. Baltimore City Health Department COVID-19 Community-based Testing Results Shamola Dye, Isabella Agnes, Darcy Phelan-Emrick, Adena Greenbaum
975 [GO] 2022―Dec―15 249. Characteristics and outcomes of cryptococcosis among patients with COVID-19 compared to non-COVID-19 controls Daniel B Chastain, Vanessa Kung, Sahand Golpayegany, Brittany T Jackson, Carlos Franco-Paredes, George R Thompson, Andrés F Henao-Martínez
976 [GO] 2022―Dec―15 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020-February 2022 Shah Melisa, Christopher Taylor, Kadam Patel, Jennifer Milucky, Michael Whitaker, Huong Pham, et al. (+16)
977 [GO] 2022―Dec―15 1059. The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala Aleena Issac, Jose J Kochuparambil
978 [GO] 2022―Dec―15 1076. The Role of Bronchoalveolar Lavage in COVID-19 Diagnoses and Management Edie Zhang, Shuman Liu, Rosemary She
979 [GO] 2022―Dec―15 1885. Experience using combined antigen and RT-PCR tests for COVID-19 diagnosis at a Veterans Affairs (VA) Health Care System during the Omicron surge Siri Chirumamilla, Krista Powell, David Gutman, Andrew S Webster, Abeer Moanna, Lauren H Epstein
980 [GO] 2022―Dec―15 1097. Risk of Severe COVID-19 Disease in Individuals with Down syndrome: a Matched Cohort Study from a Large, Integrated Health Care System Jennifer H Ku, Myron J Levin, Yi Luo, Ana Florea, I Chun Lin, Yun Tian, Hung Fu Tseng
981 [GO] 2022―Dec―15 1148. Relationship Between the Duration of Symptoms Before and COVID-19 Disease Outcome After Monoclonal Antibody Therapy Michael J Hubbard, James Polega, Diana K Haggerty, Nicholas A Andersen, Gordana Simeunovic
982 [GO] 2022―Dec―15 1895. SingHealth COVID-19 Disease Registry Jin Yee Shoon, Edwin P Conceicao, Yue Yang, Shalvi Arora, Eng Hock Marcus Ong, Sze Ling Chan, et al. (+2)
983 [GO] 2022―Dec―15 1112. Evaluating the Effects of Casirivimab-Imdevimab in Mild-to-Moderate COVID-19 Disease: A Matched Cohort Study Cindy Hage, Aileen Martinez, Alexis Dunham, Nathan Mohseni, Jarelys Hernandez-Jimenez, Lyssette L Cardona
984 [GO] 2022―Dec―15 1968. SARS-CoV-2 Anti-Spike IgG Antibodies in Neonates After Maternal Vaccination Against COVID-19 During Pregnancy and Outcomes Maria C Casillas Casillas, Claudia C Lopez-Enriquez, Jimena Reyes, Jose L Ramírez Haua, Mario E Rendon Macias
985 [GO] 2022―Dec―15 1105. A Matched-Group Comparison of Interventions for COVID-19 During the First and Second Waves of the COVID-19 Pandemic in a County Hospital in Chicago. Ruben A Hernandez Acosta, Carlos Corpuz, Sriram Gonakoti, Palak Patel, Hillary Chang, Elikplim Akaho, et al. (+3)
986 [GO] 2022―Dec―15 269. Outcomes comparison of hospitalized patients with COVID-19 during the first three pandemic waves. Experience in Colombia, South America. Fernando Rosso, Sarita Rodriguez, Estefanía Beltrán, Alvaro Martinez Valencia, Virginia Zarama, Eric Tafur, Tania Guzmán
987 [GO] 2022―Dec―15 1037. Access to hospitalization for patients with severe COVID-19 during the first wave of the pandemic in Caracas, Venezuela. Jose Orejas, David Forero, Daniela Mendoza, Oscar Omana, Fhabián S Carrión-Nessi, Maria Landaeta, Alejandro Diaz
988 [GO] 2022―Dec―15 346. Aspergillosis in COVID-19 era in Dominican Republic Rita A Rojas-Fermin, Ann S Sanchez-Marmolejos, Ricardo Acra-Tolari, Anel E Guzman-Marte, Irina Suero
989 [GO] 2022―Dec―15 1972. Sources of COVID-19 Exposure Among Health Care Personnel in a Large Tertiary Care Medical Center. Jana Shaw, Heidi Steigerwald, Paul Suits, Stephen J Thomas, Margaret Formica
990 [GO] 2022―Dec―15 258. Comparison of Different COVID Waves during COVID-19 Pandemic: A Retrospective Study from a Dedicated COVID-19 Facility of Karachi Pakistan Muneeba A Sayeed
991 [GO] 2022―Dec―15 306. Development a Predictive Score for Severe Coronavirus Disease 2019 (COVID-19) from High Risk Factor of Patient Described by Thai Government Policy Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
992 [GO] 2022―Dec―15 1965. Promoting COVID-19 Health Equity through Partnership with Community-Based Organizations and Home Vaccination Services Justin Daniels, David P Holland, Tanner Forbes, Jane Y Scott
993 [GO] 2022―Dec―15 1396. COVID-19 Hospitalization Impact of Age, Race and Ethnicity Among Medicaid and Uninsured Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
994 [GO] 2022―Dec―15 287. Procalcitonin and D-dimer levels at baseline, but not CRP, were informative of COVID-19 hospitalization outcomes Trini Mathew, Julie George, Christine N Yost, Mustafa Deebajah, Paul C Johnson, James Huang, Christopher F Carpenter
995 [GO] 2022―Dec―15 1053. Comorbidities Associated with All-Cause Readmission to the Same Hospital after Index COVID-19 Hospitalization: A Retrospective Cohort Study of 232155 Patients in the United States Gita Nadimpalli, Lyndsay M O’Hara, Lawrence Magder, J Kristie Johnson, Abdolreza Haririan, Lisa Pineles, et al. (+4)
996 [GO] 2022―Dec―15 1397. COVID-19 Hospitalizations in North Texas: Impact of Insurance Status Mamta K Jain, Yi Zhang, Mae Thamer, Michael Harms, Jillian Smartt, Stefanie Baierlipp, Kavita Bhavan
997 [GO] 2022―Dec―15 1924. Outpatient Treatment With the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Kenneth Kim, Jesus Abraham Simón Campos, Douglas Arbetter, et al. (+7)
998 [GO] 2022―Dec―15 240. Antibiotic Overuse Among Children with COVID-19 Hospitalized in a Pediatric Intensive Care Unit Jessica Gillon, Kathryn Garguilo, Kerry LeBlanc, Ritu Banerjee
999 [GO] 2022―Dec―15 288. Prognostic Factors for In-hospital Mortality of Patients with Severe COVID-19 Hospitalized in the University Medical Center, Lithuania Ieva Kubiliute, Jurgita Urboniene, Akvile Rudenaite, Birute Zablockiene, Giedre Gefenaite, Ligita Jancoriene
1000 [GO] 2022―Dec―15 301. Use of a multiplex PCR assay for detection of respiratory co-infections in COVID-19 hospitalized non-ICU patients: an ace up a clinician’s sleeve Christina Louka, Lemonia Velentza, Nektaria Rekleiti, Anastasia Apanomeritaki, Vasiliki Mamali, Alexandra Stamati, et al. (+6)
1001 [GO] 2022―Dec―15 1159. Treatment experience of regdanvimab for mild to moderate COVID-19 hospitalized patients in the Delta variant-predominant period in Korea Yee Gyung Kwak, Je Eun Song, Myung Jin Lee, Baek-Nam Kim
1002 [GO] 2022―Dec―15 789. Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir Kanal Singh, Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin L Dewar, et al. (+14)
1003 [GO] 2022―Dec―15 1111. Baricitinib versus Tocilizumab for Hospitalized Adults with Severe COVID-19 in a Community Health System: A Retrospective Cohort Alexandra Gonzalez, Aileen Martinez, Lyssette L Cardona, Jarelys Hernandez-Jimenez
1004 [GO] 2022―Dec―15 1086. COVID-19 in a Comprehensive Cancer Center: 2020-2022 Patricia Mulanovich, Roy F Chemaly, Bruno Granwehr, Kelly McConn, Physician Assistant, Nina Patel, et al. (+3)
1005 [GO] 2022―Dec―15 1871. Clinical epidemiological characterization of patients affected by COVID-19 in a General Hospital of Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Mendez, Daniel Márquez-Uscanga, Jesús Salvador Sánchez-Díaz, Omar García-Hernández, Andrés Aguilar-Silva, et al. (+7)
1006 [GO] 2022―Dec―15 1062. Examining the impact of type 2 diabetes status and severity on in-hospital outcomes amongst patients hospitalized with COVID-19 in a southwest Virginia healthcare system Jesse Bendetson, Anthony Baffoe-Bonnie
1007 [GO] 2022―Dec―15 1894. Sensitivity of Symptom-Based Screening for COVID-19 in Active Duty Service Members Zachary Matthews, Daniel Cybulski, Dianne Frankel, John Kieffer, Theresa Casey, Angela Osuna, Joseph E Marcus
1008 [GO] 2022―Dec―15 1160. Treatment-Emergent Viral Variants in the Phase 3 TACKLE Trial Investigating Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for the Treatment of Mild to Moderate COVID-19 in Adults Gustavo H Kijak, Bahar Ahani, Douglas Arbetter, Tyler Brady, Fernando Chuecos, Vancheswaran Gopalakrishnan, et al. (+7)
1009 [GO] 2022―Dec―15 784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study Jennifer H Ku, Lina S Sy, Lei Qian, Bradley Ackerson, Yi Luo, Julia Tubert, et al. (+7)
1010 [GO] 2022―Dec―15 2159. Monoclonal Antibody Treatment for COVID-19 in Children: Experience of a Pediatric Tertiary Care Center Osama Ibrahim, Kristen Ferlisi, Winston McCormick, Cristina E Alcorta, Michael Koster
1011 [GO] 2022―Dec―15 933. Antibiotic Prescribing Changes in Adults During COVID-19 in Outpatient Patient-Centered Medical Homes (PCMH) in Arkansas Jill Johnson, Cheng Peng, Ryan K Dare, Jacob T Painter, Holly Maples, Jeremy Thomas, et al. (+3)
1012 [GO] 2022―Dec―15 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial Claudia M Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, et al. (+43)
1013 [GO] 2022―Dec―15 2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States Milan Ho, Zachary M Most, Marlon Diaz, Julia A Casazza, Bhaskar Thakur, Sameh Saleh, et al. (+5)
1014 [GO] 2022―Dec―15 1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa
1015 [GO] 2022―Dec―15 2116. Long-term (2-year) outcomes and complications of COVID-19 in solid organ transplant (SOT) recipients Daniel Burack, Marcus R Pereira, Elizabeth Verna
1016 [GO] 2022―Dec―15 1104. A comparison of remdesivir versus remdesivir plus tocilizumab for patients with severe COVID-19 in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Liz De la Nuez, Ana Hernando, Cesar Jimenez, et al. (+2)
1017 [GO] 2022―Dec―15 LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO) Jessica Tuan, Manas Sharma, Jehanzeb Kayani, Matthew W Davis, Dayna McManus, Jeffrey E Topal, Onyema Ogbuagu
1018 [GO] 2022―Dec―15 LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Susanna Naggie
1019 [GO] 2022―Dec―15 1077. Understanding the Psychosocial Burden Associated with Hospitalization Among Adults Diagnosed with COVID-19 in the United States Wajeeha Ansari, Florin Draica, Joanna Atkinson, Kathy Annunziata, Martine C Maculaitis, Amie Scott
1020 [GO] 2022―Dec―15 1145. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 in the US Mindy M Cheng, Daniel C Gibbons, Helen Birch, Vishal Patel, Christopher F Bell, Myriam Drysdale, et al. (+2)
1021 [GO] 2022―Dec―15 1923. Outcomes of the adsorbed Sinovac CoronaVac COVID-19 inactivated vaccine among the employee recipients in St. Luke’s Medical Center Quezon City: an observational cohort study Almira V Uy, Medical Doctor, Ryan Llorin, Medical Doctor
1022 [GO] 2022―Dec―15 1901. Utilizing Antiviral Prescription Data as a Predictor of Increasing COVID-19 Incidence: A Retrospective Study of Citywide Data Christina Kaul, Gabriel M Cohen, Matthew Silverstein, Andrew B Wallach, Elizabeth Diago-Navarro, Mary K Foote
1023 [GO] 2022―Dec―15 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection Salman Bangash, Adriana Betancourth, Ayesha Khan, Chiu-Bin Hsiao, Cassandra Oehler, Charmaine Clarisse D Abalos
1024 [GO] 2022―Dec―15 1088. Evaluating the Effect of Donepezil on Mortality Among Alzheimer’s Disease Patients With and Without COVID-19 Infection Taissa A Bej, Elizabeth Edmiston, Brigid Wilson, Joy Phillips, Robin L Jump
1025 [GO] 2022―Dec―15 2357. Risk Factors for COVID-19 Infection and Outcomes in People Living with HIV John J Hanna, Liyu B Geresu, Marlon Diaz, Madison Pickering, Julia A Casazza, Milan Ho, et al. (+9)
1026 [GO] 2022―Dec―15 1889. Knowledge, beliefs and practices about COVID-19 infection and vaccination in healthcare personnel at non-acute care facilities Armaghan-e-Rehman Mansoor, Caroline A ONeil, David McDonald, Victoria J Fraser, Hilary Babcock, Jennie H Kwon
1027 [GO] 2022―Dec―15 354. Invasive fungal disease in patients with severe COVID-19 infection at a midwestern academic medical center Stephen M Maurer, Kathleen A Linder, Marisa H Miceli
1028 [GO] 2022―Dec―15 1092. Management of Transplant Graft and Role of Immunosuppression in the Outcome of Covid-19 Infection in Solid Organ Transplant Recipients Suhel A Sabunwala, Tuhina Cornelius, Sadaf Aslam, Sally Alrabaa, Ambuj Kumar
1029 [GO] 2022―Dec―15 1161. Vaccination During Acute COVID-19 Infection Protects Against 30 Day Adverse Outcomes Julia A Casazza, Robert W Turer, Sameh N Saleh, Madison Pickering, Marlon Diaz, Milan Ho, et al. (+5)
1030 [GO] 2022―Dec―15 1126. Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial Olli P O Nevalainen, Saana Horstia, Sanna Laakkonen, Jarno Rutanen, Jussi Mustonen, Ilkka Kalliala, et al. (+15)
1031 [GO] 2022―Dec―15 265. Cryptococcal disease in Covid-19 infection: Case series from South Texas Sumbal Babar, Marcos I Restrepo, Delvina Ford, Jose Cadena-Zuluaga
1032 [GO] 2022―Dec―15 239. Acute Thromboembolism in Non-ICU Hospitalized Patients with COVID-19 infection: Examining the Impact of Prior COVID Vaccination James McKinnell, Felix Pham, Volha Yarashenka, John Kunesh, Lisa Hughes, Kyle Fu, et al. (+3)
1033 [GO] 2022―Dec―15 1116. Comparative Efficacy of Tocilizumab and Baricitinib in Treatment of Severe COVID-19 Infections Phylicia Pellot, Nikunj M Vyas, Cindy Hou, Michael Rosati
1034 [GO] 2022―Dec―15 1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination Chris Choi, Ashley Tippett, Luis W Salazar, Laila Hussaini, Olivia D Reese, Khalel De Castro, et al. (+11)
1035 [GO] 2022―Dec―15 1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure - Results from the placebo-controlled EMPATHY trial Luis Abrishamian, Marc Bonten, Richa Chandra, Damodaran Solai Elango, Pierre Fustier, Kinfemichael Gedif, et al. (+19)
1036 [GO] 2022―Dec―15 2058. Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Preethiya Sekar, Elizabeth Nalintya, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, et al. (+7)
1037 [GO] 2022―Dec―15 1119. Covid-19 Mab Use in High-Risk Pediatric Patients Hannah Bahakel, Catherine R Murphy, Robert W Frenck, Michael Grimley, Christine Phillips, Grant Schulert, et al. (+4)
1038 [GO] 2022―Dec―15 1117. COVID-19 Monoclonal Antibodies: A Single Center Real World Experience Sara Brenner, Alexander Knee, Douglas Salvador, Erica Housman, Gladys Fernandez, Armando Paez
1039 [GO] 2022―Dec―15 316. The Value of Monocyte-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting COVID-19 Mortality: A Single-Center Retrospective Study Denise Marie J Nanas, Marjorie A Nolasco, Divina Cristy R Samin
1040 [GO] 2022―Dec―15 255. Clinical, echocardiographic and electrocardiographic manifestations of COVID-19 multisystem inflammatory syndrome in children in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Kelvin Espinal, Franzory Peralta, Hilario Maria
1041 [GO] 2022―Dec―15 1909. Steak with a Side of Omicron? Efficacy of Coordinated Outbreak Response during an early COVID-19 Omicron Outbreak amongst Restaurant Workers in Riverside County, CA Shunling Tsang, Wendy Hetherington, Wendy Hetherington, Juan Landeros-Tavera, Jennifer Chevinsky, Marshare Penny
1042 [GO] 2022―Dec―15 736. Impact of COVID-19 on Mortality Associated with Pseudomonas aeruginosa Bloodstream Infection in the Veterans Health Administration System Leila S Hojat, Brigid Wilson, Federico Perez, Robert A Bonomo
1043 [GO] 2022―Dec―15 LB1532. The Impact of COVID-19 on nursing home residents’ clinical, functional, and psychosocial outcomes Lori Popejoy, Amy Vogelsmeier, Gregory Petroski, Daivd Mehr, Marilyn Rantz, Steven Miller, et al. (+3)
1044 [GO] 2022―Dec―15 1020. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) at an Academic Medical Center Ravitej Goteti, Lea M Monday, Allison J Weinmann
1045 [GO] 2022―Dec―15 LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen Tara L Gonzales, Paula Skarda, Thomas G Bird, Michael Schnaus, Mitchell Steiner, Alan Skolnick, et al. (+7)
1046 [GO] 2022―Dec―15 2199. Herpesviridae lung reactivation and infection in patients with severe Covid-19 or influenza virus pneumonia: a comparative study Charles-Edouard Luyt, Sonia Burrel, Vincent Guiraud, Alain Combes, David Boutolleau
1047 [GO] 2022―Dec―15 1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome Filippos Filippatos, Marianna Tzanoudaki, Elizabeth-Barbara Tatsi, Vasiliki Efthymiou, Manolis Liatsis, Vasiliki Syriopoulou, Athanasios Michos
1048 [GO] 2022―Dec―15 1883. Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS) Priscilla Rupali, Malathi Murugesan, Venkata Raghava Mohan, Padmanaban Venkatesan, Senthil Kumar, Premkumar Thangavelu, et al. (+2)
1049 [GO] 2022―Dec―15 1879. Detection of COVID-19 Outbreaks in Long-Term Care Homes Using Built Environment Testing for SARS-CoV-2: A Multicentre Prospective Study Michael Fralick, Jason Moggridge, Lucas Castellani, Sylva Donaldson, David S Guttman, Aaron Hinz, et al. (+11)
1050 [GO] 2022―Dec―15 2213. Increased Early Syphilis Detection and Treatment in an Urban Emergency Department During the COVID-19 Pandemic Ashley Lipps, Carlos Malvestutto, Susan L Koletar, Michael Dick, Sommer E Lindsey, Jose A Bazan
1051 [GO] 2022―Dec―15 2214. National Testing Assessment of Select Bacterial STIs During the COVID-19 Pandemic Giuiseppe A Fonseca, Marissa Maier, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Lorenzo McFarland, et al. (+6)
1052 [GO] 2022―Dec―15 2017. Comparison of California Acute Care Hospital Central Line-Associated Bloodstream Infection Incidence by Hospital Location Before and During the COVID-19 Pandemic Lizette Brenes, Monise Magro, Tisha Mitsunaga, Erin Epson
1053 [GO] 2022―Dec―15 1919. Implementation of Hydrogen Peroxide Vapor (HPV) Decontamination of N95 Respirators for Reuse During COVID-19 Pandemic Nancy L Havill, Richard A Martinello, Patrick Kenney, Cherie Bragg, Jacqueline Epright, Margaret Cintron, et al. (+2)
1054 [GO] 2022―Dec―15 1921. Leveraging Bluetooth Low-Energy Technology to Improve Contact Tracing in Healthcare Settings during the COVID-19 Pandemic M Cristina Vazquez Guillamet, Ashraf Rjob, Jingwen Zhang, Reshad Hamauon, Ruixuan Dai, Ruiqi Wang, et al. (+5)
1055 [GO] 2022―Dec―15 2205. Potential Causative Association between Respiratory Viruses and Pneumococcus-Associated Disease in Young Children in Israel: Lessons from the COVID-19 Pandemic Ron Dagan, Bert Adriaan van der Beek, David Greenberg, Yonat Shemer Avni, Shalom Ben-Shimol, Daniel M Weinberger
1056 [GO] 2022―Dec―15 2203. Involvement of Respiratory Viruses in Community-Acquired Alveolar Pneumonia (CAAP) in Children < 5 Years in Southern Israel, Before and During the COVID-19 Pandemic Dana Danino, Bert Adriaan van der Beek, Shalom Ben-Shimol, Yonat Shemer Avni, David Greenberg, Ron Dagan
1057 [GO] 2022―Dec―15 1912. Addressing Uncertainty: An Evidence-Based, Data-Driven, Decision Matrix for Healthcare Operations During The COVID-19 Pandemic Valerie Ausborn, Luis Ostrosky-Zeichner, Misti G Ellsworth, Tawanna A McInnis-Cole, Kristine Aleman Verrill, Shannon Lutz, et al. (+2)
1058 [GO] 2022―Dec―15 1907. Initiation of Comfort Measures Only Care in the Medical Intensive Care Unit during the COVID-19 Pandemic Max Jacobs, Helene Rovnan, Deeksha Ramanujam, Amina Hamza, Stephen Caucci, Tariq Cheema
1059 [GO] 2022―Dec―15 1765. Antibiotic Consumption in a Healthcare System in Bolivia During the First Wave of COVID-19 Pandemic Rodolfo E Quiros, Elvio D Escobar, Juan Carlos Tapia, Valeria Fabre
1060 [GO] 2022―Dec―15 1400. Emergency Department (ED) Use among Persons With HIV (PWH) before and during the COVID-19 Pandemic Deana Agil, Lindsay Browne, Thibaut Davy-Mendez, Amy Durr, Heather Henderson, Kuo-Ping Li, et al. (+3)
1061 [GO] 2022―Dec―15 1425. Changes in Clinical Presentation of TB due to the COVID-19 pandemic Nazia Khan, Surksha Sirichand, Xianhong Xie, Jacqueline M Achkar
1062 [GO] 2022―Dec―15 1321. Increased Prevalence of Group A Streptococcus (GAS) High Level Macrolide Resistance During the COVID-19 Pandemic Ami B Patel, Judith A Guzman-Cottrill, Katherine E Fleming-Dutra, Sopio Chochua, Bernard Beall, Preeti Jaggi, et al. (+6)
1063 [GO] 2022―Dec―15 1215. Variation in Hand Hygiene Improvement After Implementation of an Electronic Hand Hygiene System During the COVID-19 Pandemic James P Steinberg, Elizabeth Overton, Nancye Feistritzer, Kari L Love, Jill Holdsworth, Margaret Whitson`, et al. (+4)
1064 [GO] 2022―Dec―15 1329. Pediatric Group A Streptococcus (GAS) Pharyngitis Incidence has Decreased During the COVID-19 Pandemic Ami B Patel, Matthew McHugh, Stanford Shulman, Robert R Tanz
1065 [GO] 2022―Dec―15 961. Pandemic Hits: Evaluation of an Antimicrobial Stewardship Program Website for Hospital Communication During the COVID-19 Pandemic Reinaldo Perez, Michael E Yarrington, Rebekah Wrenn, Connor R Deri, Martha B Adams, Richard H Drew, et al. (+3)
1066 [GO] 2022―Dec―15 580. Influenza, SARS-CoV-2, and routine childhood vaccines - trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic Marisa Orbea, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
1067 [GO] 2022―Dec―15 1007. Impact of an Interdisciplinary Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic During the COVID-19 Pandemic Amir Zaki, Teena H Xu, Parisa Khan, Amna Ahmed, Katharine Breaux
1068 [GO] 2022―Dec―15 944. Development & Implementation of a Biomarker-based Remotely-delivered Antimicrobial Stewardship (AMS) Strategy during the COVID-19 Pandemic Divya Deodhar, Jane Miracline, Hanna Alexander, Naveena gracelin princy Zacchaeus, Premkumar Thangavelu, Priscilla Rupali
1069 [GO] 2022―Dec―15 1107. A Survey on Remdesivir Use and Antimicrobial Stewardship Restrictions Throughout the COVID-19 Pandemic Alfredo J Mena Lora, Fischer Herald, Rodrigo M Burgos, Scott Borgetti, Brenna Lindsey, Lelia H Chaisson, Susan C Bleasdale
1070 [GO] 2022―Dec―15 268. Dengue - SARS-CoV-2 co-infection: Experience in hospitalized patients during COVID-19 pandemic Fernando Rosso, Isabel L Zapata-Vasquez, Sarita Rodriguez, Diana M Martinez, Olga Agudelo, Sebastián Robles-Castillo, Alejandro Tejada
1071 [GO] 2022―Dec―15 105. Expanding and Sustaining Influenza Vaccination Acceptance amongst Adults with HIV in Delaware during the COVID-19 Pandemic Deborah A Kahal, Christopher James, Brian Wharton
1072 [GO] 2022―Dec―15 355. Outcome of patients with non-COVID-19 related Aspergillosis during the COVID-19 pandemic Carla M Roman-Montes, Adriana Guzman-Pérez, Medical Student, Rosa Areli Martinez-Gamboa, Maria Fernanda Gonzalez, Paulette G Díaz-Lomelí, et al. (+4)
1073 [GO] 2022―Dec―15 1437. Investigation of Increased Latent Tuberculosis Infection Rates During the COVID-19 Pandemic Among International Students at a U.S. University Campus Wajih Askar, Lauri E Nandyal, RaeJean Hardig, Tina Coberley, Amanda Doner, Lisa Haglund, et al. (+4)
1074 [GO] 2022―Dec―15 1905. High food insecurity during the COVID-19 pandemic among secondary school teachers - Tajikistan, 2021 Davron Akhmedov, Roberta Horth, Dilyara Nabirova
1075 [GO] 2022―Dec―15 1903. Factors associated with response to a phone-administered alcohol and substance use survey during the COVID-19 pandemic among women in the MACS/WIHS Combined Cohort Study: Who are we missing? Hannah R Tierney, Yifei Ma, Peter Bacchetti, Ralph J DiClemente, Mirjam-Colette Kempf, Deborah L Jones, et al. (+10)
1076 [GO] 2022―Dec―15 2014. Central Line - Associated Bloodstream Infections and Their Increase With the COVID-19 Pandemic at Veterans Affairs in San Antonio, Texas Divya Chandramohan, Delvina Ford, Erica Beck, Lauren N Garza, Kelly R Reveles, Jose Cadena
1077 [GO] 2022―Dec―15 385. Impact of the COVID-19 Pandemic First Wave on Clostridioides difficile Infection Rafael Mendo-Lopez, Lauren Pacheco, Javier A Villafuerte-Galvez
1078 [GO] 2022―Dec―15 248. Change in Incidence of Multisystem Inflammatory Syndrome in Children Across the COVID-19 Pandemic in Chicago - March 2020 - March 2022 Hillary Spencer, Jennifer Seo, Massimo Pacilli, Candice L Robinson, Hannah Matzke, Maria Joseph, Stephanie Gretsch
1079 [GO] 2022―Dec―15 2040. Healthcare-Associated Infection Surveillance During the COVID-19 Pandemic in New Mexico Morgan Edwards-Fligner, Erin C Phipps
1080 [GO] 2022―Dec―15 1393. Body Mass Index Change In People Living With HIV During The COVID-19 Pandemic In New York Kai-Ming Chang, Guillermo Ramirez, Praveen Vikraman, Lemar Nadi, Cristina Sison, Michael Oey
1081 [GO] 2022―Dec―15 2209. RSV-associated Hospitalizations in Adults Aged ≥18 Years and the Impact of the COVID-19 Pandemic in the United States, October 2018 - February 2022 Fiona P Havers, Michael Whitaker, Huong Pham, Onika Anglin, Jennifer Milucky, Kadam Patel, et al. (+17)
1082 [GO] 2022―Dec―15 275. Evaluating the COVID-19 Pandemic in US Veterans: Transitioning from Delta to Omicron Variants Audun J Lier, Zeena Lobo, George Psevdos
1083 [GO] 2022―Dec―15 1573. Impact of the COVID-19 Pandemic on Antibiotic Use among Hospitalized Adults in Argentina, Brazil, and Chile Twisha S Patel, Olivia L McGovern, Garrett W Mahon, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+18)
1084 [GO] 2022―Dec―15 1917. Impact of the COVID-19 Pandemic on Antimicrobial Stewardship, Infection Prevention & Control, and Clinical Microbiology Practices in Argentina, Brazil, and Chile Hanako Osuka, Twisha S Patel, Olivia L McGovern, Icaro Boszczowski, Jose M Munita, Maria I Garzon, et al. (+11)
1085 [GO] 2022―Dec―15 2019. Understanding the Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections (CLABSIs): Expanding Analysis to the Microbiologic Level Jay Raj Krishnan, Elizabeth Dodds Ashley, Andrea Cromer, Deverick J Anderson, Sonali D Advani, Melissa D Johnson
1086 [GO] 2022―Dec―15 2042. Impact of the COVID-19 Pandemic on Healthcare-Associated Infections (HAI) by Race and Ethnicity in a Large Network of Community Hospitals: A Call to Action Erin Gettler, Ibukunoluwa Kalu, Sonali D Advani, Jessica Seidelman, Jay Raj Krishnan, Melissa Campbell, et al. (+3)
1087 [GO] 2022―Dec―15 1209. The Impact of the COVID-19 Pandemic on Hospital-Acquired Infections at a Comprehensive Cancer Center Rita Wilson Dib, Amy Spallone, Fareed Khawaja, Adina Feldman, Jalen Bartek, Sherry Cantu, et al. (+8)
1088 [GO] 2022―Dec―15 2200. Impact of COVID-19 Pandemic on Influenza-like Illness (ILI) Experience among Healthcare Workers in Military Treatment Facilities Ryan Liberg, Christina Schofield, Stephanie A Richard, Limone Collins, Christina Spooner, Srihari Seshadri, et al. (+13)
1089 [GO] 2022―Dec―15 1223. The Impact of the COVID-19 Pandemic on the Prevalence of Multidrug-resistant Organisms in Veterans Affairs Nursing Homes Monirul I Sajib, Florence M Ford, George Psevdos
1090 [GO] 2022―Dec―15 267. Delayed Pulmonary Tuberculosis (PTB) Diagnosis During the COVID-19 Pandemic: A Case Series Mikhail Khaitov, Nadim Salomon, David Perlman, Sarah Humphreys
1091 [GO] 2022―Dec―15 1214. The Effects of Modified Personal Protective Equipment (PPE) Protocols on Healthcare Personnel Providing Patient Care During the COVID-19 Pandemic: A Qualitative Assessment Emily E Chasco, Jaqueline Pereira da Silva, DeShauna Jones, Kimberly Dukes, Melissa Ward, Loreen Herwaldt
1092 [GO] 2022―Dec―15 929. A Nationwide Survey on the Role of Antimicrobial Stewardship Programs during the COVID-19 Pandemic: What is restricted and who decides? Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Rodrigo M Burgos, Scott Borgetti, Lelia H Chaisson, Susan C Bleasdale
1093 [GO] 2022―Dec―15 485. A hypermutator strain of Pseudomonas aeruginosa in a COVID-19 patient with ventilator-associated pneumonia Sophia Nozick, Egon A Ozer, Rachel Medernach, Jori Mills, Richard Wunderink, Alan R Hauser
1094 [GO] 2022―Dec―15 Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection post-vaccination for mild COVID-19 patients Santosh Dhakal, Tong Yu, Anna Yin, Nora Pisanic, Zoe O Demko, Annukka A R Antar, et al. (+4)
1095 [GO] 2022―Dec―15 1945. Effects of COVID-19 Vaccines on Outcomes Among Hospitalized COVID-19 Patients Serene Hoskins, Marcos I Restrepo, Jose Cadena
1096 [GO] 2022―Dec―15 907. Impact of Antimicrobial Stewardship Prospective Audit and Feedback on Antibiotic Utilization in Hospitalized COVID-19 Patients Ashfaq Shafiq, Taylor Hori, Selena Pham
1097 [GO] 2022―Dec―15 1123. EDP-235, A Potent and Once-daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes, with the Potential for Mitigation of Cytokine Storm in High-Risk COVID-19 Patients Yang Li, Tianzhu Indy Zang, Lisha Xu, Daniel Leonard, Khanh Hoang, Tim Greizer, et al. (+7)
1098 [GO] 2022―Dec―15 1124. Effect of High-Dose versus Standard-Dose Dexamethasone on Mortality Among Mechanically Ventilated COVID-19 Patients Pramodini Kale-Pradhan, Regina Pacitto, Lauren Krumm, Anna Hejnar, Christopher Giuliano, Leonard B Johnson
1099 [GO] 2022―Dec―15 276. Factors Predicting Bacterial Coinfection in Hospitalized COVID-19 Patients Yi Guo, Kelsie Cowman, Hongkai Bao, Victor Chen, Mimi Kim, Xianhong Xie, et al. (+4)
1100 [GO] 2022―Dec―15 165. Biofire pneumonia panel use in severe pneumonia and antibiotic treatment in COVID-19 patients Erica J Stohs, Maureen McElligott, Hannah M Creager, Paul D Fey, Trevor C Van Schooneveld
1101 [GO] 2022―Dec―15 270. Secondary bacterial infection in hospitalized COVID-19 patients. Experience in Colombia, South America Fernando Rosso, Sarita Rodriguez, Isabel L Zapata-Vasquez, Eric Tafur, Diana M Martinez, Tania Guzmán, et al. (+2)
1102 [GO] 2022―Dec―15 1875. Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease Jinghao Nicholas Ngiam, Srishti Chhabra, Wilson Goh, Meng Ying Sim, Tze Sian Liong, Nicholas W S Chew, et al. (+3)
1103 [GO] 2022―Dec―15 1090. Factors effecting mortality among Covid-19 patients in Renal Transplant Recipients from a single center in Pakistan Asma Nasim, Sunil Kumar
1104 [GO] 2022―Dec―15 291. Retrospective Study on Bacteremia in COVID-19 Patients in the Delta and Omicron Era Sunghee Park, Tark Kim, Eun Ju Choo
1105 [GO] 2022―Dec―15 1106. A Retrospective Assessment of the Effects of Baricitinib and Tocilizumab on COVID-19 Patients requiring High Flow Oxygen Kathy Tin, Annamarie Fernandes, Alexander Njoroge, Roderick Go
1106 [GO] 2022―Dec―15 1067. Predicting next 7-day Discharges of Hospitalized COVID-19 Patients Using Ensemble Learning Xiangyang Ye, Mingyuan Zhang, Matthew H Samore, Jincheng Shen, Julia Bohman, Yue zhang, Jeffrey Humpherys
1107 [GO] 2022―Dec―15 1071. Retrospective study evaluating the cytokine dynamics in COVID-19 patients who were treated with casirivimab/imdevimab Akiho Sugita, Masahiro Ishikane, Noriko Iwamoto, Masaya Sugiyama, Katsuji Teruya, Masayuki Hojo, et al. (+2)
1108 [GO] 2022―Dec―15 1045. Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration T-lymphocyte Counts and Interferon-gamma Production Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, Laura Campogiani, Alessandra Lodi, Filippo Barreca, et al. (+10)
1109 [GO] 2022―Dec―15 349. Characteristics and Outcomes of COVID-19 Patients with Candidemia at a Community Teaching Hospital in Chicago - One Year Follow Up. Oluwadamilola A Adeyemi, David Okoh, Gregg Gonzaga, Sean Cariño, Steve B Kalish
1110 [GO] 2022―Dec―15 LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial Phillip D Monk, Rachael A Evans, Victoria J Tear, Jody L Brookes, Toby Batten, Marcin Mankowski, et al. (+4)
1111 [GO] 2022―Dec―15 245. Can Inflammatory Markers be used as an Early predictor for Mechanical ventilation in COVID-19 patients with Stages IIIb-V Chronic Kidney Disease? Harinivaas Shanmugavel Geetha, Maya Gogtay, Sushmita Prabhu, Abinesh Sekar, Yuvaraj Singh, George M Abraham, Suzanne Martin
1112 [GO] 2022―Dec―15 1128. Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial Shigeru Kohno, Taiga Miyazaki, Naoki Hosogaya, Shinpei Morimoto, Hiroshi Yamamoto, Shingo Iwami, et al. (+2)
1113 [GO] 2022―Dec―15 1157. The Clinical Impact of Casirivimab-Imdevimab Monoclonal Antibody Therapy (CIMAT) in COVID-19 patients: A real-world insight from India. Jose J Kochuparambil, Aleena Issac
1114 [GO] 2022―Dec―15 277. Frequency of Pneumomediastinum and Pneumothorax in COVID-19 Patients: a Retrospective Cohort Study in a Community Hospital in Evanston, Illinois Goar Egoryan, Guillermo Rodriguez Nava, Guillermo Rodriguez Nava, Armen Kishmiryan
1115 [GO] 2022―Dec―15 LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia Bruno Mourvillier, Alexander Vlaar, Martin Witzenrath, Michael Bauer, Leo Heunks, Luis Hercilla Vasquez, et al. (+23)
1116 [GO] 2022―Dec―15 1058. Development of a Steroid Stewardship Bundle to tackle the Glucocorticoid-Induced Hyperglycemia in COVID-19 patients: Results of SUPER Diabetes Study. Aleena Issac, Jose J Kochuparambil
1117 [GO] 2022―Dec―15 1134. Lenzilumab Treatment in COVID-19 Pneumonia Reduces Circulating Cytokines and Markers of Systemic Inflammation Dale Chappell, Adrian Kilcoyne, Frank Cerasoli, John Lukas, Cameron Durrant, Zelalem Temesgen, et al. (+3)
1118 [GO] 2022―Dec―15 1125. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalized adults with severe COVID-19 pneumonia: an open-label randomized trial. Carlos Dueñas Gutierrez, Jesica Abadia-Otero, Ivan Cusacovich, Jose Ignacio Martín-González, Alberto Muela-Molinero, Luis Corral-Gudino, et al. (+16)
1119 [GO] 2022―Dec―15 LB1531. Administration of Abatacept or Infliximab Reduces Mortality in Hospitalized Patients with COVID-19 Pneumonia: Results from the ACTIV-1 IM Master Protocol Emily R Ko
1120 [GO] 2022―Dec―15 272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020 Alexander Lawandi, Jeffrey R Strich, Xioabai Li, Christina Yek, Sarah Warner, Sameer S Kadri
1121 [GO] 2022―Dec―15 1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans Sujee Jeyapalina, Margaret Lundquist, Guo Wei, Gregory Stoddard, Jay Agarwal
1122 [GO] 2022―Dec―15 591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants Christopher M Rubino, Anthony P Cammarata, Paul Ambrose, Pete Schmidt, Myra Popejoy, Jean Gong, Xia Pu
1123 [GO] 2022―Dec―15 1892. Rise of COVID-19 Re-infections as Omicron Variant Prevailed: Implications on Monitoring the Course of the Pandemic Kassiani Mellou, Kassiani Gkolfinopoulou, Kyriaki Tryfinopoulou, Ioannis Panagoulias, Panagiota Psallida, Gerasimos Gerolymatos, et al. (+4)
1124 [GO] 2022―Dec―15 202. Vintage or Vogue? The Utility of Procalcitonin for Identifying Secondary Infections in Patients With Influenza or Covid-19 Receiving Extracorporeal Membrane Oxygenation Kajal D Patel, Michal J Sobieszczyk, Joseph E Marcus, James Aden
1125 [GO] 2022―Dec―15 1152. Risk factors for 30-day all-cause mortality in hospitalized patients with COVID-19 receiving immunomodulator therapy: a retrospective cohort study Chas A Hoffmann, Adam R Patrick, David J Hutchinson, Lauren M Finoli, Tiffany L Guliano, Matthew A Moffa, et al. (+2)
1126 [GO] 2022―Dec―15 1954. Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial Odile Launay, Marine Cachanado, Liem Binh Luong, Laetitia Ninove, Marie Lachâtre, Inès Ben Ghezala, et al. (+26)
1127 [GO] 2022―Dec―15 1878. Demographic and Clinical Characteristics of COVID-19 Reinfection Robert Hoard, Eric Coate, Elizabeth A Macias, Luke B Jackson, Alice E Barsoumian, Jason Okulicz, Elizabeth Markelz
1128 [GO] 2022―Dec―15 1876. COVID-19 Reinfection and Disease Severity in the New York City Health + Hospitals System Jenny R Smolen, Thomas D Filardo, Annie George, Sakil Bhuiyan, Sowmya Kalava, Noor Shahin, et al. (+7)
1129 [GO] 2022―Dec―15 2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients Marilyne Daher, Fareed Khawaja, Georgios Angelidakis, Gabriella Rondon, Amy Spallone, Jeremy Ramdial, et al. (+3)
1130 [GO] 2022―Dec―15 78. Longitudinal Analysis of T cells in COVID-19 Survivors with Post-Acute Sequelae of COVID-19 Reveals Associations between Individual Symptoms and Inflammatory Indexes Stephanie LaVergne, Stephanie LaVergne, Taru Dutt, Kim McFann, Bridget Baxter, Tracy Webb, et al. (+5)
1131 [GO] 2022―Dec―15 317. Use cases for rapid antigen-detecting tests for COVID-19 screening and surveillance: a systematic review Apoorva Anand, Jacob Bigio, Emily MacLean, Talya Underwood, Nitika Pant Pai, Sergio Carmona, et al. (+2)
1132 [GO] 2022―Dec―15 1069. Psychometric Properties of the Symptoms of Infection with Coronavirus-19: A Patient-Reported Outcome Measure for COVID-19 Signs and Symptoms Eric K H Chan, Jeffrey Stoddard, Jerald Sadoff, Yan Liu, Ilse van Dromme, Eva G Katz, et al. (+2)
1133 [GO] 2022―Dec―15 1061. Evaluation of Measures for the Assessment of Covid-19 Signs and Symptoms in Children and Adolescents Carla Romano, Margaret Mayorga, Javier Ruiz-Guiñazu, Géralyn C Trudel, Sheri Fehnel, Kelly McQuarrie, et al. (+2)
1134 [GO] 2022―Dec―15 1888. Implementation of COVID-19 Surveillance Testing Procedures in Dental School Holly Shoemaker, Jeri Bullock, Kristina Stratford, Melodie L Weller, Wendy L Hobson-Rohrer, Wendy L Hobson-Rohrer, et al. (+3)
1135 [GO] 2022―Dec―15 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination Magdalena E Sobieszczyk, Ann R Falsey, Anne F Luetkemeyer, Grant C Paulsen, Sharon A Riddler, Merlin L Robb, et al. (+15)
1136 [GO] 2022―Dec―15 1054. Comparison of Post-Acute COVID-19 Symptoms in Infected Individuals Pre- and Post-Vaccination Dylan McDonald, Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
1137 [GO] 2022―Dec―15 1918. Impact of the SARS-CoV-2-Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) on the Severity and Progression of COVID-19 Symptoms in the Phase 3 TACKLE Trial Jesus Abraham Simón Campos, Douglas Arbetter, Hugh Montgomery, F D Richard Hobbs, Francisco Padilla, Kenneth Kim, et al. (+4)
1138 [GO] 2022―Dec―15 1156. Sustained Alleviation and Resolution of Targeted COVID-19 Symptoms with Nirmatrelvir/Ritonavir versus Placebo Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+6)
1139 [GO] 2022―Dec―15 1401. Evaluating Barriers and Potential Solutions to Speaking Up About COVID-19 Symptoms: A Survey Among Nursing Home Workers Gabrielle M Gussin, Raveena D Singh, Thomas T Tjoa, Raheeb Saavedra, Sherrie H Kaplan, Susan S Huang
1140 [GO] 2022―Dec―15 1070. Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes Giovanni Guaraldi, Jovana Milic, Sara Barbieri, Tommaso Marchio’, Agnese Caselgrandi, Federico Motta, et al. (+16)
1141 [GO] 2022―Dec―15 1407. Increasing access to COVID-19 testing in underserved Black American neighborhoods Elizabeth Avery, Tamara Olinger, Sumihiro Suzuki, Yolanda Cartwright, LaDawne Jenkins, Lelia H Chaisson, et al. (+5)
1142 [GO] 2022―Dec―15 1898. The Impact of Polymerase Chain Reaction Versus Antigen Based COVID-19 Testing on Subsequent Infections in Military Trainees Daniel Cybulski, Zachary Matthews, John Kieffer, Theresa Casey, Angela Osuna, Korey Kasper, et al. (+3)
1143 [GO] 2022―Dec―15 903. Formulary Edits and Consistent Messaging for Unproven COVID-19 Therapeutics Tyler Stephen, Alyssa Tutino, Justin Bender, Michelle Sageer, Mona Chitre, Ted Louie
1144 [GO] 2022―Dec―15 1118. COVID-19 Therapeutics: Real-World Experience in Flint, Michigan (MI) Mariam Younas, Danielle Osterholzer, Carlos Rios-Bedoya, Brandon R Flues, Ghassan Bachuwa, Ghassan Bachuwa
1145 [GO] 2022―Dec―15 1109. Rise and Fall of COVID-19 Therapies Throughout Different Waves of the Pandemic: Results of a Nationwide Survey Alfredo J Mena Lora, Fischer Herald, Brenna Lindsey, Scott Borgetti, Lelia H Chaisson, Rodrigo M Burgos, Susan C Bleasdale
1146 [GO] 2022―Dec―15 1046. Assessing School-Based COVID-19 Transmission in Middle and High Schools in an Underserved Population through Qualitative Interviews Grace Yuan, Samantha Hayes, Sara Malone, Sewuese Akuse, Tremayne Watterson, Summer M Reyes, et al. (+8)
1147 [GO] 2022―Dec―15 1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, et al. (+7)
1148 [GO] 2022―Dec―15 1149. Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1) Charlotte Hedskog, Lauren Rodriguez, John H Beigel, Walla Dempsey, Alexander L Greninger, Pavitra Roychoudhury, et al. (+10)
1149 [GO] 2022―Dec―15 1138. Optimal Duration of Systemic Corticosteroids Use in COVID-19 Treatment: A Meta-analysis Nyein Yu, Paddy Ssentongo, David Ingram, Catharine I Paules
1150 [GO] 2022―Dec―15 284. Post-Acute Sequelae of COVID-19 Two Years After Acute Infection Jennifer Logue, Nicholas M Franko, Megan M Kemp, Denise J McCulloch, Eric J Chow, Helen Y Chu
1151 [GO] 2022―Dec―15 1959. Lower B-Cell Responses Rather Than Circulating Antibody Titres Are Associated With SARS-CoV-2 Infection Post Third Dose COVID-19 Vaccination Joanne Byrne, Lili Gu, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+15)
1152 [GO] 2022―Dec―15 1935. Cardiac Tamponade Following COVID-19 Vaccination Christopher B Murphy, Sabirah N Kasule, Holenarasipur R Vikram
1153 [GO] 2022―Dec―15 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans Gina Oda, Aditya Sharma, Cynthia A Lucero-Obusan, Patricia Schirmer, Mark Holodniy
1154 [GO] 2022―Dec―15 1963. Peripartum Outcomes Associated With COVID-19 Vaccination during Pregnancy: A Systematic Review and Meta-analysis Atsuyuki Watanabe, Jun Yasuhara, Masao Iwagami, Yoshihisa Miyamoto, Yuji Yamada, Yukio Suzuki, et al. (+2)
1155 [GO] 2022―Dec―15 1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico Rodrigo Villaseñor-Echavarri, Daniel De-la-Rosa-Martinez, Emmanuel Frias-Jimenez, Alexandra Martin-Onraet, Erika Ruiz-Garcia, Alonso Cruz-Cruz, et al. (+2)
1156 [GO] 2022―Dec―15 1929. A Qualitative Analysis of COVID-19 Vaccination Intent and Recommendations to Increase Uptake Among Residents and Staff in Six Seattle Homeless Shelters Sarah N Cox, Nicholas Thuo, Julia H Rogers, Ashley A Meehan, Amy C Link, Natalie K Lo, et al. (+7)
1157 [GO] 2022―Dec―15 433. COVID-19 Vaccination Uptake Among Health Care Workers (HCW) Requesting Medical Exemptions to Vaccination. Jana Shaw, Loren Brown, Stephen J Thomas, Lynn M Cleary, Jarrod Bagatell
1158 [GO] 2022―Dec―15 1526. Time from last COVID-19 vaccination’s impact on rapidity of viral culture conversion following SARS-CoV-2 infection: a prospective cohort study Madison Gilbert, Atarere Joseph, Jacquelyn Turcinovic, Scott Seitz, Cole Sher-Jan, Laura F White, et al. (+12)
1159 [GO] 2022―Dec―15 1979. Waning of humoral immunity depending on the types of COVID-19 vaccine So Yun Lim, Ji Yeon Kim, Jiwon Jung, Sung-Cheol Yun, Sung-Han Kim
1160 [GO] 2022―Dec―15 LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States Germán Áñez, Lisa M Dunkle, Cynthia L Gay, Karen L Kotloff, Nita Patel, Joyce S Plested, et al. (+4)
1161 [GO] 2022―Dec―15 1976. Using a Patient Portal as a Recruitment Tool to Diversify the Pool of Participants in COVID-19 Vaccine Clinical Trials Tiffany Yuh, Tuhina Srivastava, Danielle Fiore, Harald Schmidt, Ian Frank, David Metzger, Florence Momplaisir
1162 [GO] 2022―Dec―15 1094. Multisystem Inflammatory Syndrome in Children (MIS-C) in Persons Fully Vaccinated with Two Doses of mRNA COVID-19 Vaccine Compared with Persons with Partial or No Vaccination Reported, U.S. National MIS-C Surveillance Anna R Yousaf, Allison D Miller, Katherine Lindsey, Michael J Wu, Michael Melgar, Laura D Zambrano, Angela P Campbell
1163 [GO] 2022―Dec―15 1937. COVID-19 Vaccine Distribution in Massachusetts Jails Nicole Cassarino, Emma Smyth, Alysse Gail Wurcel
1164 [GO] 2022―Dec―15 2297. COVID-19 Vaccine Effectiveness Among Pregnant People Ousseny Zerbo, G Thomas Ray, Kristin Goddard, Evan Layefsky, Bruce Fireman, Nicola P Klein
1165 [GO] 2022―Dec―15 1956. Impact of an Implementation Science-Based Project to Address COVID-19 Vaccine Hesitancy Scott C Ratzan, Erin Hultgren, Jeffrey D Carter, Melissa Rodriguez, Laura Simone, Leah Molloy
1166 [GO] 2022―Dec―15 1938. COVID-19 Vaccine Hesitancy among Adults Who Rely on Social Media for Health Care Information in Cameroon, Africa Kendall Baecher, Alexander Boutwell, Nuwan Gunawardhana, Nuwan Gunawardhana, Denis M Tebit, Jodie Dionne
1167 [GO] 2022―Dec―15 1939. COVID-19 vaccine immunogenicity among CD19 receptor T-cell (CAR-T) therapy Muneerah M Aleissa, Jessica S Little, Sonya Davey, Isabel H Gonzalez-Bocco, Andrew Looka, Nicolas C Issa, et al. (+3)
1168 [GO] 2022―Dec―15 224. Effect of a Mobile App Chatbot and an Interactive Small Group Webinar on COVID-19 Vaccine Intention and Confidence in Japan: A Randomized Clinical Trial Yuji Yamada, Hana Tomoi, Yuka Nishina, Ko Harada, Kyuto Tanaka, Shugo Sasaki, et al. (+10)
1169 [GO] 2022―Dec―15 99. COVID-19 Vaccine related Attitudes and Beliefs among Black and/or Hispanic respondents in Brooklyn, NY: Lessons Learned Lalitha Parameswaran, Mark Mulligan, Yangjin Park
1170 [GO] 2022―Dec―15 1950. Factors Influencing COVID-19 Vaccine Uptake among Reproductive-Aged Women in Jamaica Jodian A Pinkney, Kamali Carroll, Lenroy Bryan, Givana Witter, Dina Ashour, Fatma Shebl, et al. (+3)
1171 [GO] 2022―Dec―15 1962. Perceptions of the COVID-19 Vaccine within the Sudanese-American Community Jonathan R Freese, Harlan R Sayles, Fatima Ahmed, Mujtaba Abdellatif, Nada Fadul
1172 [GO] 2022―Dec―15 1947. Evaluating the Relationship Between Obesity and the Humoral Immune Response to COVID-19 Vaccines LaKesha Tables, Fatima Ali, Eric Gaines, Yul Eum Sim, Erica L Johnson, Lilly Immergluck
1173 [GO] 2022―Dec―15 1944. Effectiveness of COVID-19 Vaccines Against Severe Disease and Death and its Durability Over Time Against the Omicron Variant Theodore Lytras, Kassiani Mellou, Kassiani Gkolfinopoulou, Gerasimos Gerolymatos, Dimitrios Paraskevis, Theoklis Zaoutis, Sotirios Tsiodras
1174 [GO] 2022―Dec―15 1933. Assessment of Effectiveness of mRNA COVID-19 Vaccines Among Health Care Personnel: Monroe County, NY December 2020-March 2022 Savanah Russ, Christopher J Myers, Infectious Diseases, Erin Licherdell, Thomas Peer, Christine Hurley, et al. (+5)
1175 [GO] 2022―Dec―15 1941. Describing the immune response kinetics to mRNA COVID-19 vaccines among previously SARS-CoV-2-infected and -uninfected nursing home residents, a prospective longitudinal observational cohort evaluation-Georgia, October 2020 - September 2021 Zeshan A Chisty, Melia Haile, Juliana DaSilva, M A Biology, Hollis Houston, Shoshona Le, et al. (+17)
1176 [GO] 2022―Dec―15 1940. COVID-19 Vaccines and Related Adverse Effects among Health Sciences and Non-Health Sciences Students from Two Large Public Universities in Thailand Kanathip Jongmekwamsuk, Sirashat Hanvivattanakul, Jakapat Vanichanan, Thana Khawcharoenporn
1177 [GO] 2022―Dec―15 584. Prospective Observational Cohort Study of Serological Responses to COVID-19 Vaccines in Pediatric Kidney Transplant Recipients at a Single Institution Kathryn P Goggin, Elizabeth Sun, Emily J Yun, Margret Kamel, Maria Perez, Hui-Mien Hsiao, et al. (+5)
1178 [GO] 2022―Dec―15 84. One-month Humoral Response Following Two Doses of Covid-19 Vaccines in Specific populations - ANRS0001S COV POPART Cohort Study Paul LOUBET, L I nda Wittkop, Mathieu Chalouni, David-Axel Laplaud, Martine Laville, Bruno Laviolle, et al. (+10)
1179 [GO] 2022―Dec―15 786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, et al. (+4)
1180 [GO] 2022―Dec―15 1877. COVID-19-Associated Hospitalizations among Long-Term Care Facility Residents Ages ≥65 Years - COVID-NET, 14 U.S. States, March 2020-January 2022 Christopher Taylor, Michael Whitaker, Onika Anglin, Huong Pham, Kadam Patel, Jennifer Milucky, et al. (+15)
1181 [GO] 2022―Dec―15 783. Lung Transplantation for COVID-19-Associated Lung Injury (CALI): An International Registry Maha M Alamri, Rebecca Osborn, Reda Girgis, Nicholas Marschalk, Ryan Rivosecchi, Michael G Ison, et al. (+2)
1182 [GO] 2022―Dec―15 478. Lung Hybrid Neutrophils and Subsequent Extracellular Traps Are Protective In COVID-19-Associated Pulmonary Aspergillosis Simon Feys, Sam Vanmassenhove, Sirima Kraisin, Seppe Cambier, Cato Jacobs, Bram Boeckx, et al. (+10)
1183 [GO] 2022―Dec―15 247. Catching CAPA: The Healthcare Impact of COVID-19-Associated Pulmonary Aspergillosis in an Academic Medical Center Caroline Hamilton, Sarah Tran, Judy Dinh, Gina Askar, Gina Askar, Gina Askar, Gina Askar
1184 [GO] 2022―Dec―15 1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design Khalel De Castro, Ashley Tippett, Laila Hussaini, Luis W Salazar, Olivia D Reese, Meg Taylor, et al. (+11)
1185 [GO] 2022―Dec―15 1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults Olivia D Reese, Ashley Tippett, Laila Hussaini, Luis W Salazar, Meg Taylor, Caroline R Ciric, et al. (+11)
1186 [GO] 2022―Dec―15 348. Cell-free plasma next-generation sequencing assists in the evaluation of invasive mold infection in patients with COVID-19: a case series Joshua David, Bharadhwaj Kolipakkam, Megan M Morales, Nicole C Vissichelli
1187 [GO] 2022―Dec―15 1893. Risk Categorization and Outcomes among Healthcare Workers Exposed to COVID-19: A Cohort Study from A Thai Tertiary-care Center Thana Khawcharoenporn, Watcharee Chancharoenrat, Sirinporn Sajak, Suphannee Phetsaen, Padcharadda Hanchai, Kanokporn Thongphubeth, Thanus Pienthong
1188 [GO] 2022―Dec―15 1975. Trends in the parents’ intention to vaccinate their children against COVID-19: A comparative study in Peru Jose A Gonzales-Zamora, David Soriano-Moreno, Linda Ponce-Rosas, Mariano G Alarcón Parra, Noelia Morocho-Alburqueque, Valentina Murrieta-Ruiz, et al. (+6)
1189 [GO] 2022―Dec―15 1404. Factors Associated to Decrease in Quality of Life After Mild-Moderate COVID-19: A Cross-Sectional Study. Alberto Ordinola Navarro, Hector Rivera Villegas, Bruno Ali Lopez Luis
1190 [GO] 2022―Dec―15 LB1528A. Fluvoxamine for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial Matthew W McCarthy
1191 [GO] 2022―Dec―15 LB1528B. Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial David R Boulware
1192 [GO] 2022―Dec―15 1115. Effect of polymerized type I collagen in hyperinflammation of adult outpatients with symptomatic COVID-19: a double blind, randomised, placebo-controlled clinical trial Silvia Méndez-Flores, Angel Priego-Ranero, Daniel Azamar-Llamas, Héctor Olvera-Prado, Kenia Ilián Rivas-Redondo, Eric Ochoa-Hein, et al. (+13)
1193 [GO] 2022―Dec―15 252. Clinical Outcomes and Risk Factor of Severe Disease in Young Adult Patients Compared with Middle-Aged Patients Who Infected with COVID-19: A Large Cohort Study in Tertiary Hospital Preudtipong Noopetch, Rutporn Benchamanon, Samerjan Kongsuwan, Chatree Chai-adisaksopha
1194 [GO] 2022―Dec―15 292. Risk factor and clinical characteristics of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study Se Ju Lee, Jinnam Kim, Ki Hyun Lee, Jung Ah Lee, Chang Hyup Kim, Su Hwan Lee, et al. (+6)
1195 [GO] 2022―Dec―15 1153. Safety and Potential Efficacy of Exosomes Overexpressing CD24 (EXO-CD24) for the Prevention of Clinical Deterioration in Patients with Moderate or Severe COVID-19: A Phase II, Randomized, Single-blinded Study. Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, et al. (+18)
1196 [GO] 2022―Dec―15 244. Bacterial co-infection in COVID-19: an analysis of a National Cohort of Hospitalized U.S. Veterans Karim Khader, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
1197 [GO] 2022―Dec―15 787. Predictors of Co-infection with Multidrug Resistant Organisms among Hospitalized Patients with COVID-19: An Exploratory Analysis Yue Zhang, Haojia Li, Barbara E Jones, Michael Rubin, Candace Haroldsen, Tina M Willson, et al. (+3)
1198 [GO] 2022―Dec―15 2045. IVAC Plus in the Time of COVID-19: An Imperfect Metric? Camille Spears, Delvina Ford, Jose Martinez, Kelly R Reveles, Erica Beck, Lauren N Garza, et al. (+3)
1199 [GO] 2022―Dec―15 1887. Hyperglycemia and COVID-19: An independent risk factor for disease severity and death in the Dominican Republic Yori A Roque, David De Luna, Alfredo J Mena Lora, Lisa Maria Castillo Mercado, Carlos Perdomo, Mariela Acosta
1200 [GO] 2022―Dec―15 1781. Antibiotic Prescription Trends of Patients with COVID-19: Analysis of National Health Insurance Data in Republic of Korea Yunsang Choi, Minsun Kang, Dong Hoon Shin, Jongtak Jung, Seong Jin Choi, Nak-Hyun Kim, et al. (+5)
1201 [GO] 2022―Dec―15 1294. Covid-19: Impacts on Medical Students’ Mental Health in Medical Education Center of Chaophya Abhaibhubejhr Hospital Subencha Pinsai, Chalalai Klaipim
1202 [GO] 2022―Dec―15 226. Higher Doses of Adintrevimab, an Extended Half-Life Monoclonal Antibody, for the Treatment and Prevention of COVID-19: Preliminary Results from a Phase 1 Single Ascending-Dose Study Xia Pu, Jean Gong, Ed Campanaro, Kristin Narayan, Deepali Gupta, Frank Engler, et al. (+2)
1203 [GO] 2022―Dec―15 1141. Phase 3 Trial (in progress) of the SYK Inhibitor Fostamatinib in Patients Hospitalized with COVID-19: Protocol and Study Implementation Updates Lucy Yan, Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Wolfgang Dummer
1204 [GO] 2022―Dec―15 1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study Kazuaki Jindai, Hiroki Saito, Satoko Horii, Kazuhiro Kamata
1205 [GO] 2022―Dec―15 308. Do lung ultrasound abnormalities change during hospitalization for COVID-19? Jimin Hwang, Paul W Blair, Trishul Siddarthan, Gigi Liu, Erjia Cui, Jiawei Bai, et al. (+18)
1206 [GO] 2022―Dec―15 298. Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in an Immunocompromised Patient Victoria Overbeck, Jacquelyn Turcinovic, Xueting Qiu, Scott Seitz, John Connor, Beau Schaeffer, et al. (+3)
1207 [GO] 2022―Dec―15 2318. A Composite Peptide Vaccine Comprised of Conserved SARS-CoV-2 and Influenza Epitopes Generated Antisera Reponses to Both Coronavirus and Influenza Nimisha Rikhi, Kevin Muema, Kellie Kroscher, Richard F Schuman, Aba Assiaw-Dufu, Clara J Sei, Gerald W Fischer
1208 [GO] 2022―Dec―15 302. Using Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Antibody Serology in addition to the ISARIC 4C Risk Score to Better Discriminate Adverse Clinical Outcomes in Hospitalized Patients with Coronavirus Disease 2019. Wilson Goh, Jinghao Nicholas Ngiam, Srishti Chhabra, Meng Ying Sim, Paul Anantharajah Tambyah, Gail Brenda Cross, et al. (+2)
1209 [GO] 2022―Dec―15 1080. Clinical Characteristics and Outcomes of 104 Pregnant Women with Coronavirus Disease 2019 during delta wave; single-center observational study Shin Hee Hong, Hye Jin Shi, Yoonseon Park, Joong Sik Eom
1210 [GO] 2022―Dec―15 1038. Assessment of risk factors for coronavirus disease 2019 in healthcare workers: a nested case-control study, Bishkek, Kyrgyzstan, June 2020-May 2021 Venera Alymkulova, Dilyara Nabirova, Nasyat Kemelbek kyzy, Dinara Otorbaeva, Chynar Zhumalieva, Nazgul Abamuslimova
1211 [GO] 2022―Dec―15 2041. Impact of Coronavirus Disease 2019 pandemic on healthcare-associated infections at intensive care unit in South Korea: Data from Korean National Healthcare-associated Infections Surveillance System (KONIS) Yu-Mi Lee, Dong Youn Kim, Eun Jin Kim, Ki-Ho Park, Mi Suk Lee
1212 [GO] 2022―Dec―15 309. Genetic Diversity and Conservation of Envelope Gene of SARS-CoV-2 and its Variants B.1.1.7, B.1.351, P.1, B.1.617.2 and B.1.1.529 with comparison with other human coronaviruses Benjamin Liu
1213 [GO] 2022―Dec―15 1943. Effect of Vaccination on Household Transmission of SARS-CoV-2 Julianne E Burns, Jonathan Altamirano, Jorge Salinas, Clea Sarnquist, Rasika Behl, Rosita Thiessen, et al. (+6)
1214 [GO] 2022―Dec―15 1174. Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2 Simon D van Haren, Sanya Thomas, Ofer Levy, Guzman Sanchez-Schmitz, Simon Doss-Gollin, Yamile Lugo Rodriguez
1215 [GO] 2022―Dec―15 1101. Spectrum of Disease in Children Infected with SARS-CoV-2 Sarah Gillen, Taylor Wells, Bazak Sharon
1216 [GO] 2022―Dec―15 1048. Biological Determinants of Post-Acute Sequelae of SARS-CoV-2 Scott Lu, Khamal Anglin, Michel Tassetto, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Ruth Diaz Sanchez, et al. (+19)
1217 [GO] 2022―Dec―15 375. Performance Evaluation of RT-qPCR and RT-dPCR Platforms for the wastewater surveillance of SARS-CoV-2 Hosoon Choi, John David Coppin, Piyali Chatterjee, Jing Xu, Lynn Mayo, Emma Brackens, et al. (+4)
1218 [GO] 2022―Dec―15 254. Clinical significance of antineutrophil cytoplasmic antibody positivity in patients infected with SARS-CoV-2 Lucy Eunju Lee, Wooyong Jeong, Yong-Beom Park, Su Jin Jeong, Sang-Won Lee
1219 [GO] 2022―Dec―15 2301. Neurodevelopment in Infants with Antenatal or Early Neonatal Exposure to SARS-CoV-2 Sarah B Mulkey, Meagan E Williams, Nadia Jadeed, Anqing Zhang, Smitha Israel, Roberta L DeBiasi
1220 [GO] 2022―Dec―15 1133. Investigation of Treatment-Emergent Amino Acid Substitutions in Nonstructural Protein 5 from Ph2a Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor Takao Sanaki, Keiko Baba, Atsuko Yamamoto, Haruaki Nobori, Shota Uehara, Yoko Kajiwara, et al. (+8)
1221 [GO] 2022―Dec―15 1874. Comprehensive, longitudinal wastewater surveillance for SARS-CoV-2 across a university campus, demonstrates low levels of SARS-CoV-2 activity relative to the surrounding community Jangwoo Lee, Nicole Acosta, Jennifer Van Doorn, Kashtin Low, Paul Westlund, Maria Bautista Chavarriaga, et al. (+19)
1222 [GO] 2022―Dec―15 1890. Molecular Biology of SARS-CoV-2 and its Evolution within the Princeton University Campus Community Jesse T Brewer, Qiqi Yang, Irina Aranovich, Wei Wang, Daniel Notterman, Irini Daskalaki
1223 [GO] 2022―Dec―15 1060. Duration of Seroprevalence among Individuals Previously Infected with SARS-CoV-2 and their Household Contacts Jonathan Altamirano, Marcela Lopez, Marcela Lopez, Leanne X Chun, Grace K Tam, India Robinson, et al. (+10)
1224 [GO] 2022―Dec―15 1958. Longitudinal SARS-COV-2 anti-spike antibody response in pregnant people with natural infection and variable vaccine uptake Sylvia M LaCourse, Morgan C Aurelio, Jaclyn N Escudero, Sascha R Ellington, Lauren B Zapata, Margaret C Snead, et al. (+6)
1225 [GO] 2022―Dec―15 1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation Seth Warner, Rui Miao, Marcos J Ramos-Benitez, Xin Tian, Robert Reger, Peter D Burbelo, et al. (+10)
1226 [GO] 2022―Dec―15 295. SARS-CoV-2 Associated Multisystem Inflammatory Syndrome in Adults (MIS-A): a Multicenter Case Series. Ricardo Trigueros, Travis Denmeade, Danielle Pannebaker, Ryan C Maves
1227 [GO] 2022―Dec―15 314. Performance of Saliva Compared to Nasopharyngeal Swab in Detection of SARS-CoV-2 at a Field Site in Rural Guatemala Using the Roche Cobas® Liat® Point-of-Care Assay Kareen Arias, Eliceo Díaz, Claudia Paiz, Neudy Rojop, Molly Lamb, Edgar Barrios, et al. (+6)
1228 [GO] 2022―Dec―15 260. Corticosteroid treatment in influenza virus and SARS-CoV-2 co-infected patients Maaike C Swets, Clark Russell, Ewen Harrison, Annemarie Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
1229 [GO] 2022―Dec―15 2125. Determinants of Placental Transfer of HSV-specific Antibodies and the Impact of SARS-CoV-2 Coinfection Aakash Mahant Mahant, Fatima Estrada, Jennifer Aguilan, Simone Sidoli, Betsy Herold, Betsy Herold
1230 [GO] 2022―Dec―15 1537. Influenza-Associated Hospitalization Rates and Proportion of Hospitalizations with Influenza and SARS-CoV-2 Coinfection, FluSurv-NET, October 1, 2021-April 23, 2022 Shikha Garg, Charisse N Cummings, Dawud Ujamaa, Pam Daily Kirley, Nisha B Alden, Maria Correa, et al. (+13)
1231 [GO] 2022―Dec―15 253. Clinical Presentations of Hospitalized Adult Patients Infected with SARS-CoV-2 during the Omicron Variant Surge in South Florida Jianli Niu, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
1232 [GO] 2022―Dec―15 1064. Intra-Host SARS-CoV-2 Evolution Dynamics Kim El Haddad, Frank Esper, Thamali Madhushani Adhikari Mudiyanselage, Jing Li, Tu Zheng, Yu-Wei Cheng, et al. (+7)
1233 [GO] 2022―Dec―15 1143. Prophylactic and Therapeutic Activity of AZD7442 (Tixagevimab/Cilgavimab) in SARS-CoV-2 Hamster Challenge Models Yueh-Ming Loo, Andrew S Herbert, Ana I Kuehne, Patrick M McTamney, Richard Roque, Alicia M Moreau, et al. (+9)
1234 [GO] 2022―Dec―15 296. SARS-CoV-2 Illness Severity and Early Hospitalization Outcomes in a Multicenter Prospective Cohort Study Among Veterans Jennifer M Ross, Jonathan D Sugimoto, Andrew Timmons, Kathryn Moore, Jonathan Adams, Deanna Wilson, et al. (+15)
1235 [GO] 2022―Dec―15 86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020 Sandra N Bulens, Julian E Grass, Nadezhda Duffy, Jigsa Tola, Jesse T Jacob, Gillian Smith, et al. (+17)
1236 [GO] 2022―Dec―15 1931. Antibodies to SARS-CoV-2 in a Medical School Department of Pediatrics Gabriela P Del Bianco, Roukaya Al Hammoud, Mary E Aitken, Anoma Somasunderam, Stacy Gomez Hernandez, Gilhen Rodriguez, et al. (+3)
1237 [GO] 2022―Dec―15 2299. Longitudinal Serological Surveillance of SARS-CoV-2 in Children and Adolescents Using Serial At-Home Testing Amina Ahmed, Michael E DeWitt, Diane Uschner, William H Lagarde, DeAnna J Friedman-Klabanoff, Roberto P Santos, et al. (+3)
1238 [GO] 2022―Dec―15 280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination Rosario Alessandro Cavasio, Neva Braccialarghe, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Laura Campogiani, et al. (+6)
1239 [GO] 2022―Dec―15 1880. Detection of Infectious SARS-CoV-2 in Specimens with High CT Values Is More Common for Omicron than for Delta Variants Michel Tassetto, Miguel Garcia-Knight, Khamal Anglin, Dan Kelly, Scott Lu, Jesus Pineda-Ramirez, et al. (+10)
1240 [GO] 2022―Dec―15 1906. Impact of Mask Mandate Timing on Community Transmission of SARS-CoV-2 in the St. Louis Metropolitan Area Karthik W Rohatgi, Branson Fox, Khai Hoan Tram, Elvin Geng, Aaloke Mody
1241 [GO] 2022―Dec―15 1873. Comparative performance of RTqPCR vs RTddPCR for the detection of SARS-CoV-2 in wastewater (WW) collected from a range of sites and scales across the sewer network of Calgary, Alberta Barbara Jean M. Waddell, Lisa Oberding, Nicole Acosta, Maria Bautista Chavarriaga, Janine McCalder, Noah Toppings, et al. (+16)
1242 [GO] 2022―Dec―15 1081. Clinical Characteristics and Predictive Factors for the Development of Hypoxemia in SARS-CoV-2 Infected Women during Pregnancy Young Keun Kim, Eui Hyeok Kim, Hee Kyoung Choi
1243 [GO] 2022―Dec―15 2133. Protective Factors Against Infant SARS-CoV-2 Infection Anne-Marie Rick, John Williams, Judith M Martin
1244 [GO] 2022―Dec―15 1811. Use of Procalcitonin and Antimicrobial Stewardship Intervention to Limit Antibiotic Utilization in Patients Admitted to a Community Hospital with SARS-CoV-2 Infection Paula A Politis, Michael J Oravec, Lisa Hoisington, Michael J Tan, Shanu Agarwal, Thomas M File
1245 [GO] 2022―Dec―15 1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection Praveen Kumar Vikraman, Kai Ming Chang, Thien-Ly Doan, Henry Donaghy
1246 [GO] 2022―Dec―15 1129. Efficacy of a Polyclonal Ovine Fab (PR020) Against SARS-CoV-2 Infection Zainab Bascal, Aled Griffiths, Ellen Dentten, Christon Hill, Suzanne Ward
1247 [GO] 2022―Dec―15 307. Diagnostic Test Kinetics, Infectivity, and Immunological Responses Among Unvaccinated Adults During Acute SARS-CoV-2 Infection Paul K Drain, Ronit Dalmat, Meagan Bemer, Elvira Budiawan, Jennifer F Morton, Linhui Hao, et al. (+16)
1248 [GO] 2022―Dec―15 237. A Case-Control Study Investigating Household, Community, and Clinical Risk Factors Associated with Multisystem Inflammatory Syndrome in Children (MIS-C) after SARS-CoV-2 Infection Laura D Zambrano, Michael J Wu, Lora M Martin, Lacy Malloch, Margaret M Newhams, Mary Beth Son, et al. (+21)
1249 [GO] 2022―Dec―15 1872. Clusters of SARS-CoV-2 infection across six schools for children with intellectual and developmental disabilities Michael P Gemmell, Tyler Walsh, Adwoa Imbeah, Kelly Bono, Megan Baldenweck, Michael R Sherby, et al. (+2)
1250 [GO] 2022―Dec―15 310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery Ronit Dalmat, Roshni Prabhu, Marie Bauer, Matthew H Ikuma, Daphne Hamilton, Elena A Rechkina, et al. (+3)
1251 [GO] 2022―Dec―15 1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates Jiyoung Lee, Mi-Young Lee, Euiseok Jung, Ji-Na Lee, SeongMan Bae, Jiwon Jung, et al. (+6)
1252 [GO] 2022―Dec―15 1769. Characterizing Antibiotic Prescribing for Nursing Home Residents with SARS-CoV-2 Infection, April 2020-November 2021 Katryna A Gouin, Ronald M Clouse, Cameron C Mandley, Olakunle Lawal, Sarah H Yi, Qunna Li, et al. (+3)
1253 [GO] 2022―Dec―15 1102. The Host Response to SARS-CoV-2 Infection Differs by Age Emily Parsons, Stephanie A Richard, Eric D Laing, Anthony C Fries, Jeffrey Livezey, Milissa Jones, et al. (+23)
1254 [GO] 2022―Dec―15 LB1534. Cord blood and maternal cytokine levels following SARS-CoV-2 infection during pregnancy Ashwin Sunderraj, Sebastian Otero, Emily Miller, Elisheva D Shanes, Jeffery A Goldstein, Leena B Mithal
1255 [GO] 2022―Dec―15 1866. Burden of Death Associated with SARS-CoV-2 Infection during the Pandemic in Flint, Michigan (MI): Mortality Trends over the 2-year time period Mariam Younas, Carlos Rios-Bedoya, Danielle Osterholzer, Ghassan Bachuwa, Ghassan Bachuwa, Philip McDonald, Elfateh Seedahmed
1256 [GO] 2022―Dec―15 76. Clinical Features and Burden of Post-Acute Sequelae of SARS-CoV-2 Infection in Children and Adolescents Suchitra Rao, Grace Lee, Vitaly Lorman, Hanieh Razzaghi, Asuncion Mejias, Nathan Pajor, et al. (+7)
1257 [GO] 2022―Dec―15 1095. Retrospective Review of SARS-CoV-2 Infection in Immunocompromised Children at a Single Pediatric Institution Aslam Khan, Roshni Mathew, Ayelet Rosenthal
1258 [GO] 2022―Dec―15 1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab Sarah Lim, Keeley Morris, Lydia J Fess, Kathy Como-Sabetti, Ruth Lynfield
1259 [GO] 2022―Dec―15 2137. Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in Kazakhstan Dilyara Nabirova, Roberta Horth, Gaukhar Nukenova, Manar Smagul, Aizhan Yesmagambetova, Daniel Singer, et al. (+2)
1260 [GO] 2022―Dec―15 278. Long-term impact of pulmonary function among patients recovered from SARS-CoV-2 infection in Lima, Peru: a preliminary analysis of the FUNCTION cohort study Rodrigo Antonio A Cachay Figueroa, Takashi Watanabe, Katiuska Cuno, Carolina Coombes, Fernando Mejia, Felix Medina, et al. (+4)
1261 [GO] 2022―Dec―15 2300. Neonates born to mothers with SARS-CoV-2 infection in pregnancy: a follow-up and serological study Concetta Marsico, Liliana Gabrielli, Santo Arcuri, Caterina Vocale, Caterina Borgatti, Tiziana Lazzarotto, et al. (+2)
1262 [GO] 2022―Dec―15 1946. Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Andrew Hill, Toby Pepperrell
1263 [GO] 2022―Dec―15 1524. SARS-CoV-2 Infection Incidence Following Exposure Assessments for Healthcare Workers Alon Vaisman, Rob Cairns, Danielle De Graeve, Tamara Dus, Susy S Hota, John Granton
1264 [GO] 2022―Dec―15 80. SARS-CoV-2 infection is associated with decreased reported physical fitness in a US military longitudinal cohort Stephanie A Richard, Ann Scher, Jennifer Rusiecki, Celia Byrne, Catherine M Berjohn, Anthony C Fries, et al. (+24)
1265 [GO] 2022―Dec―15 312. Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination. Grace Kenny, Sophie R O’Reilly, Riya Negi, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, et al. (+12)
1266 [GO] 2022―Dec―15 1047. Asymptomatic SARS-CoV-2 Infections, BNT162b2 mRNA COVID 19 Vaccine-Related Symptoms, and Correlates of Immunity in Post-Vaccination Breakthrough Infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet, Carol D Weiss, Cara Olsen, John H Powers, Si’Ana A Coggins, David Tribble, et al. (+26)
1267 [GO] 2022―Dec―15 1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 2021 Lynda Ngo, Jessica E Ericson, Patrick Gavigan, Amanda Williams, Michelle Kwon, Leah Musser
1268 [GO] 2022―Dec―15 1882. Effects of BA.1/BA.2 Subvariant, Vaccination, and Prior Infection on Infectiousness of SARS-CoV-2 Omicron Infections Suelen Qassim, Laith J Abu-Raddad, Hiam Chemaitelly, Sawsan AlMukdad
1269 [GO] 2022―Dec―15 1052. Characteristics and Outcomes in Hospitalized Adult Patients Infected with the SARS-CoV-2 Omicron Variant at a Large Healthcare System in South Florida, January 1-14, 2022 Paula A Eckardt, Myeongji Kim, Ayesha T Jalal, Jessica E Goldberg, Elsa M Acevedo Martinez, Nathalie P Suarez Moscoso, et al. (+6)
1270 [GO] 2022―Dec―15 273. Emergence of the SARS-CoV-2 Omicron Variant in the Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED) Study Stephanie A Richard, Catherine M Berjohn, Limone Collins, Srihari Seshadri, Christina Spooner, Wesley R Campbell, et al. (+14)
1271 [GO] 2022―Dec―15 2195. Etiologies of medically attended acute respiratory infections among young Ecuadorian children prior to the start of the 2020 SARS-CoV-2 pandemic Manika Suryadevara, Freddy A Pizarro Fajardo, Cinthya Cueva Aponte, Jorge Carrillo Aponte, Cynthia Bonville, Irene Torres, Joseph B Domachowske
1272 [GO] 2022―Dec―15 1916. Evaluation of nasal swab collection methods on a university campus during the SARS-CoV-2 pandemic Jessica A O’Hanlon, Zack Acker, Julia C Bennett, Peter D Han, Devon McDonald, Tessa Wright, et al. (+12)
1273 [GO] 2022―Dec―15 1331. Pneumococcal Colonization Among Children 5 years of Age and Younger During SARS-CoV-2 Pandemic Liset Olarte, Dithi Banerjee, Douglas S Swanson, Brian R Lee, Christopher J Harrison, Rangaraj Selvarangan
1274 [GO] 2022―Dec―15 1103. Virologic and Immunologic Outcomes in People Living with HIV in a Correctional Setting During the SARS-CoV-2 Pandemic Dimple Patel, Sarah M Michienzi, Scott Borgetti, Mahesh C Patel, Anne Zheng, Michael Zhu, Melissa E Badowski
1275 [GO] 2022―Dec―15 1904. Health Behavioral Trends and Absenteeism Associated with Acute Respiratory Illness Before and During the SARS-CoV-2 Pandemic in a Community Household Cohort, King County, Washington Erin Chung, Jessica Heimonen, Jessica A O’Hanlon, Yongzhe Wang Wang, Eric J Chow, Constance E Ogokeh, et al. (+7)
1276 [GO] 2022―Dec―15 89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada Mohammad Mozafarihashjin, Alainna J Jamal, Christopher Kandel, Philipp Kohler, Laura Mataseje, Michael Mulvey, et al. (+18)
1277 [GO] 2022―Dec―15 1897. The Decline of Respiratory Viruses During the SARS-CoV-2 Pandemic: Public Health Interventions vs. Viral Competition? Waleed Malik, Ritche Hao, James Shepherd
1278 [GO] 2022―Dec―15 1364. Providing preventative care during the SARS-CoV-2 pandemic: Street medicine interventions amongst those experiencing unsheltered homelessness in the City of Detroit Seema Joshi, Yasmeen Mann, Anneliese Petersen, Eliana Small, Iven T Ayyar, Justin R Abadejos, et al. (+7)
1279 [GO] 2022―Dec―15 1099. SARS-CoV-2 Positive Pregnant Women Delivering in a Hospital From March 2020 - February 2021 in Three California Counties Brenna Hall, Jane E Lee, Pam Daily Kirley, Jeremy L Roland, Kareena Hundal
1280 [GO] 2022―Dec―15 153. Molnupiravir Exhibits a High Barrier to the Development of SARS-CoV-2 Resistance in vitro Julie Strizki, Nicholas Murgolo, John Gaspar, John Howe, Beth Hutchins, Hiroshi Mohri, et al. (+3)
1281 [GO] 2022―Dec―15 1902. Whole Genome Sequence analysis of early community transmission SARS-CoV-2 samples in the Philippines Geraldine Arevalo, Nina Theresa Dungca, Edsel Maurice Salvana, Brian Schwem
1282 [GO] 2022―Dec―15 1899. The magnitude and durability of the antibody response to mRNA-based vaccination among SARS-CoV-2 seronegative and seropositive healthcare personnel Emily Ciccone, Deanna Zhu, Samuel Hawke, Rawan Ajeen, Annika Gunderson, Evans Lodge, et al. (+9)
1283 [GO] 2022―Dec―15 1891. Repeated Assessment of SARS-CoV-2 Seroprevalence among Health Care Workers Early in the Pandemic: Relationship to Workplace Exposures Sherry Demian, Dominic O Awuah, Danielle Osterholzer, Lina Altameemi, Carlos Rios-Bedoya, Ahmad Taftaf, Hoang C Nguyen
1284 [GO] 2022―Dec―15 1100. SARS-CoV-2 Seroprevalence in Kenyan Youth living with HIV Mary Boyle, Winstone Nyandiko, Allison DeLong, Ashley Chory, Josephine Aluoch, Celestine Ashimosi, et al. (+13)
1285 [GO] 2022―Dec―15 1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys Becca A Flitter, Sarah N Tedjakusuma, Colin A Lester, Elena D Neuhaus, Susan Johnson, Emery G Dora, et al. (+3)
1286 [GO] 2022―Dec―15 2140. INO-4800, a DNA Plasmid Vaccine Encoding the Ancestral SARS-CoV-2 Spike Protein, Is Stable Over a Range of Temperatures Not Requiring Ultra-Cold Chain Storage Robert J Juba, Anthony Samawova, Katherine Seals, Peggy Kinney, E J Brandreth
1287 [GO] 2022―Dec―15 1110. AZD7442 (Tixagevimab/Cilgavimab) Demonstrates Potent In Vitro Activity Against SARS-CoV-2 Spike Variants Identified in Circulation and in Prophylaxis Clinical Studies Kevin M Tuffy, Michael E Abram, Tiffany L Roe, Bahar Ahani, Tyler Brady, Nicolette Schuko, et al. (+9)
1288 [GO] 2022―Dec―15 1527. Use of a SARS-CoV-2 Strand-specific Assay to detect Relapse or Ongoing Infection at a Tertiary Care Center, California 2020-2022 Gustavo A Contreras Anez, Jessica Ferguson, Caitlin A Contag, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, et al. (+3)
1289 [GO] 2022―Dec―15 1927. Use of a SARS-CoV-2 Strand-specific Assay to evaluate for Prolonged Viral Replication among Hospitalized Patients. Tertiary Care Center, California 2020-2022 Jessica Ferguson, Gustavo A Contreras Anez, Lucy S Tompkins, John Shepard, Ayelet Rosenthal, Aruna Subramanian, et al. (+2)
1290 [GO] 2022―Dec―15 1358. Establishing Genomic SARS-CoV-2 Surveillance at the National Level: Germany, 2021 Djin-Ye Oh, Martin Hölzer, Sofia Paraskevopoulou, Maria Trofimova, Felix Hartkopf, Matthias Budt, et al. (+25)
1291 [GO] 2022―Dec―15 1884. Evaluating SARS-CoV-2 Surveillance Strategies at the United States Naval Academy: A Comparison of Saliva and Dried Blood Spot Serosurveillance Against Molecular-Confirmed Case Detection Liana R Andronescu, Stephanie A Richard, Eric D Laing, Adam K Saperstein, Jitendrakumar Modi, Christopher D Heaney, et al. (+8)
1292 [GO] 2022―Dec―15 1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine Iannetta Marco, Ilaria Spalliera, Flavia Mallegni, Lisa Mercante, Alessandra Imeneo, Angela Crea, et al. (+7)
1293 [GO] 2022―Dec―15 311. Modeling Diagnostic Testing Strategies for SARS-CoV-2 to Minimize Societal Costs and Return People to Work Sofia Zavala, Gary M Cox, Robert W Belknap, Becky A Smith, Sarah S Lewis, Christopher R Polage, et al. (+2)
1294 [GO] 2022―Dec―15 1920. Lack of SARS-CoV-2 transmission from a Healthcare Worker to a Cohort of Immunosuppressed Patients during the Omicron Surge, California, 2022 Abraar Karan, Jessica Ferguson, Jorge Salinas
1295 [GO] 2022―Dec―15 1881. Detection of SARS-CoV-2 Transmission on a College Campus using a Combined Contact Tracing and Molecular Strategy Jesse T Brewer, Wei Wang, Irina Aranovich, Daniel Notterman, Irini Daskalaki
1296 [GO] 2022―Dec―15 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP) Katharina S Appel, Daniel Maier, Sina M Hopff, Lazar Mitrov, Melanie Stecher, Margarete Scherer, et al. (+40)
1297 [GO] 2022―Dec―15 1974. Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee adenovirus SARS-CoV-2 vaccination Tolga Turgut, Uzma Ahmed, Melissa Kachura, Lauren Kraemer, Charmaine Nganje, Meghan Hart, et al. (+11)
1298 [GO] 2022―Dec―15 1971. Severity of Self-Reported Systemic Reactions Following SARS-CoV-2 Vaccination and Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) Wendy P Bannister
1299 [GO] 2022―Dec―15 585. Safety and Immunogenicity of SARS-CoV-2 Vaccination in Children with a History of MIS-C Harrison L Howe, Justin Z Amarin, Haya Hayek, Rana Talj, Andrew J Spieker, Sophie E Katz, et al. (+13)
1300 [GO] 2022―Dec―15 1949. Evaluation of cellular and humoral immune-responses at different times after SARS-COV-2 vaccination in health care workers cohort Chiara Dentone, Daniela Fenoglio, Matteo Cerchiaro, Marta Ponzano, Tiziana Altosole, Diego Franciotta, et al. (+14)
1301 [GO] 2022―Dec―15 1932. Antibody Response to SARS-CoV-2 Vaccination in US Veterans Living with HIV Alexander Njoroge, Florence M Ford, George Psevdos
1302 [GO] 2022―Dec―15 1395. COVID 19 Incidence rates were not different among high risk health-care workers and non-health workers after SARS-CoV-2 vaccination: a prospective study in Cali-Colombia. Fernando Rosso, Laura A Torres-Canchala, Isabel L Zapata-Vasquez, Julio Llanos-Torres, Eric Tafur, Jenny P Muñoz-Lombo, et al. (+2)
1303 [GO] 2022―Dec―15 1955. Immunogenicity And Safety of a Virus-Like Particle (VLP) Protein Subunit SARS-CoV-2 Vaccine in Adults: a Phase 1/2 Study Robert Scott, Susan Thackwray, Nicholas Hourguettes, Huub Gelderblom, Niranjan Kanesa-thasan
1304 [GO] 2022―Dec―15 1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT) Afoke Kokogho, Muneerah M Aleissa, Jun Bai Park Chang, Stephen R Walsh, Trevor A Crowell, Lindsey R Baden, Amy C Sherman
1305 [GO] 2022―Dec―15 1525. The Impact of Traveler-Based Genomic Surveillance on SARS-CoV-2 Variant Detection in Arriving International Air Travelers- United States, November 29, 2021-April 24, 2022 Grace D Appiah, Teresa C Smith, Renee Wegrzyn, Robert C Morfino, Sarah Guagliardo, Scott Milford, et al. (+23)
1306 [GO] 2022―Dec―15 1964. Pre-existing Population Immunity and SARS-CoV-2 Variant Dynamics in the United States: An Ecological Study Pierre Ankomah, Mark Siedner, Roby P Bhattacharyya
1307 [GO] 2022―Dec―15 1135. Monoclonal Antibody Therapeutics in US Veterans against Delta and Omicron SARS-CoV-2 Variants Inderjit Mann, Morgan Froehlich, Audun J Lier, George Psevdos
1308 [GO] 2022―Dec―15 246. Cardiac involvement in children with multisystem inflammatory syndrome (MIS-C) following infection with different SARS-CoV-2 variants Swetha Pinninti, Camden Hebson, Connie Trieu, Sushma Boppana, Markus Buchfellner, April Yarbrough, et al. (+5)
1309 [GO] 2022―Dec―15 1896. Statewide Genomic Surveillance of SARS-CoV-2 Variants in Rhode Island Manjot Singh, Vladimir Novitsky, Mark Howison, Kristin Carpenter-Azevedo, Richard Huard, Ewa King, Rami Kantor
1310 [GO] 2022―Dec―15 1096. Riding the Waves: Infection by SARS-CoV-2 Variants in Solid Organ Transplant Recipients at Texas Children’s Hospital Leanne Buffaloe, Claire Bocchini, Elizabeth A Moulton, Daniel Ruderfer, Kristen Valencia Deray, Flor M Munoz
1311 [GO] 2022―Dec―15 1978. Vaccine effect on household transmission of omicron and delta SARS-CoV-2 variants in South Korea Yong Chan Kim, Bongyoung Kim, Nak-Hoon Son, Namwoo Heo, Yoon Soo Park, Heejung Kim
1312 [GO] 2022―Dec―15 1057. Development of a Flow Cytometry-Based Micro-Neutralisation Assay to Evaluate Humoral Immunity Against SARS-CoV-2 Variants of Concern in Vaccine Trials Sophie R O’Reilly, Grace Kenny, Tamara Alrawahneh, Nathan Francois, Matthew Angeliadis, Valentin de Masson d’Autume, et al. (+9)
1313 [GO] 2022―Dec―15 2164. Shared and Specific Systemic Cytokine Responses in Infants Hospitalized with SARS-CoV-2 versus RSV Infection Raquel Giacomelli Cao, Zhaohui Xu, Fang Ye, Sara Mertz, Shira H Cohen, Traci Pifer, et al. (+4)
1314 [GO] 2022―Dec―15 243. Association Between SARS-CoV-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital PCR Elizabeth Hastie, Harold Amogan, David Looney, Sanjay R Mehta
1315 [GO] 2022―Dec―15 315. Standardized Measurement of SARS-CoV-2 Viral Load Over Time in Respiratory Compartments and in Response to Remdesivir Treatment Curt Beckwith, Soya Sam, Vladimir Novitsky, Jimin Shin, Kevin Lethbridge, Jon Steingrimsson, et al. (+11)
1316 [GO] 2022―Dec―15 1056. Correlates of Omicron SARS-CoV-2 viral load: diagnostic and clinical implications Simon Pollett, Stephanie A Richard, Anthony C Fries, Allison M Malloy, Anuradha Ganesan, Jeffrey Livezey, et al. (+14)
1317 [GO] 2022―Dec―15 2129. Maternal Transmission of SARS-CoV-2-specific Antibodies, but not Cytokines/Chemokines to Neonates Following Infection and Vaccination During Pregnancy Jonathon M Monroe, Sohan Punia, Huy Quang Quach, Elizabeth A Enninga, Yaroslav Fedyshyn, Bohdana Fedyshyn, et al. (+12)
1318 [GO] 2022―Dec―15 1050. Breath Sample Collection from Individuals Infected with SARS-CoV-2: Biosafety Methodology Marcela Lopez, Marcela Lopez, Emma Stainton, Leanne X Chun, Grace K Tam, Rosita Thiessen, et al. (+11)
1319 [GO] 2022―Dec―15 1930. Answering the Call: Inpatient Vaccination for SARS-CoV2 Infection in an Academic Hospital Benjamin Albrecht, Sarah B Green, Peter Moran, Morgan E Corkish, Carrie Tilton, Ashley Rizzo, et al. (+11)
1320 [GO] 2022―Dec―15 2084. Importance of the Primary Care Physician in HIV PrEP Adherence During a Pandemic Isaac Daudelin, Bret McCarty, Shawn K Ahmad Chaustre, Diana Finkel
1321 [GO] 2022―Dec―15 1760. Selection of appropriate inpatients for outpatient parenteral antimicrobial therapy (OPAT) during the COVID pandemic Angela Y McKnight, Angelike P Liappis, Ayne Adenew
1322 [GO] 2022―Dec―15 1290. A Structural Intervention Improves ID Fellow Wellness Amid a Pandemic Michael Czapka, Christopher J Lehmann, Erica MacKenzie, Elizabeth Bell, John Flores, Aniruddha Hazra
1323 [GO] 2022―Dec―15 950. Impact of the COVID 19 pandemic on antimicrobial stewardship program, broad-spectrum antibiotics consumption and Clostridioides difficile diarrhea incidence Jose Luis Lamas Ferreiro, Judith Álvarez Otero, Ana Sanjurjo Rivo, Ignacio Enríquez de Salamanca Holzinger, Jorge Cavero, Jose Carlos de Miguel Bouzas, et al. (+5)
1324 [GO] 2022―Dec―15 1357. Collateral consequence of COVID pandemic: Increased incidence of cat scratch disease. Maria L Praino, Peditric Infectologist, Grigioni Julia, Peditric Infectologist, Soledad Tineo, Peditric Infectologist, et al. (+7)
1325 [GO] 2022―Dec―15 77. Demonstration of stable clusters of symptoms in long COVID Grace Kenny, Kathleen McCann, Conor O'Brien, Stefano Savinelli, Cathal O'Broin, Willard Tinago, et al. (+8)
1326 [GO] 2022―Dec―15 250. Clinical Disease in Pediatric Long Covid Taylor Wells, Sarah Gillen, Bazak Sharon
1327 [GO] 2022―Dec―14 Tale of the Titers: Serologic Testing for SARS-CoV-2 -Yes, No, and Maybe, with Clinical Examples from the IDSA Diagnostics Committee Robert Colgrove, Lou Ann Bruno-Murtha, Cody A Chastain, Kimberly E Hanson, Francesca Lee, Audrey R Odom John, Romney Humphries
1328 [GO] 2022―Dec―07 Immune-based therapy for hospitalized patients with COVID-19 and risk of secondary infections: A systematic review and meta-analysis Dima Kabbani, Ashlesha Sonpar, Benson Weyant, Keith C K Lau, Mark Robbins, Sandra Campbell, et al. (+6)
1329 [GO] 2022―Dec―01 Meeting the Challenges of Sepsis in Severe COVID-19: A Call to Arms Thomas J Walsh, Rick A Bright, Aparna Ahuja, Matthew W McCarthy, Richard A Marfuggi, Steven Q Simpson
1330 [GO] 2022―Nov―30 Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection Lisa Tomasi, Anais Thiriard, Leo Heyndrickx, Daphnée Georges, Sigi Van den Wijngaert, Véronique Olislagers, et al. (+6)
1331 [GO] 2022―Nov―28 High co-circulation of influenza and SARS-CoV-2 John T Kubale, Aaron M Frutos, Angel Balmaseda, Cristhiam Cerpas, Saira Saborio, Sergio Ojeda, et al. (+10)
1332 [GO] 2022―Nov―25 An Elastic Net Regression Model for Identifying Long COVID Patients Using Health Administrative Data: A Population-Based Study Mawuena Binka, Braeden Klaver, Georgine Cua, Alyson W Wong, Chad Fibke, Héctor A Velásquez García, et al. (+6)
1333 [GO] 2022―Nov―24 Impact of COVID-19 Pandemic on Antiretroviral Therapy Initiation and Care Delivery for Newly Diagnosed HIV in an Integrated Health Care System Kurtis B Mohr, Christian Lee-Rodriguez, Zahra Samiezade-Yazd, Jennifer O Lam, Brandon M Imp, Mitchell N Luu
1334 [GO] 2022―Nov―24 Statistical analysis of mortality rates of COVID-19 patients in Japan across the 4C mortality score risk groups, age groups, and epidemiological waves: A report from the nationwide COVID-19 cohort Hiroaki Baba, Saori Ikumi, Shotaro Aoyama, Tetsuo Ishikawa, Yusuke Asai, Nobuaki Matsunaga, et al. (+5)
1335 [GO] 2022―Nov―24 Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study Wataru Mimura, Chieko Ishiguro, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
1336 [GO] 2022―Nov―22 Real-world evidence of novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the 1st, 2nd, 3rd and 4th wave in the Netherlands M A Slim, B Appelman, H Peters-Sengers, D A Dongelmans, N F de Keizer, R P Schade, et al. (+5)
1337 [GO] 2022―Nov―21 Post Intensive Care Syndrome (PICS) among survivors in a safety net hospital in South Bronx -a comparison of patients with and without COVID-19 Sebastian Ocrospoma Heraud, Virali Shah, Victor Perez-Gutierez, Mohannad Al-Khateeb, Sebastian Gandarillas Fraga, Afsheen Afzal, et al. (+8)
1338 [GO] 2022―Nov―20 Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection Nina Ekström, Anu Haveri, Anna Solastie, Camilla Virta, Pamela Österlund, Hanna Nohynek, et al. (+8)
1339 [GO] 2022―Nov―11 Predictors of SARS-CoV-2 RNA from nasopharyngeal swabs and concordance with other compartments in non-hospitalized adults with mild to moderate COVID-19 Carlee Moser, Jonathan Z Li, Joseph J Eron, Evgenia Aga, Eric S Daar, David A Wohl, et al. (+11)
1340 [GO] 2022―Nov―11 Persistence of neutralizing antibodies and clinical protection up to 12 months after SARS-CoV-2 infection in elderly R Collarino, C Vauloup-Fellous, A Allemang-Trivalle, L Mouna, E P Baudouin, H Keravec, et al. (+10)
1341 [GO] 2022―Nov―10 Subgenomic RNA abundance relative to total viral RNA among SARS-CoV-2 variants Maxwell Su, Sara Ping, Phuong-Vi Nguyen, Alejandra Rojas, Laila Hussaini, Ludy Registre Carmola, et al. (+8)
1342 [GO] 2022―Nov―08 A Systematic Review of COVID-19 Vaccine Antibody Responses in People Living with HIV Helen M Chun, Kyle Milligan, Elfriede Agyemang, Nathan Ford, Ajay Rangaraj, Shalini Desai, et al. (+3)
1343 [GO] 2022―Nov―07 Global emergence of resistance to fluconazole and voriconazole in Candida parapsilosis in tertiary hospitals in Spain during the COVID-19 pandemic Nuria Trevijano-Contador, Alba Torres-Cano, Cristina Carballo-González, Mireia Puig-Asensio, María Teresa Martín-Gómez, Emilio Jiménez-Martínez, et al. (+30)
1344 [GO] 2022―Nov―03 Lung abnormalities in SARS-CoV-2 infection: An analysis of paired computed tomography scans before and after infection. Katrine K Iversen, Andreas Ronit, Thomas S Kristensen, Shoaib Afzal, Jelena Jankovic, Anna Kalhauge, et al. (+4)
1345 [GO] 2022―Nov―02 Risk factors for severe COVID-19 among HIV-infected and-uninfected individuals in South Africa, April 2020- March 2022 - data from sentinel surveillance Sibongile Walaza, Stefano Tempia, Anne von Gottberg, Nicole Wolter, Jinal N Bhiman, Amelia Buys, et al. (+14)
1346 [GO] 2022―Oct―31 Correction to: Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
1347 [GO] 2022―Oct―31 Genomic Investigation to Identify Sources of SARS-CoV-2 Infection Among Healthcare Personnel in an Acute Care Hospital Sarah E Sansom, Hannah Barbian, Mary K Hayden, Christine Fukuda, Nicholas M Moore, Lahari Thotapalli, et al. (+4)
1348 [GO] 2022―Oct―31 Correction to: SARS-CoV-2 Surface Swabs in Locations With Public Access- Potential for Improved Source Control
1349 [GO] 2022―Oct―27 Bebtelovimab for high-risk outpatients with early COVID-19 in a large US health system Scott Dryden-Peterson, Andy Kim, Mary-Ruth Joyce, Jennifer A Johnson, Arthur Y Kim, Lindsey R Baden, Ann E Woolley
1350 [GO] 2022―Oct―22 Impact of the COVID-19 pandemic on the clinical features of pediatric RSV infection in Japan Shoko Ozeki, Jun-ichi Kawada, Daiki Yamashita, Chika Yasufuku, Takuya Akano, Masahiro Kato, et al. (+10)
1351 [GO] 2022―Oct―22 Evaluation of SARS-CoV-2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding Sujata Mathur, Michelle C Davidson, Khamal Anglin, Scott Lu, Sarah A Goldberg, Miguel Garcia-Knight, et al. (+21)
1352 [GO] 2022―Oct―22 Comparison of SARS-CoV-2 viral loads in the nasal mucosa of patients infected with BA.1, BA.2 or BA.5 Omicron lineages Kyla Tozer, Calvin P Sjaarda, Emily Moslinger, Henry Wong, Samira Mubareka, Finlay Maguire, et al. (+4)
1353 [GO] 2022―Oct―19 Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles Paul C Adamson, Judith S Currier, Daniel Z Uslan, Omai B Garner
1354 [GO] 2022―Oct―17 A multicenter comparison of prevalence and predictors of antimicrobial resistance in hospitalized patients before and during the SARS-CoV-2 pandemic Karri A Bauer, Laura A Puzniak, Kalvin C Yu, Kenneth P Klinker, Janet Watts, Pamela A Moise, et al. (+3)
1355 [GO] 2022―Oct―17 Effect of SARS-CoV-2 vaccine booster on HIV reservoirs and immune markers M Ali Rai, Victoria Shi, Brooke D Kennedy, Jesse S Justement, Kathleen Gittens, Genevieve McCormack, et al. (+3)
1356 [GO] 2022―Oct―10 Viral co-infections in hospitalised COVID-19 patients recruited to the ISARIC WHO CCP-UK study Elen Vink, Chris Davis, Alasdair MacLean, David Pascall, Sarah E McDonald, Rory Gunson, et al. (+6)
1357 [GO] 2022―Oct―06 Host biomarkers reflect prognosis in patients presenting with moderate Covid-19 - a prospective cohort study Arjun Chandna, Raman Mahajan, Priyanka Gautam, Lazaro Mwandigha, Pragya Kumar, George M Varghese, et al. (+3)
1358 [GO] 2022―Oct―06 Demographics and outcomes of initial phase of COVID-19 Medicines Delivery Units across 4 UK centres during peak B1.1.529 omicron epidemic: a service evaluation. M Brown, J Saund, A Qureshi, M Plowright, K Drury, J Gahir, et al. (+11)
1359 [GO] 2022―Oct―06 Early outpatient treatment with remdesivir in patients at high risk for severe COVID-19: a prospective cohort study Sandra Rajme-López, Bernardo A Martinez-Guerra, Jessica Zalapa-Soto, Carla M Román-Montes, Karla M Tamez-Torres, María F González-Lara, et al. (+5)
1360 [GO] 2022―Oct―06 Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch Raymund R Razonable, Sidna M Tulledge-Scheitel, Sara N Hanson, Richard F Arndt, Leigh L Speicher, Teresa A Seville, et al. (+3)
1361 [GO] 2022―Oct―05 Relative Risks of COVID-19-Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity-March 2020-March 2021 Catherine H Bozio, Kristen Butterfield, Stephanie A Irving, Gabriela Vazquez-Benitez, Toan C Ong, Kai Zheng, et al. (+4)
1362 [GO] 2022―Oct―05 Misdiagnoses in the context of suspected pandemic influenza or COVID-19: A systematic review Lucy Bray, Katerina Meznikova, Daniel James, Razan Rislan, Rahul Shah, Pavan Mason, et al. (+4)
1363 [GO] 2022―Oct―05 At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area Ann E Woolley, Scott Dryden-Peterson, Andy Kim, Sarah Naz-McLean, Christina Kelly, Hannah H Laibinis, et al. (+9)
1364 [GO] 2022―Oct―01 Discriminatory ability of gas chromatography-ion mobility spectrometry to identify patients hospitalised with COVID-19 and predict prognosis Joshua Nazareth, Daniel Pan, Jee Whang Kim, Jack Leach, James G Brosnan, Adam Ahmed, et al. (+10)
1365 [GO] 2022―Oct―01 Evaluation of Bebtelovimab for Treatment of COVID-19 During the SARS-CoV-2 Omicron Variant Era Erin K McCreary, Kevin E Kip, Kevin Collins, Tami E Minnier, Graham M Snyder, Ashley Steiner, et al. (+12)
1366 [GO] 2022―Sep―30 Predictors of SARS-CoV-2 seropositivity prior to COVID-19 vaccination among children 0-4 years and their household members in the SEARCh Study Maria Garcia Quesada, Marissa K Hetrich, Scott Zeger, Jayati Sharma, Yu Bin Na, Vic Veguilla, et al. (+19)
1367 [GO] 2022―Sep―29 Population-based evaluation of post-acute COVID-19 chronic sequelae in patients who tested positive for SARS-CoV-2 Nicole H Goldhaber, W Scott Ogan, Andrew Greaves, Ming Tai-Seale, Amy Sitapati, Christopher A Longhurst, Lucy E Horton
1368 [GO] 2022―Sep―27 Podcast 39: Marginalized communities and the disproportionate impacts of AIDS, COVID-19, and monkeypox - An interview with Gregg Gonsalves
1369 [GO] 2022―Sep―27 mRNA vaccination decreases COVID-19-associated morbidity and mortality among organ transplant recipients: a contemporary cohort study Alexis Hope Lerner, Panos Arvanitis, Kendra Vieira, Elizabeth Jessica Klein, Dimitrios Farmakiotis
1370 [GO] 2022―Sep―27 Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis after SARS-CoV-2 mRNA-1273 (“Moderna”) Vaccine: A Case Report Jennifer Chen Li, Jonathan Siglin, Michael S Marshall, Anat Stemmer-Rachamimov, Seth M Bloom, Kimberly G Blumenthal
1371 [GO] 2022―Sep―23 Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Takeru Inoue, Yuki Yanagihara, et al. (+9)
1372 [GO] 2022―Sep―21 Prediction of Symptomatic SARS-CoV-2 infection by Quantitative Digital PCR Normalized to International Units Diego R Hijano, Zhengming Gu, Jessica Brazelton de Cardenas, Haiqing Zhu, Sri Suganda, Heather L Glasgow, et al. (+10)
1373 [GO] 2022―Sep―20 Prolonged SARS-CoV-2 Delta Variant Shedding in a Patient with AIDS; Case Report and Review of the Literature Jillian L Peters, Amary Fall, Steven D Langerman, Margueritta El Asmar, Mari Nakazawa, Aishat Mustapha, et al. (+3)
1374 [GO] 2022―Sep―12 Oral Polio Vaccine (OPV) to mitigate the risk of illness and mortality during the COVID-19 pandemic: A cluster-randomised trial in Guinea-Bissau Ane B Fisker, Justiniano S D Martins, Line M Nanque, Andreas M Jensen, Elsi J C Ca, Sebastian Nielsen, et al. (+2)
1375 [GO] 2022―Sep―12 Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study Daniel Ayoubkhani, Matthew L Bosworth, Sasha King, Koen B Pouwels, Myer Glickman, Vahé Nafilyan, et al. (+4)
1376 [GO] 2022―Sep―11 Correlation of SARS-CoV-2 Nasopharyngeal CT-values to Viremia and Mortality in Adults Hospitalised with Covid-19 Karl Hagman, Magnus Hedenstierna, Jacob Oesman, Emelie Arvidsson, Berit Hammas, Lena Grillner, et al. (+3)
1377 [GO] 2022―Sep―11 Impact of a Pharmacist Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Healthcare Resource Utilization Andrew J FRATONI, Abigail K KOIS, Jessica L COLMERAUER, Kristin E LINDER, David P NICOLAU, Joseph L KUTI
1378 [GO] 2022―Sep―11 COVID-19 vaccine effectiveness against progression to in-hospital mortality in Zambia, 2021-2022 Duncan Chanda, Jonas Z Hines, Megumi Itoh, Sombo Fwoloshi, Peter A Minchella, Khozya D Zyambo, et al. (+11)
1379 [GO] 2022―Sep―07 Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study Hannah Chung, Peter C Austin, Kevin A Brown, Sarah A Buchan, Deshayne B Fell, Cindy Fong, et al. (+8)
1380 [GO] 2022―Sep―07 Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children Amina Ahmed, Whitney Rossman, Lauren C Lu, Connell O Dunn, Anna M Harris, Jennifer S Priem, et al. (+6)
1381 [GO] 2022―Sep―02 High risk of secondary infections following thrombotic complications in patients with COVID-19 Marco Ripa, Laura Galli, Armando D’Angelo, Luca Apruzzi, Diego Palumbo, Corrado Campochiaro, et al. (+19)
1382 [GO] 2022―Sep―02 Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission from Donor Stool Christopher McChalicher, Ahmad Abdulaziz, S Steve Zhou, Mary Jane Lombardo, Brooke Hasson, John G Auniņš, et al. (+2)
1383 [GO] 2022―Sep―01 Using a cloud-based machine-learning classification tree analysis to understand the demographic characteristics associated with COVID-19 booster vaccination among adults in the United States Lu Meng, Hannah E Fast, Ryan Saelee, Elizabeth Zell, Bhavini Patel Murthy, Neil Chandra Murthy, et al. (+5)
1384 [GO] 2022―Aug―29 SARS-CoV-2 surface swabs in locations with public access - potential for improved source control Jacob PS Nielsen, Johannes R Madsen, Kamille Fogh, Emma H Mikkelsen, Emil Wolsk, Nikolai S Kirkby, et al. (+2)
1385 [GO] 2022―Aug―25 Dying at Home Due to COVID-19 Jessie K Edwards, Wohl David Alain
1386 [GO] 2022―Aug―25 Reduction in risk of death among patients admitted with COVID-19 between first and second epidemic waves in New York City Anthony Bowen, Jason Zucker, Yanhan Shen, Simian Huang, Qiheng Yan, Medini K Annavajhala, et al. (+4)
1387 [GO] 2022―Aug―25 Surge in Incidence and COVID-19 Hospital Risk of Death, United States, September 2020 to March 2021 Bela Patel, Robert E Murphy, Siddharth Karanth, Salsawit Shiffaraw, Richard M Peters, Samuel F Hohmann, Raymond S Greenberg
1388 [GO] 2022―Aug―25 Prevalence and Health Outcomes of Clostridioides difficile Infection during the COVID-19 Pandemic in a National Sample of United States Hospital Systems Kelly R Reveles, Alexa L Frei, Kelsey A Strey, Eric H Young
1389 [GO] 2022―Aug―25 Detection of viral infection and bacterial co- and superinfection in COVID-19 patients presenting to the emergency department using the 29-mRNA host response classifier BVN-3 - a multicenter study Wolfgang Bauer, Sven Gläser, Dorina Thiemig, Katrin Wanner, Alexander Peric, Steffen Behrens, et al. (+9)
1390 [GO] 2022―Aug―25 Description of Hospitalizations due to the SARS-CoV-2 Omicron Variant Based on Vaccination Status Matthew A Moffa, Nathan R Shively, Dustin R Carr, Derek N Bremmer, Carley Buchanan, Tamara L Trienski, et al. (+3)
1391 [GO] 2022―Aug―24 MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study Natalie J Atallah, Vahe S Panossian, Christine J Atallah, Andrej Schwabe, Sascha Johannes, Jan Wiemer, Michael K Mansour
1392 [GO] 2022―Aug―23 Sexually transmitted infection testing in the national Veterans Health Administration patient cohort during the COVID-19 pandemic Lauren A Beste, Shimrit Keddem, Joleen Borgerding, Elliott Lowy, Carolyn Gardella, Lorenzo McFarland, et al. (+7)
1393 [GO] 2022―Aug―22 Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials Andrea Perez Navarro, Victoria Pilkington, Toby Pepperrell, Manya Mirchandani, Jacob Levi, Andrew Hill
1394 [GO] 2022―Aug―20 Impact of innate immunity, endothelial damage, and metabolic biomarkers on COVID-19 severity and mortality Joseph M Rocco, Paola Laghetti, Mariantonietta Di Stefano, Irini Sereti, Ana Ortega-Villa, Jing Wang, et al. (+9)
1395 [GO] 2022―Aug―17 Nucleocapsid antigenemia in patients receiving anti-CD20 therapy with protracted COVID-19 Eli Wilber, Anne Piantadosi, Ahmed Babiker, Kaleb McLendon, William O’Sick, Eric Fitts, et al. (+11)
1396 [GO] 2022―Aug―17 Post Lung Transplantation Outcomes and Ex Vivo Histopathological Findings in Severe Post COVID-19 Pulmonary Disease - A Single Center Experience Hana Javaid, Masayuki Nigo, Bihong Zhao, Daniel Ocazionez Trujillo, Rodrigo Hasbun, Luis Ostrosky-Zeichner, et al. (+2)
1397 [GO] 2022―Aug―16 Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, controlled, phase 2 study Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, et al. (+4)
1398 [GO] 2022―Aug―16 Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies Amy C Sherman, Jennifer L Crombie, Chi An Cheng, Michaël Desjardins, Guohai Zhou, Omolola Ometoruwa, et al. (+13)
1399 [GO] 2022―Aug―09 Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection
1400 [GO] 2022―Aug―09 Impact of age and symptom development on SARS-CoV-2 transmission in households with children-Maryland, New York, and Utah, August 2020-October 2021 Kelsey M Sumner, Ruth A Karron, Melissa S Stockwell, Fatimah S Dawood, Joseph B Stanford, Alexandra Mellis, et al. (+19)
1401 [GO] 2022―Aug―08 A Randomized Clinical Trial of Regdanvimab in High-Risk Patients with Mild-to-Moderate COVID-19 Jin Yong Kim, Oana Săndulescu, Liliana Lucia Preotescu, Norma E Rivera-Martínez, Marta Dobryanska, Victoria Birlutiu, et al. (+18)
1402 [GO] 2022―Aug―06 Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
1403 [GO] 2022―Aug―05 Long COVID symptomatology after twelve months and its impact on quality of life according to initial COVID-19 disease severity Aurélie Fischer, Lu Zhang, Abir Elbéji, Paul Wilmes, Pauline Oustric, Therese Staub, et al. (+3)
1404 [GO] 2022―Aug―03 Prevalence of medical contraindications to nirmatrelvir/ritonavir in a cohort of hospitalized and non-hospitalized patients with COVID-19 Sarah Lim, Christopher J Tignanelli, Nicolas Hoertel, David R Boulware, Michael G Usher
1405 [GO] 2022―Aug―03 High-risk US international travelers seeking pretravel consultation during the COVID-19 pandemic Emily P Hyle, Mylinh H Le, Sowmya R Rao, Nora M Mulroy, Allison T Walker, Edward T Ryan, Regina C LaRocque
1406 [GO] 2022―Jul―30 Applying lessons learned from COVID-19 therapeutic trials to improve future ALI/ARDS trials Qun Wu, Meghan E Pennini, Julie N Bergmann, Marina L Kozak, Kristen Herring, Kimberly L Sciarretta, Kimberly L Armstrong
1407 [GO] 2022―Jul―29 Extended Remdesivir Infusion for Persistent COVID-19 Infection Mario A Martinez, Ting Yi Chen, Hosoon Choi, Munok Hwang, Dhammika Navarathna, Linhue Hao, et al. (+4)
1408 [GO] 2022―Jul―28 Correction to: Risk Factors Associated With Hospitalization and Death in COVID-19 Breakthrough Infections
1409 [GO] 2022―Jul―27 Correction to: 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases
1410 [GO] 2022―Jul―26 Cognitive Impairment 13 Months After Hospitalization for COVID-19 Knut Stavem, Gunnar Einvik, Christofer Lundqvist
1411 [GO] 2022―Jul―26 Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections Brian Grunau, Janessa Tom, Michael Asamoah-Boaheng, Sheila F O’Brien, Steven J Drews, Sadaf Sediqi, et al. (+3)
1412 [GO] 2022―Jul―25 Adjunctive Recombinant Human Plasma Gelsolin for Severe COVID-19 Pneumonia Mark J DiNubile, Sandra Parra, Antoni Castro Salomó, Susan L Levinson
1413 [GO] 2022―Jul―25 Aggregating human judgment probabilistic predictions of COVID-19 transmission, burden, and preventative measures Allison Codi, Damon Luk, David Braun, Juan Cambeiro, Tamay Besiroglu, Eva Chen, et al. (+3)
1414 [GO] 2022―Jul―25 Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects Emanuela MARTINUZZI, Jacques BOUTROS, Nicolas GLAICHENHAUS, Charles Hugo MARQUETTE, Paul HOFMAN, Jonathan BENZAQUEN
1415 [GO] 2022―Jul―22 Missed opportunity, the unseen driver for low COVID-19 vaccination rates in underserved patients Tania Campagnoli, Geetika Mohan, Nigist Taddese, Yaveen Santhiraj, Natasa Margeta, Saad Alvi, et al. (+4)
1416 [GO] 2022―Jul―20 Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation Megan M Stumpf, Brandi Freeman, Lisa Mills, Sandra Lester, Victoria T Chu, Hannah L Kirking, et al. (+2)
1417 [GO] 2022―Jul―05 A More Accurate Measurement of the Burden of COVID-19 Hospitalizations Christina Vu, Eric S Kawaguchi, Cesar H Torres, Austin H Lee, Noah Wald-Dickler, Paul D Holtom, et al. (+3)
1418 [GO] 2022―Jul―04 Prevalence of and factors associated with post-COVID-19 condition in the 12 months following the diagnosis of COVID-19 in adults followed in general practices in Germany Karel Kostev, Lee Smith, Ai Koyanagi, Louis Jacob
1419 [GO] 2022―Jun―30 Risk Factors for Admission Within a Hospital-Based COVID-19 Home Monitoring Program Heather Sperring, Melissa Hofman, Heather E Hsu, Yian Xiao, Elizabeth A Keohane, Sara Lodi, et al. (+2)
1420 [GO] 2022―Jun―28 An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection Ann I Scher, Catherine M Berjohn, Celia Byrne, Rhonda E Colombo, Christopher J Colombo, Margaret Sanchez Edwards, et al. (+19)
1421 [GO] 2022―Jun―24 Comparative COVID-19 Vaccine Effectiveness over Time in Veterans Florian B Mayr, Victor B Talisa, Obaid Shaikh, Saad B Omer, Adeel A Butt, Sachin Yende
1422 [GO] 2022―Jun―23 Factors Associated with Hospitalization with Symptomatic COVID-19 Illness Among Pregnant Individuals: A Multi-Center Retrospective Cohort Study Carmen Sofia Arriola, De Kun Li, Flor Muñoz, Michael Daugherty, Caroline Doughty-Skierski, Sascha Ellington, et al. (+15)
1423 [GO] 2022―Jun―23 Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients Keun Hyung Park, Chan-Young Jung, Wonjeong Jeong, Gongmyung Lee, Jae Seok Yang, Chung Mo Nam, et al. (+2)
1424 [GO] 2022―Jun―17 US County-level COVID-19 Vaccine Uptake and Rates of Omicron Cases and Deaths John M McLaughlin, Timothy L Wiemken, Farid Khan, Luis Jodar
1425 [GO] 2022―Jun―15 Decreased Risk of COVID-19-Related Hospitalization Associated with Omicron Variant of SARS-CoV-2 Jessica P Ridgway, Samuel Tideman, Bill Wright, Ari Robicsek
1426 [GO] 2022―Jun―10 Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients with COVID-19 Infection Scott Schoninger, Yanina Dubrovskaya, Kassandra Marsh, Diana Altshuler, Prithiv Prasad, Eddie Louie, et al. (+4)
1427 [GO] 2022―Jun―07 Projected Effects of Disruptions to HIV Prevention Services During the COVID-19 Pandemic Among Black/African American Men Who Have Sex with Men in an Ending the HIV Epidemic Priority Jurisdiction Jennifer Labs, Amy S. Nunn, Philip A. Chan, S. Bessey, Carolyn J. Park, Brandon D. L. Marshall, et al. (+3)
1428 [GO] 2022―Jun―07 COVID-19 patient reported symptoms using FLU-PRO Plus in a cohort study: associations with infecting genotype, vaccine history, and return-to-health Stephanie A. Richard, Nusrat J. Epsi, David A. Lindholm, Allison M. W. Malloy, Ryan C. Maves, Catherine M. Berjohn, et al. (+23)
1429 [GO] 2022―Jun―07 Real-World Experience of Sotrovimab in High-Risk, Immunocompromised COVID-19 Patients Navina K. Birk, Saniya Jain, Louis Massoud, Diya Ramesh, Lea Monday, Bruce Muma, et al. (+3)
1430 [GO] 2022―Jun―07 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How did it change in 2021? Rena C. Moon, Ning A. Rosenthal
1431 [GO] 2022―Jun―07 Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis Nicola K Wills, Nikhil Nair, Kashyap Patel, Omaike Sikder, Marguerite Adriaanse, John Eikelboom, Sean Wasserman
1432 [GO] 2022―Jun―07 Characterization of early-onset SARS-CoV-2 infection in immunocompromised patients who received tixagevimab-cilgavimab prophylaxis Eloy E. Ordaya, Elena Beam, Joseph D. Yao, Raymund R. Razonable, Paschalis Vergidis
1433 [GO] 2022―Jun―06 The Politicization of Ivermectin Tweets during the COVID-19 Pandemic Marlon I. Diaz, John J. Hanna, Amy E. Hughes, Christoph U. Lehmann, Richard J. Medford
1434 [GO] 2022―Jun―06 Long COVID in the long run - 23 months follow-up study of persistent symptoms Gunnhild Helmsdal, Katrin Dahl Hanusson, Marnar Fríðheim Kristiansen, Billa Mouritsardóttir Foldbo, Marjun Eivindardóttir Danielsen, Bjarni á Steig, et al. (+4)
1435 [GO] 2022―May―31 Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant Ilinca I. Ciubotariu, Jack Dorman, Nicole M. Perry, Lev Gorenstein, Jobin J. Kattoor, Abebe A. Fola, et al. (+5)
1436 [GO] 2022―May―31 Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients M Veronica Dioverti, David C Gaston, C Paul Morris, Carol Ann Huff, Tania Jain, Richard Jones, et al. (+5)
1437 [GO] 2022―May―23 Corrigendum to: Do Stay at Home Orders and Cloth Face Coverings Control COVID-19 in New York City? Results From a SIER Model Based on Real-world Data Jian Li, Yuming Wang, Jing Wu, Jing-Wen Ai, Hao-Cheng Zhang, Michelle Gamber, et al. (+3)
1438 [GO] 2022―May―20 Antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective cross-sectional study Min Hyung Kim, Yooju Nam, Nak-Hoon Son, Namwoo Heo, Bongyoung Kim, Eawha Kang, et al. (+6)
1439 [GO] 2022―May―20 COVID-19 vaccine uptake and factors associated with being unvaccinated among lesbian, gay, bisexual, transgender, queer, and other sexual identities (LGBTQ+) New Yorkers Andrea Low, Connor Wright, Joey Platt, Christiana Chang, Joanne E. Mantell, Emily Romero, et al. (+5)
1440 [GO] 2022―May―17 Ethnic differences in COVID-19 hospitalization and hospital outcomes in a multi-ethnic population in the Netherlands Didier Collard, Karien Stronks, Vanessa Harris, Liza Coyer, Kees Brinkman, Martijn Beudel, et al. (+8)
1441 [GO] 2022―May―16 Clerkship in infectious diseases for medical students during covid-19 Edward Chávez-Cruzado, Jose Galvez-Olortegui, Anderson Vilchez-Chávez, Alex Castañeda-Sabogal
1442 [GO] 2022―May―13 Transmission potential of the Omicron variant of SARS-CoV-2 in South Korea: From November 25, 2020 to January 8, 2022 Eunha Shim, Wongyeong Choi, Donghyok Kwon, Taeyoung Kim, Youngji Song
1443 [GO] 2022―May―13 CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021- July 2021 Megha L. Mehrotra, Esther Lim, Katherine Lamba, Amanda Kamali, Kristina W. Lai, Erika Meza, et al. (+12)
1444 [GO] 2022―May―11 Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial Kevin L. Winthrop, Alan W. Skolnick, Adnan M. Rafiq, Scott H. Beegle, Julian Suszanski, Guenther Koehne, et al. (+10)
1445 [GO] 2022―May―11 Quantification and progress over time of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with BNT162b2 Pfizer-BioNTech COVID-19 vaccine (LacCOVID) Erika Esteve-Palau, Araceli Gonzalez-Cuevas, M. Eugenia Guerrero, Clara Garcia-Terol, M. Carmen Alvarez, Geneva Garcia, et al. (+4)
1446 [GO] 2022―May―09 “Effectiveness of COVID-19 Vaccines in Preventing Infection, Hospital Admission and Death: A Historical Cohort Study Using Iranian Registration Data During Vaccination program” Alireza Mirahmadizadeh, Alireza Heiran, Kamran Bagheri Lankarani, Mohammadreza Serati, Mohammad Habibi, Owrang Eilami, et al. (+2)
1447 [GO] 2022―May―09 Clinical Features and Duration of Viral Shedding Individuals with SARS-CoV-2 Omicron Variant Infection Young R. Jang, Jeong-Min Kim, Jee E. Rhee, Dongju Kim, Nam-Joo Lee, Hyeokjin Lee, et al. (+3)
1448 [GO] 2022―May―07 The protective effect of covid-19 vaccination on post-acute sequelae of covid-19 (pasc): a multicenter study from a large national health research network Sokratis N. Zisis, Jared C. Durieux, Christian Mouchati, Jamie A. Perez, Grace A. McComsey
1449 [GO] 2022―May―07 Detection of SARS-CoV-2 by Canine Olfaction: A Pilot Study Maureen Maurer, Todd Seto, Claire Guest, Amendeep Somal, Catherine Julian
1450 [GO] 2022―May―07 SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection Christian Gaebler, Justin DaSilva, Eva Bednarski, Frauke Muecksch, Fabian Schmidt, Yiska Weisblum, et al. (+8)
1451 [GO] 2022―May―05 Risk of SARS-CoV-2 transmission through solid organ transplantation and outcomes of COVID-19 among recent transplant recipients Rebecca J. Free, Pallavi Annambhotla, Ricardo M. La Hoz, Lara Danziger-Isakov, Jefferson M. Jones, Lijuan Wang, et al. (+7)
1452 [GO] 2022―May―05 COVID-19 vaccine dosage in children, adolescents, and young adults - is less more? Nicole H. Tobin, Otto O. Yang
1453 [GO] 2022―May―05 COVID-19 Vaccine Hesitancy Among Healthcare Workers in Four Healthcare Systems in Atlanta Sheetal Kandiah, Onyinye Iheaku, Mirza Farrque, Jasmah Hanna, Kalisha Bonds Johnson, Zanthia Wiley, et al. (+5)
1454 [GO] 2022―May―05 Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission Katharine A Relph, Clark D Russell, Cameron J Fairfield, Lance Turtle, Thushan I de Silva, Matthew K Siggins, et al. (+362)
1455 [GO] 2022―May―05 Initial SARS-CoV-2 viral load is associated with disease severity: a retrospective cohort study Dennis Souverein, Karlijn van Stralen, Steven van Lelyveld, Claudia van Gemeren, Milly Haverkort, Dominic Snijders, et al. (+9)
1456 [GO] 2022―Apr―28 Unravelling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2 Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, Vincent C. Marconi, Corri B. Levine, Hana M. El Sahly, et al. (+13)
1457 [GO] 2022―Apr―28 Mission, Organization and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies Jane C Figueiredo, Fred R Hirsch, Lawrence H Kushi, Wendy N Nembhard, James M Crawford, Nicholas Mantis, et al. (+91)
1458 [GO] 2022―Apr―21 Population-based assessment of contact tracing operations for COVID-19 in Pirkanmaa hospital district, Finland Juha Rannikko, Hanna Viskari, Simo Sirkeoja, Pekka Tamminen, Ville Kaila, Anni Ala-Mursula, et al. (+4)
1459 [GO] 2022―Apr―19 The collapse of infectious disease diagnoses commonly due to communicable respiratory pathogens during the COVID-19 pandemic: A time series and hierarchical clustering analysis Ali Zhang, Matthew D. Surette, Kevin L. Schwartz, James I. Brooks, Dawn M.E. Bowdish, Roshanak Mahdavi, et al. (+5)
1460 [GO] 2022―Apr―19 Bamlanivimab and etesevimab improve symptoms and associated outcomes in ambulatory patients at increased risk for severe COVID-19: results from the placebo-controlled double-blind Phase 3 BLAZE-1 trial Peter Chen, Gerhard Behre, Corey Hebert, Princy Kumar, Lisa Farmer Macpherson, Peita Louise Graham-Clarke, et al. (+6)
1461 [GO] 2022―Apr―18 A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease Melissa M Higdon, Brian Wahl, Carli B Jones, Joseph G Rosen, Shaun A Truelove, Anurima Baidya, et al. (+7)
1462 [GO] 2022―Apr―15 SARS-CoV-2 mRNA vaccine effectiveness in healthcare workers by dosing interval and time since vaccination: test negative design, British Columbia, Canada Shiraz El Adam, Macy Zou, Shinhye Kim, Bonnie Henry, Mel Krajden, Danuta M Skowronski
1463 [GO] 2022―Apr―14 Health care workers’ sick leave due to COVID-19 vaccination in context with SARS-CoV-2 infection and quarantine - a multicenter cross-sectional survey Stilla Bauernfeind, Gunnar Huppertz, Karolina Mueller, Florian Hitzenbichler, Loredana Hardmann, Sylvia Pemmerl, et al. (+12)
1464 [GO] 2022―Apr―14 Outcomes of B-cell-depleted Patients with Coronavirus Disease 2019 Treated with Anti-spike Monoclonal Antibodies Zachary A. Yetmar, Ryan B. Khodadadi, Maria Teresa Seville, Lisa Brumble, John C. O’Horo, Ravindra Ganesh, Raymund R. Razonable
1465 [GO] 2022―Apr―13 Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Chad J. Achenbach, Sally McFall, et al. (+37)
1466 [GO] 2022―Apr―12 EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 B.1.617.2 (COVID-19 DELTA VARIANT) INFECTION Mohanad MM. Al-Obaidi, Ahmet B. Gungor, Saman Nematollahi, Tirdad T. Zangeneh, Edward J. Bedrick, Katherine M. Johnson, et al. (+11)
1467 [GO] 2022―Apr―12 Performance of a Triage Protocol for Monoclonal Antibodies in a Mixed Vaccinated and Unvaccinated Cohort of Covid-19 Patients Treated with Intravenous Infusion or Subcutaneous Injection Emily B. Rubin, Mofei Liu, Anita Giobbie-Hurder, Lauren A. Canha, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan
1468 [GO] 2022―Apr―10 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for 
Real-Time Pandemic Surveillance Sally B Coburn, Yukari C Manabe, Oliver Laeyendecker, Susan G Sherman, Owen R Baker, Thomas C Quinn, et al. (+11)
1469 [GO] 2022―Apr―08 Avoidance of Emergency Care in the Southeastern United States During the COVID-19 Pandemic Erin Gettler, Rebecca Stern, Bin Ni, Heather M Munro, Mark Steinwandel, David M Aronoff, et al. (+4)
1470 [GO] 2022―Apr―07 Barriers to worldwide access for Paxlovid, a new treatment for COVID-19 Toby Pepperrelll, Leah Ellis, Junzheng Wang, Andrew Hill
1471 [GO] 2022―Apr―05 Pathogen Species is Associated With Mortality in Nosocomial Bloodstream Infection in Patients with COVID-19 Juan Gago, D Filardo Thomas, Sarah Conderino, Samuel J Magaziner, Yanina Dubrovskaya, Kenneth Inglima, et al. (+9)
1472 [GO] 2022―Apr―05 Rheumatic symptoms following COVID-19: a chronic post COVID-19 condition Dan Cui, Yeming Wang, Lixue Huang, Xiaoying Gu, Zhisheng Huang, Shengrui Mu, et al. (+2)
1473 [GO] 2022―Apr―02 Vaccinated individuals with prior COVID-19 have likely lower risk of incident SARS-CoV-2 infection when compared to vaccinated individuals without prior infection N Kojima, A Roshani, A Baca, J D Klausner
1474 [GO] 2022―Mar―29 Screening Large Population Health Databases for Potential COVID-19 Therapeutics: A Pharmacopeia-Wide Association Study (PWAS) of Commonly Prescribed Medications Derek R MacFadden, Kevin Brown, Sarah A Buchan, Hannah Chung, Rob Kozak, Jeffrey C Kwong, et al. (+3)
1475 [GO] 2022―Mar―25 Population attributable fractions of underlying medical conditions for COVID-19 diagnosis and COVID-19 hospitalizations, ventilations, and deaths among adults in the United States Jennifer L Nguyen, Tamuno Alfred, Maya Reimbaeva, Deepa Malhotra, Farid Khan, David Swerdlow, Frederick J Angulo
1476 [GO] 2022―Mar―25 Ibrutinib for Hospitalized Adults with Severe COVID-19 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study Steven E Coutre, Christopher Barnett, Olayemi Osiyemi, Daanish Hoda, Moti Ramgopal, Alexander C Fort, et al. (+6)
1477 [GO] 2022―Mar―25 Singing Is a Risk Factor for SARS-CoV-2 Infection: A Case-control Study of Karaoke-related COVID-19 Outbreaks in Two Cities in Hokkaido, Japan, Linked by Whole Genome Analysis Manami Nakashita, Yuta Takagi, Hiroyuki Tanaka, Haruna Nakamura, Yusuke Serizawa, Tomohiko Ukai, et al. (+27)
1478 [GO] 2022―Mar―25 SARS-CoV-2 humoral and cellular immune responses of patients with HIV after vaccination with BNT162b2 mRNA COVID-19 vaccine in the Tel-Aviv Medical Center Luba Tau, Dan Turner, Amos Adler, Rotem Marom, Svetlana Ahsanov, Natasha Matus, et al. (+8)
1479 [GO] 2022―Mar―25 High and rapid increase in seroprevalence for SARS-CoV-2 in Conakry, Guinea: results from three successive cross-sectional surveys (ANRS COV16-ARIACOV) Abou Aissata Soumah, Mamadou Saliou Kalifa Diallo, Emilande Guichet, David Maman, Guillaume Thaurignac, Alpha Kabinet Keita, et al. (+9)
1480 [GO] 2022―Mar―25 Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas Joshua L Kennedy, J Craig Forrest, Sean G Young, Benjamin Amick, Mark Williams, Laura James, et al. (+22)
1481 [GO] 2022―Mar―18 Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected with the SARS-CoV-2 Delta Variant Charlotte B Acharya, John Schrom, Anthea M Mitchell, David A Coil, Carina Marquez, Susana Rojas, et al. (+10)
1482 [GO] 2022―Mar―16 Viral burden and clearance in asymptomatic COVID-19 Patients Avanka B Gunatilaka, Nicholas Marco, Graham H Read, Maggie Sweeney, Greg Regan, Cynthia Tsang, et al. (+9)
1483 [GO] 2022―Mar―16 A Tale of Three Pandemics - SARS-CoV-2, HCV, and HIV in an Urban Emergency Department in Baltimore, Maryland Yu-Hsiang Hsieh, Richard E Rothman, Sunil S Solomon, Mark Anderson, Michael Stec, Oliver Laeyendecker, et al. (+9)
1484 [GO] 2022―Mar―16 Confirmed SARS-CoV-2 reinfections after a second wave with predominance of Lambda in Lima and Callao, Peru Luis Pampa-Espinoza, Carlos Padilla-Rojas, Javier Silva-Valencia, Victor Jimenez-Vasquez, Iris Silva, Orson Mestanza, et al. (+15)
1485 [GO] 2022―Mar―13 Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults Marcelo Wolff, Margarita Gilabert, Rodrigo Hernández
1486 [GO] 2022―Mar―10 COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective Jasmine R Marcelin, Audrey Pettifor, Holly Janes, Elizabeth R Brown, James G Kublin, Kathryn E Stephenson
1487 [GO] 2022―Mar―09 Increased risk of herpes zoster in adults ≥50 years old diagnosed with COVID-19 in the United States Amit Bhavsar, Germain Lonnet, Chengbin Wang, Konstantina Chatzikonstantinidou, Raunak Parikh, Yves Brabant, et al. (+4)
1488 [GO] 2022―Mar―07 Risk factors associated with hospitalization and death in COVID-19 breakthrough infections Geehan Suleyman, Raef Fadel, Indira Brar, Rita Kassab, Rafa Khansa, Nicholas Sturla, et al. (+7)
1489 [GO] 2022―Mar―07 New Onset Dementia Among Survivors of Pneumonia Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Adnan I Qureshi, William I Baskett, Wei Huang, S Hasan Naqvi, Chi-Ren Shyu
1490 [GO] 2022―Mar―07 Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms Grace Kenny, Kathleen McCann, Conor O’Brien, Stefano Savinelli, Willard Tinago, Obada Yousif, et al. (+40)
1491 [GO] 2022―Mar―03 Coronavirus disease 2019 (COVID-19) associated pulmonary aspergillosis (CAPA): Re-framing the debate Cornelius J Clancy, M Hong Nguyen
1492 [GO] 2022―Mar―03 Characteristics and Risk Factors for Mortality by COVID-19 Pandemic Waves in Fulton County, Georgia: A Cohort Study March 2020-February 2021 Nathaniel Chishinga, Neel R Gandhi, Udodirim N Onwubiko, Carson Telford, Juliana Prieto, Sasha Smith, et al. (+5)
1493 [GO] 2022―Mar―02 Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study Thomas W McDade, Amelia Sancilio, Richard D’Aquila, Brian Mustanski, Lauren A Vaught, Nina L Reiser, et al. (+6)
1494 [GO] 2022―Feb―25 Long-term outcomes and recovery of patients who survived COVID-19: LUNG INJURY COVID-19 Study Gianna Vargas Centanaro, Myriam Calle Rubio, José Luis Álvarez-Sala Walther, Fernando Martinez-Sagasti, Andrea Albuja Hidalgo, Rafael Herranz Hernández, Juan Luis Rodríguez Hermosa
1495 [GO] 2022―Feb―24 Serologic and cytokine signatures in children with multisystem inflammatory syndrome (MIS-C) and COVID-19 Stacey A Lapp, Joseph Abrams, Austin T Lu, Laila Hussaini, Carol M Kao, David A Hunstad, et al. (+23)
1496 [GO] 2022―Feb―22 Corrigendum to: 204. Mucosal Cytokine Profiles in Children with COVID-19 Ana M Quintero, Shira H Cohen, Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Fang Ye, et al. (+10)
1497 [GO] 2022―Feb―21 Impact of Casirivimab-Imdevimab on SARS-CoV-2 delta variant nasopharyngeal virus load and Spike quasispecies Camille Vellas, Arnaud Del Bello, Géraldine Gaube, Pauline Tremeaux, Nicolas Jeanne, Noémie Ranger, et al. (+4)
1498 [GO] 2022―Feb―20 Vaccination against SARS-CoV-2 is associated with a lower viral load and likelihood of systemic symptoms Carolyn T Bramante, Jennifer L Proper, David R Boulware, Amy Karger, Thomas Murray, Via Rao, et al. (+22)
1499 [GO] 2022―Feb―18 Quantifying the Population-level Effect of the COVID-19 Mass Vaccination Campaign in Israel: a Modeling Study Ido Somekh, Wasiur R KhudaBukhsh, Elisabeth Dowling Root, Lital Keinan Boker, Grzegorz Rempala, Eric A F Simões, Eli Somekh
1500 [GO] 2022―Feb―14 Coinfections in Patients with Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study Gowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, Elizabeth J Klein, Maheen Abidi, Shailesh M Advani, et al. (+51)
1501 [GO] 2022―Feb―14 Comparative efficacy of early Covid-19 monoclonal antibody therapies: a retrospective analysis Savanna San Filippo, Brynna Crovetto, John Bucek, Ronald G Nahass, Marc Milano, Luigi Brunetti
1502 [GO] 2022―Feb―14 Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults Lacy M Simons, Ramon Lorenzo-Redondo, Meg Gibson, Sarah L Kinch, Jacob P Vandervaart, Nina L Reiser, et al. (+12)
1503 [GO] 2022―Feb―14 Prospective assessment of symptoms to evaluate asymptomatic SARS-CoV-2 infections in a cohort of healthcare workers Emilie Goguet, John H Powers, Cara H Olsen, David R Tribble, Julian Davies, Luca Illinik, et al. (+29)
1504 [GO] 2022―Feb―13 Candidemia among COVID-19 patients in Turkey admitted to ICUs: A retrospective multicenter study Amir Arastehfar, Nevzat Ünal, Tuğrul Hoşbul, Muhammed Alper Özarslan, Ayşe Sultan Karakoyun, Furkan Polat, et al. (+9)
1505 [GO] 2022―Feb―09 Community-Acquired Pneumonia in Canada During COVID-19 L A Mandell, G G Zhanel, C Rotstein, J Muscedere, M Loeb, J Johnstone
1506 [GO] 2022―Feb―09 Characteristics of post-vaccination COVID-19 hospitalizations prior to booster vaccines Matthew A Moffa, Nathan R Shively, Thomas L Walsh
1507 [GO] 2022―Feb―09 An outpatient management strategy using a Coronataxi digital early warning (CDEW) system reduces COVID-19 mortality Adeline Lim, Theresa Hippchen, Inga Unger, Oliver Heinze, Andreas Welker, Hans-Georg Kräusslich, et al. (+2)
1508 [GO] 2022―Feb―09 Comparative Analysis of Mortality From Coronavirus Disease 2019 Across the European Union Countries and the Effects of Vaccine Coverage Panayiotis D Ziakas, Irene S Kourbeti, Eleftherios Mylonakis
1509 [GO] 2022―Feb―09 Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection Andrew Hill, Anna Garratt, Jacob Levi, Jonathan Falconer, Leah Ellis, Kaitlyn McCann, et al. (+4)
1510 [GO] 2022―Feb―09 Rapid Deployment of Multiple-Tactics to Address SARS-CoV-2 Vaccine Uptake in Healthcare Employees with a focus on Those Who Identify as Black, Indigenous, and People of Color (BIPOC) Dominic K Chan, Brittany D Alegria, Smitha R Chadaga, Lisa J Goren, Traci J Mikasa, Anna M Pearson, et al. (+3)
1511 [GO] 2022―Feb―09 Association of non-alcoholic fatty liver disease with COVID-19 severity and pulmonary thrombosis: CovidFAT, a prospective, observational cohort study Nina Vrsaljko, Lara Samadan, Klaudija Viskovic, Armin Mehmedović, Jelena Budimir, Adriana Vince, Neven Papic
1512 [GO] 2022―Feb―02 Small Towns, Big Cities: Rural and Urban Disparities among Hospitalized Patients with COVID-19 in the Central Savannah River Area Caroline A Hamilton, Deepak Ayyala, David Walsh, Christian Bramwell, Christopher Walker, Rita Wilson Dib, et al. (+6)
1513 [GO] 2022―Feb―02 Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients with Mild-to-Moderate Coronavirus Disease 2019 Anca Streinu-Cercel, Oana Săndulescu, Liliana-Lucia Preotescu, Jin Yong Kim, Yeon-Sook Kim, Shinhye Cheon, et al. (+11)
1514 [GO] 2022―Jan―31 Seroprevalence of SARS-CoV-2-specific antibodies in Australia following the first epidemic wave in 2020: a national survey Kaitlyn M Vette, Dorothy A Machalek, Heather F Gidding, Suellen Nicholson, Matthew V N O'Sullivan, John B Carlin, et al. (+16)
1515 [GO] 2022―Jan―30 SARS-CoV-2 Seroprevalence and Reported COVID-19 Cases in U.S. Children, August 2020-May 2021 Alexia Couture, B Casey Lyons, Megha L Mehrotra, Lynn Sosa, Ngozi Ezike, Farah S Ahmed, et al. (+14)
1516 [GO] 2022―Jan―28 Factors associated with SARS-COV-2 attack rates in aged care- a meta-analysis Mohana Kunasekaran, Ashley Quigley, Bayzidur Rahman, Abrar A Chughtai, David J Heslop, Christopher J Poulos, C Raina MacIntyre
1517 [GO] 2022―Jan―28 Detection of the omicron variant virus with the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay James Regan, James P Flynn, Manish C Choudhary, Rockib Uddin, Jacob Lemieux, Julie Boucau, et al. (+4)
1518 [GO] 2022―Jan―22 Sustained Reduction in Urgent Care Antibiotic Prescribing During the COVID-19 pandemic: An Academic Medical Center’s Experience David Ha, Sharon Ong’uti, Amy Chang, Emily Mui, Ian Nelligan, Brooke Betts, et al. (+9)
1519 [GO] 2022―Jan―21 Feasibility and Acceptability of Home-collected Samples for HIV Pre-exposure Prophylaxis (PrEP) and SARS-CoV-2 Laboratory Tests in San Francisco Primary Care Clinics Parya Saberi, Kristin Ming, Isha Shrestha, Hyman Scott, Brad Thorson, Albert Liu
1520 [GO] 2022―Jan―20 Metrics for Phased Prevention of Coronavirus Disease 2019 Transmission for Institutions of Higher Education: 2022 and Beyond Neil Jay Sehgal
1521 [GO] 2022―Jan―19 Outpatient Therapies for COVID-19: How do we choose? Todd C Lee, Andrew M Morris, Steven A Grover, Srinivas Murthy, Emily G McDonald
1522 [GO] 2022―Jan―17 Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud Andrew Hill, Manya Mirchandani, Victoria Pilkington
1523 [GO] 2022―Jan―17 Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021 Marie C D Stoner, Frederick J Angulo, Sarah Rhea, Linda Morris Brown, Jessica E Atwell, Jennifer L Nguyen, et al. (+3)
1524 [GO] 2022―Jan―14 Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers Si’Ana A Coggins, Eric D Laing, Cara H Olsen, Emilie Goguet, Matthew Moser, Belinda M Jackson-Thompson, et al. (+25)
1525 [GO] 2022―Jan―12 Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas Atul Kothari, Elizabeth Woodland Borella, Michelle R Smith
1526 [GO] 2022―Jan―12 Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019 Juliette Dessemon, Christelle Elias, Laetitia Henaff, Mitra Saadatian-Elahi, Philippe Vanhems
1527 [GO] 2022―Jan―06 Twelve-month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity Melisa M Shah, Mohammad Ata Ur Rasheed, Jennifer L Harcourt, Glen R Abedi, Megan M Stumpf, Hannah L Kirking, et al. (+14)
1528 [GO] 2022―Jan―03 Assessment of COVID-19 intervention strategies in the Nordic countries using genomic epidemiology Sebastian Duchene, Leo Featherstone, Birgitte Freiesleben de Blasio, Edward C Holmes, Jon Bohlin, John H-O Pettersson
1529 [GO] 2021―Dec―31 Short term safety of booster immunization with BNT162b2 mRNA COVID-19 vaccine in healthcare workers Yael Paran, Esther Saiag, Avishay Spitzer, Yoel Angel, Michal Yakubovsky, Hagit Padova, et al. (+6)
1530 [GO] 2021―Dec―30 A small but significantly greater incidence of inflammatory heart disease identified after vaccination for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) Kirk U Knowlton, Stacey Knight, Joseph B Muhlestein, Viet T Le, Benjamin D Horne, Heidi T May, et al. (+2)
1531 [GO] 2021―Dec―28 Delay in the Effect of Restricting Community Mobility on the Spread of COVID-19 During the First Wave in the United States Shan He, Jooyoung Lee, Benjamin Langworthy, Junyi Xin, Peter James, Yang Yang, Molin Wang
1532 [GO] 2021―Dec―27 Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019 Nikolaos Tziolos, Emmanouil Karofylakis, Ioannis Grigoropoulos, Pinelopi Kazakou, Emmanouil Koullias, Athina Savva, et al. (+11)
1533 [GO] 2021―Dec―25 Association Between SARS-CoV-2 RNAemia and Post-Acute Sequelae of COVID-19 Nikhil Ram-Mohan, David Kim, Angela J Rogers, Catherine A Blish, Kari C Nadeau, Andra L Blomkalns, Samuel Yang
1534 [GO] 2021―Dec―23 Evaluating the impact of language concordance on COVID-19 contact tracing outcomes among Spanish-speaking adults in San Francisco between June and November 2020 Amity Eliaz, Alden H Blair, Yea-Hung Chen, Alicia Fernandez, Alexandra Ernst, Joy Mirjahangir, et al. (+4)
1535 [GO] 2021―Dec―23 Adapting serosurveys for the SARS-CoV-2 vaccine era Nathan Duarte, Mercedes Yanes-Lane, Rahul K Arora, Niklas Bobrovitz, Michael Liu, Mariana G Bego, et al. (+9)
1536 [GO] 2021―Dec―22 A dehumanizing experience with COVID-19 infection and hospitalization - An interview with Chris Stolarski
1537 [GO] 2021―Dec―21 Corridengum to: Self-Rated Smell Ability Enables Highly Specific Predictors of COVID-19 Status: A Case-Control Study in Israel Noam Karni, Hadar Klein, Kim Asseo, Yuval Benjamini, Sarah Israel, Musa Nimri, et al. (+5)
1538 [GO] 2021―Dec―21 Persistence, Magnitude and Patterns of Post-acute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement Michael J Peluso, J Daniel Kelly, Scott Lu, Sarah A Goldberg, Michelle C Davidson, Sujata Mathur, et al. (+41)
1539 [GO] 2021―Dec―20 Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020-July 2021 Sundar S Shrestha, Lyudmyla Kompaniyets, Scott D Grosse, Aaron M Harris, James Baggs, Kanta Sircar, Adi V Gundlapalli
1540 [GO] 2021―Dec―17 Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19 Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
1541 [GO] 2021―Dec―14 Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity Joseph M Rocco, Luxin Pei, Frances Galindo, Elizabeth Laidlaw, Irini Sereti
1542 [GO] 2021―Dec―11 Persistence of robust humoral immune response in COVID-19 convalescent individuals over twelve months after infection Kei Miyakawa, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Hirofumi Go, Yutaro Yamaoka, Norihisa Ohtake, et al. (+14)
1543 [GO] 2021―Dec―10 Aiming for Zero: Reducing Transmission of Coronavirus Disease 2019 in the D.C. Department of Corrections Mallory E Epting, Jacob A Pluznik, Samantha R Levano, Xinyi Hua, Isaac C H Fung, Beth Jordan, et al. (+11)
1544 [GO] 2021―Dec―08 Circulation of Non- SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic Katharine Uhteg, Adannaya Amadi, Michael Forman, Heba H Mostafa
1545 [GO] 2021―Dec―08 Low versus High Dose Methylprednisolone in Adult Patients with COVID-19: Less is More Seema Joshi, Zachary Smith, Sana Soman, Saniya Jain, Atheel Yako, Marwa Hojeij, et al. (+7)
1546 [GO] 2021―Dec―08 Anatomical site, viral RNA abundance, and time of sampling correlate with molecular detection of SARS-CoV-2 during infection F Julian Lantry, Nusrat Epsi, Simon Pollett, Mark P Simons, David A Lindholm, Rhonda E Colombo, et al. (+22)
1547 [GO] 2021―Dec―07 US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19 Robert W Finberg, Madiha Ashraf, Boris Julg, Folusakin Ayoade, Jai G Marathe, Nicolas C Issa, et al. (+4)
1548 [GO] 2021―Dec―05 296. Description of Super-infections in Hospitalized Patients with COVID-19 Geena Kludjian, Stephanie Spivack, Stefania Gallucci, Laurie Kilpatrick, Aaron D Mishkin, Umadevi Sajjan, et al. (+3)
1549 [GO] 2021―Dec―05 286. Infectious Complications and Antimicrobial Utilization in Hospitalized Patients with COVID-19 J Hunter Fraker, Vidhi Gandhi, Lan Duong, Jai Kumar, Princy N Kumar, Joseph G Timpone
1550 [GO] 2021―Dec―05 293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19 Anne-Marie Chaftari, Alexandre Malek, Hiba Dagher, Ying Jiang, Arnaud Bayle, Arvinder Bhinder, et al. (+10)
1551 [GO] 2021―Dec―05 361. Aseptic Meningitis Associated to SARS Cov2 Infection and MIS-C: Pediatric Presentation of Covid-19 Mónica J Olguín Quintero, Sergio RenÉ Bonilla Pellegrini, Rodolfo N JimÉnez JuÁrez, María Citlalli Casillas Casillas
1552 [GO] 2021―Dec―05 338. Multicenter Evaluation of Superinfection Occurrence and Impact on Clinical Outcomes in Patients with COVID-19 Taryn A Eubank, Katherine Perez, William L Musick, Kevin W Garey
1553 [GO] 2021―Dec―05 337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19 Simon Pollett, Benjamin Wier, Stephanie A Richard, Anthony C Fries, Ryan C Maves, Ryan C Maves, et al. (+21)
1554 [GO] 2021―Dec―05 313. Host Protein Biomarkers Predicting Severity of Lung Damage due to COVID-19 Isabell Kerschbaumer, Melissa Fazzari, Shana R Burstein, Aisha Furey, Amy S Fox, Adam M Cole, et al. (+3)
1555 [GO] 2021―Dec―05 309. TB Quantiferon Testing Predicts Mortality in Patients with COVID-19 Mirza Z Baig, Siyun Liao, Margaret Powers-Fletcher, Moises A Huaman, Senu Apewokin
1556 [GO] 2021―Dec―05 311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19 Nina Vrsaljko, Lara Samadan, Jelena Budimir, Mirjana Balen Topic, Ivan Kurelac, Adriana Vince, Neven Papić
1557 [GO] 2021―Dec―05 391. Small Towns, Big Cities: Rural and Urban Disparities Among Hospitalized Patients with COVID-19 Caroline Hamilton, Deepak Nag Ayyala, David Walsh, Christian-Jevon Bramwell, Christopher Walker, Rita Wilson Dib, et al. (+6)
1558 [GO] 2021―Dec―05 306. Association of Antibiotic Use and Development Secondary Infection from Clostridium difficile, Multidrug-Resistant Bacteria, and Candida in Hospitalized Patients with History of COVID-19 Jessica K Costales, Helen Lee, Kathleen A Quan, Keith M Madey, Kurt McArthur, Shruti K Gohil, et al. (+3)
1559 [GO] 2021―Dec―05 582. Risk Factors for Progression to Hospitalization in Adolescents Presenting with Mild or Moderate COVID-19 Melanie Dubois, Jeffrey Campbell, Gabriella S Lamb, Gabriella S Lamb, Mari M Nakamura
1560 [GO] 2021―Dec―05 358. Early Cardiac Marker of Mortality in COVID-19 Douglas Salguero, Juliana Ferri-Guerra, Angel Porras, Marissa Donatelle, Everett Rogers, Lee Seiffer, et al. (+4)
1561 [GO] 2021―Dec―05 349. Diagnostic Testing and Antibiotic Utilization in Patients with COVID-19 Lauren Groft, Iulia Opran, Yeabsera Tadesse, Hang Vo, Emily Heil, Emily Heil, et al. (+2)
1562 [GO] 2021―Dec―05 457. High Levels of Serum Troponin I Indicate Higher Mortality Risk in Patients with COVID-19 Paula Ramirez, Daniela Parra-Tanoux, Ingrid G Bustos-Moya, Yuli Fuentes, Elsa Daniela Ibañez-Prada, Oriana Narváez - Ramírez, et al. (+6)
1563 [GO] 2021―Dec―05 351. Antibiotic Management Decisions and Use of a Multiplex PCR Panel for Pneumonia Diagnosis Among Critically Ill Patients with COVID-19 Neda Bionghi, Donald E Dietz, Jason Zucker, Jason Zucker, Simian Huang, Susan Whittier, et al. (+4)
1564 [GO] 2021―Dec―05 357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19 Alexandre Malek, Hiba Dagher, Ray Y Hachem, Ying Jiang, Anne-Marie Chaftari, Issam I Raad
1565 [GO] 2021―Dec―05 323. Distribution of Pathogens in Coinfections of Patients Admitted with COVID-19 Srilatha Neshangi, Budder Siddiqui, Sarah Tran, Phillip Zhang
1566 [GO] 2021―Dec―05 356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19 Hiba Dagher, Anne-Marie Chaftari, Ray Y Hachem, Ying Jiang, Alexandre Malek, Natalie J Dailey Garnes, et al. (+3)
1567 [GO] 2021―Dec―05 510. Reduced Mortality Rate in Critically Ill Patients with COVID-19 with the Implementation of a Treatment Protocol-Experience of a Tertiary Care Center in the Midwest During the Initial Surge of COVID-19 Ashlesha Kaushik, Sandeep Gupta, Jitendra Gupta
1568 [GO] 2021―Dec―05 407. Minimum Manufacturing Costs, National Prices and Estimated Global Availability of New Repurposed Therapies for COVID-19 Junzheng Wang, Jacob Levi, Leah Ellis, Andrew Hill
1569 [GO] 2021―Dec―05 334. Impact of Overall Dexamethasone Exposure on Development of Invasive Pulmonary Aspergillosis in Hospitalized Patients with COVID-19 Erik Skoglund, Amy Kum, Allison Mac, Mark Nguyen
1570 [GO] 2021―Dec―05 501. Implementation and Outcomes of a Program to Coordinate and Administer Monoclonal Antibody Therapy to Long-Term Care Facility Residents with COVID-19 Andrew B Watkins, Lisa M Brand, Michelle Schwedhelm, Heather L Jensen, Brandon Scott, Dan K German, et al. (+4)
1571 [GO] 2021―Dec―05 500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19 Lea Monday, George J Alangaden, Indira Brar, Ramesh Mayur
1572 [GO] 2021―Dec―05 418. Low Frequency of Healthcare Worker Infections Following Occupational Exposures to COVID-19 Jessica Seidelman, Ibukunoluwa Akinboyo, Maya Rinehart, Matthew Stiegel, Rebekah W Moehring, Deverick J Anderson, et al. (+4)
1573 [GO] 2021―Dec―05 417. COVID-19 Aerostudy: Evaluation of SARS-CoV-2 Virus in the Air of Patients Hospitalized with COVID-19 Hamed Hamza, Margaret Seitsema, Lorraine Conroy, Alfredo J Mena Lora, Eric Wenzler, Scott Borgetti, et al. (+8)
1574 [GO] 2021―Dec―05 399. Epidemiology of Laboratory-identified Late-onset SARS-CoV-2 Positivity in Two Large, Urban, Acute-Care Hospitals: Implications for Surveillance of Hospital-Acquired COVID-19 William Trick, Michael Y Lin, Sharon F Welbel, Onfofre T Donceras, Huiyuan Zhang, Marion Tseng, Carlos Santos
1575 [GO] 2021―Dec―05 441. The Effects of Race and Comorbidity Burden on Inflammatory Biomarkers Among Persons Hospitalized with COVID-19 Yetunde A Fatade, Lauren F Collins, Lauren F Collins, Zakaria Almuwaqqat, ZhenChao Chen, Mahadev Prasad, et al. (+2)
1576 [GO] 2021―Dec―05 516. Evaluation of COVID-19 Monoclonal Antibody Therapies for the Treatment of Non-hospitalized Patients with COVID-19 Faiza Morado, Neha Nanda
1577 [GO] 2021―Dec―05 438. Phenotypic Differences Between Distinct Immune Biomarker Clusters During the ‘Hyperinflammatory’ Middle-Phase of COVID-19 Paul W Blair, Joost Brandsma, Nusrat J Epsi, Stephanie A Richard, Deborah Striegel, Josh Chenoweth, et al. (+10)
1578 [GO] 2021―Dec―05 542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19 Patricia Brock, Hiba Dagher, Adriana H Wechsler, Demis N Lipe, Patrick Chaftari, Anne-Marie Chaftari, et al. (+9)
1579 [GO] 2021―Dec―05 548. Convalescent Plasma in Hospitalized Pediatric and Obstetric patients with COVID-19 Saki Ikeda, Eduardo Benzi, Lisa Hensch, Sridevi Devaraj, Shiu-Ki Rocky Hui, Manisha Gandhi, et al. (+3)
1580 [GO] 2021―Dec―05 547. Risk Factors Associated with 30-Day Mortality in a Large Cohort of Patients who Received Remdesivir and Corticosteroids for Severe COVID-19 Kartik Gupta, Lea Monday, Milan Kaushik, George J Alangaden, Indira Brar
1581 [GO] 2021―Dec―05 523. Use of Immune-Viral Dynamics Modeling to Understand Molnupiravir Drug Effect for COVID-19 Youfang Cao, Wei Gao, Ruthie Birger, Julie Stone
1582 [GO] 2021―Dec―05 633. Preliminary Results from a Phase 1 Single Ascending-Dose Study Assessing Safety, Serum Viral Neutralizing Antibody Titers (sVNA), and Pharmacokinetic (PK) Profile of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19) Helen Paguntalan, Zoltán Magyarics, Lynn E Connolly, Ellie Hershberger, Kristin Narayan, Deepali Gupta, et al. (+5)
1583 [GO] 2021―Dec―05 Variation in SARS-CoV-2 bioaerosol production in exhaled breath Renu Verma, Eugene Kim, Nicholas Degner, Katharine S Walter, Upinder Singh, Jason R Andrews
1584 [GO] 2021―Dec―05 277. Low Rates of Bacterial Co-infection in Hospitalized Patients with COVID-19 Stephanie Spivack, Geena Kludjian, Stefania Gallucci, Laurie Kilpatrick, Aaron D Mishkin, Umadevi Sajjan, et al. (+3)
1585 [GO] 2021―Dec―05 280. Burden of Hyperglycemia in Patients Receiving Dexamethasone for Severe COVID-19 Kirk B Fetters, Stephen Judge, Timothy Hatlen, Eric Daar
1586 [GO] 2021―Dec―05 170. Reduction in Bloodborne Pathogen Splash Exposures After Implementation of Universal Masking and Eye Protection for COVID-19 Marci Drees, Tabe Mase, Jennifer Garvin, Kimberly Miller
1587 [GO] 2021―Dec―05 947. Nocardiosis in Renal Transplant Recipients Linked to Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19 Terrence McSweeney, Jennifer Marvin, Elizabeth A Cohen, Vincent Do, Kristen Belfield, Sarthak Virmani, et al. (+4)
1588 [GO] 2021―Dec―05 1089. Use of a Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model to Support Dose Selection of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Prevention of Coronavirus Disease (COVID-19) Scott A Van Wart, Evan D Tarbell, Kristin Narayan, Laura M Walker, Lynn E Connolly, Paul G Ambrose
1589 [GO] 2021―Dec―05 1088. A Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model to Support Dose Selection of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment of Coronavirus Disease (COVID-19) Evan D Tarbell, Scott A Van Wart, Dhaval K Shah, Laura M Walker, Andrew Santulli, Lynn E Connolly, et al. (+3)
1590 [GO] 2021―Dec―05 1086. A Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model that a priori Predicts Intramuscular (IM) Pharmacokinetics of ADG20: an Extended Half-life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19) Scott A Van Wart, Evan D Tarbell, Donald E Mager, Dhaval K Shah, Lynn E Connolly, Paul G Ambrose
1591 [GO] 2021―Dec―05 843. Targeted HIV Testing for Patients Hospitalized for COVID-19 Michael D Virata, Merceditas Villanueva, Janet Miceli
1592 [GO] 2021―Dec―05 839. Examining the Effects of HIV Infection on Severity of Outcomes in Those with COVID-19 Melissa Parkinson, Rebecca Gerrity, Rachel Strength, Christian J Fuchs, Christopher Jackson, Dipen Kadaria, et al. (+3)
1593 [GO] 2021―Dec―05 840. Clinical Characteristics of Patients Living with HIV Hospitalized for COVID-19 Nimra Chaudhry, Eris Cani, Tae Park, Cosmina Zeana, Paul Kelly, Haozhe Sun
1594 [GO] 2021―Dec―05 81. SARS-CoV-2 RNAemia and Disease Severity in Pediatric Coronavirus Disease 2019 (COVID-19) Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Colin L Peachey, Lauren Miller, Pablo J Sanchez, et al. (+7)
1595 [GO] 2021―Dec―05 39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19 Anna Hardesty, Elizabeth Klein, Kendra Vieira, Dimitrios Farmakiotis
1596 [GO] 2021―Dec―05 36. Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19 Elisa Akagi Fukushima, Claudia Villatoro Santos, Mamta Sharma, Susan M Szpunar, Louis Saravolatz, Ashish Bhargava
1597 [GO] 2021―Dec―05 29. Sustained Recovery in Patients Admitted to Hospital With COVID-19 Kasper S Moestrup, Adrian G Zucco, Joanne Reekie, Cameron MacPherson, Sisse R Otrowski, Carsten Utoft Niemann, et al. (+2)
1598 [GO] 2021―Dec―05 27. Co-infections and antimicrobial use in patients hospitalized with COVID-19 Prithiv Prasad, Ioannis Zacharioudakis, Jordan Poles, Yanina Dubrovskaya, Dinuli Delpachitra, Eduardo Iturrate, Sigridh Munoz-Gomez
1599 [GO] 2021―Dec―05 204. Mucosal Cytokine Profiles in Children with COVID-19 Shira H Cohen, Cameron Mertz, Rebecca M Glowinski, Sara Mertz, Fang Ye, Zhaohui Xu, et al. (+9)
1600 [GO] 2021―Dec―05 170. Antimicrobial Use Before and During COVID-19 - Data from 108 VA Facilities Matthew B Goetz, Matthew B Goetz, Tina M Willson, Vanessa W Stevens, Christopher J Graber, Michael Rubin
1601 [GO] 2021―Dec―05 466. Symptom Profile of Hospitalized, Adult Patients with COVID-19 - Findings From COVID-Net Database Chun T Siu, Amogh Joshi
1602 [GO] 2021―Dec―05 315. A Multi-center Study to Describe Obese Pediatric Patients with COVID-19 Across the United States Roukaya Al Hammoud, James Murphy, Gabriela P Del Bianco, Gloria Heresi, Michael L Chang
1603 [GO] 2021―Dec―05 448. COVID-19 Acute Care at Home: A Substitution for Hospitalization in Patients with Mild Symptoms Joel A Kammeyer, Brian Perkins, Sara Seegert, Dave E Caris, Caitlyn M Hollingshead, Evan D Brochin, Benjamin H Russell
1604 [GO] 2021―Dec―05 531. Risk Factors and Therapeutic Interventions Associated with Mortality in Veterans Diagnosed With SARS-CoV-2 Infection (or COVID-19) Admitted to a Large Academic Medical Center Elwyn Welch, Shazia Raheem, Andrew Hunter, Uma Ayyala, Venkata Bandi, Lavannya Pandit, Christina Kao
1605 [GO] 2021―Dec―05 285. Outcomes and Antibiotic Use in Patients with COVID-19 Admitted to an Intensive Care Unit Megan Petteys, Leigh Ann Medaris, Julie E Williamson, Travis Denmeade, Rohit Soman, William E Anderson, et al. (+2)
1606 [GO] 2021―Dec―05 403. Clinical Characteristics and Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit in the Dominican Republic Rita Alexandra Rojas-Fermin, Ann Sanchez, Anel E Guzman, Edwin Germosen, Cesar Matos, Alfredo J Mena Lora
1607 [GO] 2021―Dec―05 959. Online CME Successful at Improving Knowledge, Competence and Confidence on Incorporating mAbs for COVID-19 Among a Global Audience Allison Armagan, Elaine Bell, Maria B Uravich, Shanthi Voorn
1608 [GO] 2021―Dec―05 565. Risk of COVID-19 Among Healthcare Workers After Launch of Vaccination Campaign at an Academic Medical Center Bhagyashri D Navalkele, Jose Lucar, James B Brock, Jason Parham
1609 [GO] 2021―Dec―05 344. Prevalence and Impact of Post-Acute Sequelae of COVID-19 Among People Experiencing Homelessness in King County, WA Between September 2020 - May 2021 Emily M Scott, Sarah N Cox, Julia H Rogers, Jessica Knaster Wasse, Helen Y Chu
1610 [GO] 2021―Dec―05 953. Online Medical Education Improves Knowledge of Monoclonal Antibody Treatment for COVID-19 Among Physicians Allison Armagan, Maria B Uravich
1611 [GO] 2021―Dec―05 291. Epidemiology of Candidemia Rates during COVID-19 and Comparison of Outcomes in Candidemia Between COVID-19 and Non-COVID-19 Patients Angela Beatriz Cruz, Jennifer LeRose, Kenisha J Evans, Monica Meyer, Teena Chopra, Teena Chopra
1612 [GO] 2021―Dec―05 901. Integrated Community Health Screening for COVID-19 and HIV Promotes HIV Diagnoses and Linkage to Care Corey L Rosmarin-DeStefano, Eugene G Martin, Gratian Salaru, Barbara Tempalski, Diana Finkel, Eileen Scarinci
1613 [GO] 2021―Dec―05 279. Clinical Characteristics of Critically Ill Patients with COVID-19 and Invasive Pulmonary Aspergillosis: A Case Series From Mexico City Patricia Galindo-Lopez, Benjamin Valente-Acosta, Francisco Moreno-Sanchez, Luis Espinosa-Aguilar, Irma Hoyo-Ulloa, Raquel Mendoza-Aguilar, et al. (+3)
1614 [GO] 2021―Dec―05 189. Bacteremia among COVID-19 and Non-Covid-19 Patients Admitted in the ICU paraskeui chra, Evdokia Gavrielatou, prodromos Temperikidis, Michalis Tsimaras, eleni magira
1615 [GO] 2021―Dec―05 336. COVID-19 and Pneumocystis jiroveci Pneumonia Christopher Saling, Sabirah N Kasule, Holenarasipur R Vikram
1616 [GO] 2021―Dec―05 1212. COVID-19 and the Importance of Institutional Trust to Public Health Karin Kricorian, Katherine Kricorian
1617 [GO] 2021―Dec―05 325. Empiric Antibiotics for COVID-19 and the Utility of Procalcitonin Adrienne D Desens, Kiya D Mohadjer, Jessica Thompson
1618 [GO] 2021―Dec―05 326. Radiologic Findings of COVID-19 Associated Mucormycosis (CAM) from India Aswath Govindaraju, Deepti H Vijayakumar, Raghavendra Tirupathi, Jaffar A Al-Tawfiq, Ali A Rabaan
1619 [GO] 2021―Dec―05 771. COVID-19 on the Line: A Significant Increase in CLABSI in Hospitalized Patients with COVID-19 at a Major Teaching Hospital Pishoy Haroun, Michael Ben-Aderet, Meghan Madhusudhan, Matthew J Almario, Ryan C Raypon, Sharon E Fawcett, Jonathan Grein
1620 [GO] 2021―Dec―05 521. Predictors of Hospitalization Due to Coronavirus Disease 2019 (COVID-19) at a Veterans Affairs Medical Center Macy Ho, Sarah Le, Rajkumar J Sevak, Jamie G Chapman-Bueno, Stephen M Berman, Patricia Chun, Yong S Moon
1621 [GO] 2021―Dec―05 388. Epidemiologic and Microbiologic Characteristics of Hospital-acquired Infections in Patients with COVID-19 at Intensive Care Unit, Mexico City Paulo Castañeda-Méndez, Maria Lorena Cabrera-Ruiz, Armando Barragán-Reyes, Esperanza Aleman Aguilar, Brenda Aceves Sanchez, Maria Fernanda Ruiz Salgado, et al. (+10)
1622 [GO] 2021―Dec―05 1342. TOSCANA: The Observational Seroepidemiologic Study of COVID-19 at the United States Naval Academy Eugene Millar, Eric Laing, Adam Saperstein, Jitu Modi, Christopher Heaney, Jamie Fraser, et al. (+5)
1623 [GO] 2021―Dec―05 1005. COVID-19 At-Home Capillary Blood Specimen Collection Pilot - Gaining Insight into Independent Self- Collection of Blood Specimens and COVID-19 Within the Veteran Population Tseli Mohammed, Jessica V Brewer, Mary E Pyatt, Juan P Romero Casas, Stacey Whitbourne, J Michael Gaziano, et al. (+2)
1624 [GO] 2021―Dec―05 525. Atovaquone for Treatment of COVID-19 (Ataq COVID-19) Trial Mamta K Jain, Mamta K Jain, Hesham Sadek, James de Lemos, Darren mcGuire, Colby Ayers, et al. (+7)
1625 [GO] 2021―Dec―05 190. Epidemiology of COVID-19 Breakthrough Infections in Dallas County, Texas, 2021 Suzanne Wada, Jared Wiegand, Mary Markarian, Victoria Hung, Christina Zhu, Megin Parayil, et al. (+3)
1626 [GO] 2021―Dec―05 44. Impact of Nursing Home (NH) Universal Decolonization and COVID Prevention Training on COVID-19 Burden During the 2020-2021 Winter Surge in Orange County (OC), California (CA) Gabrielle Gussin, Raveena Singh, Shruti K Gohil, Raheeb Saavedra, Thomas Tjoa, Robert Pedroza, et al. (+10)
1627 [GO] 2021―Dec―05 1204. Assessing Perceptions and Efficacy of COVID-19 Case and Contact Investigations - Dallas County, Texas, 2020 Jose Serrano, Harper R Clouston, Jared Wiegand, Kyoo Shim, Nathan Popper, Kayla Maaraoui, et al. (+5)
1628 [GO] 2021―Dec―05 444. County-level COVID-19 Case Fatality Rate in Medicaid Expansion States Compared to Non-Expansion States Walid El-Nahal, Stephen Berry, Kevin Psoter, Kelly Gebo
1629 [GO] 2021―Dec―05 43. SARS-CoV-2 Cycle threshold (Ct) values predict future COVID-19 cases Matthew Phillips, David Quintero, Susan Butler-Wu
1630 [GO] 2021―Dec―05 187. Characterizing Household Clustering of COVID-19 Cases in Fulton County, Georgia, June 2020-April 2021 Carol Liu, Sasha Smith, Allison Chamberlain, Neel Gandhi, Fazle N Khan, Steve Williams, Sarita Shah
1631 [GO] 2021―Dec―05 460. Disproportionalities in COVID-19 Clinical Drug Trials in the United States: A Systematic Literature Review Daniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, Sharmon P Osae, Joeanna S Chastain, Andrés F Henao Martínez, et al. (+2)
1632 [GO] 2021―Dec―05 627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials Reema Charles, Parvesh Paul, Heather Stone, Serghei Gorobet, Belinda Nhundu, Katarzyna M Borkowski, et al. (+2)
1633 [GO] 2021―Dec―05 343. RURAL-COVID-19 Trial: Retrospective Analysis of COVID-19 Coinfections in Hospitalized Urban and Rural Adults Caroline Hamilton, Heather Frazier, Jose A Vazquez
1634 [GO] 2021―Dec―05 374. Need to Improve Minority Representation through COVID-19 Community Research Partnership Keerti Dantuluri, Whitney Rossman, Lauren C Lu, Connell O Dunn, Anna M Harris, Timothy Hetherington, et al. (+3)
1635 [GO] 2021―Dec―05 588. Seroconversion Among Adults After Receiving At Least One Dose of a COVID-19 Vaccine: COVID-19 Community Research Partnership, Mid-Atlantic, Southeast and Southern United States, December 2020-May 2021 DeAnna J Friedman-Klabanoff, Ashley Tjaden, Michele Santacatterina, Iqra Munawar, John W Sanders, David M Herrington, et al. (+2)
1636 [GO] 2021―Dec―05 1213. Vaccine Uptake Amongst Participants in the North Carolina COVID-19 Community Research Partnership Who Were Initially Receptive or Hesitant to Receive a COVID-19 Vaccine Iqra Munawar, Austin L Seals, John W Sanders, David M Herrington, Thomas F Wierzba
1637 [GO] 2021―Dec―05 292. Antibiotic Use Is Increased in Patients with Acute Respiratory Distress Syndrome (ARDS) Requiring Extracorporeal Membrane Oxygenation (ECMO) due to COVID-19 Compared with Influenza J Alex Viehman, Christina K Thorngren, M Hong Nguyen, Palash Samanta, Cornelius J Clancy, Holt Murray, Ryan Rivosecchi
1638 [GO] 2021―Dec―05 348. Characteristics and Outcomes in Hospitalized Patients with Covid-19 Complicated by Fungemia: A Single Center Retrospective Study Aleena Zahra, Bettina C Fries, Bettina C Fries, Sutthichai Sae-Tia
1639 [GO] 2021―Dec―05 79. Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations Zhaohui Xu, Rebecca M Glowinski, Shira H Cohen, Cameron Mertz, Sara Mertz, Fang Ye, et al. (+3)
1640 [GO] 2021―Dec―05 350. Joint Modeling of EHR and CXR Data to Predict COVID-19 Deterioration Emily Mu, Sarah Jabbour, Michael Sjoding, John Guttag, Jenna Wiens, Adrian Dalca
1641 [GO] 2021―Dec―05 275. Clinical and Laboratory Predictors of Stroke Associated with COVID-19 Disease Valerie R Bromberg, Leigh Cressman, Pam C Tolomeo, Hatem Abdallah, Alexis Holmes, Jay Garcia, et al. (+7)
1642 [GO] 2021―Dec―05 LB10. Impact of SARS-CoV-2 Delta Variant on the Spectrum of Pediatric COVID-19 Disease in Arkansas Jose R Romero, Donald E Warden, Michael Cima
1643 [GO] 2021―Dec―05 328. Bacteremia in Patients Hospitalized with Covid-19 Disease, Risk Factors, Impact of immunomodulator Therapy, Role of Inflammatory Markers, Antibiotic Use, and Outcomes: A Single Center Retrospective Study Aleena Zahra, Bettina C Fries, Bettina C Fries
1644 [GO] 2021―Dec―05 322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States Shemra Rizzo, Ryan Gan, Devika Chawla, Kelly Zalocusky, Xin Chen, Yifeng Chia
1645 [GO] 2021―Dec―05 571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster Pablo Tebas, Joseph Agnes, Mary Giffear, Kimberly A Kraynyak, Elliott Blackwood, Dinah Amante, et al. (+39)
1646 [GO] 2021―Dec―05 423. Implementation of a Hierarchy of Controls in a Mobile Health Unit to Safely Care for Inpatients with COVID-19 during Healthcare System Surge Paige Reason, Jerome A Leis, Claudia Cocco, Lynfa Stroud, Michelle Hladunewich, Debra Carew, et al. (+6)
1647 [GO] 2021―Dec―05 364. Individualized Prognostics in COVID-19 Facilitated by Computer Recognition of Blood Leukocyte Subsets Claudia R Libertin, Prakash Kempaiah, Ravindra Durvasula, Ariel Rivas
1648 [GO] 2021―Dec―05 318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization Mahmoud Al-Saadi, Carlos Malvestutto, Mohammad Mahdee Sobhanie, Courtney Hebert, Nora Colburn, Mark Lustberg
1649 [GO] 2021―Dec―05 459. COVID-19 Hospitalization and 30-Day Readmission: A Cohort Study of U.S. Hospitals Essy Mozaffari, Shuting Liang, Henry Morgan Stewart, Mark Thrun, Paul Hodgkins, Richard Haubrich
1650 [GO] 2021―Dec―05 551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Qishuo Zhang, Chul Won Chung, et al. (+5)
1651 [GO] 2021―Dec―05 432. An Outbreak of Coronavirus Disease, 2019 (COVID-19) in a Skilled Nursing Facility - California, 2021: Description, Mitigation, Challenges, and Opportunities Anastasia Maletz, Grace Kang, Raymond Y Chinn, John D Malone, Hosniyeh Bagheri, Margaret M Turner, et al. (+8)
1652 [GO] 2021―Dec―05 LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila, Seth Seegobin, et al. (+13)
1653 [GO] 2021―Dec―05 494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis T Shaifer Jones, Myles Stone, Amy Nham, Nicole A Bratsch, Trevor N Thompson, Christopher Jentoft, Ryan M Close
1654 [GO] 2021―Dec―05 340. Outcomes of COVID-19 in Hospitalized SOT Recipients: Experence in Colombia, South America Fernando Rosso, Eric Tafurt
1655 [GO] 2021―Dec―05 1207. Coronavirus Disease, 2019 (COVID-19) in Long-Term Care Facilities (LTCF): One Large County’s Response, California 2020-2021 Raymond Y Chinn, Sayone Thihalolipavan, Jennifer Wheeler, Grace Kang, John D Malone, Eric McDonald
1656 [GO] 2021―Dec―05 317. Invasive Fungal Infections in Critically-ill Patients with COVID-19 in Mexico City Eduardo S Bojorges-Aguilar, Carla M Roman-Montes, Areli Martinez-Gamboa, Andrea Rangel-Cordero, Paulette G Diaz-Lomeli, Eduardo Rivero-Sigarroa, et al. (+3)
1657 [GO] 2021―Dec―05 321. Clinical Characteristics of Hospitalized HIV Patients with COVID-19 in Miami Folusakin Ayoade, Jose G Castro, Priscilla Valls, Tanya R Quiroz, Annette Amoros
1658 [GO] 2021―Dec―05 1336. Outcomes of COVID-19 in Recent Kidney Transplants Recipients at a Large Transplant Center in Miami Maria A Mendoza, Ana Coro, Yoichiro Natori, Shweta Anjan, Giselle Guerra, Adela Mattiazzi, et al. (+5)
1659 [GO] 2021―Dec―05 555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System Aisling Caffrey, J Xin Liao, Vrishali Lopes
1660 [GO] 2021―Dec―05 524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge Benjamin Gee, Anita Cheruvanky, Graciela Faiad, Aldon Li, Huan Pham, Earl Quijada, et al. (+2)
1661 [GO] 2021―Dec―05 515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States Kelly Zalocusky, Shemra Rizzo, Devika Chawla, Yifeng Chia, Tripthi Kamath, Larry Tsai
1662 [GO] 2021―Dec―05 26. Risk of Post-COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States Kelly Zalocusky, Devika Chawla, Margaret Neighbors, Shemra Rizzo, Larry Tsai
1663 [GO] 2021―Dec―05 121. Mucormycosis and COVID-19 in the United States: a Real-World Evidence Analysis of Risk Factors and Survival Among Patients with Mucormycosis, with and without COVID-19 Preceding the Infection Kaylen Brzozowski
1664 [GO] 2021―Dec―05 498. Baricitinib in Patients with Severe Pneumonia due to COVID-19 in Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Méndez, Gustavo Miguel Zamudio-Severino, Jesús Salvador Sánchez-Díaz, Benito Navarrete-Espinosa, Miguel Ángel Rivera-Viñas, et al. (+20)
1665 [GO] 2021―Dec―05 46. Racial and Ethnic Disparities in COVID-19 Incidence among Persons with HIV in a Multisite-Cohort Edward R Cachay, laura Bamford, Adrienne Shapiro, Bridget M Whitney, Darcy Wooten, Maile Karris, et al. (+12)
1666 [GO] 2021―Dec―05 450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient Debra Yee, Marana Tso, Elana Shaw, Lindsey B Rosen, Emily Samuels, Paul Bastard, et al. (+16)
1667 [GO] 2021―Dec―05 411. Significance of a Known Epidemiological Link to a COVID-19 Index Case and Severity of COVID-19 Infection Christopher Kandel, Allison McGeer, Joshua Friedland, Altynay Shigayeva, Samira Mubareka
1668 [GO] 2021―Dec―05 360. Evaluation of Cycle Threshold Values in Patients with Symptomatic COVID-19 Infection Danielle Dixon, Julieta Madrid-Morales, Jose Cadena-Zuluaga, Christopher R Frei
1669 [GO] 2021―Dec―05 961. Experience, Lessons, and Strategies in Developing a High-Impact Real-Time Learning Network for Clinicians Caring for Patients with COVID-19 Infection Ravina Kullar, Payal K Patel, Marjorie Connolly, Coran Jallah, Gayle Levy, Varun Phadke, et al. (+6)
1670 [GO] 2021―Dec―05 409. High Engagement in Social Distancing and Mask Wearing and Associations with Reduced COVID-19 Infection Among California College Students Lindsey Walicek, Annette Regan, Kelly L’Engle, Marie-Claude Couture
1671 [GO] 2021―Dec―05 201. Comparison of Bloodstream Infections Between Hospitalized Patients with and without COVID-19 Infection During the First Wave of the COVID-19 Pandemic in a Community Hospital in South Bronx: An Observational Study Afsheen Afzal, Edgar Gomez, Victor Perez Guttierrez, Aye Myat Mon, Carolina Moreira Sarmiento, Amna Khalid, et al. (+12)
1672 [GO] 2021―Dec―05 549. Monoclonal Antibody Therapy for COVID-19 Infection in Michigan: The Flint Experience Mariam Younas, Danielle Osterholzer, Brandon R Flues, Carlos Rios-Bedoya, Philip McDonald, Ghassan Bachuwa, et al. (+2)
1673 [GO] 2021―Dec―05 402. COVID-19 Infection in Nepal: Epidemiological Analysis from April 2020 to March 2021 Hai V Le
1674 [GO] 2021―Dec―05 467. COVID-19 Infection in Persons Living with HIV in a Network of Community Health Centers in New York Aisha S Khan, Christine A Kerr, Jenny Doyle, Sonia Punj, Julie Coleman, Iris Arzu, et al. (+3)
1675 [GO] 2021―Dec―05 310. Cryptococcal Infection Following COVID-19 infection in Solid Organ Transplant Recipients: A Case Series Jeremey Walker, Peter Pappas, Lauren Nicholas Herrera, Cameron White, Anoma Nellore, Todd P McCarty
1676 [GO] 2021―Dec―05 146. Intact Sense of Taste and Smell During COVID-19 Infection Is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic Illness James M Wilson, Sheena Gillani, Robert Bencshop, Josh Poorbaugh, Ajay Nirula, Lin Zhang, et al. (+6)
1677 [GO] 2021―Dec―05 181. Potential Benefit of Masking and other COVID-19 Infection Prevention Measures on Late-Onset Infections in the NICU Charlene Bultmann, Jaclyn Wiggins, Sagori Mukhopadhyay, Dustin Flannery, Mark Conaway, Miren Dhudasia, et al. (+18)
1678 [GO] 2021―Dec―05 426. COVID-19 Infection Prevention Practices That Exceed CDC Guidance: Balancing Extra Caution Against Impediments to Care Shruti K Gohil, Edward Septimus, Kenneth Sands, Eunice J Blanchard, Julia Moody, Annabelle De St Maurice, et al. (+16)
1679 [GO] 2021―Dec―05 41. Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients Shruti K Gohil, Annabelle De St Maurice, Deborah S Yokoe, Deborah S Yokoe, Stuart H Cohen, Francesca J Torriani, et al. (+7)
1680 [GO] 2021―Dec―05 926. COVID-19 Infections After SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients Kapil Saharia, Judy Streit, Susan E Beekmann, Philip M Polgreen, Matthew Kuehnert, Dorry Segev, et al. (+2)
1681 [GO] 2021―Dec―05 331. Hospitalized COVID-19 infections in Infants < 1 Year of Age Christina Gagliardo, Eberechi I Nwaobasi-Iwuh, Niva Shah, Aparna Prasad, Neeraja Kairam, Stephanie Chiu, et al. (+4)
1682 [GO] 2021―Dec―05 365. Assessing Provider Utilization of COVID-19 Inflammatory Marker Trends in Hospitalized Patients and Implications in Optimizing Value-Based Care During a Pandemic Praveen Subramanian, Lucy Stun, Nathan Bahr, Lewis Satterwhite, Maharshi Bhakta, Wissam El Atrouni, et al. (+2)
1683 [GO] 2021―Dec―05 446. Prognostic Value of Absolute Lymphocyte Count for Disease Severity and Clinical Outcomes in Adult COVID-19 Inpatients Jianli Niu, Candice Sareli, Maria Deane, Aharon E Sareli
1684 [GO] 2021―Dec―05 414. Observed Time Burden with Nursing Practices in an Emergency Room COVID-19 Isolation Zone at a University Affiliated Hospital in Korea Imyoung Choi, JaHyun Kang
1685 [GO] 2021―Dec―05 559. A Nationwide Survey of COVID-19 Management in the Dominican Republic Over the Course of the Pandemic Alfredo J Mena Lora, Rita Alexandra Rojas-Fermin, David de Luna, Stephanie L Echeverria, Yori Roque, Ruben Calcano, et al. (+9)
1686 [GO] 2021―Dec―05 973. Utilization of Project ECHO for COVID-19 Medical Knowledge and Best Practices for Health Professionals serving an Underserved Population Natalia Rodriguez, Melanie Goebel, Sheena Bhushan, Shital Patel
1687 [GO] 2021―Dec―05 861. Impact of COVID-19 Mitigation Measures on PrEP Care at a Safety Net Health System in Atlanta Valeria D Cantos, Kate Ferencsik, Jennifer Prevot, Kelly Reyna, Gabriela Georgial, Karla I Galaviz, et al. (+5)
1688 [GO] 2021―Dec―05 537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center Pratish C Patel, Ayne Adenew, Angela McKnight, Kevin Jeng, Angelike P Liappis
1689 [GO] 2021―Dec―05 522. Evaluation of Three COVID-19 Monoclonal Antibody Regimens in the Context of Rising B.1.526 Prevalence in New York City Hongkai Bao, Yi Guo, Kelsie Cowman, Victor Chen, Priya Nori, Priya Nori
1690 [GO] 2021―Dec―05 558. Implementation and Outcomes of a COVID-19 Monoclonal Antibody Treatment Program in an Urban Safety-net Community Hospital Alfredo J Mena Lora, Stephanie L Echeverria, Fischer Herald, James McSweeney, Harshil Gumasana, Rodrigo M Burgos, Scott Borgetti
1691 [GO] 2021―Dec―05 288. Clinical Variables Associated with COVID-19 Mortality and ICU Admission in a Public Safety-net Hospital in Chicago Ruben A Hernandez-Acosta, Juan Sarmiento, Palak Patel, Michael Hoffman, Katayoun Rezai
1692 [GO] 2021―Dec―05 339. COVID-19 Mortality in a Private Hospital in Mexico City Maria Lorena Cabrera Ruiz, Paulo Castañeda-Méndez, Daniel Aguilar-Zapata, Javier Reyes Mar, Gonzalez Chon Octavio, Luis E Soto-Ramirez
1693 [GO] 2021―Dec―05 443. Pre-vaccination Antibody Titers Against Seasonal Coronaviruses And Antibody Responses to the Pfizer-BioNTech BNT162b2 COVID-19 mRNA Vaccine in Healthcare Workers Eric Laing, Si’Ana Coggins, Kevin Schully, Emily Samuels, Emilie Goguet, Matthew Moser, et al. (+19)
1694 [GO] 2021―Dec―05 572. Real-world Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in a Retrospective Cohort Farhaan S Vahidy, Lauren Pischel, Mauricio E Tano, Alan Pan, Marc L Boom, Henry Sostman, et al. (+2)
1695 [GO] 2021―Dec―05 25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients Bruce P Bausk, Amy C Sherman, Michaël Desjardins, Natalie E Izaguirre, Chi-An Cheng, Megan Powell, et al. (+17)
1696 [GO] 2021―Dec―05 586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies Natalie E Izaguirre, Amy C Sherman, Jennifer Crombie, Michaël Desjardins, Chi-An Cheng, Tal Gilboa, et al. (+9)
1697 [GO] 2021―Dec―05 404. COVID-19 Normality Rate: Criteria for Optimal Time to Return to In-person Learning Carlos Starling, Jackson Machado-Pinto, Unaí Tupinambás, Estevão Urbano Silva, Bráulio R G M Couto
1698 [GO] 2021―Dec―05 352. COVID-19 Not a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea Jeehyun Kim, Kwan Hong, Sujin Yum, Raquel Elizabeth Gomez Gomez, Byung Chul Chun
1699 [GO] 2021―Dec―05 130. Effects of COVID-19 on a Complex Behavioral Intervention to Improve the Diagnosis and Management of UTI in Nursing Homes James H Ford, Sally Jolles, Dee Heller, Katie Selle, Daniela Uribe-Cano, Susan Nordman-Oliveira, et al. (+3)
1700 [GO] 2021―Dec―05 753. Impact of COVID-19 on Healthcare Facility-Onset Clostridiodes difficile Infection Geehan Suleyman, Rafa Khansa, Ramesh Mayur, Indira Brar, Rachel Kenney
1701 [GO] 2021―Dec―05 171. The Impact of COVID-19 on Healthcare-Associated Infections Meghan A Baker, Kenneth Sands, Susan S Huang, Ken Kleinman, Edward Septimus, Neha Varma, et al. (+16)
1702 [GO] 2021―Dec―05 454. Impact of Covid-19 on Infectious Disease Fellows in the United States: A National Survey to Identify Targets for Intervention Shuba Balan, Shweta Anjan, Alison Ohringer, Jose Gonzales-Zamora, Deborah Jones Weiss, Michele I Morris, et al. (+3)
1703 [GO] 2021―Dec―05 LB3. Baricitinib plus Standard of Care for Hospitalized Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomized, Placebo-Controlled Trial E Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, Stephanie de Bono, Ran Liao, Maria Lucia B Piruzeli, et al. (+4)
1704 [GO] 2021―Dec―05 597. The Impact of COVID-19 on Outpatient Intravenous Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers (POICs) Clifford P Martin, Robin H Dretler, Jorge R Bernett, Barry Statner, Thomas K Sleweon, Quyen Luu, et al. (+5)
1705 [GO] 2021―Dec―05 415. A Whole Genome Sequencing Analysis of a Multi-unit Long-term Care Facility COVID-19 Outbreak Ling Yuan Kong, Leighanne Parkes, Yves Longtin, Christina Greenaway, Jerry Zaharatos, Vivian Loo, et al. (+5)
1706 [GO] 2021―Dec―05 366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers Krishna Surasi, Kristin J Cummings, Carl V Hanson, Mary Kate Morris, Maria Salas, David Seftel, et al. (+4)
1707 [GO] 2021―Dec―05 425. Sustained Control and Prevention of COVID-19 Outbreaks in Detroit Skilled Nursing Facilities Seema Joshi, Abigail Manning, James Bivins, Samia Arshad, Amen Agbonze, Anita M Berger, et al. (+14)
1708 [GO] 2021―Dec―05 188. Visualizing the Impact of a Wedding Leading to COVID-19 Outbreaks in Healthcare Settings, Washington State, July - August 2020 Audrey Brezak, Anna Unutzer, James W Lewis, Shauna Clark, Jessica Ferro, Siri Bliesner, et al. (+11)
1709 [GO] 2021―Dec―05 433. Role of Community Vaccination Coverage in Controlling Future COVID-19 Outbreaks in Nursing Homes: A Modeling Study Brajendra K Singh, Joseph Walker, Prabasaj Paul, Sujan Reddy, John A Jernigan, John A Jernigan, Rachel Slayton
1710 [GO] 2021―Dec―05 32. Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome Alon Angel, Niv Samuel Mastboim, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, et al. (+23)
1711 [GO] 2021―Dec―05 747. Association of Clostridiodes difficile Infection Incidence With Renewed Vigor in Infection Prevention Practices With the Onset of the COVID-19 Pandemic Ahmed A Khan, Sana Waqar
1712 [GO] 2021―Dec―05 624. Perceptions of Telemedicine among Infectious Disease Outpatient Providers during the COVID-19 Pandemic Prishanya Pillai, Karen Carvajal, Angelina Winbush, Rohith Palli, Ted Louie
1713 [GO] 2021―Dec―05 738. Comparison of Characteristics of US International Travelers Seeking Pretravel Health Consultations at US Global TravEpiNet Sites Before and During the COVID-19 Pandemic Mylinh H Le, Sowmya R Rao, Alison T Walker, Edward T Ryan, Regina C LaRocque, Emily P Hyle
1714 [GO] 2021―Dec―05 465. Mental Health Treatment Disparities During the COVID-19 Pandemic Katherine Kricorian, Karin Kricorian
1715 [GO] 2021―Dec―05 557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic J Xin Liao, Vrishali Lopes, Aisling Caffrey
1716 [GO] 2021―Dec―05 422. Sustainability of Improvements to Hand Hygiene Performance Throughout the COVID-19 Pandemic Victoria R Williams, Matthew Muller, Jeff Powis, Daniel R Ricciuto, Dominik Mertz, Kevin Katz, et al. (+6)
1717 [GO] 2021―Dec―05 428. Assessing the Confidence, Knowledge and Preferences of Hospital Staff with Regards to Personal Protective Equipment (PPE) Practices During the COVID-19 Pandemic Rachel Brown, Sharon Markman, Amanda Brown, Rukhshan Mian, Vineet Arora, Craig Umscheid
1718 [GO] 2021―Dec―05 469. The Mental Health Implications of Job Loss for Never-married Women During the COVID-19 Pandemic Katherine Kricorian
1719 [GO] 2021―Dec―05 429. Infection Prevention During Use of a Warm Zone Model in Cohort Patient Care Locations during the COVID-19 Pandemic Joseph Sacht, Samantha Holton, Mylinh Yun, Jay Varkey
1720 [GO] 2021―Dec―05 477. Increased Referrals for New PFAPA (Aphthous Stomatitis, Pharyngitis, Adenitis) Diagnosis During the COVID-19 Pandemic Bessey Geevarghese, Shan Sun, Ravi Jhaveri
1721 [GO] 2021―Dec―05 295. SARS-CoV-2 Infection in a Referral Cancer Center in Mexico City During the First Year of the COVID-19 Pandemic Diana Vilar-Compte, Daniel De La Rosa Martinez, Alexandra Martín-Onraet, Carolina Pérez-Jiménez, Beda Islas-Muñoz, Pamela Alatorre-Fernández, et al. (+5)
1722 [GO] 2021―Dec―05 1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic Olivia D Reese, Ashley Tippett, Laila Hussaini, Luis Salazar, Megan Taylor, Caroline Ciric, et al. (+16)
1723 [GO] 2021―Dec―05 1175. Influenza Vaccine Hesitancy in Hospitalized Children, Before and During the COVID-19 Pandemic Marisa Orbea, Jose Dominguez, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
1724 [GO] 2021―Dec―05 152. Use of Antimicrobials among Suspected COVID-19 Patients at Selected 12 Hospitals in Bangladesh: Findings from the First Wave of COVID-19 Pandemic Syeda Mah-E-Muneer, Md Zakiul Hassan, Md Abdullah Al Jubayer Biswas, Zubair Akhtar, Pritimoy Das, Fahmida Rahman, et al. (+2)
1725 [GO] 2021―Dec―05 163. MIC Shifts in Response to Increased Antibiotic Utilization During COVID-19 Pandemic Jonathan Byrd, Neena Thomas-Gosain, Jane V Eason, Jessica Bennett, Jarred Bowden
1726 [GO] 2021―Dec―05 160. Urgent Care Prescriber Perspectives on Antibiotic Prescribing During the COVID-19 Pandemic Brooke Betts, David R Ha, Marisa Holubar, Marisa Holubar, Maja Artandi, Sharon Onguti, Ian Nelligan
1727 [GO] 2021―Dec―05 16. An Ambulatory Quality Improvement Initiative to Optimize Influenza Vaccination Amongst Adults Living with HIV During the COVID-19 Pandemic Deborah A Kahal, Christopher James, Brian Wharton, Sherine Eaddy, Elizabeth Gaines, Karen Henry, et al. (+2)
1728 [GO] 2021―Dec―05 161. The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic Sara C Keller, Tania M Caballero, Pranita Tamma, Pranita Tamma, Melissa A Miller, Prashila Dullabh, et al. (+7)
1729 [GO] 2021―Dec―05 183. Decrease in Invasive Pneumococcal Disease in 7 United States Children’s Hospitals during the COVID-19 Pandemic Adriana Sarmiento Clemente, Sheldon L Kaplan, William J Barson, Philana L Lin, Jose R Romero, John S Bradley, et al. (+4)
1730 [GO] 2021―Dec―05 152. Sharp Decline in Rates of Community Respiratory Viral Infections Among NIH Clinical Center Patients During the COVID-19 Pandemic Michele Woolbert, Ninet Sinaii, Christine Spalding, David K Henderson, Tara N Palmore
1731 [GO] 2021―Dec―05 1129. Outpatient Prescribing During the COVID-19 Pandemic Ganga Moorthy, Congwen Zhao, Michael J Smith
1732 [GO] 2021―Dec―05 867. Telehealth and HIV Care During the COVID-19 Pandemic Smitha Gudipati, Monica Lee, Indira Brar, Norman Markowitz
1733 [GO] 2021―Dec―05 874. Impact of Telehealth in HIV Ambulatory Clinic during COVID-19 Pandemic Impact of Telehealth in HIV Ambulatory Clinic during COVID-19 Pandemic Sandhya Nagarakanti, Eliahu Bishburg, Donna George, Kristen Ehlers
1734 [GO] 2021―Dec―05 174. Increase in Candida auris cases in New Jersey healthcare facilities during the COVID-19 pandemic - 2017-2020 Reed Magleby, Gabriel Innes, Diya Cherian, Jessica Arias, Jason Mehr, Kaitlin Forsberg, et al. (+2)
1735 [GO] 2021―Dec―05 1441. Significant Decrease in the Incidence Rate of Common Outpatient Upper Respiratory Tract Infection Diagnoses per Clinic Visit in the First Respiratory Season of October 2020 to March 2021 During the Covid-19 Pandemic. A Report From an Outpatient Antimicrobial Stewardship Program at a community hospital in Brooklyn Jilan M Shah, Olga Badem, Zeyar Thet, Thinzar Wai, Karthik Seetharam, Olawale Akande, et al. (+5)
1736 [GO] 2021―Dec―05 758. Increased Prevalence of Clostridioides difficile Infection During the COVID-19 Pandemic Among Hospitalized Veterans in South Texas, USA Eric H Young, Erica Beck, Delvina Ford, Julieta Madrid-Morales, Ann Hoffman, Jose Cadena-Zuluaga, et al. (+2)
1737 [GO] 2021―Dec―05 476. A Global Survey of Countermeasures Against the COVID-19 Pandemic Among Solid Organ Transplant Centers Aasith Villavicencio, Mohammed Raja, Deepali Kumar, Deepali Kumar, Lara Danziger-Isakov, Lara Danziger-Isakov, et al. (+5)
1738 [GO] 2021―Dec―05 12. Modeled Impact of the COVID-19 Pandemic and Associated Reduced Adult Vaccinations on Herpes Zoster in the United States Elizabeth M La, Desmond Curran, Ahmed Salem, David Singer, Nicolas Lecrenier, Sara Poston
1739 [GO] 2021―Dec―05 1123. Appropriateness of Antibiotic Prescribing Through the COVID-19 Pandemic and Associated Telehealth Visits Bethany A Wattles, James A Stahl, Kahir S Jawad, Yana Feygin, Maiying Kong, Navjyot Vidwan, et al. (+2)
1740 [GO] 2021―Dec―05 779. COVID-19 Pandemic and Catheter-associated Urinary Tract Infection Trends Geehan Suleyman, Rita Kassab, Smitha Gudipati, Ramesh Mayur, Indira Brar
1741 [GO] 2021―Dec―05 385. SARS-CoV-2 Infections Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic and One-Year Follow-Up Elizabeth Cooper, Tida Lee, Eric Laing, Andrew Ritter, Melissa Lee, Matthew Baker, et al. (+11)
1742 [GO] 2021―Dec―05 774. Outbreak of Central-Line-Associated Bloodstream Infections (CLABSI) amid the COVID-19 Pandemic Associated with Changes in Central Line Dressing Care Accompanying Changes in Nursing Education, Nursing Documentation, and Dressing Supply Kits Ahad Azeem, Irene L Newquist, Lesley L Royal, Kimberly S Hemrick, Zachary A Creech, Shiv A Patel, et al. (+4)
1743 [GO] 2021―Dec―05 154. Antibiotic Use During Three Separate Waves of the COVID-19 Pandemic at a Large Academic Medical Center in Detroit, MI Deepika Sivakumar, Shelbye R Herbin, Raymond Yost, Marco R Scipione
1744 [GO] 2021―Dec―05 48. Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic Walid El-Nahal, Nicola Shen, Catherine Lesko, Anthony Fojo, Bryan Lau, Jeanne Keruly, et al. (+5)
1745 [GO] 2021―Dec―05 410. The Importance of Personal Protective Equipment Education Opportunities and Messages of Encouragement at the Workplace to Reduce Burnout: Cross-sectional Survey After the First Wave of the COVID-19 Pandemic in Japan Takahiro Matsuo, Fumika Taki, Daiki Kobayashi, Torahiko Jinta, Chiharu Suzuki, Akiko Ayabe, et al. (+5)
1746 [GO] 2021―Dec―05 1199. Decreased Human Respiratory Syncytial Virus Activity during the COVID-19 Pandemic in Japan: An Ecological Time-Series Analysis, 2014 through 2020 Keita Wagatsuma, Iain S Koolhof, Reiko Saito
1747 [GO] 2021―Dec―05 1209. The Evolving Nature of Syndromic Surveillance During the COVID-19 Pandemic in Massachusetts Sarah J Willis, Karen Eberhardt, Liisa Randall, Alfred DeMaria, Catherine M Brown, Lawrence C Madoff, et al. (+4)
1748 [GO] 2021―Dec―05 804. Infection Control and Clinical Support in Long-Term Care Homes During the COVID-19 Pandemic in North Toronto: A Quasi-Experimental Study Maria M Magaz, Jaclyn O’Brien, Victoria R Williams, Christina Chan, Adrienne Chan, Natasha Salt, Jerome A Leis
1749 [GO] 2021―Dec―05 341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab Barbara Barsoum, Kai-Ming Chang, Nicole Mulvey, Henry Donaghy, Thien-Ly Doan
1750 [GO] 2021―Dec―05 34. Stemming the Rise in Antibiotic Prescription for Community Acquired Respiratory Infections (ARI) During COVID-19 Pandemic in Singapore General Hospital (SGH) Shena Yun Chun Lim, Peijun Yvonne Zhou, Daphne Yah Chieh Yii, Kai Chee Hung, Lai Wei Lee, Yi Xin Liew, et al. (+9)
1751 [GO] 2021―Dec―05 707. Hospital-Onset Clostridioides difficile Infection Rates During COVID-19 Pandemic in the ICU Patients Evdokia Gavrielatou, prodromos Temperikidis, Michalis Tsimaras, eleni magira
1752 [GO] 2021―Dec―05 1179. PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the US Liping Huang, Jennifer L Nguyen, Johnna Perdrizet, Tamuno Alfred, Adriano Arguedas
1753 [GO] 2021―Dec―05 101. PCV13 Pediatric Vaccination Disparity and Impact Due to COVID-19 Pandemic in the US Liping Huang, Jennifer L Nguyen, Johnna Perdrizet, Tamuno Alfred, Adriano Arguedas
1754 [GO] 2021―Dec―05 970. Medical Student Engagement with the COVID-19 Pandemic Is Increased Through Participation in a Preclinical Elective Kaelyn C Cummins, Katherine Naeger, Prathit A Kulkarni
1755 [GO] 2021―Dec―05 169. The Resurgence of Candida auris in California during the Novel Coronavirus (COVID-19) Pandemic, May 2020-May 2021 Tisha Mitsunaga, Diana Holden, Ellora Karmarkar, Idamae Kennedy, Teresa Nelson, Vikram Haridass, et al. (+24)
1756 [GO] 2021―Dec―05 1339. Impact of COVID-19 Pandemic on Activity of Other Respiratory Viral Pathogen and Norovirus Lauren DiBiase, Emily Sickbert-Bennett, David J Weber, David J Weber, Melissa B Miller
1757 [GO] 2021―Dec―05 47. Impact of COVID-19 Pandemic on an Emergency Department Opt-out HIV Screening Program: An Interrupted Time Series Analysis Jianli Niu, Paula Eckardt
1758 [GO] 2021―Dec―05 162. The Impact of the COVID-19 Pandemic on Antibiotic Prescribing in Pediatric Primary Care Lauren Dutcher, Yun Li, Giyoung Lee, Robert Grundmeier, Keith W Hamilton, Jeffrey Gerber
1759 [GO] 2021―Dec―05 408. Impact of the COVID-19 Pandemic on Antimicrobial Use and Resistance in the United States and the Dominican Republic Alfredo J Mena Lora, Rita Alexandra Rojas-Fermin, Stephanie L Echeverria, Katia Castro, Anel E Guzman, Scott Borgetti, Susan C Bleasdale
1760 [GO] 2021―Dec―05 964. Impact of the COVID-19 Pandemic on Bedside Medical Education: A Mixed-Methods Study Eva Clark, Jennifer Freytag, Sylvia J Hysong, Bich Dang, Thomas P Giordano, Prathit A Kulkarni
1761 [GO] 2021―Dec―05 660. Effect of the COVID-19 Pandemic on Blood Culture Contamination Rates and Quality Improvement Processes Alexander G Hosse
1762 [GO] 2021―Dec―05 770. Impact of COVID-19 Pandemic on Central Line-associated Bloodstream Infections in Metropolitan Detroit Geehan Suleyman, Nicholas sturla, Smitha Gudipati, Indira Brar, Ramesh Mayur
1763 [GO] 2021―Dec―05 886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US Gerald Pierone, Jennifer S Fusco, Laurence Brunet, Cassidy Henegar, Jean A van Wyk, Supriya Sarkar, et al. (+4)
1764 [GO] 2021―Dec―05 896. Examining the Impact of the COVID-19 Pandemic on Delivery of HIV Care and Prevention Services Among Patients in a Ryan White Clinic Michelle Zhang, Sharlay Butler, Jason Kennedy, Molly McKune, Ghady Haidar, Deborah McMahon
1765 [GO] 2021―Dec―05 492. Impact of the COVID-19 Pandemic on Diabetes Surrogate Markers in a Population of People Living with HIV Tyler Maxwell, Esther Kanner, Nubriel Hernandez, Suzanne Molino, Jessica E Yager, Shannon Ramdeen, Roopali Sharma
1766 [GO] 2021―Dec―05 172. Impact of COVID-19 Pandemic on Healthcare-associated Infections (HAIs) in a Large Network of Hospitals Sonali D Advani, Sonali D Advani, Emily Sickbert-Bennett, Elizabeth Dodds Ashley, Andrea Cromer, Yuliya Lokhnygina, et al. (+5)
1767 [GO] 2021―Dec―05 1338. Before and After: The Impact of the COVID-19 Pandemic on Influenza-Like Illness Trends in PAIVED Rhonda E Colombo, Stephanie A Richard, Christina Schofield, Limone Collins, Anuradha Ganesan, Casey Geaney, et al. (+16)
1768 [GO] 2021―Dec―05 1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children Helen E Groves, Jesse Papenburg, Kayur Mehta, Julie A Bettinger, Manish Sadarangani, Scott Halperin, Shaun Morris
1769 [GO] 2021―Dec―05 193. Impact of COVID-19 Pandemic on Pulmonary Tuberculosis Evaluations and Diagnosis at a Large Safety Net Hospital in Los Angeles, California Aditya J Jones, Edward C Jones-Lopez, Susan Bulter-Wu, Melissa L Wilson, John Rodman, Christian Voyageur, Brenda E Jones
1770 [GO] 2021―Dec―05 706. Effect of the Covid-19 Pandemic on Rates of Recurrent Clostridiodes difficile Infection in the Veterans Affairs System Dimitri M Drekonja, Jane Zhang, Andrew R Reinink, Ruth Anway, Sean Nugent, Aasma Shaukat
1771 [GO] 2021―Dec―05 845. Impact of the COVID-19 Pandemic on Routine HIV Screening in an Emergency Department Elizabeth A Aguilera, Gilhen Rodriguez, Gabriela P Del Bianco, Gloria Heresi, James Murphy, Samuel Prater
1772 [GO] 2021―Dec―05 811. Impact of the COVID-19 Pandemic on Surgical Volume and Surgical Site Infections (SSI) in a Large Network of Community Hospitals Erin Gettler, Jessica Seidelman, Becky A Smith, Deverick J Anderson
1773 [GO] 2021―Dec―05 604. Impact of COVID-19 Pandemic on Telehealth Practices in Pediatric Infectious Diseases Sindhu Mohandas, Daniel Olson, Sergio Fanella, Amin Hakim, Claudia Gaviria-Agudelo, Sabah Kalyoussef
1774 [GO] 2021―Dec―05 1407. The Latent Tuberculosis Infection Cascade of Care during the COVID-19 Pandemic Response in a Mid-Sized US City Trevor M Stantliff, Lauren Houshel, Rinki Goswami, Serenity Millow, Gabrielle Cook, Robin Knapmeyer, et al. (+3)
1775 [GO] 2021―Dec―05 452. Correlation of Charleston Comorbidity Index Score as the COVID-19 Pandemic Surged Throughout HCA Healthcare Facilities and Patient Outcomes Irene Riestra Guiance, Ernesto Robalino Gonzaga, Isabel Riestra, Steven Char, Minh Q Ho
1776 [GO] 2021―Dec―05 19. Delivery of Flu Immunizations to Healthcare Workers During COVID-19 Pandemic Using a Multidisciplinary Flu Team Approach in a Tertiary Center in the Middle East Lyssette Cardona, Shafii Mohammed, Samah Nour, Mu’ed Alkhalaileh
1777 [GO] 2021―Dec―05 420. Emergency Nurses’ Experiences over 1 Year of the COVID-19 Pandemic: A Qualitative Study Ki Rog Lee, JaHyun Kang
1778 [GO] 2021―Dec―05 165. Decreased Antimicrobial Consumption and Decreased Rates of Multi-drug Resistant Organisms Following Onset of the COVID-19 Pandemic: Experience from an Australian Tertiary Hospital Michael Moso, Kelly Cairns, Trisha Peel, Nenad Macesic
1779 [GO] 2021―Dec―05 149. Impact of Stewardship on Antibiotic Utilization Rates During the COVID-19 Pandemic: Successes and Challenges in a Regional Hospital Ana Macias, Jennifer Elgin, Donna Duerson, Cirle A Warren
1780 [GO] 2021―Dec―05 11. People Living with HIV During the COVID-19 Pandemic: Who Did (or Did Not) Receive Annual Influenza Vaccination? Deborah A Kahal, Brian Wharton, Christopher James, Richard Caplan, Bincsik K Arlene
1781 [GO] 2021―Dec―05 974. The Use of Social Media for Medical Education During the COVID-19 Pandemic; A Vision to the Future Maria Jose Reyes Fentanes, Paula Amescua Guerra, Armelle Perez Cortes Villalobos
1782 [GO] 2021―Dec―05 327. Assessment of Bacterial Co-infection Rates and Antibiotic Exposure in COVID-19 Patients Adam J Luetkemeyer, Nick Bennett, Laura Aragon, Jeannette Ploetz, Sarah E Boyd
1783 [GO] 2021―Dec―05 304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients Francisco Javier Membrillo de Novales, Miriam Estébanez Muñoz, Tatiana Mata Forte, Germán Ramírez-Olivencia, María Isabel Zamora Cintas, María Simón Sacristán, et al. (+3)
1784 [GO] 2021―Dec―05 330. Evaluating the Relationship Between Comorbidity Treatment Status and In-hospital Mortality Among COVID-19 Patients Cristy Davenport, Sharmon P Osae, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Daniel B Chastain
1785 [GO] 2021―Dec―05 455. Diagnostic Value of Hematological Parameters in Different Stages of the Disease in Covid-19 Patients Ruhma Ali, Aditya Patel, Kok Hoe Chan, Jihad Slim
1786 [GO] 2021―Dec―05 504. Case SEries: Nasal Antimicrobial Photodisinfection (APDT) as Treatment Protocol for Asymptomatic and Early Stage COVID-19 Patients Jack Kolenda, Josepmaria Argemi
1787 [GO] 2021―Dec―05 307. Predictors of Respiratory Bacterial Co-Infection in Hospitalized COVID-19 Patients Erica E Reed, Austin Bolker, Kelci E Coe, Jessica M Smith, Kurt Stevenson, Shu-Hua Wang
1788 [GO] 2021―Dec―05 1335. High Serum Levels of Interleukin-10 as a Predictor Factor of In-Hospital Mortality in COVID-19 Patients Salome Gomez-Duque, Enrique Gamboa-Silva, Ingrid G Bustos-Moya, Yuli Fuentes, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+9)
1789 [GO] 2021―Dec―05 LB2. Safety and Efficacy of Combination SARS-CoV-2 Monoclonal Neutralizing Antibodies (mAb) BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients Teresa H Evering, Mark Giganti, Kara W Chew, Michael Hughes, Carlee Moser, David Alain Wohl, et al. (+12)
1790 [GO] 2021―Dec―05 299. D-dimer as an ICU Admission Risk Predictor in COVID-19 Patients, A Prospective Study Oriana Narváez - Ramírez, Lina Morales-Cely, Ingrid G Bustos-Moya, Yuli Viviana Fuentes-Barreiro, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+7)
1791 [GO] 2021―Dec―05 138. Tele-COVID Rounds and Tele-Stewardship Surveillance Reduces Antibiotic Use in COVID-19 Patients Admitted to 17 Small Community Hospitals John J Veillette, Stephanie C Shealy, Stephanie Gelman, Edward A Stenehjem, Steven K Throneberry, Michael Pirozzi, et al. (+5)
1792 [GO] 2021―Dec―05 282. Risk Factors for Mortality in Severe COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Single-Center Study in Saudi Arabia Sherif Khattab, Souad AlMuthree, Mohamed Bakry, Noha Ibraheem, Omar Alghamdi, Mahassen Khalifa, et al. (+2)
1793 [GO] 2021―Dec―05 284. Antibiotic Prescribing Trends in Hospitalized Influenza Versus COVID-19 Patients at a Community-Based Health System Aileen Martinez, Lyssette Cardona, Nina Ricci
1794 [GO] 2021―Dec―05 303. Evaluation of Antimicrobial Utilization and the Incidence of Bacterial Pneumonia Co-infection in Non-ICU COVID-19 Patients at an Urban Academic Medical Center Sara Groome, Claudine El-Beyrouty, Meghan Mitchell
1795 [GO] 2021―Dec―05 435. Outcomes for E484K Mutation Negative COVID-19 Patients Cohorted with E484K Mutation Positive COVID-19 Patients: A Retrospective Cohort Study Fahad Buskandar, Amber L Linkneheld-Struk, Victoria R Williams, Adrienne Chan, Lorraine Maze Dit Mieusement, Natasha Salt, Jerome A Leis
1796 [GO] 2021―Dec―05 312. Clinical Attributes and Risk Factors for In- Hospital Mortality among Covid-19 Patients in a Community Hospital Setting: A Propensity Matched Analysis Karthik Seetharam, Premila Bhat, Kelash Kumar, Thinzar Wai, Vamsi Yenugadhati, Bhargav Desai, et al. (+27)
1797 [GO] 2021―Dec―05 802. Corynebacterium striatum Outbreak Among Ventilated COVID-19 Patients in an Acute Care Hospital - California, 2021 Janice J Kim, Nancy E Turner, Emily Holman, Linda Lefrak, Fady A Youssef, Patrizia Richardson, et al. (+4)
1798 [GO] 2021―Dec―05 395. Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar Safae Abuyousef, Shaikha Alnaimi, Nabil E Omar, Reem Elajez, Eman Zeyad Ibrahim Elmekaty, Eiman Abdelfattah-Arafa, et al. (+14)
1799 [GO] 2021―Dec―05 298. Examining the Relationship Between Excess Weight and In-Hospital Mortality in COVID-19 Patients in Southwest Georgia, U.S Austin C Dykes, Daniel B Chastain, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Sharmon P Osae
1800 [GO] 2021―Dec―05 406. Incidence of Community and Hospital Acquired Infections in Critically Ill COVID-19 Patients in the Dominican Republic Rita Alexandra Rojas-Fermin, Anel E Guzman, Ann Sanchez, Edwin Germosen, Cesar Matos, Alfredo J Mena Lora
1801 [GO] 2021―Dec―05 281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S Devika Chawla, Xin Chen, Klaus Kuhlbusch, Kelly Zalocusky, Shemra Rizzo
1802 [GO] 2021―Dec―05 33. Evaluation of Rural-Urban Differences in Hospitalization and Mortality Rates for US COVID-19 Patients in the United States Alfred (Jerrod) Anzalone, Ronald Horswell, San Chu, Brian Hendricks, Jeremy Harper, William Beasley, et al. (+4)
1803 [GO] 2021―Dec―05 440. Detection of COVID-19 Patients Requiring Escalation to ICU Status Using a Naïve Bayes Classifier William R Barnett, Chad Jaenke, Zachary Holtzapple, James Williams, Nithin Kesireddy, Waleed Khokher, Ragheb Assaly
1804 [GO] 2021―Dec―05 405. A Qualitative Study Based on a Case Series of Obstetric COVID-19 Patients to Determine Risks in Management Associated with Severity in a Government Hospital in the Philippines Sheila Patrice D Funelas-Santos, Judith P Peralta
1805 [GO] 2021―Dec―05 536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study François Raffi, Nadir Arber, Casper Rokx, Lambert Assoumou, Pallav L Shah, Nathalie De Castro, et al. (+13)
1806 [GO] 2021―Dec―05 319. Presepsin as a Prognostic Biomarker for Mortality in COVID-19 Patients vs Community-Adquired Pneumonia (CAP) Patients Lina Morales-Cely, Laura A Bravo-Castelo, Ingrid G Bustos-Moya, Yuli Fuentes, Julian Lozada-Arciniegas, Elsa Daniela Ibañez-Prada, et al. (+7)
1807 [GO] 2021―Dec―05 287. Characteristics and Outcomes of COVID-19 Patients with Candidemia at a Community Hospital in Chicago Oluwadamilola A Adeyemi, Gregg Gonzaga, Sean Cariño, Steve B Kalish
1808 [GO] 2021―Dec―05 463. Factors of Social Determinants of Health Associated with Length of Stay in COVID-19 Patients with Multimorbidity in Southwest Georgia, United States Sahand Golpayegany, Sharmon P Osae, Geren Thomas, Henry N Young, Andrés F Henao Martínez, Carlos Franco-Paredes, Daniel B Chastain
1809 [GO] 2021―Dec―05 431. SARS-CoV-2 Environmental Contamination in Hospitalized COVID-19 Patients’ Rooms Bobby G Warren, Alicia Nelson, Aaron Barrett, Bechtler S Addison, Amanda M Graves, Sarah S Lewis, et al. (+5)
1810 [GO] 2021―Dec―05 445. COVID-19 Pharmacotherapy Was Not Associated with Mortality in a Community Teaching System Eric Urnoski, Thomas Butler
1811 [GO] 2021―Dec―05 527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia Sarah Lim, Pamela Schreiner, Alan Lifson, Erica Bye, Kathryn Como-Sabetti, Ruth Lynfield, Ruth Lynfield
1812 [GO] 2021―Dec―05 545. A Retrospective Review of 30-day Mortalities in Solid-Organ Transplant Recipients (SOT) versus Non-Transplant Patients (NTP) Receiving Remdesivir (REM) and Dexamethasone (DEX) for COVID-19 Pneumonia Krina Vyas, Kevin L Epps, Nan Zhang, Sadia Shah, Matthew Soto-Arenall, Lisa Brumble, Claudia R Libertin
1813 [GO] 2021―Dec―05 367. Role of Conventional Biomarker for Prediction of Chest CT-confirmed COVID-19 Pneumonia Monprach Harnphadungkit, Taweegrit Siripongboonsitti
1814 [GO] 2021―Dec―05 342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia Adam Warner, Mujahed Abbas, Benjamin S Avner, Thomas E Flynn, Todd A Walroth, Brett W Jagger
1815 [GO] 2021―Dec―05 518. Model-informed Dose Selection of Dual Toll-like Receptor 7/8 Inhibitor Enpatoran (M5049) for the Treatment of COVID-19 Pneumonia Lena Klopp-Schulze, Jamie Shaw, Jennifer Dong, Akash Khandelwal, Elizabeth Adams, Dongzi Yu, Kosalaram Goteti
1816 [GO] 2021―Dec―05 562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports Fatima iqbal, Shiema A Ahmed, Kamran Mushtaq, Faraj S Howady, Fatima Rustom, Muna Almaslamani
1817 [GO] 2021―Dec―05 470. Relapsing COVID-19 Pneumonia in Patients Receiving Rituximab Therapy Jolie Gallagher, Kevin H Hall, Benjamin Albrecht
1818 [GO] 2021―Dec―05 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico Luis Del Carpio-Orantes, Sergio García-Méndez, Jesús Salvador Sánchez-Díaz, Andrés aguilar-silva, Elisa Estefania Aparicio-Sánchez, Sonia Cruz-Albarrán, et al. (+13)
1819 [GO] 2021―Dec―05 563. Experience of a Private Hospital in the Treatment of COVID-19 Pneumonia in Veracruz, Mexico Luis Del Carpio-Orantes, Luis Alberto Márquez-Rodriguez, José Luis García-Pérez, Christian Alberto Rodríguez-Santos, Carlos Yahir Llaven-Velázquez, Eduardo Gutiérrez-Martínez, et al. (+6)
1820 [GO] 2021―Dec―05 308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA) Ryan Rivosecchi, J Alex Viehman, Christina K Thorngren, Ryan K Shields, Fernanda P Silveira, Fernanda P Silveira, et al. (+6)
1821 [GO] 2021―Dec―05 31. Development a Novel Score (SAD-60) for Predicting Mortality in Hospitalised Patients with COVID-19 Pneumonia: A Multicenter Retrospective Study of 1013 Patients Serkan Surme, Hatice Kubra Karanalbant, Gulsah Tuncer, Osman Bayramlar, Betul Copur, Esra Zerdali, et al. (+9)
1822 [GO] 2021―Dec―05 Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe COVID-19 Pneumonia: A Randomized Clinical Trial Princy N Kumar, Jules Hernández-Sánchez, Sandra Nagel, Yuning Feng, Fang Cai, Joseph Rabin, et al. (+11)
1823 [GO] 2021―Dec―05 302. Using Antiphospholipid Antibody Presence as an Additional Biomarker to Identify COVID-19 Positive Patients with High Risk for Thrombosis Jennifer R Hewlett, Jing Du, M Sung Lee, Gavin McLeod, Herbert Archer
1824 [GO] 2021―Dec―05 544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System Alexander T Paras, Kathryn E DeSilva, Nora T Oliver, Lauren H Epstein, Nadine M Harris, Emily J Cartwright, Abeer Moanna
1825 [GO] 2021―Dec―05 394. Descriptive Evaluation of Epidemiology and Microbiology of Patients with COVID-19 Pre/post Implementation of Corticosteroids as Standard of Care Goran Flajc, Ahmed Zaki
1826 [GO] 2021―Dec―05 538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis Bernard Demot, Kristin Ivan Mark Hizon
1827 [GO] 2021―Dec―05 955. Trends in Top COVID-19 Questions Among a National Audience of Primary Care Clinicians Aylin Madore, Margaret Oliverio, Steven Nock
1828 [GO] 2021―Dec―05 493. Incidence and Characterization of Chronic Active COVID Among Patients Infected with the Novel Coronavirus (COVID-19) Receiving B-cell Depleting Therapies (BCDTs) Jacob Kartes, Emily S Spivak, Hannah Imlay
1829 [GO] 2021―Dec―05 80. The Utility of Cultures for Isolated Fevers in Patients with Influenza or COVID-19 Receiving Extracorporeal Membrane Oxygenation Joseph E Marcus, Valerie Sams, Michal Sobieszcyk, Alice E Barsoumian
1830 [GO] 2021―Dec―05 LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen Eleftherios Mylonakis, Selin Somersan-Karakaya, Sumathi Sivapalasingam, Shazia Ali, Yiping Sun, Rafia Bhore, et al. (+26)
1831 [GO] 2021―Dec―05 499. Rapid and Sustained Decline in CXCL-10 (IP-10) Annotates Clinical Outcomes Following TNF-α Antagonist Therapy in Hospitalized Patients with Severe and Critical COVID-19 Respiratory Failure Courtney Schroeder, Hilal Hachem, Amandeep Godara, Daniel Fein, Hashim Mann, Christian Lawlor, et al. (+6)
1832 [GO] 2021―Dec―05 424. The Impact of COVID-19 Response on Infection Prevention Programs and Practices in Southeastern United States Sonali D Advani, Sonali D Advani, Andrea Cromer, Brittain A Wood, Esther Baker, Kathryn L Crawford, et al. (+9)
1833 [GO] 2021―Dec―05 485. Pediatrics Institutional COVID-19 Review Prakash Karna, Lauren Farrand, Uzma Hasan
1834 [GO] 2021―Dec―05 461. Classical Antigen Presenting Cell Activation Correlates with T Cell Immunity and COVID-19 Severity Zhongyan Lu, Jarina Pena-DaMata, Katherine Pohida, Camille Lake, Nusrat J Epsi, Stephanie A Richard, et al. (+9)
1835 [GO] 2021―Dec―05 437. Longitudinal Plasma Cytokine Profiles Differentiating COVID-19 Severity Groups Amanda M Green, Aisha Souquette, Mona Agrawal, Joshua Wolf, Joshua Wolf, Aditya Gaur, et al. (+5)
1836 [GO] 2021―Dec―05 40. Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial Zelalem Temesgem, Charles Burger, Jason Baker, Christopher Polk, Claudia R Libertin, Colleen F Kelley, et al. (+9)
1837 [GO] 2021―Dec―05 208. Comparison of Bloodstream Infections in Hospitalized Patients Before and During the COVID-19 Surge in a Community Hospital in the South Bronx: An Observational Study Afsheen Afzal, Edgar Gomez, Victor Perez Guttierrez, Aye Myat Mon, Carolina Moreira Sarmiento, Amna Khalid, et al. (+12)
1838 [GO] 2021―Dec―05 35. Health-related quality of life in COVID-19 survivors after 12 months, a prospective cohort study Sebastiaan Siegerink, Marië Nijpels, Sander Albers, Frédérique Jurgens, Felix K Pettai, Laura Samwel, et al. (+5)
1839 [GO] 2021―Dec―05 456. The Racial Divide: A Follow Up Study on Racial Disparity Amongst COVID-19 Survivors in an Urban Community in New Jersey Christopher Millet, Humberto Jimenez, Emily Racoosin, George Horani, Yezin Shamoon, Spandana Narvaneni, et al. (+11)
1840 [GO] 2021―Dec―05 436. U-shaped-aggressiveness of SARS-CoV-2: Period Between Initial Symptoms and Clinical Progression to COVID-19 Suspicion. A Population-Based Cohort Study Bruno G Buitano, Dan Morgenstern, Juan Talavera, Andrea Zaldívar, Mercedes Martínez
1841 [GO] 2021―Dec―05 512. Does Time From COVID-19 Symptom Onset to Administration of Anti-spike Protein Monoclonal Antibody Predict Response? Savanna SanFilippo, Brynna Crovetto, Marc Milano, John Bucek, Ronald G Nahass, Luigi Brunetti
1842 [GO] 2021―Dec―05 294. Surveillance for Potential Post-Acute COVID-19 Syndrome Medical Complications in the Emergency Department (ED) - A Retrospective Longitudinal Study of ED Patients Who Had Evidence of SARS-CoV-2 Infection Versus Those Who Did Not Isabel Lake, Richard C Wang, Richard E Rothman, Oliver Laeyendecker, Reinaldo Fernandez, Gaby Dashler, et al. (+2)
1843 [GO] 2021―Dec―05 145. SARS-CoV-2 (COVID-19) Testing Experience within a Military Treatment Facility Sara Robinson, Wesley R Campbell, Yuliya Johnson, Michael Backlund, Daniel Brooks
1844 [GO] 2021―Dec―05 416. Diagnostic Yield of Serial COVID-19 Testing in Hospitalized Patients Jeremy Li, Charles Frenette, Vivian Loo
1845 [GO] 2021―Dec―05 386. A Systematic Review of COVID-19 Transmission Dynamics and Clinical Response on Cruise Ships Globally Between January and October 2020 Kathryn Willebrand, Lauren Pischel, Amyn A Malik, Samuel Jenness, Saad Omer
1846 [GO] 2021―Dec―05 430. Strategies for Prevention of COVID-19 Transmission in Hospitals Wooyoung Jang, Bongyoung Kim, Eu Suk Kim, Kyoung-Ho Song, Song Mi Moon, Myung Jin Lee, et al. (+5)
1847 [GO] 2021―Dec―05 502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab Anil K Gupta, Yaneicy Gonzalez Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego Rodrigues Falci, et al. (+16)
1848 [GO] 2021―Dec―05 529. Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials Hannah Wentzel, Junzheng Wang, Abbienaya Dayanamby, Victoria Pilkington, Jacob Levi, Andrew Hill, Leah Ellis
1849 [GO] 2021―Dec―05 346. Head to Toe Imaging of Complications and Sequelae of COVID- 19 and COVID-19 Vaccination Deepti H Vijayakumar, Deepali Saxena, Rajesh V Helavar, Raghavendra Tirupathi
1850 [GO] 2021―Dec―05 590. Persisting COVID-19 vaccination hesitancy in the South Bronx Danelly Gomez D' Aza, Masood A Shariff, Israel Duran Santibanez, Raquel Horowitz, Hina Asad, Dennis Mensah, et al. (+4)
1851 [GO] 2021―Dec―05 587. An Intervention to Improve COVID-19 Vaccination Rates Among Inpatients at a Veterans Affairs Hospital Ayako Fujita, Tiffany Goolsby, Krista Powell, Emily J Cartwright
1852 [GO] 2021―Dec―05 573. Digital Patient/Caregiver Education: A Tool to Improve COVID-19 Vaccination Rates and Confidence Among the Public Amy Larkin, Allison Armagan
1853 [GO] 2021―Dec―05 566. Impact of a Culturally Sensitive Multilingual Community Outreach Model on COVID-19 Vaccinations at an Urban Safety-net Community Hospital Alfredo J Mena Lora, Stephanie L Echeverria, Ella Li, Miguel Morales, Rita Esquiliano, Genessa Schultz, et al. (+4)
1854 [GO] 2021―Dec―05 584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine Sybil Tasker, Daryl Bendel, Melissa Bevan, Steffen Mueller, Anna Kushnir, Brandon Londt, J Robert Coleman
1855 [GO] 2021―Dec―05 495. Evaluation of Antigen Testing for Detection of COVID-19 Vaccine Breakthrough Cases in Long-Term Care Meghan Linder, Sarah Humphrey-King, Rebecca Pierce, Sheri L Hearn, Melissa Sutton, Shane Sevey, et al. (+3)
1856 [GO] 2021―Dec―05 186. Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021 Stephanie Meyer, Amy Saupe, Aaron Bieringer, Corinne Holtzman, Luke Magnuson, Erica Bye, et al. (+6)
1857 [GO] 2021―Dec―05 98. COVID-19 Vaccine Breakthrough Hospitalizations and Deaths in the Veterans Health Administration Gina Oda, Aditya Sharma, Cynthia A Lucero-Obusan, Patricia Schirmer, Mark Holodniy, Connor W Edson, Ramin Khaksar
1858 [GO] 2021―Dec―05 569. Characterization of COVID-19 Vaccine Breakthrough Infections in Metropolitan Detroit Nicholas sturla, Rita Kassab, Rafa Khansa, Thomas Chevalier, David Allard, Robert Tibbetts, et al. (+2)
1859 [GO] 2021―Dec―05 1010. Cross-Species Translation of Correlates of Protection for COVID-19 Vaccine Candidates Using Quantitative Tools Anna Largajolli, Nele Plock, Bhargava Kandala, Akshita Chawla, Seth H Robey, Kenny Watson, et al. (+5)
1860 [GO] 2021―Dec―05 576. Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in 3 Communities in the United States and Lebanon Mohamad Yasmin, Mohamad Ali Tfaily, Rebecca P Emery, Habiba Hassouna, Rita Obeid, Mudita Bhugra, et al. (+2)
1861 [GO] 2021―Dec―05 574. High Acceptance and Rapid Implementation of COVID-19 Vaccine in a Public HIV Clinic in Northern California: An Initial Analysis of Social Determinants Jennifer Lin, Frank Oi-Shan Wong, Christopher Thibodeaux, Moon Choi-McInturff, Aracely Tamayo, Vivian Levy
1862 [GO] 2021―Dec―05 585. Safety of Pfizer-BioNtech COVID-19 Vaccine in Healthcare Workers, Singapore Kai-Qian Kam, Chee Fu Yung, Chia Yin Chong, Jia hui Li, Karen Donceras Nadua, Natalie W Tan, Koh Cheng Thoon
1863 [GO] 2021―Dec―05 439. Corowa-kun: Impact of a COVID-19 Vaccine Information Chatbot on Vaccine Hesitancy, Japan 2021 Takaaki Kobayashi, Yuka Nishina, Hana Tomoi, Ko Harada, Eiyu Matsumoto, Kanako Inaba, et al. (+8)
1864 [GO] 2021―Dec―05 335. Staphylococcus aureus Bacteremia as a Potential and Severe Complication from Intramuscular COVID-19 Vaccine Injection Miguel Sebastian Pedromingo Kus
1865 [GO] 2021―Dec―05 581. COVID-19 Vaccine Perceptions in Adults from Greater Nashville Tennessee Kailee N Fernandez, Danielle A Rankin, Harrison L Howe, Sean M Bloos, Seifein Salib, Rana Talj, et al. (+8)
1866 [GO] 2021―Dec―05 577. COVI-VAC™, a Live Attenuated COVID-19 Vaccine, Provides Single Dose Protection Against Heterologous Challenge with SARS-CoV-2 Beta (B.1.351) in the Syrian Golden Hamster Model Anna Kushnir, Steffen Mueller, Sybil Tasker, J Robert Coleman
1867 [GO] 2021―Dec―05 1196. A Multi-faceted, Iterative Program to Increase COVID-19 Vaccine Uptake in a Midwestern HIV Clinic Sara H Bares, Rachelle Carr, Samantha L Jones, Nichole N Regan, Valentina Orduna, Daniel W Cramer, et al. (+2)
1868 [GO] 2021―Dec―05 567. Reasons for Deferral of COVID-19 Vaccines Among Arab American Healthcare Professionals Living in the United States Anita Shallal, Evi Abada, Rami Musallam, Omar Fehmi, Linda Kaljee, Ziad Fehmi, et al. (+7)
1869 [GO] 2021―Dec―05 490. Uptake and Perceptions of COVID-19 Vaccines Among US Pregnant Women Annette Regan, Pallavi Aytha Swathi, Marcianna Nosek, Ning Yan Gu
1870 [GO] 2021―Dec―05 570. Prioritized Access to COVID-19 Vaccines Among Vulnerable Communities Increases Vaccination Rates Leonor Fernandez, Ashley O'Donoghue, Peter Shorett, Jonathan Blair, Lawrence Markson, Tenzin Dechen, et al. (+2)
1871 [GO] 2021―Dec―05 580. Hesitancy in Uptake and Recommendation of COVID-19 Vaccines by US Healthcare Workers Steven S Spires, Rebecca Rayburn-Reeves, Elizabeth Dodds Ashley, Jenna Clark, Avani P Desai, Jan Lindemans
1872 [GO] 2021―Dec―05 475. The Utility of Community-Academic Partnerships in Promoting the Equitable Delivery of COVID-19 Vaccines in Black Communities Jacinda Abdul-Mutakabbir, Samuel Casey, Veatrice Jews, Andrea King, Kelvin Simmons, Bridgette Peteet, et al. (+3)
1873 [GO] 2021―Dec―05 24. Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients Megan Powell, Amy C Sherman, Julia Klopfer, Michaël Desjardins, Chi-An Cheng, Yasmeen Senussi, et al. (+13)
1874 [GO] 2021―Dec―05 178. Comparing the Incidence of Multidrug Resistant Bacteremia, Fungemia and Hospital-acquired Clostridioides difficile Infection in COVID-19 Versus Non-COVID-19 Patients: a Single Hospital, One-year Observational Study in New York City Chia-Yu Chiu, Amara Sarwal, Michael Widjaja, Addi Feinstein
1875 [GO] 2021―Dec―05 45. COVID-19 Vulnerability and Data Reporting in Africa: Reflections from Cameroon Seth D Judson, Kevin Njabo, Judith Torimiro
1876 [GO] 2021―Dec―05 1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy Filippo Lagi, Alessandro Bartoloni, Catalina Suarez-Cuervo
1877 [GO] 2021―Dec―05 541. Comparing Patients with Severe COVID-19 Who Improve to the Point of Discharge Following an Abbreviated Course (< 5 Days) of Remdesivir (RDV) Versus a Standard Course (≥5 Days) Huan Pham, Qiaoling Chen, Aldon Li, Adam Baghban, Anita Cheruvanky, Graciela Faiad
1878 [GO] 2021―Dec―05 173. Deciphering COVID-19-Associated Effects on Hospital MRSA Transmission and Social Networks Gregory Madden, Matthew Bielskas, Methun Kamruzzaman, Parantapa Bhattacharya, Bryan Lewis, Eili Klein, et al. (+2)
1879 [GO] 2021―Dec―05 324. COVID-19-Associated Pulmonary Aspergillosis (CAPA) at Veterans Affairs (VA) Hospitals in Southern California and Arizona Michelle Fang, Phuong Khanh Nguyen, Tony T Chau, Ashley Doan, Andrew S Varker, Marshall T Renna, et al. (+8)
1880 [GO] 2021―Dec―05 333. Comparing COVID-19-related Morbidity and Mortality between Patients with and without Substance Use Disorder: A Retrospective Cohort Study Angela McLaughlin, Rebecca Burns, Morgan Ryan, Sabrina A Assoumou
1881 [GO] 2021―Dec―05 38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert L Gottlieb, et al. (+6)
1882 [GO] 2021―Dec―05 320. Differentiating Dengue from COVID-19: A Diagnostic Challenge in the Tropical Regions of the Americas Fernando Rosso, Olga Lucia agudelo Rojas
1883 [GO] 2021―Dec―05 353. New-Onset Diabetes as an Acute Complication of COVID-19: A National Population Cohort Analysis Kwan Hong, Jeehyun Kim, Sujin Yum, Raquel Elizabeth Gómez Gómez, Byung Chul Chun
1884 [GO] 2021―Dec―05 LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial Joshua A Hill, Roger Paredes, Carlos Vaca, Jorge Mera, Brandon J Webb, Gilberto Perez, et al. (+16)
1885 [GO] 2021―Dec―05 514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience Katherine Belden, Bryan Hess, Caroline Brugger, Rachel Carr, Todd Braun, Joseph L DeRose, John Zurlo
1886 [GO] 2021―Dec―05 468. Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for Covid-19: An International Multicenter Study Madeleine R Heldman, Olivia S Kates, Robert M Rakita, Erika D Lease, Ajit P Limaye, Cynthia E Fisher
1887 [GO] 2021―Dec―05 950. The Challenge of Fellowship Interviews During COVID-19: An Online Post-interview Survey Rattanaporn Mahatanan, Maxwell Vergo, Richard A Zuckerman
1888 [GO] 2021―Dec―05 1409. Pulmonary Non-tuberculous Mycobacterium Infection (PNTMI) and COVID-19: Characterization of the National COVID Collaborative Cohort (N3C) Carlos E Figueroa Castro, William Hersh
1889 [GO] 2021―Dec―05 546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial Michael G Ison, Jin Yong Kim, Oana Sandulescu, Liliana-Lucia Preotescu, Norma Erendira Rivera Martinez, Marta Dobryanska, et al. (+17)
1890 [GO] 2021―Dec―05 314. Six-Month Post-Acute Sequelae of COVID-19: High Self-Reported Morbidity among Women and Younger Adults Ashish Bhargava, Wei Zhao, Mamta Sharma, Susan M Szpunar, Louis Saravolatz
1891 [GO] 2021―Dec―05 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome Ray Y Hachem, Anne-Marie Chaftari, Nigo Masayuki, Nelson Hamerschlak, Hiba Dagher, Ying Jiang, et al. (+28)
1892 [GO] 2021―Dec―05 526. Implementation of Use of Monoclonal Antibody Therapy in a Large Academic Center for the Outpatient Treatment of Covid-19: Impact on 30 Day Hospitalization Rates, ED Visits and Death Azra Bhimani, Vinay Srinivasan, Stacey Weinstein, Nathan Clemons, Quanna Batiste, Shangxin Yang, et al. (+2)
1893 [GO] 2021―Dec―05 1191. Pediatric Long Haul Post COVID-19: Is New Jersey’s Experience Different? Aakriti Bhargava, Lauren Farrand, Stephen Zieniewicz, Dennis J Brenner, Timothy S Yeh, Uzma Hasan
1894 [GO] 2021―Dec―05 497. Moderate Versus High Dose Corticosteroids in Adult Patients with Severe COVID-19: Less Is More Seema Joshi, Sana Soman, Saniya Jain, Atheel Yako, Marwa Hojeij, Louis Massoud, et al. (+5)
1895 [GO] 2021―Dec―05 1326. Possible Predictors of Coinfection in COVID-19: Making a Difficult Diagnosis Christopher J Lehmann, Rohan N Shah, Mengqi Zhu, Natasha N Pettit, Jessica Ridgway, Renslow Sherer
1896 [GO] 2021―Dec―05 561. Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia Ziad Mallat, Suzana Margareth Lobo, Anuj Malik, Sandra Tong
1897 [GO] 2021―Dec―05 506. Outpatient Bamlanivimab, Casirivimab and Imdevimab for COVID-19: Single Center Feasibility Analysis Vahini Chundi, Jennifer J Wenner, Christopher Scheib, Yatin Patel, Cynthia snider, Jeffrey C Hatcher, Douglas B McQuaid
1898 [GO] 2021―Dec―05 442. Sex-Related Differences in Mortality from COVID-19: Survival Analysis of Patients from an Urban Hospital Mamta Sharma, Susan M Szpunar, Ashish Bhargava, Leonard B Johnson, Louis Saravolatz
1899 [GO] 2021―Dec―05 305. Cholecystitis as a Possible Immunologic Consequence of COVID-19; Case Series from a Large Healthcare System Anna Jacobs, Christopher Polk, Mindy Sampson, Banks Kooken, Thomas Ludden, Catherine Passaretti, et al. (+2)
1900 [GO] 2021―Dec―05 451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19? Hemang Patel, Ashish Bhargava, Daniel Lebovic, Tiziano Scarabelli, Meredith M Coyle, Natali Salaytah, Louis Saravolatz
1901 [GO] 2021―Dec―05 535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, et al. (+5)
1902 [GO] 2021―Dec―05 553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting Courtney Nichols, Mark Lustberg, Mohammad Mahdee Sobhanie, Joy Lehman, Erica E Reed, Nicholas E Kman, et al. (+5)
1903 [GO] 2021―Dec―05 401. Natural History of Shedding and Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Using Intensive High-Resolution Sampling Jonathan Altamirano, Prasanthi Govindarajan, Andra Blomkalns, Sean Leary, India Robinson, Leanne Chun, et al. (+11)
1904 [GO] 2021―Dec―05 784. Efficiency of Quaternary Ammonium Disinfectants against SARS-CoV-2 and Coronavirus 229E Charles P Gerba
1905 [GO] 2021―Dec―05 472. Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2: 2021 Update Deeksha Jandhyala, Jessica Lewis, Ruth Adekunle
1906 [GO] 2021―Dec―05 Letter to the Editor: Response to ‘Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician‘ by Tleyjeh et al Martin Wolkewitz, Oksana Martinuka
1907 [GO] 2021―Dec―05 508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study Rand A Alattar, Shiema A Ahmed, Tasneem Abdallah, Rashid Kazman, Aseelah N Qadmour, Tawheeda Ibrahim, et al. (+19)
1908 [GO] 2021―Dec―05 564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity M G Joyce, Wei-Hung Chen, Rajeshwer Sankhala, Agnes Hajduczki, Paul Thomas, Elizabeth Martinez, et al. (+3)
1909 [GO] 2021―Dec―05 1347. Comparison Between SARS-Cov-2, non-SARS-Cov-2 Coronavirus, Influenza and RSV Infections Among Solid Organ Transplant Recipients Maria A Mendoza, Motoa Gabriel, Mohammed Raja, Shweta Anjan, Anmary A Fernandez, Steve Courel, et al. (+13)
1910 [GO] 2021―Dec―05 412. Estimating the Impact of School Classroom Sizes on the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infectivity or Exposure Sanya J Thomas, Rebecca R Young, Ibukunoluwa Akinboyo, Michael J Smith, Tara Buckley, Sarah S Lewis
1911 [GO] 2021―Dec―05 519. Risk Factor Analysis for Hospital Admission Following Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Monoclonal Antibody Treatment Lana Abusalem, Cole Wood, Juan Carlos Rico Crescencio, Ryan K Dare
1912 [GO] 2021―Dec―05 1331. Seasonality of Common Human Coronaviruses in the United States, 2014-2021 Melisa Shah, Amber K Haynes, Rebecca M Dahl, Krista Kniss, Benjamin Silk, Marie E Killerby
1913 [GO] 2021―Dec―05 539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2 Michael Rosati, Nikunj M Vyas, Cindy Hou
1914 [GO] 2021―Dec―05 278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2 Jessica Tarabay, Ahmed Babiker, Max W Adelman, Victoria D Stittleburg, Jay Varkey, Stephanie M Pouch, et al. (+2)
1915 [GO] 2021―Dec―05 387. Predictors of Seropositivity to SARS-CoV-2 Among Workforce Members at a Large Urban Medical Center Evelyn A Flores, Deborah Kupferwasser, Prudencio Merino, Donna Phan Tran, Honghu Liu, Yilan Huang, et al. (+8)
1916 [GO] 2021―Dec―05 347. SARS-CoV-2 and Acute Otitis Media in Children: A Case Series Holly M Frost, Thresia Sebastian, Amy Keith, Melanie Kurtz, Samuel R Dominguez, Samuel R Dominguez, et al. (+2)
1917 [GO] 2021―Dec―05 821. Changes in Cleaning Practices and Non-conventional Personal Protective Equipment Use due to SARS-CoV-2 and Association with Increases in Multi-drug Resistant Organism Cases Medora L Witwer, Susan E Kline, Patricia Ferrieri, Samantha Saunders, Ginette Dobbins, Kari Gand, Alison Galdys
1918 [GO] 2021―Dec―05 396. Disparities in SARS-CoV-2 Antibody Prevalence: Findings from a Citywide Serosurvey in Holyoke, Massachusetts, November 2020-January 2021 Wilfredo Matias, Isabel Fulcher, Cody Nolan, Yodeline Guillaume, Jack Zhu, Francisco Molano, et al. (+11)
1919 [GO] 2021―Dec―05 674. Evaluation of the Access Bio CareStart™ Rapid SARS-CoV-2 Antigen Test in Asymptomatic Individuals Tested at a Community Mass-testing Program in Western Massachusetts Wilfredo Matias, Sara suliman, Isabel Fulcher, Francisco Molano, Shannon Collins, Elizabeth Uceta, et al. (+12)
1920 [GO] 2021―Dec―05 297. Infectious Complications Associated with Tocilizumab Use in Patients Infected with SARS-CoV-2 at a Mid-Atlantic Hospital Consortium Kristen R Kent, Nellie Darling, Xue Geng, Gavin Clark, Marybeth Kazanas, Princy N Kumar, Joseph G Timpone
1921 [GO] 2021―Dec―05 189. Potential Tiger-to-Human Transmission of SARS-CoV-2 at a Tennessee Zoo: A One Health Approach to Outbreak Investigation Heather N Grome, Becky Meyer, Erin Read, Martha Buchanan, Andrew C Cushing, Kara J Levinson, et al. (+10)
1922 [GO] 2021―Dec―05 533. Protocol for and Efficacy of Monoclonal Antibody (mAb) Treatment of SARS-CoV-2 at a VA Medical Center Phuong Khanh Nguyen, Thomas D Dieringer, Adela Greeley, Suny Kun, Feliza Calub, My-Phuong Pham, et al. (+4)
1923 [GO] 2021―Dec―05 375. High Laboratory-confirmed SARS-CoV-2 Attack Rate in Lima Health Care Personnel During August 2020-March 2021 Suggests Role for Improved Infection Control Matthew Westercamp, Giselle Soto, Rachel Smith, Eduardo Azziz-Baumgartner, Susan Bollinger, Roger Castillo, et al. (+10)
1924 [GO] 2021―Dec―05 373. Household transmission of SARS-CoV-2 B.1.1.7 lineage -2 U.S. States, 2021 Raymond Soto, Christoper Hsu, Meagan Chuey, Marisa Donnelly, Victoria T Chu, Noah G Schwartz, et al. (+11)
1925 [GO] 2021―Dec―05 390. Can Testing the Environment for SARS-CoV-2 Be a Signal for Staff Infections in Nursing Homes (NHs)? Gabrielle Gussin, Raveena Singh, Izabela Coimbra Ibraim, Raheeb Saavedra, Thomas Tjoa, Micaila Curtis, et al. (+2)
1926 [GO] 2021―Dec―05 568. Comparison of Humoral Immune Response to the SARS-CoV-2 BNT162b2 Vaccine Between Solid Organ Transplant Recipients and Healthy Controls Ahmad Yanis, Zaid Haddadin, Andrew Speaker, Danya Waqfi, Rana Talj, Danielle A Rankin, et al. (+8)
1927 [GO] 2021―Dec―05 376. Sensitivity and Specificity of the WHO Probable SARS-CoV-2 Case Definition Among Symptomatic Healthcare Personnel Han Nguyen, Sarah Weber, Yachana Kataria, Manisha Cole, Elizabeth Duffy, Elizabeth Ragan, et al. (+8)
1928 [GO] 2021―Dec―05 505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study Vincenzo Spagnuolo, Marta Voarino, Marco Tonelli, Laura Galli, Andrea Poli, Elena Bruzzesi, et al. (+10)
1929 [GO] 2021―Dec―05 464. Structural Vulnerability among Patients with HIV and SARS-CoV-2 Coinfection: Descriptive Case Series from the U.S. Midwest Natasha E Hongsermeier-Graves, Rohan Khazanchi, Nada Fadul
1930 [GO] 2021―Dec―05 290. Persistence of Long COVID in SARS-CoV-2 Confirmed Cases One-Year Post Infection Harrison L Howe, Danielle A Rankin, Sean M Bloos, Kailee N Fernandez, Seifein Salib, Rana Talj, et al. (+7)
1931 [GO] 2021―Dec―05 834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial Shiven Chabria, Stephane De Wit, Amy Pierce, Bronagh M Shepherd, Michael Warwick-Sanders, Fangfang Du, et al. (+3)
1932 [GO] 2021―Dec―05 678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients Catherine Murphy, Emily Sheboy Scarcello, Sheila M Nolan
1933 [GO] 2021―Dec―05 419. SARS-CoV-2 Environmental Surface Contamination of Healthcare Staff Common Areas Helen L Zhang, Brendan Kelly, Michael Z David, Ebbing Lautenbach, Elizabeth Huang, Selamawit Bekele, et al. (+5)
1934 [GO] 2021―Dec―05 556. Ruxolitinib for the Management of Severe Pneumonia Caused by SARS-CoV-2. Exploring the Combination with dexamethasone Aaron Molina, Alejandro Olmedo-Reneaum, Maria Del Rocio Reyes-Paniagua, Mariana Molina
1935 [GO] 2021―Dec―05 511. Treatment with Molnupiravir in the MOVe-In and MOVe-Out Clinical Trials Results in an Increase in Transition Mutations Across the SARS-CoV-2 Genome Julie Strizki, Jay Grobler, Ying Zhang, Jiejun Du, Shunbing Zhao, Diane Levitan, et al. (+3)
1936 [GO] 2021―Dec―05 377. SARS-CoV-2 Genomic Surveillance Reveals Little Spread Between a Large University Campus and the Surrounding Community Andrew Valesano, William Fitzsimmons, Christopher Blair, Robert Woods, Julie Gilbert, Dawn Rudnik, et al. (+4)
1937 [GO] 2021―Dec―05 LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV Matthew A Spinelli, Michael J Peluso, Kara Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, et al. (+2)
1938 [GO] 2021―Dec―05 491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children Susan Dolan, Jean Mulcahy Levy, Angela Moss, Kelly Pearce, Molly Butler, Samuel R Dominguez, et al. (+5)
1939 [GO] 2021―Dec―05 42. Outbreak of SARS-CoV-2 in Hospitalized Hemodialysis Patients: an Epidemiologic and Genomic Investigation Charles E Marvil, Anne Piantadosi, Aaron Preston, Andrew Webster, Jeannette Guarner, Kari L Love, et al. (+6)
1940 [GO] 2021―Dec―05 589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans Susan Johnson, Clarissa Martinez, Mario Cortese, Josefina Martinez, Shaily Garg, Nadine Peinovich, et al. (+2)
1941 [GO] 2021―Dec―05 283. Population-Based Co-infection of Carbapenem-Resistant Organisms and SARS-CoV-2 in Massachusetts Ashley Geoghegan, Jessica Leaf, Monina Klevens, Scott Troppy
1942 [GO] 2021―Dec―05 380. Environmental Contamination with SARS-CoV-2 in Nursing Homes Lona Mody, Kristen Gibson, Liza Bautista, Karen Neeb, Ana Montoya, Grace Jenq, et al. (+7)
1943 [GO] 2021―Dec―05 487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis Patricia Saunders-Hao, Sumeet Jain, Bruce Hirsch, Pranisha Gautam-Goyal
1944 [GO] 2021―Dec―05 453. Neutralizing Antibody Responses to SARS-CoV-2 in Professional Soccer Players Jorge Pagura, Clovis Arns de Cunha, Roberto Nishimura, Sergio Wey, André Pedrinelli, Sergio Cimerman, et al. (+6)
1945 [GO] 2021―Dec―05 397. Impact of School Opening Model on Cases of SARS-CoV-2 in Surrounding Communities: A Nationwide, Retrospective Cohort Study Westyn Branch-Elliman, Zeynep Ertem, Elissa Perkins, Polly van den Berg, Isabella Epshtein, Nathorn Chaiyakunapruk, et al. (+3)
1946 [GO] 2021―Dec―05 447. An Ordinal Scale Assessing SARS-CoV-2 Infected Patient Outcomes Using Electronic Health Records Maryam Khodaverdi, Bradley S Price, Susan L Santangelo, Alfred (Jerrod) Anzalone, Wesley Kimble, J Zachary Porterfield, et al. (+6)
1947 [GO] 2021―Dec―05 554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection Inderjit Mann, Melinda Monteforte, Roderick Go
1948 [GO] 2021―Dec―05 513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection Jessica Abrantes-Figueiredo, Stephanie Nalewyko, Dora E Wiskirchen
1949 [GO] 2021―Dec―05 316. Use of (1-3)-β-D-Glucan Assay for Diagnosis of Candidemia in Patients Hospitalized with SARS-CoV-2 Infection Yesha Malik, Amy Dupper, Jaclyn Cusumano, Dhruv Patel, Kathryn Twyman, Deena Altman, et al. (+2)
1950 [GO] 2021―Dec―05 301. Detection of Pneumococcal Pneumonia During SARS-CoV-2 Infection Anne Watkins, Devyn Yolda-Carr, Isabel M Ott, Maura Nakahata, Adam Moore, M Catherine Muenker, et al. (+14)
1951 [GO] 2021―Dec―05 147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection Sanjat Kanjilal
1952 [GO] 2021―Dec―05 144. Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection Sudeb C Dalai, Jennifer N Dines, Thomas M Snyder, Rachel M Gittelman, Tera Eerkes, Pashmi Vaney, et al. (+16)
1953 [GO] 2021―Dec―05 483. Disease Severity and Clinical Manifestations of SARS-CoV-2 Infection Among Infants Over the First Year of the Pandemic in Canada Pierre-Philippe Piché-Renaud, Luc Panetta, Daniel Farrar, Charlotte Moore Hepburn, Olivier Drouin, Fatima Kakkar, Shaun Morris
1954 [GO] 2021―Dec―05 931. Epidemiology and Clinical Outcomes of SARS-CoV-2 Infection Among Pediatric Solid Organ Transplant Recipients: A Single-Center Case Experience Jesus Sotelo, Esra Akkoyun, Giselle S Chery, Amal Aqul, Dev M Desai, Paul K Sue, Alyssa Power
1955 [GO] 2021―Dec―05 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination Thomas M Snyder, Rachel M Gittelman, Mark Klinger, Damon H May, Edward J Osborne, Ruth Taniguchi, et al. (+38)
1956 [GO] 2021―Dec―05 486. Characteristics Associated with SARS-CoV-2 Infection in Children F Curtis Sudbury, Amanda Williams, Michelle Kwon, Leah Musser, Patrick Gavigan, Jessica E Ericson
1957 [GO] 2021―Dec―05 462. Differences in the Humoral Response to SARS-CoV-2 Infection in Children vs. Adult Girlande Mentor, Olivier Drouin, Silvie Valois, Suzanne Taillefer, Christian Renaud, Fatima Kakkar
1958 [GO] 2021―Dec―05 1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF) Megan Taylor, Ashley Tippett, Laila Hussaini, Luis Salazar, Caroline Ciric, Olivia Reese, et al. (+16)
1959 [GO] 2021―Dec―05 481. SARS-CoV-2 Infection in Hospitalized Children: An Elevated Body Mass Index is a Marker of Increased Risk of Acute Respiratory Failure Catherine Foster, Shelley Kumar, Elizabeth Tocco, Galit Holzmann-Pazgal, Judith R Campbell, Lucila Marquez, Ankhi Dutta
1960 [GO] 2021―Dec―05 276. SARS-CoV-2 Infection in Solid Organ Transplant Candidates and Recipients at Texas Children’s Hospital: A Retrospective Review Leanne Petters, Flor M Munoz, Claire Bocchini, Elizabeth A Moulton, Daniel Ruderfer
1961 [GO] 2021―Dec―05 34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection Stephanie A Richard, Simon Pollett, Nusrat J Epsi, Ryan C Maves, Ryan C Maves, Gregory Utz, et al. (+20)
1962 [GO] 2021―Dec―05 49. Effects of Maternal SARS-CoV-2 Infection on Neonatal Discharge Planning and Care: Exacerbation of Racial and Ethnic Healthcare Disparities Jennifer Jubulis, Amanda Goddard, Sarah Dibrigida, Carol A McCarthy
1963 [GO] 2021―Dec―05 530. Bamlanivimab (BAM) for SARS-CoV-2 Infection: Rates and Risk Factors for Hospitalization after Monoclonal Antibody Administration in a High-Risk Population John M Curtin, Varea H Costello, Benjamin L Custer, Jason M Blaylock, Catherine F Decker, Roseanne Ressner, et al. (+5)
1964 [GO] 2021―Dec―05 575. Local Experience of Breakthrough SARS-CoV-2 Infections After Full Vaccination Ahmed A Khan, Gayla Havener, Donald Graham, Brian Miller, Gail O'Neill, Vidya Sundareshan
1965 [GO] 2021―Dec―05 378. Descriptive Analysis of SARS-CoV-2 Infections Among Health System and University Employees Jessica Seidelman, Ibukunoluwa Akinboyo, Maya Rinehart, Rebekah W Moehring, Deverick J Anderson, Kristen Said, et al. (+4)
1966 [GO] 2021―Dec―05 479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients Kristen Zeitler, Nicholas Piccicacco, Lyndsey Bowman, Jose Montero, Margarita Cancio, Sally Houston, Kami Kim
1967 [GO] 2021―Dec―05 532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities Allison J Hare, Judith M Rivera McPhaul, Patrick Cargan, Pablo Tebas, Kathleen Degnan, Jillian T Baron, Keith W Hamilton
1968 [GO] 2021―Dec―05 421. Effect of SARs-Cov-2 mRNA Vaccination in Healthcare Workers with Household COVID Exposure Laura Selby, Richard Starlin
1969 [GO] 2021―Dec―05 458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes Nusrat J Epsi, John H Powers, David A Lindholm, David A Lindholm, Alison Helfrich, Nikhil Huprikar, et al. (+16)
1970 [GO] 2021―Dec―05 610. Tele-ID Consult Services at Academic Medical Centers: Experience and Outcomes During the SARS-CoV-2 Pandemic Aryn M Andrzejewski, Rima Abdel-Massih, Rima Abdel-Massih, John Mellors, Nupur Gupta
1971 [GO] 2021―Dec―05 1141. Effect of the SARS-CoV-2 Pandemic on Staphylococcus aureus Colonization in Healthy Children Jonathon C McNeil, Marritta Joseph, Lauren Sommer, Anthony R Flores, Anthony R Flores
1972 [GO] 2021―Dec―05 221. Evaluation of Rates of Culture Positive Blood Stream Pathogens Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation Laura A Puzniak, Karri A Bauer, Kalvin Yu, Pamela Moise, Vikas Gupta
1973 [GO] 2021―Dec―05 156. Evaluation of Trends in Antimicrobial Use and Proportion of Culture Positive Gram-Negative/Gram-Positive Pathogens Comparing Prior to and During the SARS-CoV-2 Pandemic: A Multicenter Evaluation Laura A Puzniak, Karri A Bauer, Kalvin Yu, Vikas Gupta
1974 [GO] 2021―Dec―05 363. Characteristics of Envelope and Nuclear Gene Expression Patterns in Asymptomatic SARS-CoV-2 Patients: A Single Center Retrospective Observational Study Keiko Mizuno, Takayuki Komatu, Daisuke Usuda, Shiori Hocchi, Karin Ashizawa, Takashi Aoki, et al. (+4)
1975 [GO] 2021―Dec―05 370. Examining the Relationship Between SARS-CoV-2 PCR Cycle Threshold, Disease Severity and Epidemiologic Trends Jessica Penney, Amanda Jung, Benjamin Koethe, Shira Doron
1976 [GO] 2021―Dec―05 359. Clinical implications of SARS-CoV-2 PCR presumptive positive results Takeru Yamamoto, Masako Mizusawa
1977 [GO] 2021―Dec―05 354. SARS-CoV-2 Viral Viability Culture and Sequencing from Immunocompromised Patients with Persistently Positive SARS-CoV-2 PCR Results Abby Sung, Adam Bailey, Meghan Wallace, Henry B Stewart, David McDonald, Candace R Miller, et al. (+10)
1978 [GO] 2021―Dec―05 507. Impact of Baricitinib on Outcomes in Patients Treated with Remdesivir and Dexamethasone for SARS-CoV-2 Pneumonia: A Retrospective Cohort Study Lauren Dea, Hal Piwonka, Learned Gonzales, Shubha Kerkar, Xolani Mdluli, Yisu Kim
1979 [GO] 2021―Dec―05 28. Utilizing the Charleston Comorbidity Index as an Independent Predictor for Outcomes in SARS-Cov-2 Positive Patients Irene Riestra Guiance, Steven Char, Ernesto Robalino Gonzaga, Isabel Riestra, Minh Q Ho
1980 [GO] 2021―Dec―05 398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States Karri A Bauer, Kalvin Yu, Vikas Gupta, Laura A Puzniak
1981 [GO] 2021―Dec―05 482. SARS-CoV-2 Prevalence in Feces of Very Young Children, A Longitudinal Study Lydia M Nashed, Jyoti Mani, Sahel Hazrati, Tiana Richards, Naya Nerikar, Shreeya Ravi, et al. (+4)
1982 [GO] 2021―Dec―05 389. Demographic and Clinical Characteristics of Suspect SARS-CoV-2 Reinfection Cases in Los Angeles County from March 10 to June 1, 2021: A Cross-sectional Study of Case Interview Data Joseph Thompson, Laureen Masai, Nageena Khalid, Katie Chun, Diana Khuu, Nouran Mahmoud Alkhoudairy, Jennifer B Griffin
1983 [GO] 2021―Dec―05 393. Characteristics of SARS-CoV-2 RNA Viral Loads among Nursing Home Residents and Staff with Repeat Positive Tests ≥ 90 Days After Initial Infection: 5 US Jurisdictions, July 2020-March 2021 W Wyatt Wilson, Kelly M Hatfield, Stacy Tressler, Cara Bicking Kinsey, Renee Zell, Channyn Williams, et al. (+16)
1984 [GO] 2021―Dec―05 372. Detection of SARS-CoV-2 RNAemia in Deceased Tissue Donors Melissa Greenwald, Eduard Grebe, Valerie Green, Alyce Linthurst Jones, Philip Williamson, Michael Busch, Matthew Kuehnert
1985 [GO] 2021―Dec―05 489. SARS-CoV-2 Seroprevalence and Antibody Response Among Pregnant People in Seattle, WA Sylvia LaCourse, Alisa Kachikis, Kelsey L Kinderknecht, Romeo R Galang, Lauren B Zapata, Krissy M Yamamoto, et al. (+4)
1986 [GO] 2021―Dec―05 371. Estimating SARS-CoV-2 Seroprevalence from Spent Blood Samples, January-March 2021 Daniel Graciaa, Hans Verkerke, Jeannette Guarner, Ana Maria Moldoveanu, Narayana Cheedarla, Connie Arthur, et al. (+6)
1987 [GO] 2021―Dec―05 148. Single-amplicon, Multiplex Real-time RT-PCR with Tiled Probes to Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern Maxwell Su, Katherine S Immergluck, Samuel Stampfer, Anuradha Rao, Leda Bassitt, Vi Nguyen, et al. (+8)
1988 [GO] 2021―Dec―05 583. SARS-CoV-2 Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians Maria Lopera, Romina Vera, Carlos Tapia, Carlos Cabrera, Jose Gonzales-Zamora, jorge Alave
1989 [GO] 2021―Dec―05 383. Feasibility of Specimen Self-collection in Young Children Undergoing SARS-CoV-2 Surveillance for In-person Learning Jonathan Altamirano, Grace Tam, Marcela Lopez, India Robinson, Leanne Chun, Nuzhat Shaikh, et al. (+11)
1990 [GO] 2021―Dec―05 384. SARS-CoV-2 Surveillance Testing Patterns among Hospitalized Pediatric Patients in a Single Academic Medical Center Areej Bukhari, Jessica Seidelman, Becky A Smith, Sarah S Lewis, Michael J Smith, Rebekah W Moehring, et al. (+2)
1991 [GO] 2021―Dec―05 400. Impact of SARS-CoV-2 Test-based Strategy to Reduce Quarantine Days Among Asymptomatic Healthcare Workers After Household Exposure Bhagyashri D Navalkele, Jose Lucar, James B Brock, Jason Parham
1992 [GO] 2021―Dec―05 379. Abstract For Comparison of Mandatory vs Non-Mandatory Compliance Rates For SARS-CoV-2 Testing in Grades K-12 Jennifer Veltman, Philip Papayanis, Alex Dubov
1993 [GO] 2021―Dec―05 362. Saliva as a Reliable Sample Type for Mass SARS-CoV-2 Testing Strategies Anne Wyllie, Chantal B Vogels, Orchid M Allicock, Anne Watkins, Mary Petrone, Devyn Yolda-Carr, et al. (+8)
1994 [GO] 2021―Dec―05 369. Alternative Workflow for SARS-CoV-2 Testing Using a Heat Lysis Protocol for Respiratory Specimens Meghna Yadav, Tiffany Martinez, Isabel Regoli, Osvaldo Hernandez, Phuong Le, Heather Carolan, et al. (+2)
1995 [GO] 2021―Dec―05 LB9. Longitudinal antibody dynamics in children infected with SARS-CoV-2 through 6 months post-infection Lauren E Gentles, Leanne P Kehoe, Katharine D Crawford, Kirsten Lacombe, Jane Dickerson, Joanna H Yuan, et al. (+7)
1996 [GO] 2021―Dec―05 509. Clinical Characteristics and Outcomes in Patients Infected with SARS-CoV-2 Treated with Remdesivir, Tocilizumab, and/or Dexamethasone at a Mid-Atlantic Hospital Consortium Nellie Darling, Kristen R Kent, Gavin Clark, Xue Geng, Marybeth Kazanas, Princy N Kumar, Joseph G Timpone
1997 [GO] 2021―Dec―05 1172. SARS-CoV-2 Vaccine Hesitancy in Caregivers of Hospitalized Children Marisa Orbea, Rachel Cunningham, C Mary Healy, Julie A Boom, Claire Bocchini
1998 [GO] 2021―Dec―05 520. Pharmacokinetic and Safety Phase 1 Study and Microneutralization Assay Results with BRII-196/BRII-198, a Novel Antibody Cocktail Active Against a Wide Range of SARS-CoV-2 Variants David A Margolis, Fujie Zhang, Xiaohua Hao, Yanyan Li, Mingming Wang, Chunming Li, et al. (+4)
1999 [GO] 2021―Dec―05 578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants Viviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, Jared Tur, Charles C Reed, Richa Kalia, et al. (+18)
2000 [GO] 2021―Dec―05 543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical Studies Jay Grobler, Julie Strizki, Nicholas Murgolo, Wei Gao, Youfang Cao, Ying Zhang, et al. (+7)
 [1]  [2] [ Next > ]

2635 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.298 sec